ANTI-BACTERIAL METHODS AND MATERIALS

Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel S. aureus mutants useful in vaccines.

Description: ANTI-BACTERIAL METHODS AND MATERIALS The invention relates generally to the identification of genes responsible for the virulence of Staphylococcus bacteria, thereby allowing the identification of new anti-bacterial agents that target these virulence genes and their products and the provision of novel S. aureus mutants useful in vaccines. BACKGROUND OF THE INVENTION The staphylococci, of which Staphylococcus aureus is the most important human pathogen, are hardy, gram-positive bacteria that colonize the skin of most humans. Staphylococcal strains that produce coagulase are designated S. aureus; other clinically important coagulase-negative staphylococci are S. epidermidis and S. saprophyticus . When the skin or mucous membrane barriers are disrupted, staphylococci can cause localized and superficial infections that are commonly harmless and self-limiting. However, when staphylococci invade the lymphatics and the blood, potentially serious complications may result, such as bacteremia, septic shock, and serious metastatic infections, including endocarditis, arthritis, osteomyelitis, pneumonia and abscesses in virtually any organ. Certain strains of S. aureus produce toxins that cause skin rashes, food poisoning, or multisystem dysfunction (as in toxic shock syndrome). 5". aureus and S. epidermidis together have become the most common cause of nosocomial non-urinary tract infection in U.S. hospitals. They are the most frequently isolated pathogens in both primary and secondary bacteremias and in cutaneous and surgical wound infections. See generally Harrison 's Principles of Internal Medicine, 13th ed., Isselbacher et al., eds., McGraw-Hill, New York (1994), particularly pages 611-617. Transient colonization of the nose by S. aureus is seen in 70 to 90 percent of people, of which 20 to 30 percent carry the bacteria for relatively prolonged periods of time. Independent colonization of the perineal area occurs in 5 to 20 percent of people. Higher carriage rates of S. aureus have been documented in persons with atopic dermatitis, hospital employees, hospitalized patients, patients whose care requires frequent puncture of the skin, and intravenous drug abusers. Infection by staphylococci usually results from a combination of bacterial virulence factors and a diminution in host defenses. Important microbial factors include the ability of the staphylococcus to survive under harsh conditions, its cell wall constituents, the production of enzymes and toxins that promote tissue invasion, its capacity to persist intracellularly in certain phagocytes, and its potential to acquire resistance to antimicrobials. Important host factors include an intact mucocutaneous barrier, an adequate number of functional neutrophils, and removal of foreign bodies or dead tissue. Cell wall components of S. aureus include a large peptidoglycan complex that confers rigidity on the organism and enables it to survive under unfavorable osmotic conditions, a unique teichoic acid linked to peptidoglycan, and protein A, which is found both attached to peptidoglycan over the outermost parts of the cell and released in soluble form. Proteins designated femA and femB are involved in the formation of cell wall peptidoglycan pentaglycine cross-bridges and are factors in methicillin resistance. [Berger-Bachi et al. , Mol. Gen. Genet., 279:263-269 (1989).] S. aureus also has specific receptors for laminin and fibronectin that may mediate the organism's spread through the bloodstream to other tissues. Both peptidoglycan and teichoic acid are capable of activating the complement cascade via the alternative pathway. S. aureus also appears to activate tissue factor in the coagulation pathway. Certain enzymes produced by S. aureus may play a role in virulence. Catalase degrades hydrogen peroxide and may protect the organism during phagocytosis. Coagulase is present in both soluble and cell-bound forms and causes plasma to clot by formation of thrombin-like material. The high correlation between coagulase production and virulence suggests that this substance is important in the pathogenesis of staphylococcal infections, but its precise role as a determinant of pathogenicity has not been determined. Many strains also produce hyaluronidase, an enzyme that degrades hyaluronic acid in the connective tissue matrix and that may promote spreading of infection. A trypsin-like protease from some strains enhances influenza virus infection by proteolytic cleavage of the viral precursor hemagglutinin into its active fragments and may contribute to the morbidity of such coinfections. S. aureus produces numerous extracellular exotoxins that have been implicated in disease processes. The exfoliatin toxins A and B, the staphylococcal enterotoxins, and the toxic shock syndrome toxin, TSST-1, belong to the growing family of microbial superantigens that activate T cells and monocytes/macrophages, resulting in the production of cytokines that mediate local or systemic effects depending on the amount of toxin formed, the immune status of the host, and the access of the toxin to the circulation. The exfoliatin toxins mediate the dermatologic manifestations of the staphylococcal scalded- skin syndrome and bullous impetigo. These toxins cause intraepidermal cleavage of the skin at the stratum granulosum, leading to bullae formation and denudation. Seven distinct enterotoxins (A, B, Cl, C2, C3, D, and E) have been implicated in food poisoning due to S. aureus. These toxins enhance intestinal peristalsis and appear to induce vomiting by a direct effect on the central nervous system. Toxic shock syndrome (TSS) is most commonly mediated by TSST-1, which is present in 5 to 25 percent of clinical isolates of S. aureus. TSS is also mediated less frequently by enterotoxin B and, rarely, enterotoxin Cl . S. aureus produces other toxins whose role in virulence is incompletely understood. Four different red blood cell hemolysins, which are designated alpha, beta, gamma, and delta toxins, have been identified. Alpha toxin also causes necrosis of the skin when injected subcutaneously into animals, while delta toxin also inhibits water absorption in the intestines and may play a role in the acute watery diarrhea seen in some cases of staphylococcal infection. Leukocidin lyses granulocyte and macrophage membranes by producing membrane pores permeable to cations. The agr, xpr, sae and sar genes have been identified as being involved in the regulation of staphylococcal exotoxins. See U.S. Patent No. 5,587,228 and International Patent Publication Nos. WO 96/10579 and WO 97/11690. Of interest is the report in WO 97/11690 of screening for inhibitors of these regulatory systems. Staphylococci can invade the skin or mucosa through plugged hair follicles and sebaceous glands or areas traumatized by burns, wounds, abrasions, insect bites, or dermatitis. Staphylococci often colonize prosthetic devices and intravenous catheters; S. aureus infection of the vascular access site is a major cause of morbidity and death among patients on hemodialysis. Colonization and invasion of the lungs may occur with endotracheal intubation, or when the lungs' clearance mechanisms are depressed, e.g. , after viral infections, after aspiration, or in patients with cystic fibrosis. Mucosal damage to the gastrointestinal tract following cytotoxic chemotherapy or radiotherapy predisposes to invasion from that site. Once the skin or mucosa have been breached, local bacterial multiplication is accompanied by inflammation, neutrophil accumulation, tissue necrosis, thrombosis and fibrin deposition at the site of infection. Later, fibroblasts create a relatively avascular wall about the area. When host mechanisms fail to contain the cutaneous or submucosal infection, staphylococci may enter the lymphatics and the bloodstream. Common sites of metastatic spread include the lungs, kidneys, cardiac valves, myocardium, liver, spleen, bones and brain. Bacteremia due to S. aureus may arise from any local infection, at either extravascular (cutaneous infections, burns, cellulitis, osteomyelitis, arthritis) or intravascular foci (intravenous catheters, dialysis access sites, intravenous drug abuse). Rarely, patients with bacteremia die within 12 to 24 hours with high fever, tachycardia, cyanosis, and vascular collapse. Disseminated intravascular coagulation may produce a disease mimicking meningococcemia. Commonly, the disease progresses more slowly, with hectic fever and metastatic abscess formation. A major complication of S. aureus bacteremia is endocarditis. S. aureus is the second most common cause of endocarditis and the most common cause among drug addicts. The disease is typically acute, with high fever, progressive anemia, and frequent embolic and extracardiac septic complications. Valve ring and myocardial abscesses are common. The mortality rate is 20 to 30 percent. Staphylococcal scalded-skin syndrome (SSSS) is a generalized exfoliative dermatitis that is a complication of infection by exfoliatin toxin- producing strains of S. aureus. The disease typically occurs in newborns (Ritter's disease) and in children under the age of five. A scarlatiniform rash begins in the perioral area, becomes generalized over the trunk and extremities, and finally desquamates. The disease may consist of rash alone (staphylococcal scarlet fever), or large, flaccid bullae develop that may be localized (more common in adults) or generalized. The bullae burst, resulting in red, denuded skin resembling a burn. Most adults with SSSS are immunosuppressed or have renal insufficiency. Blood cultures are frequently positive, and mortality is significant. Toxic shock syndrome (TSS) is a multisystem disease mediated by toxins (generally TSST-1 , and less frequently enterotoxins B and Cl) produced by certain strains of S. aureus. It was first described in children, but in 1980 became epidemic among young women, with onset during menstruation. The diagnosis of TSS is based on clinical criteria that include high fever, a diffuse rash that desquamates on the palms and soles over the subsequent one or two weeks, hypotension that may be orthostatic, and evidence of involvement in three or more organ systems. Such involvement commonly includes gastrointestinal dysfunction (vomiting or diarrhea), renal or hepatic insufficiency, mucous membrane hyperemia, thrombocytopenia, myalgias with elevated creatine phosphokinase (CK) levels, and disorientation with a normal cerebrospinal fluid examination. The mortality rate of TSS is three percent. S. aureus causes approximately three percent of community- acquired bacterial pneumonias. This disease occurs sporadically except during influenza outbreaks, when staphylococcal pneumonia is relatively more common, although still less frequent than pneumococcal pneumonia. Primary staphylococcal pneumonia in infants and children frequently presents with high fever and cough. Multiple thin- walled abscesses are seen on the chest X-ray, and empyema formation is common. In older children and healthy adults, staphylococcal pneumonia is generally preceded by an influenza-like respiratory infection. Onset of staphylococcal involvement is abrupt, with chills, high fever, progressive dyspnea, cyanosis, cough, pleural pain, and sometimes bloody sputum. Staphylococcal pneumonia is seen more frequently in patients with cystic fibrosis, in intubated patients in intensive care units and in debilitated patients who are prone to aspiration. S. aureus is responsible for the majority of cases of acute osteomyelitis. Although the disease is most common in people under the age of 20, it is becoming increasingly prevalent in adults over 50, particularly with involvement of the spine. A primary portal of entry is frequently not identified, although many patients give a history of preceding trauma to the involved area. Once established, infection spreads through the bone to the periosteum or along the marrow cavity. Rarely, the joint capsule is penetrated, producing pyogenic arthritis. Osteomyelitis in children may present as an acute process beginning abruptly with chills, high fever, nausea, vomiting, and progressive pain at the site of bony involvement. S. aureus causes 1 to 9 percent of cases of bacterial meningitis and 10 to 15 percent of brain abscesses. Most commonly, the bacteria are spread from a focus outside the central nervous system, typically from infective endocarditis, by extension from a paraspinal or parameningeal abscess, or by nosocomial infection following neurosurgical procedures. Over 50 percent of epidural abscesses are due to S. aureus; up to half of these cases may be associated with vertebral osteomyelitis. Patients present with either acute or chronic back pain, usually with low-grade fever and malaise. The onset of radicular pain is an ominous sign that the disease may progress to neurologic dysfunction and ultimate paralysis. Antimicrobial resistance by staphylococci favors their persistence in the hospital environment. Over 90 perceni of both hospital and community strains of S. aureus causing infection are resistant to penicillin. This resistance is due to the production of β-lactamases enzymes; the genes for these enzymes are usually carried by plasmids. Infections due to organisms with such acquired resistance can sometimes be treated with penicillinase-resistant β-lactam antimicrobial agents. However, the true penicillinase-resistant S. aureus organisms, called methicillin-resistant S. aureus (MRS A), are resistant to all the β-lactam antimicrobials as well as the cephalosporins. MRSA resistance is chromosomally mediated and involves production of an altered penicillin-binding protein (PBP 2a or PBP 2') with a low binding affinity for β-lactams. MRSA frequently also have acquired plasmids mediating resistance to erythromycin, tetracycline, chloramphenicol, clindamycin, and aminoglycosides. MRSA have become increasingly common worldwide, particularly in tertiary-care referral hospitals. In the United States, approximately 5 percent of hospital isolates of S. aureus are methicillin-resistant. Thus, there continues to exist a need for new agents useful for treating bacterial infections, particularly those caused by antibiotic-resistant bacteria, and for methods of identifying such new agents. Such methods ideally would identify agents that are unrelated to existing antimicrobials and that target different aspects of staphylococcal invasion of and replication in the host, compared to existing antimicrobials. SUMMARY OF THE INVENTION The present invention relates generally to the identification of genes responsible for the virulence of Staphylococcus bacteria, thereby allowing the identification of new anti-bacterial agents that target these virulence genes and their products and the provision of novel S. aureus mutants useful in vaccines. According to one aspect of the present invention, methods are provided for identifying anti-bacterial agents that target the function of staphylococcal virulence genes or gene products. Such methods include assaying potential agents for the ability to interfere with expression of virulence gene products represented by the DNA sequences set forth in any one of SEQ ID NOS: 1 through 94, or assaying potential agents for the ability to interfere with the function of a bacterial protein encoded in whole or in part by a DNA sequence set forth in any one of SEQ ID NOS: 1 through 94 or the complementary strand thereof, followed by identifying agents that are positive in such assays. The use of a number of different assays is contemplated according to this aspect of the invention. When the function of the virulence gene product is known or predicted by sequence similarity to a known gene product, potential inhibitors can be screened in enzymatic or other types of assays keyed to the function of the gene product. When the virulence gene product is known or predicted by sequence similarity to a known gene product to interact with another protein or nucleic acid, inhibitors of this interaction can be screened directly in binding assays or using the two-hybrid assay. Other assays may be used when a ligand for the virulence gene product is not known, including two- hybrid screening assays that identify gene products that interact with target protein, assays that identify ligands of target protein through measuring of direct binding of test ligand to target protein, and assays that identify ligands of target proteins through affinity ultrafiltration with ion spray mass spectroscopy/HPLC methods or other physical and analytical methods. In another aspect of this invention, methods are provided for assaying potential agents for the ability to interfere with expression of or function of virulence gene products, wherein the virulence genes encoding these products are obtainable by identification through signature-tagged mutagenesis as defined herein and exemplified in Example 1. According to a further aspect of this invention, novel antibacterial agents identified by the methods described herein are provided, as well as methods for treating a subject suffering from infection with staphylococci involving administration of such novel anti-bacterial agents. In particular, agents that interfere with the expression of virulence gene products include antisense polynucleotides that are complementary to the virulence gene sequences. Agents that interfere with the function of virulence gene products include variants of virulence gene products, ligands of these virulence gene products and variants thereof, and enzyme inhibitors (where the product is an enzyme). Yet a further aspect of this invention provides Staphylococcus aureus organisms containing a functional mutation in a gene represented by any one of SEQ ID NOS: 1 through 94, said functional mutation resulting in a reduction in virulence of the organism. Also contemplated are vaccine compositions comprising such mutated S. aureus organisms, optionally comprising a suitable adjuvant and a pharmaceutically acceptable diluent or carrier. Numerous additional aspects and advantages of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of the invention which describes presently prepared embodiments thereof. DETAILED DESCRIPTION OF THE INVENTION "Virulence genes," as used herein, are genes whose function or products are required for successful establishment and/or maintenance of bacterial infection in a host animal. Thus, virulence genes and/or the proteins encoded thereby are involved in pathogenesis in the host organism, but may not be necessary for growth in vitro. Since antibiotics are typically screened in vitro, identification of these in vivo virulence genes provides a means for discovering new antimicrobials with different targets and mechanisms of action compared to existing antibiotics. There may be 50 to 100 virulence genes in S. aureus [see Groisman and Ochman, Trends Microbiol. Sci., 2:289-294 (1984) (discussing Salmonella virulence genes); Muhldorfer and Hacker, Microb. Pathogenesis, 16: 171-181 (1994) (discussing E. coli virulence genes). "Signature-tagged mutagenesis," as used herein, is a method generally described in International Patent Publication No. WO 96/17951, incorporated herein by reference, and includes, for example, a method for identifying S. aureus genes required for virulence in a murine model of bacteremia. In this method, each insertional mutation carries a different DNA signature tag which allows mutants to be differentiated from each other. The tags comprise 40-bp variable central regions flanked by invariant "arms" of 20-bp which allow the central portions to be co-amplified by polymerase chain reaction (PCR). Tagged mutant strains are assembled in microtitre dishes, then combined to form the "inoculum pool" for infection studies. At an appropriate time after inoculation, bacteria are isolated from the animal and pooled to form the "recovered pool. " The tags in the recovered pool and the tags in the inoculum pool are separately amplified, labelled, and then used to probe filters arrayed with the different tags representing the mutants in the inoculum. Mutants with attenuated virulence are those with tags that give hybridization signals when probed with tags from the inoculum pool but not when probed with tags from the recovered pool. Signature-tagged mutagenesis allows a large number of insertional mutant strains to be screened simultaneously in a single animal for loss of virulence. Screening thirteen pools of 96 mutant S. aureus strains resulted in the identification of 50 strains with reduced virulence, many of which were confirmed to be attenuated in virulence by subsequent analysis of individual mutants. The nucleotide sequences of the regions flanking the transposon insertion points of these mutants were analyzed by searching DNA and protein sequence databases to identify the genes inactivated by the insertion of the transposon. On the basis of these searches many of the virulence genes may be grouped into different classes. The first class encodes proteins involved in cell surface metabolism {e.g. , P2C73, P11C29, P13C83, P9B65, P10B89). Both femA and femB, which are involved in the formation of cell wall peptidoglycan pentaglycine cross bridges, were identified as virulence genes. Mutant P2C73 contains a transposon insertion in a previously unknown gene that shares significant similarity to femB. Mutant P14C15 contains a transposon insertion in a gene whose product is similar to aspartate semialdehyde dehydrogenase (Asd) from different bacteria, with the highest level of similarity to Asd from Bacillus subtilis. Asd is a key enzyme in the biosynthesis of methionine, threonine, isoleucine, lysine and diaminopimelic acid (DAP), which is an important component of cell wall peptidoglycan. The second class encodes enzymes involved in cellular biosynthetic pathways {e.g. , P9B74, P5C4, P9B66, P14C15, P13B26, P7C18, P15C31, P10B18, P6B18, P10B66, P10C34, P12C3). Deduced protein products of two genes (mutants P7C18 and P13B26) show strong similarity to B. subtilis LysA and ThrB. These enzymes, like Asd, are involved in aspartate metabolism. LysA is diaminopimelate decarboxylase, which converts diaminopimelate to lysine, and ThrB phosphorylates homoserine before conversion into threonine. Transposon insertions were also obtained in genes homologous to Methanococcus jannaschii trpA, Lactococcus lactis trpB and L. lactis trpD. These genes encode enzymes of the tryptophan biosynthetic pathway: the alpha chain of tryptophan synthetase, the beta chain of tryptophan synthetase, and anthranilate phosphoribosyltransferase, respectively. The gene mutated in P15C31 is a homolog of L. lactis purL encoding phosphoribosylformylglycinamidine decarboxylase, an enzyme of the purine biosynthetic pathway. Mutant P9B66 contains an insertion in a gene whose product is similar to peptide methionine sulphoxide reductases. A third class of genes are those encoding components of the TCA cycle {e.g. , mutants P4C27, P4C52, P10B2, P10C20, P12C32). Strains P10B2 and P12C32 carry mutations in genes for a subunit of the oxoglutarate dehydrogenase complex and aconitase, respectively. The fourth class is composed of genes whose products are similar to a oligopeptide transport proteins of the ATP-binding cassette (ABC) transporter superfamily {e.g. , mutants P7C26, P10C15, P5C3, P11C66, P5C34). Oligopeptide transport is important for peptide utilization and the proteolytic system in lactococci. In Group A streptococci, Opp proteins are involved not only in obtaining nutrients but also in adherence, protease production and processing of secreted proteins. The fifth class of genes are involved in cellular regulatory and repair processes {e.g. , mutants P4C15, P13B74, P13C72, P10B30, P6C63, P14B25). Mutant P4C15 and P6C63 contain insertions in S. aureus MarR/LuxR-like regulatory proteins. MarR and LuxR belong to a family of transcription regulators and these MarR/LuxR-like proteins likely have a similar function in S. aureus. In Streptococcus pneumoniae, Neisseria gonorrhoeae and Escherichia coli this enzyme helps to maintain surface adhesins in their functional oxidative state. Mutant P10B30 is associated with a transposon insertion in a gene with a product similar to the ATP-dependent Clp protease of E. coli. The Clp stress response system for intracellular protein degradation is widely conserved in bacteria and components of the system are important for virulence of Listeria monocytogenes and S. typhimurium. Mutants P13B74 and P13C72 have stem-loop termination sequences which possibly function in transcription termination. The identification of these genes as virulence genes renders them useful in methods of identifying new anti-bacterial agents according to the present invention. Such methods include assaying potential agents for the ability to interfere with expression of virulence gene products represented by the DNA sequences set forth in any one of SEQ ID NOS: 1 through 94 {i.e. , the genes represented by DNA sequences of SEQ ID NOS: 1 through 94 encode the virulence gene product, or the DNA sequences of SEQ ID NOS: 1 through 94 are adjacent to the gene encoding the virulence gene product, or are involved in regulation of expression of the virulence gene product), or assaying potential agents for the ability to interfere with the function of a bacterial protein encoded in whole or in part by a DNA sequence set forth in any one of SEQ ID NOS: 1 through 94 or the complementary strand thereof, followed by identifying agents that are positive in such assays. Polynucleotides and polypeptides useful in these assays include not only the genes and encoded polypeptides as disclosed herein, but also variants thereof that have substantially the same activity as the wild-type genes and polypeptides. "Variants," as used herein, includes polynucleotides or polypeptides which contain one or more deletions, insertions or substitutions, as long as the variant retains substantially the same activity of the wild-type polynucleotide or polypeptide. With regard to polypeptides, deletion variants are contemplated to include fragments lacking portions of the polypeptide not essential for biological activity, and insertion variants are contemplated to include fusion polypeptides in which the wild-type polypeptide or fragment thereof have been fused to another polypeptide. The virulence genes may be cloned by PCR, using S. aureus genomic DNA as the template. For ease of inserting the gene into expression vectors, PCR primers are chosen so that the PCR-amplified gene has a restriction enzyme site at the 5' end preceding the initiation codon ATG, and a restriction enzyme site at the 3' end after the termination codon TAG, TGA or TAA. If desirable, the codons in the gene are changed, without changing the amino acids, according to E. coli codon preference described by Grosjean and Fiers, Gene, 75: 199-209 (1982), and Konigsberg and Godson, Proc. Natl. Acad. Sci. (USA), 50:687-691 (1983). Optimization of codon usage may lead to an increase in the expression of the gene product when produced in E. coli. If the gene product is to be produced extracellularly, either in the periplasm of E. coli or other bacteria, or into the cell culture medium, the gene is cloned without its initiation codon and placed into an expression vector behind a signal sequence. For example, cloning and expression of the femA gene is described in Example 3 below. To simplify the protein purification process, a purification tag may be added either at the 5' or 3' end of the gene coding sequence. Commonly used purification tags include a stretch of six histidine residues (U.S. Patent Nos. 5,284,933 and 5,310,663), a streptavidin-affinity tag described by Schmidt and Skerra, Protein Engineering, 6: 109-122 (1993), a FLAG peptide [Hopp et al , Biotechnology, 6: 1205-1210 (1988)], glutathione S-transferase [Smith and Johnson, Gene, 67:31-40 (1988)], and thioredoxin [LaVallie et al , Bio/Technology, 77: 187-193 (1993)]. To remove these peptide or polypeptides, a proteolytic cleavage recognition site may be inserted at the fusion junction. Commonly used proteases are factor Xa, thrombin, and enterokinase. Proteins are produced in any number of well-known prokaryotic or eukaryotic expression systems using known promoters, vectors, and hosts. Any suitable host cell may be used for expression of the gene product, such as E. coli, other bacteria, including Bacillus and S. aureus, yeast, including Pichia pastoris and Saccharomyces cerevisiae, insect cells, or mammalian cells, including CHO cells, utilizing suitable vectors known in the art. Proteins may be produced directly or fused to a peptide or polypeptide, and either intracellularly or extracellularly by secretion into the periplasmic space of a bacterial cell or into the cell culture medium. Secretion of a protein requires a signal peptide (also known as pre-sequence); a number of signal sequences from prokaryotes and eukaryotes are known to function for the secretion of recombinant proteins. During the protein secretion process, the signal peptide is removed by signal peptidase to yield the mature protein. The virulence gene products produced by the methods described above are used in high throughput assays to screen for inhibitory agents. The sources for potential agents to be screened are chemical compound libraries, fermentation media of Streptomycetes, other bacteria and fungi, and cell extracts of plants and other vegetations. For proteins with known enzymatic activity, assays are established based on the activity, and a large number of potential agents are screened for ability to inhibit the activity. For proteins that interact with another protein or nucleic acid, binding assays are established to measure such interaction directly, and the potential agents are screened for ability to inhibit the binding interaction. Alternatively, such binding interactions are evaluated indirectly using the yeast two-hybrid system described in Fields and Song, Nature, 340:245-246 (1989), and Fields and Sternglanz, Trends in Genetics, 70:286-292 (1994), both of which are incorporated herein by reference. The two-hybrid system is a genetic assay for detecting interactions between two proteins or polypeptides. It can be used to identify proteins that bind to a known protein of interest, or to delineate domains or residues critical for an interaction. Variations on this methodology have been developed to clone genes that encode DNA-binding proteins, to identify peptides that bind to a protein, and to screen for drugs. The two-hybrid system exploits the ability of a pair of interacting proteins to bring a transcription activation domain into close proximity with a DNA-binding domain that binds to an upstream activation sequence (UAS) of a reporter gene, and is generally performed in yeast. The assay requires the construction of two hybrid genes encoding (1) a DNA-binding domain that is fused to a protein X, and (2) an activation domain fused to a protein Y. The DNA-binding domain targets the first hybrid protein to the UAS of the reporter gene; however, because most proteins lack an activation domain, this DNA- binding hybrid protein does not activate transcription of the reporter gene. The second hybrid protein, which contains the activation domain, cannot by itself activate expression of the reporter gene because it does not bind the UAS. However, when both hybrid proteins are present, the noncovalent interaction of protein X and protein Y tethers the activation domain to the UAS, activating transcription of the reporter gene. When the virulence gene product (protein X, for example) is already known to interact with another protein or nucleic acid (protein Y, for example), this assay can be used to detect agents that interfere with the interaction of X and Y. Expression of the reporter gene is monitored as different test agents are added to the system; the presence of an inhibitory agent results in lack of a reporter signal. When the function of the virulence gene product is unknown and no ligands are known to bind the gene product, the yeast two-hybrid assay can also be used to identify proteins that bind to the gene product. In an assay to identify proteins that bind to protein X (the target protein), a large number of hybrid genes each containing a different protein Y are produced and screened in the assay. Typically, Y is encoded by a pool of plasmids in which total cDNA or genomic DNA is ligated to the activation domain. This system is applicable to a wide variety of proteins, and it is not even necessary to know the identity or function of protein Y. The system is highly sensitive and can detect interactions not revealed by other methods; even transient interactions may trigger transcription to produce a stable mRNA that can be repeatedly translated to yield the reporter protein. Other assays may be used to search for agents that bind to the target protein. One such screening method to identify direct binding of test ligands to a target protein is described in U.S. Patent No. 5,585,277, incorporated herein by reference. This method relies on the principle that proteins generally exist as a mixture of folded and unfolded states, and continually alternate between the two states. When a test ligand binds to the folded form of a target protein (i.e., when the test ligand is a ligand of the target protein), the target protein molecule bound by the ligand remains in its folded state. Thus, the folded target protein is present to a greater extent in the presence of a test ligand which binds the target protein, than in the absence of a ligand. Binding of the ligand to the target protein can be determined by any method which distinguishes between the folded and unfolded states of the target protein. The function of the target protein need not be known in order for this assay to be performed. Virtually any agent can be assessed by this method as a test ligand, including, but not limited to, metals, polypeptides, proteins, lipids, poly sacchar ides, polynucleotides and small organic molecules. For example, use of femA in this method of screening for potential ligands is described in Example 3 below. Another method for identifying ligands for a target protein is described in Wieboldt et al , Anal. Chem., 69: 1683-1691 (1997), incorporated herein by reference. This technique screens combinatorial libraries of 20-30 agents at a time in solution phase for binding to the target protein. Agents that bind to the target protein are separated from other library components by centrifugal ultrafiltration. The specifically selected molecules that are retained on the filter are subsequently liberated from the target protein and analyzed by HPLC and pneumatically assisted electrospray (ion spray) ionization mass spectroscopy. This procedure selects library components with the greatest affinity for the target protein, and is particularly useful for small molecule libraries. The inhibitors/binders identified by the initial screens are evaluated for their effect on virulence in in vivo mouse models of S. aureus infections. Models of bacteremia, endocarditis, septic arthritis, soft tissue abscess or pneumonia may be utilized. Inhibitors/binders that interfere with bacterial virulence are capable of preventing the establishment of an infection or reversing the outcome of an infection once it is established. The identification of S. aureus virulence genes also provides for microorganisms exhibiting reduced virulence, which are useful in vaccines. Such microorganisms include the S. aureus mutants generated in Example 1 below and other S. aureus mutants containing at least one functional mutation in a gene represented by any one of SEQ ID NOS: 1 through 94. The reduced virulence of these organisms and their immunogenicity may be confirmed by administration to a subject. While it is possible for an avirulent microorganism of the invention to be administered alone, one or more of such mutant microorganisms are preferably administered in a vaccine composition containing suitable adjuvant(s) and pharmaceutically acceptable diluent(s) or carrier(s). The carrier (s) must be "acceptable" in the sense of being compatible with the avirulent microorganism of the invention and not deleterious to the subject to be immunized. Typically, the carriers will be water or saline which will be sterile and pyrogen free. The subject to be immunized is a subject needing protection from a disease caused by a virulent form of S. aureus. Any adjuvant known in the art may be used in the vaccine composition, including oil-based adjuvants such as Freund's Complete Adjuvant and Freund's Incomplete Adjuvant, mycolate-based adjuvants {e.g., trehalose dimycolate), bacterial lipopolysaccharide (LPS), peptidoglycans {i.e., mureins, mucopeptides, or glycoproteins such as N-Opaca, muramyl dipeptide [MDP], or MDP analogs), proteoglycans {e.g., extracted from Klebsiella pneumoniae), streptococcal preparations (e.g., OK432), Biostim™ (e.g., 01K2), the "Iscoms" of EP 109 942, EP 180 564 and EP 231 039, aluminum hydroxide, saponin, DEAE-dextran, neutral oils (such as miglyol), vegetable oils (such as arachis oil), liposomes, Pluronic® polyols or the Ribi adjuvant system (see, for example GB-A-2 189 141). Recently, an alternative adjuvant consisting of extracts of Amycolata, a bacterial genus in the order Actinomycetales, has been described in U.S. Patent No. 4,877,612. Additionally, proprietary adjuvant mixtures are commercially available. The adjuvant used will depend, in part, on the recipient organism. The amount of adjuvant to administer will depend on the type and size of animal. Optimal dosages may be readily determined by routine methods. The vaccine compositions optionally may include pharmaceutically acceptable (i.e., sterile and non-toxic) liquid, semisolid, or solid diluents that serve as pharmaceutical vehicles, excipients, or media. Any diluent known in the art may be used. Exemplary diluents include, but are not limited to, polyoxyethylene sorbitan monolaurate, magnesium stearate, methyl- and propylhydroxybenzoate, talc, alginates, starches, lactose, sucrose, dextrose, sorbitol, mannitol, gum acacia, calcium phosphate, mineral oil, cocoa butter, and oil of theobroma. The vaccine compositions can be packaged in forms convenient for delivery. The compositions can be enclosed within a capsule, sachet, cachet, gelatin, paper or other container. These delivery forms are preferred when compatible with entry of the immunogenic composition into the recipient organism and, particularly, when the immunogenic composition is being delivered in unit dose form. The dosage units can be packaged, e.g., in tablets, capsules, suppositories or cachets. The vaccine compositions may be introduced into the subject to be immunized by any conventional method including, e.g., by intravenous, intradermal, intramuscular, intramammary, intraperitoneal, or subcutaneous injection; by oral, sublingual, nasal, anal, vaginal, or transdermal delivery; or by surgical implantation, e.g., embedded under the splenic capsule or in the cornea. The treatment may consist of a single dose or a plurality of doses over a period of time. It will be appreciated that the vaccine of the invention may be useful in the fields of human medicine and veterinary medicine. Thus, the subject to be immunized may be a human or an animal, for example, cows, sheep, pigs, horses, dogs and cats, and poultry such as chickens, turkeys, ducks and geese. Other aspects and advantages of the present invention will be understood upon consideration of the following illustrative examples. Example 1 addresses identification of S. aureus genes associated with virulence by generating S. aureus mutants that contain a chromosomal insertion of a signature-tagged transposon and identifying the mutants with reduced virulence. Example 2 addresses confirmation of the attenuated virulence of individual mutants. Example 3 addresses use of the virulence genes and gene products in assays for screening potential agents for anti-bacterial activity. Figure legends Fig. 1. A. Map of svr and plasmids for complementation. Sites for restriction enzymes are indicated (A, Alul; E, EcoRl; P, Pst I). B. Deduced amino acid sequence of the Svr protein. C. Southern hybridization of chromosomal DNA. DNAwas extracted from S. aureus strains RN6390, Newman, Wood 46, ID401 and ID402 and digested with H dIII. The digested DNA was separated by agarose gel electrophoresis. transferred onto nylon membrane and probed with 2p-labeled S vr gene. Fig.2. Phenotypic analysis of P6C63. A. Production of α-, β- and δ- toxins. S. aureus strains were streaked onto rabbit blood agar plate (for α-toxin), sheep blood agar plates (for β-toxin) and horse blood agar plates (for δ-toxin) culture overnight. Halos surrounding bacterial colonies are indicative of toxin activity. B. Western immunoblot of protein A. Whole cell proteins were extracted from each strain and equal amounts were separated by SDS-PAGE electrophoresis followed by Western immunoblotting with anti-protein A monoclonal antibody. C. Protein samples in (B) detected by PAGE and Coomassie Blue staining. Fig. 3. In vivo survival kinetics of bacterial strains. Two groups of mice were infected i.p. with 1x10^ cfu of S. aureus wild-type strain RN6390 or svr mutant P6C63. At 6, 24, 48, 72, 96 and 120 hours post-inoculation, two mice/group were killed and the number of bacterial cfu/spleen was determined. Data are the mean + standard deviations at each time point. Fig. 4. A. RT-PCR analysis of svr transcripts in strains RN6390, RN6911 and P6C63. Total RNA isolated from lθ" cfu of post-exponential phase growth S. aureus strains. RT-PCR was performed using two primers that amplify a 200 bp region within the svr gene. B and C. Northern blot analysis. Total RNA was isolated from 10^ cfu of post-exponential phase growth 5". aureus strains RN6390, RN6911, P6C63 and complemented strain P6C63(pID437). RNA was separated by 1.5% agarose-0.66M formaldehyde gel electrophoresis, transferred to a nylon membrane and probed with 32p-i a b e n ec i genes as indicated. EXAMPLE 1 Identification of S. aureus genes associated with virulence S. aureus genes associated with virulence were identified by signature-tagged mutagenesis as follows, generally according to International Patent Publication No. WO 96/17951 and Hensel et al , Science, 269:400-403 (1995). A. Construction of Plasmid pID408 A temperature-sensitive shuttle plasmid pID408 was constructed for use in transferring the signature-tagged transposons into S. aureus. DNA restriction digestions and ligations were performed as described by Sambrook et al , Molecular cloning: a laboratory manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989). A 6.5 kb BarriΑl fragment of pTV32ts [described in Youngman, in Plasmids: a practical approach, K. Hard, ed., Oxford: IRL Press, pages 79-103 (1985); obtained from J. Iandolo, Department of Diagnostic Medicine, College of Veterinary Medicine, Manhattan, Kansas] carrying the temperature-sensitive replicon pE194ts and a chloramphenicol (cm) resistance gene (cm R ) was inserted into the BamHl site of plasmid pSP72 (Promega), forming pID402. Plasmid pID402 was digested with Smal and self-ligated to remove a small fragment containing a BamHl site between the Smal sites, resulting in pID405. A DNA fragment of pBR322 (New England BioLabs) containing the ampicillin resistance gene (amp R )/ori/rop region (corresponding to bases 1904-4359 of pBR322) was prepared by polymerase chain reaction (PCR) amplification using primers pBRl (5'- GGAGCTCACTAGTCGGAGGCATCAGTGACC-3' , SEQ ID NO: 95) and pBR2 (5'-GGGATCCCATGAGAATTCTTGAAGACG-3\ SEQ ID NO: 96). Primer pBRl contains sites for Sacl and Spel, and pBR2 contains sites for BamHl and EcoRl. The PCR product was digested with BamRl and Sacl and ligated to the TfømHI/SαcI-digested fragment of pID405 (carrying replicon pE194ts and cm R ) to create pID406, in which the amp R /ori region of pSP72 is replaced with the replicon of pBR322. Finally, a 6.5 kb BamHl-EcoRl fragment from pTV9 [described in Youngman, in Plasmids: a practical approach, K. Hard, ed., Oxford: IRL Press, pages 79-103 (1985)], containing transposon Tn977 and its erythromycin (erm) resistance gene (erm R ), was ligated with BamHl and Eco l digested pID406, resulting in plasmid pID408. The origin of replication from pBR322 allows pID408 to replicate in E. coli, and the temperature-sensitive replicon pE194ts (from pTV32ts) allows replication in S. aureus at 32°C. B. Cloning and Selection of Signature Tags DNA signature tags were prepared as described by Hensel et al. , Science, 269:400-403 (1995) and inserted into the transposon Tn917 carried by pID408 as follows. Oligonucleotides tags in pool RT1 (5'- CTAGGTACCTACAACCTCAAGCTT-[NK] 20 - AAGCTTGGTTAGAATGGGTACCATG-3" , SEQ ID NO: 97, where N is A, C, G or T, and K is G or T were synthesized on an oligonucleotide synthesizer (Applied Biosystems). The 80bp tags from oligonucleotide pool RT1 were PCR-amplified from the using primers P10 (5'- CTAGAATTCTACAACCTCAAGCTT-3' , SEQ ID NO: 98) and Pl l (5'- AAGCTTGGTTAGAATGGAATTCATG-3' , SEQ ID NO: 99). The PCR- amplified tags were digested with Eco l, gel-purified, and ligated with EcoRI digested, dephosphorylated pID408, to form plasmids containing uniquely signature-tagged Tn9 7 transposons. The ligated DNA was transformed into 5. aureus strain RN4220 (a restriction defective strain derived from NCTC 8325-4 and described in Youngman, in Plasmids: a practical approach, K. Hard, ed., Oxford: IRL Press, pages 79-103 (1985) by electroporation. Εlectroporation was performed by the method of Schenk and Laddaga, FEMS Microbiol. Lett., 94: 133-138 (1992), with the following modifications: electrotransformed bacteria were plated on non-selective brain-heart infusion (BHI, Difco) agar plates (1.5 % agar), grown at 32°C for 8 to 12 hours and then replicated using an Accutran Replica Plater (Schleicher and Schuell) onto BHI agar plates containing 20 μg/ml erm and 20 μg/ml cm, and grown at 32°C overnight. A total of 400 erm R , cm R transformants were then screened to identify 150 tags that amplified and labelled efficiently. The 150 transformants were each cultured in 10 ml BHI broth containing 20 μg/ml erm and 20 μg/ml cm at 32°C overnight. Plasmid DNA was extracted from each culture using a Qiagen Plasmid Miniprep Kit according to the manufacturer's protocol except that the bacterial cells were lysed by lysostaphin (Sigma; 200 mg/ml) at 37°C for 30 min. in the PI solution of the Qiagen miniprep kit. An aliquot of each plasmid DNA preparation (1 μg) was transferred onto a Hybond N + membrane (Amersham) by using a Bio-Dot Microfiltration Apparatus according to the manufacturer's protocol (Bio-Rad) to give 75 different plasmids per membrane. The membranes were then transferred to Whatman 3MM paper saturated with denaturing solution (0.5 N NaOH, 1.5 M NaCl), incubated for 5 min. then transferred to another piece of Whatman 3MM paper saturated with neutralizing solution (1.5 M NaOH, 0.5 M Tris-Cl pH 7.4) for 5 min. After neutralization, the membranes were dried at 80°C for 10 min and the DNA cross-linked by UV light using a Stratalinker (Stratagene) . The signature tags from the 150 transformants were also labelled for use as probes. Aliquots of the plasmid preparations were combined to form four pools of 37, 37, 38 and 38 plasmids. The DNA signature tags from these four pools were PCR-amplified with primers P12 (5'-GAATTCCATTCTAAC-3\ SEQ ID NO: 100) and P13 (5'- ATTCCATTCTAACCAAGC-3', SEQ ID NO: 101) according to Hensel et al , Science, 269:400-403 (1995). These PCR products were gel-purified, subjected to a digoxygenin (DIG)-labelling PCR using a PCR DIG Probe Synthesis Kit as described by the manufacturer (Boehringer Mannheim). The DIG-labelled PCR products were hybridized separately with the membranes according to the method described in the DIG Probe Synthesis Kit, to identify tags that gave strong hybridization signals, but which did not cross-hybridize with tags in the other pools. From these experiments, a total of 96 plasmids were chosen on the basis of labelling efficiency of tags and lack of cross-hybridization. C. Generation of the S. aureus Mutant Bank The 96 plasmids containing uniquely signature tagged-transposons were used to generate S. aureus mutants with a chromosomal transposon insertion. A series of identical membranes for dot-blot hybridizations were prepared by transferring 1 μg of each of the 96 plasmids onto Hybond N + membranes using the Bio-Dot Microfiltration Apparatus. The 96 plasmids were separately transformed into S. aureus strain RN6390 by electroporation [Schenk and Laddaga, FEMS Microbiol Lett., 94: 133-138 (1992)] . Electrotransformed bacteria were plated directly on BHI agar plates containing 20 μg/ml cm and 20 μg/ml erm at 32°C overnight. A single colony from each transformation was transferred into each well of a microtitre dish containing 200 μl BHI broth, 20 μg/ml erm and 20 μg/ml cm. The microtitre dish was incubated at 32°C overnight. Glycerol was added to each well to give a final concentration of 50% and the plates were stored at 80°C. This collection of 96 transformants was designated the master pool and was used for all subsequent mutagenesis. To generate 96 different Tn977 mutants, bacteria from the master pool were replicated using a microtitre dish replicator (Sigma) into the wells of a new microtitre dish containing 200 μl BHI broth and 20 μg/ml erm. This dish was incubated at 43°C overnight and then bacteria from each well were streaked on BHI agar containing 20 μg/ml erm and incubated at 43°C overnight to obtain single colonies. Approximately five different erm R colonies obtained from each well were transferred onto BHI agar containing 20 μg/ml cm and incubated at 32°C, and onto BHI agar containing 20 μg/ml erm and incubated at 43°C, to screen for cm s colonies. Erm R , cm s colonies should lack the plasmid and carry a chromosomal insertion of Tn9 7. Individual erm R , cm s colonies from each of the 96 wells were transferred into a new 96 well microtitre dish with BHI broth containing 20 μg/ml erm and grown overnight at 43°C for use as inoculum. These 96 mutants, taken together, form one "inoculum pool. " Mutant pools were also stored at " 80°C in 50% glycerol. To verify that erm R , cm s colonies lack the plasmid and carry a single chromosomal insertion of Tn917, chromosomal DNA samples from individual mutant strains and from a pool of 46 colonies that had been cultured separately were digested with EcoR and subjected to Southern analysis using a fragment of the β-lactamase gene as a probe. For each of 12 separately analyzed mutants, a single hybridizing fragment of different size was observed in each lane. A large number of hybridizing fragments were observed in the lane containing DNA from 46 mutants. These results indicate that the majority of Tn917 insertions occur singly and at different locations in the S. aureus chromosome. P. Infection Studies to Identify Mutants with Reduced Virulence The "inoculum pool" of 96 S. aureus mutants containing chromosomal transposon insertions was evaluated for attenuated virulence in a mouse model of bacteremia. After overnight incubation at 43°C, the 96 different mutants from individual wells of the microtitre dish were pooled together and washed twice with BHI broth by centrifugation at 4000 x g for 10 min and resuspended in BHI broth. The OD 620 was determined using a spectrophotometer (OD 620 of 1.6 x 10 9 colony forming units (CFU)/ml) [Cheung et al , J. Bacteriol, 777:3220-3226 (1995).]. The bacterial suspension was diluted to approximately 5xl0 6 CFU/ml and then mixed with an equal volume of pre-autoclaved 4% (w/v) Brewer's yeast (Sigma) in BHI broth. A total of 0.2 ml of this mixture, containing approximately 5xl0 5 CFU bacteria, was injected intraperitoneally into a CD-I mouse (approximately 25 g in weight). The number of CFU in the inoculum was verified by viable counts after plating a diluted aliquot of the inoculum to BHI agar. Two to four mice were inoculated with each pool. 48 hours after inoculation, bacteria were recovered from the spleens of the animals as described by Hensel et al , Science, 269:400-403 (1995) and pooled to form the "recovered pool. " Each recovered pool was made from at least 10,000 bacterial colonies. The signature tags present in the recovered pools were compared with the signature tags present in the inoculum pools by PCR amplifying the tags using primers P12 and P13 (described in section B above), DIG labelling the tags, and hybridizing the labelled tags to the 96 plasmids which had been transferred to Hybond N + membranes using the Bio-Dot Microfiltration Apparatus as described above in section C. E. Virulence Gene Identification and DNA Sequencing A total of 13 pools, each comprising 96 S. aureus Tn977 mutants, were screened as described above for loss of virulence in mice. From these, 50 mutants were identified whose tags hybridized strongly to probes from the inoculum pools but weakly to probes from the corresponding recovery pools. To clone the chromosomal DNA flanking the transposon insertion points of these 50 mutants, 3-5 μg of S. aureus chromosomal DNA from each mutant was isolated as described by Pospiech and Neumann, Trends Genetc, 77:217-218 (1995) and completely digested with Hindlll. Half of the digested DNA was then subjected to Southern hybridization analysis using the pBR322 fragment of pID408 as a probe to determine the size of the DNA fragment carrying this part of the transposon. The rest of the DNA was resuspended in 200 μl of ligation buffer (Gibco-BRL) and self-ligated overnight at 16°C. The ligated products were transformed into E. coli DH5 (Gibco) and plated onto Luria Bertani (LB) agar containing 50 μg/ml ampicillin, and incubated at 37°C overnight. A single amp R colony from each transformation was grown up in LB broth containing 100 μg/ml amp. Plasmid DNA was extracted using a Qiagen plasmid miniprep kit. Chromosomal DNA flanking the transposon was obtained using primer pseq-1 (5'-TGAACTGCCACTGTAGAGAGA-3\ SEQ ID NO: 102) based on the erm-proximal end of Tn977, and sequenced (for a stretch of several hundred nucleotides) using a Model 373A Sequencing System (Applied Biosystems). The sequence obtained is indicated in Table 1 below with reference to the corresponding nucleotides of the SEQ ID NO: . These DNA sequences were analyzed by searching the S. aureus database from Human Genome Sciences and the European Molecular Biology Laboratory and Genbank DNA and Protein Databases using the BLAST and FASTA network service at the Human Genome Mapping Project Recourse Centre, Hinxton, UK. Results of the searches done to date in identifying the virulence genes and their possible function are shown in Table 1. Table 1 below displays the signature tag identification number, the SEQ ID NO: corresponding to each virulence gene (and the nucleotide positions within the SEQ ID NO: that correspond to the actual stretch of DNA that was sequenced), the possible function of the gene, and the LD 50 of the knockout mutant as determined in Example 2 below. EXAMPLE 2 Assessment of virulence of S. aureus knockout mutants The virulence of individual knockout mutants, identified in Example 1 as having reduced virulence when tested in pools of 96 mutants, was assessed by carrying out an LD 50 determination for each mutant. Confirmation that a given mutation is in a virulence gene may be obtained by comparing the parent and mutated bacterial strains in terms of whether both strains are equally effective in establishing an infection with the same consequences for the host animal. In practice, this may be done by comparing LD 50 values (the number of bacteria required to produce a 50% mortality rate in the animals under standardized conditions) between the wild-type strain and the mutant derivative strain. If the LD 50 values are within standard error of each other then the mutation is not in or does not affect a virulence gene. If significant differences occur between the wild-type and the mutant strain, where the mutant strain is significantly less able to cause lethal infection, then the mutation is in a virulence gene or dramatically affects a virulence gene. Briefly, LD 50 determinations were conducted as follows. CF1 female mice weighing between 19 and 22 grams were injected intraperitoneally with a set concentration of either wild-type or mutant S. aureus in 0.2 ml of BHI broth containing 4% (w/v) dried brewer's yeast as an adjuvant for establishment of infection. The amount of brewer's yeast may vary from 0-8% dependent upon the bacteria being utilized in the infection. A single LD 50 determination utilizes five log-dilutions of bacteria (10 3 to 10 7 ), with each log-dilution being tested in 10 mice. The actual number of bacteria employed was estimated in each LD 50 determination by a plate count conducted on the bacterial stock to determine the number of CFU of bacteria. Following infection, the mice were monitored daily for mortality for a period of at least one week. At the end of the observation period the LD 50 was determined using probit analysis on the mortality data. The LD 50 value of the wild-type S. aureus strain RN6390 ranges from 1.4 x 10 4 to 1.4 x 10 5 . The LD 50 values for the virulence gene mutants are shown in Table 1 below. The LD 50 for wild-type S. aureus RN6390 is normally 1.4 x 10 4 to 1.4 x 10 5 EXAMPLE 3 Use of virulence gene products in screen for anti-bacterial agents The virulence genes and their gene products are utilized in assays for identifying new anti-bacterial agents against S. aureus. The genes are cloned, the proteins encoded by the genes are produced and purified, high throughput assays are established to screen for inhibitors, and the inhibitors identified in the primary screen are evaluated in secondary assays. The cloning and expression of FemA, and its use in screening potential inhibitory agents, is described below. A. Cloning of FemA Gene DNA restriction digestions and ligations are performed as described by Sambrook et al , Molecular cloning: a laboratory manual. 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989). Cloning of the S. aureus femA gene [Berger-Bachi et al. , Mol. Gen. Genet., 279:263-269 (1989)] for intracellular expression in E. coli is carried out as follows. To clone the gene with six histidine residues at the 3 '-terminus, the following two oligonucleotides primers, 5'-GGCCATCGATAATGAAATTAATTAACGAGAGACAAATAGG-3\ SEQ ID NO: 103, and 5'- GGCCGGATCCCTAGTGATGGTGATGGTGATGAAAAATTCTGTCTTTAA CTTTTTT-3', SEQ ID NO: 104, are used to PCR amplify the gene from S. aureus genomic DNA. The resulting femA gene has a Clal site at 5'-end and a BamHl site at 3 '-end for cloning into E. coli expression vectors. For secretion of the femA gene with six histidine residues at the 3 '-terminus into the periplasm of E. coli, PCR amplification using the following two oligonucleotide primers, 5'-GGCCGGTACCAAATTAATTAACGAGAGACAAATAGG-3\ SEQ ID NO: 105 and 5 * - GGCCGGATCCCTAGTGATGGTGATGGTGATGAAAAATTCTGTCTTTAA CTTTTTT-3' , SEQ ID NO: 106, results in a fragment with a Kpnl site at the 5' -end and a BamHl site at the 3'- end. The approximately 1.3 kb PCR fragment may be sequenced directly, or after cloning into an expression vector, to confirm the sequence of the femA gene and its flanking regions. B. Recombinant FemA Protein Production and Purification Expression of femA in E. coli is carried out as follows. The E. coli expression vector pSRtac-pelB contains the synthetic tac promoter and the signal sequence of PelB [Lei et al , J. Bact., 769:4379-4383 (1987)], with transcription terminators upstream and downstream to minimize transcription read through. For intracellular expression, the femA gene generated by PCR as described above in section A with Clal and BamHl sites at the termini is cloned into pSRtac-pelB digested with Clal and BamHl (replacing the PelB signal sequence). For secretion into periplasm, the femA gene generated by PCR as described above in section A with Kpnl and BamHl sites at the termini is cloned into pSRtac-pelB digested with Kpnl and BamHl, directly downstream from the pelB signal sequence. E. coli are transformed with the expression vector containing the femA gene. To induce the tac promoter and optimize expression level, the transformed bacteria are incubated with IPTG (isopropylthio-β- galactoside) at concentrations ranging from 2 x 10 "3 M to 1 x 10 "5 M, at cell growth temperatures between 27°C to 42°C in rich medium or minimal medium. The recombinant FemA thus produced contains six histidine residues at the C-terminus and can be purified via the affinity of histidine to nickel. Chromatography may be carried out with the metal chelating resin Ni- nitrilotriacetic acid (Ni-NTA) (available from Qiagen, Chatsworth, CA) under native or denaturing conditions. C. High Throughput Assays Using FemA for Screening Potential Inhibitors The screening method described in U.S. Patent No. 5,585,277 is used as follows to establish a high throughput assay to identify ligands that bind to FemA. The test ligand and femA are combined under conditions (e.g., temperature, pH, salt concentration, time) appropriate for detecting binding of femA to a ligand. If too little target protein is unfolded, the observed signal will occur at too low a level or rate to be conveniently measured. The conditions are optimized using known methods. Binding of a test ligand to femA is assessed in one of several ways: by determining the extent to which folded femA is present in the test ligand-femA combination, by determining the extent to which unfolded femA is present in the test Mgand-femA combination, or by determining the ratio of folded femA to unfolded femA in the combination. There are numerous methods to carry out these determinations. For example, proteolysis may be used. A protease which acts preferentially on unfolded femA is combined with the test ligand-fem/i combination, and after an appropriate period of incubation, the difference between intact or degraded femA in the presence and in the absence of the test ligand is determined. The addition of a test ligand which binds the folded femA, thus stabilizing it in the protease-resistant form, changes the rate of proteolysis. A wide variety of known proteases, such as trypsin, chymotrypsin, V8 protease, elastase, carboxypeptidase, proteinase K, thermolysin and subtilisin, can be used. As another example, the binding of the test ligand to the femA is assessed through the use of antibodies that specifically bind to the protein only in the unfolded state. There are numerous methods known in the art for producing antibodies to a particular protein. D. In Vivo Assays to Evaluate Inhibitors The inhibitors/binders identified by the initial screens such as the one described in section C above are evaluated for their effect on virulence in mouse models of S. aureus infection. Mice are infected with 100 LD 50 's of the wild-type bacteria and treated with varying doses of the test inhibitory agent. The ED 50 of the test inhibitory agent (the amount in milligrams of drug per kilogram of body weight required to cure 50% of infected animals) is determined. Each trial contains two control groups, a negative control group given an LD 50 dose of bacteria and no test inhibitory agent (which ensures that the infecting dose is operationally close to 100 LD 50 's), and a positive control group given a 100 LD 50 dose of bacteria and an ED 50 dose of a known and effective antibiotic for that bacterial infection (which confirms that the infection can be cured under appropriate conditions). Five dosage levels of test inhibitory agent, utilizing serial twofold dilutions, are employed. An exemplary dosage scheme begins with a minimum of 6.25 mg of drug per kg of body weight per dose, and ranges up to a maximum dose of 100 mg/kg. Each dosage level is tested in six mice and deaths following infection and treatment are monitored for at least 6 days. At the end of the test period, probit analysis is employed to determine the ED 50 value of the inhibitor or the amount of drug in milligrams of drug per kilogram of body weight required to reverse virulence so as to result in only 50% mortality of infected animals in the test. In tests designed to detect the prevention of infection by interference with virulence factors, the first dose of the inhibitor is given one hour prior to infection, and then four and eight hours post infection. In tests designed to detect virulence inhibitors which reverse the outcome of infection, the inhibitor is administered one and four hours post infection on the first day of infection and once in the morning and afternoon (separated by 6-8 hours) on the second and third days following infection. Inhibitory agents that successfully prevent the establishment of an infection or reverse the outcome of an infection once established are identified. Example 4: Syr, a virulence regulator of Staphylococcus aureus The identification of large number of putative virulence genes in Staphylococcus aureus using signature-tagged mutagenesis is reported in Examples 1 to 3. Many of these had no significant similarity to sequences in the DNA and protein databases. To investigate further the role of these genes in virulence, mutant strains were subjected to a series of phenotypic tests. One mutant strain was found with pleiotropic effects on virulence factors. We thus designated the mutated gene in this strain staphylococcal virulence regulator (svr). Compared with its parent wild-type strain, the svr mutant strain expressed greatly reduced amounts of α-, β- and δ-toxins but increased amounts of protein A. DNA sequence analysis of the cloned svr gene did not reveal any significant similarities to entries in the DNA and protein databases. Northern hybridization with probes specific for hla, the gene encoding a-toxin, and spa, the gene encoding protein A, showed that svr affected the expression of α-toxin and protein A at the mRNA level. Northern analysis of svr, agr and RNAIII transcripts showed that agr mRNA and RNAIII were detectable in the wild-type strain and an svr mutant strain carrying the svr gene on a plasmid but was absent in the agr ~ and svr ~ strains. Svr transcripts were present in wild-type and agr ~ strains but were not detected in the svr ~ strain. This indicates that svr is required for the expression of agr and RNAIII. The svr product is therefore likely to be a novel compenent in the agr regulatory network controlling virulence of S. aureus. METHODS Bacterial strains and plasmids Bacterial strains and plasmids are listed in Table 1. S. aureus strains were grown in Brain Heart Infusion (BHI) medium (Difco) with or without agar (1.5%) and antibiotics (erythromycin [erm] at 20 μg/ml and/or chloramphenicol [cm] at 20 μg/ml). E. coli strain DH5a was grown in Luria Bertani (LB) medium with or without ampicillin [amp] at 50 μg/ml). Table 1. Bacterial strains and plasmids used in this study Table 1. Bacterial strains and plasmids used in this study Strain or plasmid Phenotype or characteristics Source or reference Strains E. coli DH5 V-supE44 ΔlacU169 (Φ801acZ l 75) Gibco BRL hsdRl 7 recAl gyr thi-1 S. aureus RN4220 NCTC8325-4, restriction minus. Peng et al. 1988 RN6390 Propagated laboratory strain Peng et al. 1988 RN6911 RN6390.dα#r. Peng et α/. 1988 P6C63 svr strain. selected by STM Examples 1 to 3 Newman Wild-type strain NCTC10833 Wood46 An -hemolysin-producing strain. NCTC 10345 ID401 Clinical isolate from Hammersmith This study Hospital, Mec r ID402 Clinical isolate from Hammersmith This study Hospital, Mec r Plasmids pBR322 Cloning vector, Amp r , Tc r New England BioLab pSP72 Cloning vector, Amp r . Gibco BRL pVA380-l Cloning vector of S. aureus. Tc r . Macrina et al. 1980 pCW59 Cloning vector, Tc r Wilson et al. 1981 pID431 Screened from pBR322 S.aureus library. This study Contains svr, orf2 and orf3. pID413 Cloning vector, derived from pVA380- This study l,Tc r . pID437 pID413 carrying svr. This study pID439 pID413 carrying svr, orf2 and orO. This study pID4311 pID413 carrying svr and orf2 plus 287 bp This study upstream sequence of orf2 pID4312 pID413 carrying svr, orf2 and orf3 plus This study 287 bp upstream sequence of orf2. DNA manipulations, PCR, digoxygenin labelling and hybridizations Chromosomal DNA from Staphylococcus aureus was isolated as described by Pospiech et al, (8). DNA restriction digestions and modifications were performed as described by Sambrook et al, (9). Plasmid DNA from S. aureus strain RN4220 was isolated using a Qiagen Plasmid Miniprep Kit according to the manufacturer's protocol except that the bacterial cells were lysed by lysostaphin (Sigma; 200 mg/ml) at 37°C for 30 min prior to plasmid purification. Construction of plasmids Plasmid pID413 was derived from pVA380-l(10). A 2.5 kb fragment carrying the pVA380-l replicon was PCR-amplified from pVA380-l . Restriction sites for BgM and H dIII were introduced in the 5' end of the amplified fragment by using forward primer 5'-TGGAGATCTAAGCTTTGCATAACTTTCTCGTCC- 3' (SEQ ID No 107) and reverse primer 5'-TCCTGGCGATTCTGAGAC-3' (SEQ ID No 108). The amplified fragment was filled in with DNA polymerase Klenow fragment and ligated with a 2.3 kb DNA fragment carrying the tetracycline resistance gene from pCW59 after digestion by Hinάlll and filling in with DNA polymerase Klenow fragment, resulting in plasmid pID413. A DNA polylinker of plasmid pSP72 was digested with BgHl and H dIII and inserted into Bgϊll and Hinάlll digested pID413 to generate pID413PL. Construction of genomic library of S. aureus. A S. aureus (RN6390) chromosomal DNA library was constructed in pBR322 as follows: chromosomal DNA was partially digested with BamHl and EcoRl to an average size of 5 kb and purified by phenol: chloroform extraction. The purified DNA fragments were ligated with BamHl and EcoRI digested pBR322. This ligation product was transformed into E. coli DΗ5a by electroporation and plated on LB agar plate containing 50 μg/ml ampicillin. Complementation of svr mutant P6C63 Four DNA fragments with different sizes were cloned into pID413PL to complement mutant strain P6C63 (Fig. 1A). All of these four fragments were amplified by PCR using primers based on the DNA sequence flanking the svr gene. Restriction sites for BamHl and Hinάlll were introduced in the 5' end and the 3' end of each fragment, respectively. The amplified fragments were digested by BamHl and H dIII and inserted into ifømΗI and H dIII digested pID413PL to generate pID437, pID439, pID4311 and pID4312. The svr gene was amplified from genomic DNA of RN6390 by PCR using primers 5'- TGGGGATCCGATAAGTGTGACTGGTAG-3' (SEQ ID No 109) and 5'- TGGAAGCTTACATTACTTCAAATAAATTA-3' (SEQ ID No. 110) to generate pID437. A 2.1 kb fragment containing svr, orf2 and orf3 was amplified by PCR using primers 5'-TGGGGATCCTGCATATCAAAATGTTTATGGC-3' (SEQ ID No. I l l) and 5'-TGGAAGCTTACACATATGCCAATCTCAC-3' (SEQ ID No. 112) to generate pID439. A 1.3 kb fragment containing svr and orf2 plus 287 bp upstream sequence of orf2 was amplified by PCR using primers 5'-GTTGGATCCGCTGTTGTTACTTTGATGC-3' (SEQ ID No. 113) and 5'-TGGAAGCTTACATTACTTCAAATAAATTA-3' (SEQ ID No. 114) to generate pID4311. A 2.4 kb fragment containing svr, orf2, and orO plus 287 bp upstream sequence of orf2 was amplified by PCR using primers 5'- GTTGGATCCGCTGTTGTTACTTTGATGC-3' (SEQ ID No. 115) and 5'- TGGAAGCTTACACATATGCCAATCTCAC-3' (SEQ ID No 116) to generate pID4312. All of these four plasmids were individually transformed into P6C63 by electroporation. Transformants were selected by resistance to tetracycline and tested for restoration of wild-type phenotype. Phenotypic characterisation Lipase activity was assayed on 1 % Tween agar plates (Difco). DNase production was assayed on DNase agar (Difco). Coagulase was assayed by the method described by Smeltzer et al. (11). α-, β- and δ-toxins were assayed on cross-streaked sheep, rabbit and horse blood agar plates. Protein A was detected by Western blot using anti-protein A monoclonal antibody (Sigma). Southern and Northern Blot analysis Southern hybridization analysis was performed as described by Sambrook et al (9) with DIG-labelling DNA fragments as probes. For Northern hybridization, total RNA from S. aureus was isolated by using Quiagen RNA easy kit according to the manufacturer's protocol except that the bacterial cells were lysed by lysostaphin (Sigma; 200 mg/ml) at 37 C for 3-5 min. Equal amounts of RNA were separated on 1.2% agarose gels containing 0.66 M formaldehyde and transferred onto nitrocellulose membrane. Hybridizations were carried out at 42°C. All probes were radiolabelled with [α- P]dATP by PCR amplification using PCR-generated DNA fragments as templates. Oligonucleotide primers used for PCR were as follows: amplification of an hla fragment was performed with primer HI (5'-ATTTGATATGTCTCAACTGC-3') (SEQ ID No 117) and H2 (5'-GCTCTAATTTTTAAGTGAGG-3') (SEQ ID No 118). For amplification of spa, primers used were SI (5'- TATCTGGTGGCGTAACACCTG-3') (SEQ ID No 119) and S2 (5'- GATGAAGCCGTTACGTTGTTC-3') (SEQ ID No 120). For agr, primers Al (5'-GCCATAAGGATGTGAATGTATG-3') (SEQ ID No 121) and A2 (5'- GCATTTGCTAGTTATCTTG-3') (SEQ ID No. 122) were used. Primers Rl (5'-AGATCTATCAAGGATGTGATGGTT-3') (SEQ ID No 123) and R2 (5'- GTCATTATACGATTTAGTACAATC-3') (SEQ ID No 124) were used for the amplification of RNAIII. Reverse transcription-polymerase chain reaction (RT-PCR) Total RNA (1 mg) from post-exponential phase cultures of bacteria was reverse transcribed using First-strand cDNA synthesis kit (Pharmacia Biotech) according to the manufacturer's instructions. PCR was performed in a volume of 100 ml with 10 ml cDNA sample, 200 pmol of each primer and 200 nM of dNTPs and 2.5 U of Taq-DNA polymerase (Sigma). PCR products were analysed by agarose gel electrophoresis. Infection studies For single strain infection studies, CD-I female mice (20 g; Charles River Labs) were individually injected intraperitoneally with 0.2 ml of a suspension containing a 5 x 10 cfu bacteria and 2% (w/v) Brewer's yeast in BHI broth. At 6, 24, 48, 72, 96 and 120 hours post-injection, two mice were killed from each group. Dilution series of spleen homogenates were spread over BHI agar plates and incubated at 37°C overnight. The number of bacterial cfu were counted at each time point. RESULTS Cloning and sequencing of the svr region To clone the chromosomal region surrounding the transposon insertion site of strain P6C63, a genomic library of S. aureus was generated in plasmid pBR322. By hybridising colonies from this genomic library with a probe consisting of a 0.5 kb DNA flanking the transposon insertion, one positive clone was identified. Restriction analysis of this recombinant plasmid revealed a 2.5 kb Alul fragment which had been disrupted by Tn977 in P6C63. SEQ ID Nos: 8 and 10 are the nucleotide and amino acid sequences initially identified for P6C63. Transposon Tn977 had inserted into one of three open reading frames (orfs) in this fragment. This orf was designated svr (Fig. 1A). It is 372 bp in length and codes for a protein of 124 amino acid residues (Fig. IB; SEQ ID No: 125). Upon further sequencing of P6C63 the nucleotide and amino acid sequences were determined as SEQ ID No: 126 and SEQ ID No: 127. FAST A and BLAST searches of the protein databases revealed that svr and orf3 had no significant similarity to known proteins or motifs. However, orf2, immediately upstream of svr showed significant similarity (28% identity over 148 amino acid residues) to the Escherichia coli sly A, which is a member of the mar family of transcription factors of Bacillus subtilis. To establish whether the virulence defect of strain P6C63 was due to interruption of svr or a polar effect on orf3 or other genes of a possible operon, a series of plasmids was constructed and transformed into P6C63 to test for complementation of defects in α-, β- and δ-toxin production (see below). The insert in the smallest complementing plasmid (pID437) contained only the svr gene (Fig. lA), indicating that the toxin-deficient phenotype is due to mutation of the svr gene. When plasmids pID437, pID439, pID4311 and pID4312 were transformed into P6C63, only a proportion of transformants showed complete restoration of the wild-type phenotype. A Southern analysis was performed on these transformants to test for the presence of the plasmid in the complemented strains, using the svr gene as the probe. Southern hybridization showed that in the complemented transformants, the plasmid had integrated into the chromosomal DNA (data not shown), whereas the uncomplemented transformants carried unintegrated plasmids. To demonstrate whether other strains of S. aureus, particularly clinical isolates also contain the svr gene, a Southern hybridization analysis was performed on S. aureus strains RN6390, Newman, Wood 46, ID401 and ID402, which were from different clinical sources in the USA and UK. Chromosomal DNA from each strain was digested with H dIII and probed with the svr gene. A common 8.2 kb fragment was observed in strain RN6390, Newman, Wood 46 and ID401, whereas a 10 kb fragment was observed in strain ID402 (Fig. 1C). This indicates that svr is widely conserved in S. aureus. Phenotypic characterisation To investigate the svr phenotype in more detail, P6C63 was subjected to a number of tests for S. aureus virulence determinants. The expression levels of a-, b- and d-toxins were examined on different blood agar plates. The expression levels of a-, b-, and d-toxins are greatly reduced in P6C63 and RN6911 (an agr strain) compared with their parental strain RN6390, and the production of toxins was restored in P6C63 when transformed with pID437 (Fig. 2A). A characteristic of agr ~ strains is the overproduction of cell wall protein A. In view of the similar toxin-deficient phenotype of agr ~ and svr ~ strains, we examined protein A by Western blot using an anti-protein A monoclonal antibody. As shown in Fig 2B, protein A was not detectable in the wild-type strain, was barely detectable in the complemented strain, and was present in both agr ~ and svr ~ strains. Virulence studies Mutant P6C63 was originally isolated by STM in a pool of 96 mutants and LD50 analysis has shown that it is highly attenuated in virulence compared with the wild-type strain RN6390 (7). To study the growth kinetics of P6C63 in more detail, strains RN6390 and P6C63 were injected intraperitoneally into groups of CD-I mice at a dose of 1x10 cfu of bacteria. Bacteria were recovered from spleens at different time points and cfu quantified. The bacterial load of RN6390 in spleens exceeded 10^ cfu at 6, 24, 48 and 72 hours post- inoculation. The numbers of P6C63 cells increased over the first 6 hours, then decreased, and were eventually cleared by 96 hours. Mice inoculated with RN6390 appeared very sick compared with those injected with the mutant strain and one of 18 mice died in 24 hours. Trans criptional analysis of svr As attempts to detect svr mRNA in RN6390 by Northern hybridization were not successful, RT-PCR was employed to determine the transcription of svr in various genetic backgrounds. Total RNA from P6C63 (svr), RN6911 (agr ~ ) and RN6390 (wild-type) were subjected to RT-PCR using primers corresponding to the svr DNA sequence. As shown in Fig. 4A, svr transcripts were detected in RN6911 and RN6390 but not in P6C63. A control RT-PCR was performed by using same conditions as above except that reverse transcriptase was inactived at 95 C for 5 min. No PCR products were obtained for any of the three strains, indicating that the products shown in Fig.4A were not due to DNA contamination. Effect of SVR on transcription of hla and spa. As the svr mutant strain showed reduced production of α-, β- and δ-toxins and increased levels of protein A, Northern hybridizations were performed to determine whether they were affected at the mRNA level. Total RNA extracted from post-exponential phase cultures of RN6390, RN6911, P6C63 and the complemented strain P6C63 (pID437) were subjected to Northern analysis using probes specific for hla and spa. With the hla probe, a strong band was observed in RNA from the wild-type strain RN6390 and the complemented strain but was not observed in either the agr ~ strain RN6911 or svr ~ strain P6C63. The membranes were stripped and reprobed with spa gene, and in contrast to hla, a hybridizing band was identified in RNA from RN6911 and P6C63 but not in strain RN6390 or the complemented strain (Fig. 4B). These results are consistent with the protein analysis (above) and indicated that the svr affected the expression of α-toxin and protein A at the mRNA level. Svr is required for the transcription of agr and RNAIII Since phenotypic analysis and Northern hybridization results indicated that the svr mutant has similar characteristics to those of an agr ~ strain, Northern hybridizations were performed to investigate whether svr is related to the agr regulatory system. Total RNA isolated from post-exponential phase cultures of RN6390, RN6911, P6C63 and the complemented strain was subjected to Northern hybridizations using probes specific for agr and RNAIII. As shown in Fig. 4C, both the agr and RNAIII probes hybridized to RNA isolated from the wild-type strain and complemented strain, but did not hybridize to RNA from the svr mutant strain or the agr ~ strain. This result suggests that svr is required for the transcription of agr and RNAIII. Using STM, an approach for the identification of bacterial virulence genes (7), we have identified svr, a novel staphylococcal virulence regulator whose mutant phenotype is similar to that of an agr strain. However, DNA sequence analysis of svr shows that it not a member of the known agr regulatory system, and has no similarity to known proteins in the DNA and protein databases. The svr ~ mutant phenotype was complemented by a plasmid containing svr indicating that the phenotypic defect was not due to a polar effect on genes downstream of svr. Interestingly, complementation occurred in cells containing chromosomally integrated plasmid, but not in cells containing no n- integrated plasmids. The reason for this is unclear, but as the plasmid copy number is in the order of 15-25/cell (10), it could be related to over-expression of svr. Certainly the abundance of svr mRNA seems to be very low in wild-type cells, as it was not detectable by Northern hybridization using RNA recovered from bacteria at various stages of growth. The phenotypic and Northern hybridization analysis of toxins and protein A in the svr mutant showed it is similar pattern to that of an agr ~ mutant strain. We therefore asked whether svr is linked with agr regulatory system. The svr mRNA was detected in an agr ~ strain and wild-type strain but not in the svr ~ strain, suggesting that agr has no effect on svr activity. By contrast, agr mRNA and RNAIII were detected in the wild-type strain and svr-complemented strain, but not in the svr ~ strain. This suggests that svr is required for the expression of agr and RNAIII. It was recently shown that agr is autoinduced by a proteinaceous factor called RAP (RNAIII activating protein), which is produced and secreted by S. aureus. (16). Although the sequence of RAP has not been published, it seems unlikely that svr encodes the RAP protein, because the length of svr is 372 bp, which could encode a 13 kDa protein, and RAP is a 38 kDa protein (16). The fact that sar is also necessary for the expression of agr and RNAIII (6) indicates that three distinct regulatory pathways could influence the expression of the agr locus and virulence factors of S. aureus. Studies on the relationship between svr, sar and RAP will help to clarify the mechanisms by whichS. aureus controls virulence gene expression. The recent emergence of methicillin resistant S. aureus (MRSA) represents a very important public health problem (18). Thus there is an urgent need for alternative approaches to control S. aureus infections. Balaban et al. (17) reported that mice vaccinated with RAP were protected from infection by a subsequent S. aureus challenge. The fact that svr is required for virulence, most likely through regulation of agr and RNAIII, suggests that svr might be another target for the development of antibiotics and vaccines against S. aureus infections. REFERENCES FOR EXAMPLE 4 1. Sherris, J.C. and Plorde, J.J. (1990) Staphylococci. In Medical Microbiology: An Introduction to Infectious Diseases, ed. Sherris, J.C. (Elsvier Science Publishing Co. Inc. , New York), pp. 275-289. 2. Peng, H.-L, Novick, R.P., Kreiswirth, B., Kornblum, J. and Schlievert, P. (1988) J. Bacteriol 170: 4365-4372 3. Cheung, A.L., Koomey, J.M., Butler, C.A., Projan, S.J., and Fischetti, V.A. (1992) Proc Natl Acad Sci USA 89: 6462-6466. 4. Novick, R. P., S. J. Projan, J. Kronblum, H. F. Ross, G. Ji, B. Kreiswirth, F. Vandenesch and S. Moghazeh. (1995) Mol Gen Genet 248: 446-458. 5. Novick, R. P. , H. F. Ross, S. J. Projan, J. Kronblum, B. Kreiswirth, and S. Moghazeh. (1993) EMBO J. 12: 3967-3975. 6. Cheung A. L., M. G. Bayer and Heinrichs J. H. (1997) J. Bacteriol 179:3963-3971. 7. Mei J-M., Nourbakhsh F., Ford C. W. and Holden, D. W. (1997) Mol Microbiol 26:399-407 8. Pospiech, A., and Neumann, B. (1995) Trends Genet 11: 217-218. 9. Sambrook, J., Fritsch, E.F. , and Maniatis, T. (1989) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor. New York. 10. Macrina, F. L., P. H. Wood, and Jones K. R. (1980) Infect Immun 28:692- 699. 11. Smeltzer, M.S. , Hart, M.E., Iandolo, J. J. (1993) Infect Immun 61: 919- 925. 12. Morfeldt, E., Tegmark, K & Arvidson, S. (1996) Mol. Microbiol 21: 1227- 1237. 13. Cheung, A. L., Bayer, M. G., and Heinrichs, J. H. (1997) J. Bacteiol. 179:3963-3971 14. Novick, R. P. , H. F. Ross, S. J. Projan, J. Kronblum, B. Kreiswirth, and Moghazeh, S. (1993) EMBO J. 12: 3967-3975. 15. Schenk, S. and Laddaga, R.A. (1992) FEMS Microbiology Letters 94: 133- 138. 16. Balaban, N. and Novick, R. P. (1995) Proc. Natl. Acad. Sci. USA 92: 1619-1623. 17. Balaban, N., Goldkorn, T., Nhan, R. T., Dang, L. B., Scott, S., Ridgley, R. M., Rassooly, A., Wright, A.C., Larrick, J.W., Rasooly. R. and Carlson, J. R. (1998) Science 280: 438-440. 18. Mulligan M. E., K. A. Murray-Leisure, B. S. Ribner, H. C. Standiford, J. F. John, J. A. Korvick, C. A. Kauffman and Yu V. L. (1993)z The American J. Med. 94:313-328. Numerous modifications and variations of the above-described invention are expected to occur to those of skill in the art. Accordingly, only such limitations as appear in the appended claims should be placed thereon. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Holden, David W. (ii " ) TITLE OF INVENTION: ANTI -BACTERIAL METHODS AND MATERIALS (iii) NUMBER OF SEQUENCES: 127 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Eric Potter Clarkson (B) STREET: Park View House, 58 The Ropewalk (C) CITY: Nottingham (D) STATE: (E) COUNTRY: United Kingdom (F) ZIP: NG1 5DD (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Miles, John Stephen (B) REGISTRATION NUMBER: (C) REFERENCE/DOCKET NUMBER: RPMW/P19192PC (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: +44 115 955 2211 (B) TELEFAX: (C) TELEX: (2) INFORMATION FOR SEQ ID NO : 1 : (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1260 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p2c73)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1257 (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 : ATG AAA TTT ACA GAG TTA ACT GTT ACC GAA TTT GAC AAC TTT GTA CAA 48 Met Lys Phe Thr Glu Leu Thr Val Thr Glu Phe Asp Asn Phe Val Gin 1 5 10 15 AAT CCA TCA TTG GAA AGT CAT TAT TTC CAA GTA AAA GAA AAT ATA GTT 96 Asn Pro Ser Leu Glu Ser His Tyr Phe Gin Val Lys Glu Asn lie Val ACC CGT GAG AAT GAT GGC TTT GAA GTA GTT TTA TTA GGT ATT AAA GAC 144 Thr Arg Glu Asn Asp Gly Phe Glu Val Val Leu Leu Gly lie Lys Asp 35 40 45 GAC AAT AAC AAA GTA ATT GCA GCA AGC CTT TTC TCT AAA ATT CCT ACT 192 Asp Asn Asn Lys Val lie Ala Ala Ser Leu Phe Ser Lys lie Pro Thr 50 55 60 ATG GGA AGT TAT GTT TAC TAT TCG AAT CGT GGT CCA GTA ATG GAT TTT 240 Met Gly Ser Tyr Val Tyr Tyr Ser Asn Arg Gly Pro Val Met Asp Phe 65 70 75 80 TCA GAT TTA GGA TTA GTT GAT TAT TAT TTA AAA GAG TTA GAT AAA TAT 288 Ser Asp Leu Gly Leu Val Asp Tyr Tyr Leu Lys Glu Leu Asp Lys Tyr 85 90 95 TTA CAG CAA CAT CAA TGT TTA TAT GTT AAA TTA GAT CCG TAT TGG TTA 336 Leu Gin Gin His Gin Cys Leu Tyr Val Lys Leu Asp Pro Tyr Trp Leu 100 105 110 TAT CAT CTA TAT GAT AAA GAT ATC GTG CCA TTT GAA GGT CGC GAG AAA 384 Tyr His Leu Tyr Asp Lys Asp lie Val Pro Phe Glu Gly Arg Glu Lys 115 120 125 AAT GAT GCC CTA GTA AAC TTG TTT AAA TCA CAT GGT TAC GAG CAT CAT 432 Asn Asp Ala Leu Val Asn Leu Phe Lys Ser His Gly Tyr Glu His His 130 135 140 GGC TTT ACA ACT GAG TAT GAT ACA TCG AGC CAA GTA CGA TGG ATG GGC 480 Gly Phe Thr Thr Glu Tyr Asp Thr Ser Ser Gin Val Arg Trp Met Gly 145 150 155 160 GTA TTA AAC CTT GAA GGT AAA ACA CCC GAA ACA TTG AAA AAG ACA TTT 528 Val Leu Asn Leu Glu Gly Lys Thr Pro Glu Thr Leu Lys Lys Thr Phe 165 170 175 GAT AGT CAA CGT AAA CGT AAT ATT AAT AAA GCG ATA AAC TAT GGT GTT 576 Asp Ser Gin Arg Lys Arg Asn lie Asn Lys Ala lie Asn Tyr Gly Val 180 185 190 AAA GTC AGA TTC CTT GAA CGT GAT GAG TTC AAT CTT TTC TTA GAT TTA 624 Lys Val Arg Phe Leu Glu Arg Asp Glu Phe Asn Leu Phe Leu Asp Leu 195 200 205 TAT CGT GAA ACT GAA GAG CGT GCT GGA TTT GTA TCA AAA ACA GAT GAT 672 Tyr Arg Glu Thr Glu Glu Arg Ala Gly Phe Val Ser Lys Thr Asp Asp 210 215 220 TAT TTT TAT AAC TTT ATT GAC ACA TAT GGA GAT AAA GTA TTA GTA CCA 720 Tyr Phe Tyr Asn Phe lie Asp Thr Tyr Gly Asp Lys Val Leu Val Pro 225 230 235 240 TTA GCA TAT ATT GAC CTT GAT GAA TAT GTG TTA AAG TTG CAA CAG GAA 768 Leu Ala Tyr lie Asp Leu Asp Glu Tyr Val Leu Lys Leu Gin Gin Glu 245 250 255 TTG AAT GAC AAA GAA AAT CGT CGT GAT CAA ATG ATG GCG AAA GAA AAC 816 Leu Asn Asp Lys Glu Asn Arg Arg Asp Gin Met Met Ala Lys Glu Asn 260 265 270 AAA TCA GAT AAG CAA ATG AAG AAA ATT GCA GAA TTA GAT AAG CAA ATT 864 Lys Ser Asp Lys Gin Met Lys Lys lie Ala Glu Leu Asp Lys Gin lie 275 280 285 GAT CAT GAT CAG CAT GAA TTA TTG AAT GCA AGT GAA TTG AGC AAA ACG 912 Asp His Asp Gin His Glu Leu Leu Asn Ala Ser Glu Leu Ser Lys Thr 290 295 300 GAC GGC CCA ATT CTA AAC CTT GCT TCT GGC GTT TAT TTT GCA AAT GCA 960 Asp Gly Pro lie Leu Asn Leu Ala Ser Gly Val Tyr Phe Ala Asn Ala 305 310 315 320 TAT GAA GTG AAT TAT TTC TCT GGT GGT TCA TCA GAA AAA TAT AAT CAA 1008 Tyr Glu Val Asn Tyr Phe Ser Gly Gly Ser Ser Glu Lys Tyr Asn Gin 325 330 335 TTT ATG GGA CCA TAC ATG ATG CAT TGG TTT ATG ATT AAC TAT TGC TTC 1056 Phe Met Gly Pro Tyr Met Met His Trp Phe Met lie Asn Tyr Cys Phe 340 345 350 GAT AAT GGC TAT GAT CGT TAT AAT TTC TAT GGT TTA TCA GGT GAT TTT 1104 Asp Asn Gly Tyr Asp Arg Tyr Asn Phe Tyr Gly Leu Ser Gly Asp Phe 355 360 365 ACG GAA AAC AGT GAA GAT TAT GGC GTA TAC CGC TTT AAA CGT GGA TTT 1152 Thr Glu Asn Ser Glu Asp Tyr Gly Val Tyr Arg Phe Lys Arg Gly Phe 370 375 380 AAT GTA CAA ATC GAA GAA TTA ATA GGG GAT TTC TAT AAA CCA ATT CAT 1200 Asn Val Gin lie Glu Glu Leu He Gly Asp Phe Tyr Lys Pro He His 385 390 395 400 AAA GTG AAA TAT TGG TTG TTC ACA ACA TTG GAT AAA TTA CGT AAA AAA 1248 Lys Val Lys Tyr Trp Leu Phe Thr Thr Leu Asp Lys Leu Arg Lys Lys 405 410 415 TTA AAG AAA TAG 1260 Leu Lys Lys (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 419 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 2 : Met Lys Phe Thr Glu Leu Thr Val Thr Glu Phe Asp Asn Phe Val Gin 1 5 10 15 Asn Pro Ser Leu Glu Ser His Tyr Phe Gin Val Lys Glu Asn He Val 20 25 30 Thr Arg Glu Asn Asp Gly Phe Glu Val Val Leu Leu Gly He Lys Asp 35 40 45 Asp Asn Asn Lys Val He Ala Ala Ser Leu Phe Ser Lys He Pro Thr 50 55 60 Met Gly Ser Tyr Val Tyr Tyr Ser Asn Arg Gly Pro Val Met Asp Phe 65 70 75 80 Ser Asp Leu Gly ' Leu Val Asp Tyr Tyr Leu Lys Glu Leu Asp Lys Tyr 85 90 95 Leu Gin Gin His Gin Cys Leu Tyr Val Lys Leu Asp Pro Tyr Trp Leu 100 105 110 Tyr H-is Leu Tyr Asp Lys Asp He Val Pro Phe Glu Gly Arg Glu Lys 115 120 125 Asn Asp Ala Leu Val Asn Leu Phe Lys Ser His Gly Tyr Glu His His 130 135 140 Gly Phe Thr Thr Glu Tyr Asp Thr Ser Ser Gin Val Arg Trp Met Gly 145 150 155 160 Val Leu Asn Leu Glu Gly Lys Thr Pro Glu Thr Leu Lys Lys Thr Phe 165 170 175 Asp Ser Gin Arg Lys Arg Asn He Asn Lys Ala He Asn Tyr Gly Val 180 185 190 Lys Val Arg Phe Leu Glu Arg Asp Glu Phe Asn Leu Phe Leu Asp Leu 195 200 205 Tyr Arg Glu Thr Glu Glu Arg Ala Gly Phe Val Ser Lys Thr Asp Asp 210 215 220 Tyr Phe Tyr Asn Phe He Asp Thr Tyr Gly Asp Lys Val Leu Val Pro 225 230 235 240 Leu Ala Tyr He Asp Leu Asp Glu Tyr Val Leu Lys Leu Gin Gin Glu 245 250 255 Leu Asn Asp Lys Glu Asn Arg Arg Asp Gin Met Met Ala Lys Glu Asn 260 265 270 Lys Ser Asp Lys Gin Met Lys Lys He Ala Glu Leu Asp Lys Gin He 275 280 285 Asp His Asp Gin His Glu Leu Leu Asn Ala Ser Glu Leu Ser Lys Thr 290 295 300 Asp Gly Pro He Leu Asn Leu Ala Ser Gly Val Tyr Phe Ala Asn Ala 305 310 315 320 Tyr Glu Val Asn Tyr Phe Ser Gly Gly Ser Ser Glu Lys Tyr Asn Gin 325 330 335 Phe Met Gly Pro Tyr Met Met His Trp Phe Met He Asn Tyr Cys Phe 340 345 350 Asp Asn Gly Tyr Asp Arg Tyr Asn Phe Tyr Gly Leu Ser Gly Asp Phe 355 360 365 Thr Glu Asn Ser Glu Asp Tyr Gly Val Tyr Arg Phe Lys Arg Gly Phe 370 375 380 Asn Val Gin He Glu Glu Leu He Gly Asp Phe Tyr Lys Pro He His 385 390 395 400 Lys Val Lys Tyr Trp Leu Phe Thr Thr Leu Asp Lys Leu Arg Lys Lys 405 410 415 Leu Lys Lys (2) INFORMATION FOR SEQ ID NO • 3 (l) SEQUENCE CHARACTERISTICS (A) LENGTH 431 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY linear (n) MOLECULE TYPE other nucleic acid (A) DESCRIPTION /desc = "DNA (genomic) (p2c90)" (Xl) SEQUENCE DESCRIPTION. SEQ ID NO .3 GACGTGCTGA TGCAAATATA AGTNCATGAC CATCATGTTG TAATTGTNAC AATGTATCAA 60 TAATAGTCTG GTCAATTAAT CGGCCGTCAA AACAAAGCGT ACCATCAATA TCANAGACAA 120 ATCTCATCAN ATCACTCCAA ACAATATAAT ACCATGATTA TAGCATAAGT NAGTCATGTN 180 ACGATATTAG ATAATGATTA TNATGTAGGG TACCTTTTGC CTTACACACA TATNACTTCC 240 TATNATATAT ATTATGTCAA CNNGAATGTN AAATTCCATA AGGGGACTTA TATAACTGTN 300 TGTCTGTNTA GTGTTTATGT CAGTCAGCTA AATTNACATT CATGTTATGT CTCATTAAAC 360 CAATTACTCA CGTNTTGGTG CATATCNCAT CTTTCATATC GTCATACATC TATCCTCATT 420 CTCNTGNCTG A 431 (2) INFORMATION FOR SEQ ID NO 4 (l) SEQUENCE CHARACTERISTICS (A) LENGTH 729 base pairs (B) TYPE nucleic acid (C) STRANDEDNESS single (D) TOPOLOGY linear (n) MOLECULE TYPE other nucleic acid (A) DESCRIPTION /desc = "DNA (genomic) (p9b74)" (ix) FEATURE (A) NAME/KEY CDS (B) LOCATION 1 726 (xi) SEQUENCE DESCRIPTION SEQ ID NO 4 ATG ACT AAA TTA TTT ATA CCT TAT ATT ATG GGC AAT AAA GAT TTG ATT 48 Met Thr Lys Leu Phe He Pro Tyr He Met Gly Asn Lys Asp Leu He 1 5 10 15 GAA AAT GCA ACA TTG TTG AGT GAA AAT GGT GCA GAT ATA ATT GAA ATT 96 Glu Asn Ala Thr Leu Leu Ser Glu Asn Gly Ala Asp He He Glu He 20 25 30 GGA GTA CCT TTC TCT GAT CCG GTT GCT GAT GGT CCA GTT ATC ATG GAA 144 Gly Val Pro Phe Ser Asp Pro Val Ala Asp Gly Pro Val He Met Glu 35 40 45 GCA GGT CAA CAA GCG ATT AAA CAA GGC ATC ACG ATA GAT TAT ATT TTC 192 Ala Gly Gin Gin Ala He Lys Gin Gly He Thr He Asp Tyr He Phe 50 55 60 AAT CAA TTA GAA AAA CAT GGT GAT CAA ATT AAG TGT AAC TAT GTA TTA 240 Asn Gin Leu Glu Lys His Gly Asp Gin He Lys Cys Asn Tyr Val Leu 65 - 70 75 80 ATG ACG TAT TAT AAT ATT ATT TGT CAT TAT GGA GAA CAA GCG TTT TTT 288 Met Thr Tyr Tyr Asn He He Cys His Tyr Gly Glu Gin Ala Phe Phe 85 90 95 GAA AAA TGT CGA GAT ACT GGT GTC TAC GGC TTA ATT ATT CCT GAT TTA 336 Glu Lys Cys Arg Asp Thr Gly Val Tyr Gly Leu He He Pro Asp Leu 100 105 110 CCA TAT GAA TTA TCG CAG CGT TTA AAA CAA CAA TTT AGT CAC TAT GGC 384 Pro Tyr Glu Leu Ser Gin Arg Leu Lys Gin Gin Phe Ser His Tyr Gly 115 120 125 GTC AAA ATC ATA TCG TTA GTT GCG ATG ACT ACT GAT GAC AAA CGT ATA 432 Val Lys He He Ser Leu Val Ala Met Thr Thr Asp Asp Lys Arg He 130 135 140 AAA GAT ATC GTA TCC CAT GCG GAA GGC TTT ATT TAT ACT GTG ACG ATG 480 Lys Asp He Val Ser His Ala Glu Gly Phe He Tyr Thr Val Thr Met 145 150 155 160 AAT GCG ACA ACA GGG CAA AAC GGT GCG TTT CAT CCA GAA TTA AAA CGA 528 Asn Ala Thr Thr Gly Gin Asn Gly Ala Phe His Pro Glu Leu Lys Arg 165 170 175 AAA ATT GAG TCA ATT AAA GCG ATA GCC AAT GTG CCA GTT GTC GCA GGA 576 Lys He Glu Ser He Lys Ala He Ala Asn Val Pro Val Val Ala Gly 180 185 190 TTT GGT ATA AGA ACA CCA CAA CAT GTT GCA GAT ATA AAA GAG GTT GCA 624 Phe Gly He Arg Thr Pro Gin His Val Ala Asp He Lys Glu Val Ala 195 200 205 GAT GGC ATT GTC ATT GGT AGC GAA ATC GTT AAG CGA TTT AAA TCT AAC 672 Asp Gly He Val He Gly Ser Glu He Val Lys Arg Phe Lys Ser Asn 210 215 220 ACG CGT GAG GAA ATC ATT AAA TAT TTA CAA TCT ATC CAA CAA ACA TTG 720 Thr Arg Glu Glu He He Lys Tyr Leu Gin Ser He Gin Gin Thr Leu 225 230 235 240 AAT AAT TAA 729 Asn Asn (2) INFORMATION FOR SEQ ID NO : 5 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 242 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 : Met Thr Lys Leu Phe He Pro Tyr He Met Gly Asn Lys Asp Leu He 1 ' 5 10 15 Glu Asn Ala Thr Leu Leu Ser Glu Asn Gly Ala Asp He He Glu He 20 25 30 Gly Val Pro Phe Ser Asp Pro Val Ala Asp Gly Pro Val He Met Glu 35 40 45 Ala Gly Gin Gin Ala He Lys Gin Gly He Thr He Asp Tyr He Phe 50 55 60 Asn Gin Leu Glu Lys His Gly Asp Gin He Lys Cys Asn Tyr Val Leu 65 70 75 80 Met Thr Tyr Tyr Asn He He Cys His Tyr Gly Glu Gin Ala Phe Phe 85 90 95 Glu Lys Cys Arg Asp Thr Gly Val Tyr Gly Leu He He Pro Asp Leu 100 105 110 Pro Tyr Glu Leu Ser Gin Arg Leu Lys Gin Gin Phe Ser His Tyr Gly 115 120 125 Val Lys He He Ser Leu Val Ala Met Thr Thr Asp Asp Lys Arg He 130 135 140 Lys Asp He Val Ser His Ala Glu Gly Phe He Tyr Thr Val Thr Met 145 150 155 160 Asn Ala Thr Thr Gly Gin Asn Gly Ala Phe His Pro Glu Leu Lys Arg 165 170 175 Lys He Glu Ser He Lys Ala He Ala Asn Val Pro Val Val Ala Gly 180 185 190 Phe Gly He Arg Thr Pro Gin His Val Ala Asp He Lys Glu Val Ala 195 200 205 Asp Gly He Val He Gly Ser Glu He Val Lys Arg Phe Lys Ser Asn 210 215 220 Thr Arg Glu Glu He He Lys Tyr Leu Gin Ser He Gin Gin Thr Leu 225 230 235 240 Asn Asn (2) INFORMATION FOR SEQ ID NO : 6 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1260 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pllc29/pl3c83) " (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1257 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: ATG AAA TTT ACA GAG TTA ACT GTT ACC GAA TTT GAC AAC TTT GTA CAA 48 Met Lys Phe Thr Glu Leu Thr Val Thr Glu Phe Asp Asn Phe Val Gin 1 5 10 15 AAT CCA TCA TTG GAA AGT CAT TAT TTC CAA GTA AAA GAA AAT ATA GTT 96 Asn P-ro Ser Leu Glu Ser His Tyr Phe Gin Val Lys Glu Asn He Val 20 25 30 ACC CGT GAG AAT GAT GGC TTT GAA GTA GTT TTA TTA GGT ATT AAA GAC 144 Thr Arg Glu Asn Asp Gly Phe Glu Val Val Leu Leu Gly He Lys Asp 35 40 45 GAC AAT AAC AAA GTA ATT GCA GCA AGC CTT TTC TCT AAA ATT CCT ACT 192 Asp Asn Asn Lys Val He Ala Ala Ser Leu Phe Ser Lys He Pro Thr 50 55 60 ATG GGA AGT TAT GTT TAC TAT TCG AAT CGT GGT CCA GTA ATG GAT TTT 240 Met Gly Ser Tyr Val Tyr Tyr Ser Asn Arg Gly Pro Val Met Asp Phe 65 70 75 80 TCA GAT TTA GGA TTA GTT GAT TAT TAT TTA AAA GAG TTA GAT AAA TAT 288 Ser Asp Leu Gly Leu Val Asp Tyr Tyr Leu Lys Glu Leu Asp Lys Tyr 85 90 95 TTA CAG CAA CAT CAA TGT TTA TAT GTT AAA TTA GAT CCG TAT TGG TTA 336 Leu Gin Gin His Gin Cys Leu Tyr Val Lys Leu Asp Pro Tyr Trp Leu 100 105 110 TAT CAT CTA TAT GAT AAA GAT ATC GTG CCA TTT GAA GGT CGC GAG AAA 384 Tyr His Leu Tyr Asp Lys Asp He Val Pro Phe Glu Gly Arg Glu Lys 115 120 125 AAT GAT GCC CTA GTA AAC TTG TTT AAA TCA CAT GGT TAC GAG CAT CAT 432 Asn Asp Ala Leu Val Asn Leu Phe Lys Ser His Gly Tyr Glu His His 130 135 140 GGC TTT ACA ACT GAG TAT GAT ACA TCG AGC CAA GTA CGA TGG ATG GGC 480 Gly Phe Thr Thr Glu Tyr Asp Thr Ser Ser Gin Val Arg Trp Met Gly 145 150 155 160 GTA TTA AAC CTT GAA GGT AAA ACA CCC GAA ACA TTG AAA AAG ACA TTT 528 Val Leu Asn Leu Glu Gly Lys Thr Pro Glu Thr Leu Lys Lys Thr Phe 165 170 175 GAT AGT CAA CGT AAA CGT AAT ATT AAT AAA GCG ATA AAC TAT GGT GTT 576 Asp Ser Gin Arg Lys Arg Asn He Asn Lys Ala He Asn Tyr Gly Val 180 185 190 AAA GTC AGA TTC CTT GAA CGT GAT GAG TTC AAT CTT TTC TTA GAT TTA 624 Lys Val Arg Phe Leu Glu Arg Asp Glu Phe Asn Leu Phe Leu Asp Leu 195 200 205 TAT CGT GAA ACT GAA GAG CGT GCT GGA TTT GTA TCA AAA ACA GAT GAT 672 Tyr Arg Glu Thr Glu Glu Arg Ala Gly Phe Val Ser Lys Thr Asp Asp 210 215 220 TAT TTT TAT AAC TTT ATT GAC ACA TAT GGA GAT AAA GTA TTA GTA CCA 720 Tyr Phe Tyr Asn Phe He Asp Thr Tyr Gly Asp Lys Val Leu Val Pro 225 230 235 240 TTA GCA TAT ATT GAC CTT GAT GAA TAT GTG TTA AAG TTG CAA CAG GAA 768 Leu Ala Tyr He Asp Leu Asp Glu Tyr Val Leu Lys Leu Gin Gin Glu 245 250 255 TTG AAT GAC AAA GAA AAT CGT CGT GAT CAA ATG ATG GCG AAA GAA AAC 816 Leu Asn Asp Lys Glu Asn Arg Arg Asp Gin Met Met Ala Lys Glu Asn 260 265 270 AAA TCA GAT AAG CAA ATG AAG AAA ATT GCA GAA TTA GAT AAG CAA ATT 864 Lys Ser Asp Lys Gin Met Lys Lys He Ala Glu Leu Asp Lys Gin He 275 280 285 GAT CAT GAT CAG CAT GAA TTA TTG AAT GCA AGT GAA TTG AGC AAA ACG 912 Asp His Asp Gin His Glu Leu Leu Asn Ala Ser Glu Leu Ser Lys Thr 290 295 300 GAC GGC CCA ATT CTA AAC CTT GCT TCT GGC GTT TAT TTT GCA AAT GCA 960 Asp Gly Pro He Leu Asn Leu Ala Ser Gly Val Tyr Phe Ala Asn Ala 305 310 315 320 TAT GAA GTG AAT TAT TTC TCT GGT GGT TCA TCA GAA AAA TAT AAT CAA 1008 Tyr Glu Val Asn Tyr Phe Ser Gly Gly Ser Ser Glu Lys Tyr Asn Gin 325 330 335 TTT ATG GGA CCA TAC ATG ATG CAT TGG TTT ATG ATT AAC TAT TGC TTC 1056 Phe Met Gly Pro Tyr Met Met His Trp Phe Met He Asn Tyr Cys Phe 340 345 350 GAT AAT GGC TAT GAT CGT TAT AAT TTC TAT GGT TTA TCA GGT GAT TTT 1104 Asp Asn Gly Tyr Asp Arg Tyr Asn Phe Tyr Gly Leu Ser Gly Asp Phe 355 360 365 ACG GAA AAC AGT GAA GAT TAT GGC GTA TAC CGC TTT AAA CGT GGA TTT 1152 Thr Glu Asn Ser Glu Asp Tyr Gly Val Tyr Arg Phe Lys Arg Gly Phe 370 375 380 AAT GTA CAA ATC GAA GAA TTA ATA GGG GAT TTC TAT AAA CCA ATT CAT 1200 Asn Val Gin He Glu Glu Leu He Gly Asp Phe Tyr Lys Pro He His 385 390 395 400 AAA GTG AAA TAT TGG TTG TTC ACA ACA TTG GAT AAA TTA CGT AAA AAA 1248 Lys Val Lys Tyr Trp Leu Phe Thr Thr Leu Asp Lys Leu Arg Lys Lys 405 410 415 TTA AAG AAA TAG 1260 Leu Lys Lys (2) INFORMATION FOR SEQ ID NO : 7 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 419 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7 : Met Lys Phe Thr Glu Leu Thr Val Thr Glu Phe Asp Asn Phe Val Gin 1 5 10 15 Asn Pro Ser Leu Glu Ser His Tyr Phe Gin Val Lys Glu Asn He Val 20 25 30 Thr Arg Glu Asn Asp Gly Phe Glu Val Val Leu Leu Gly He Lys Asp 35 40 45 Asp Asn Asn Lys Val He Ala Ala Ser Leu Phe Ser Lys He Pro Thr 50 55 60 Met Gly Ser Tyr Val Tyr Tyr Ser Asn Arg Gly Pro Val Met Asp Phe 65 - 70 75 80 Ser Asp Leu Gly Leu Val Asp Tyr Tyr Leu Lys Glu Leu Asp Lys Tyr 85 90 95 Leu Gin Gin His Gin Cys Leu Tyr Val Lys Leu Asp Pro Tyr Trp Leu 100 105 110 Tyr His Leu Tyr Asp Lys Asp He Val Pro Phe Glu Gly Arg Glu Lys 115 120 125 Asn Asp Ala Leu Val Asn Leu Phe Lys Ser His Gly Tyr Glu His His 130 135 140 Gly Phe Thr Thr Glu Tyr Asp Thr Ser Ser Gin Val Arg Trp Met Gly 145 150 155 160 Val Leu Asn Leu Glu Gly Lys Thr Pro Glu Thr Leu Lys Lys Thr Phe 165 170 175 Asp Ser Gin Arg Lys Arg Asn He Asn Lys Ala He Asn Tyr Gly Val 180 185 190 Lys Val Arg Phe Leu Glu Arg Asp Glu Phe Asn Leu Phe Leu Asp Leu 195 200 205 Tyr Arg Glu Thr Glu Glu Arg Ala Gly Phe Val Ser Lys Thr Asp Asp 210 215 220 Tyr Phe Tyr Asn Phe He Asp Thr Tyr Gly Asp Lys Val Leu Val Pro 225 230 235 240 Leu Ala Tyr He Asp Leu Asp Glu Tyr Val Leu Lys Leu Gin Gin Glu 245 250 255 Leu Asn Asp Lys Glu Asn Arg Arg Asp Gin Met Met Ala Lys Glu Asn 260 265 270 Lys Ser Asp Lys Gin Met Lys Lys He Ala Glu Leu Asp Lys Gin He 275 280 285 Asp His Asp Gin His Glu Leu Leu Asn Ala Ser Glu Leu Ser Lys Thr 290 295 300 Asp Gly Pro He Leu Asn Leu Ala Ser Gly Val Tyr Phe Ala Asn Ala 305 310 315 320 Tyr Glu Val Asn Tyr Phe Ser Gly Gly Ser Ser Glu Lys Tyr Asn Gin 325 330 335 Phe Met Gly Pro Tyr Met Met His Trp Phe Met He Asn Tyr Cys Phe 340 345 350 Asp Asn Gly Tyr Asp Arg Tyr Asn Phe Tyr Gly Leu Ser Gly Asp Phe 355 360 365 Thr Glu Asn Ser Glu Asp Tyr Gly Val Tyr Arg Phe Lys Arg Gly Phe 370 375 380 Asn Val Gin He Glu Glu Leu He Gly Asp Phe Tyr Lys Pro He His 385 390 395 400 Lys Val Lys Tyr Trp Leu Phe Thr Thr Leu Asp Lys Leu Arg Lys Lys 405 410 415 Leu Lys Lys (2) INFORMATION FOR SEQ ID NO : 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 731 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p4cl5/p6c63) ; Unknown = Xaa" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..417 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 524..730 (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 8 : ATG GAA TTC ACT TAT TCG TAT TTA TTT AGA ATG ATT AGT CAT GAG ATG 48 Met Glu Phe Thr Tyr Ser Tyr Leu Phe Arg Met He Ser His Glu Met 1 5 10 15 AAA CAA AAG GCT GAT CAA AAG TTA GAG CAA TTT GAT ATT ACA AAT GAG 96 Lys Gin Lys Ala Asp Gin Lys Leu Glu Gin Phe Asp He Thr Asn Glu 20 25 30 CAA GGT CAT ACG TTA GGT TAT CTT TAT GCA CAT CAA CAA GAT GGA CTG 144 Gin Gly His Thr Leu Gly Tyr Leu Tyr Ala His Gin Gin Asp Gly Leu 35 40 45 ACA CAA AAT GAT ATT GCT AAA GCA TTA CAA CGA ACA GGT CCA ACT GTC 192 Thr Gin Asn Asp He Ala Lys Ala Leu Gin Arg Thr Gly Pro Thr Val 50 55 60 AGT AAT TTA TTA AGG AAC CTT GAA CGT AAA AAG CTG ATC TAT CGC TAT 240 Ser Asn Leu Leu Arg Asn Leu Glu Arg Lys Lys Leu He Tyr Arg Tyr 65 70 75 80 GTC GAT GCA CAA GAT ACG AGA AGA AAG AAT ATA GGG CTG ACT ACC TCT 288 Val Asp Ala Gin Asp Thr Arg Arg Lys Asn He Gly Leu Thr Thr Ser 85 90 95 GGG ATT AAA CTC GTA GAA GCA TTC ACT TCG ATA TTT GAT GAA ATG GAA 336 Gly He Lys Leu Val Glu Ala Phe Thr Ser He Phe Asp Glu Met Glu 100 105 110 CAA ACA CTC GTA TCG CAG TTA TCT GAA GAA GAA AAT GAA CAA ATG AAA 384 Gin Thr Leu Val Ser Gin Leu Ser Glu Glu Glu Asn Glu Gin Met Lys 115 120 125 GCA AAC TTA ACT AAA ATG TTA TCT AGT TTA CAA TAAATGATAA GTGTGACTGG 437 Ala Asn Leu Thr Lys Met Leu Ser Ser Leu Gin 130 135 TAGAAATCAG TCACTTTGTC TTTAATATTA TAGTTAGATA TCTAATTGTT AGTAAGCTAA 497 TTATTGGAAA AGACAAGGAG TATTGA ACA ATG AAA GAC GAA CAA TTA TAT TAT 550 Thr Met Lys Asp Glu Gin Leu Tyr Tyr 1 5 TTT GAG AAA TCG CCA GTA TTT AAA GCG ATG ATG CAT TTC TCA TTG CCA 598 Phe Glu Lys Ser Pro Val Phe Lys Ala Met Met His Phe Ser Leu Pro 10 15 20 25 ATG ATG ATA GGG ACT TTA TTA AGC GTT ATT TAT GGC ATA TTA AAT ATT 646 Met Met He Gly Thr Leu Leu Ser Val He Tyr Gly He Leu Asn He 30 35 40 TAC TTT ATA GGA TTT TYA GAM GAY AGC CAC ATG ATT TCT GCT AAT CTC 694 Tyr Phe He Gly Phe Xaa Xaa Asp Ser His Met He Ser Ala Asn Leu 45 50 55 TCT AAC ACT GCC AGT ATT TGC TAT CTT AAT GGG GTT A 731 Ser Asn Thr Ala Ser He Cys Tyr Leu Asn Gly Val 60 65 (2) INFORMATION FOR SEQ ID NO : 9 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 139 amino acids (B) TYPE: ammo acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 : Met Glu Phe Thr Tyr Ser Tyr Leu Phe Arg Met He Ser His Glu Met 1 5 10 15 Lys Gin Lys Ala Asp Gin Lys Leu Glu Gin Phe Asp He Thr Asn Glu 20 25 30 Gin Gly His Thr Leu Gly Tyr Leu Tyr Ala His Gin Gin Asp Gly Leu 35 40 45 Thr Gin Asn Asp He Ala Lys Ala Leu Gin Arg Thr Gly Pro Thr Val 50 55 60 Ser Asn Leu Leu Arg Asn Leu Glu Arg Lys Lys Leu He Tyr Arg Tyr 65 70 75 80 Val Asp Ala Gin Asp Thr Arg Arg Lys Asn He Gly Leu Thr Thr Ser 85 90 95 Gly He Lys Leu Val Glu Ala Phe Thr Ser He Phe Asp Glu Met Glu 100 105 110 Gin Thr Leu Val Ser Gin Leu Ser Glu Glu Glu Asn Glu Gin Met Lys 115 120 125 Ala Asn Leu Thr Lys Met Leu Ser Ser Leu Gin 130 135 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS; (A) LENGTH: 69 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: Thr Met Lys Asp Glu Gin Leu Tyr Tyr Phe Glu Lys Ser Pro Val Phe 1 5 10 15 Lys Ala Met Met His Phe Ser Leu Pro Met Met He Gly Thr Leu Leu 20 25 30 Ser Val He Tyr Gly He Leu Asn He Tyr Phe He Gly Phe Xaa Xaa 35 40 45 Asp Ser His Met He Ser Ala Asn Leu Ser Asn Thr Ala Ser He Cys 50 55 60 Tyr Leu Asn Gly Val 65 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 828 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p5c4)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..825 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: GTG AGG TAC TTG CCT GTG AAT GCG ATT GAA ATC CCG ACT ACC GCC GGC 48 Val Arg Tyr Leu Pro Val Asn Ala He Glu He Pro Thr Thr Ala Gly 1 5 10 15 ACG CCT GAC GCG CCC TTC TAC CAA CCG TTG GGC AAT GAA GAG CAG CTG 96 Thr Pro Asp Ala Pro Phe Tyr Gin Pro Leu Gly Asn Glu Glu Gin Leu 20 25 30 TTC CAG CAG GCC TGG CAG CAC GGC ATG CCC GTG CTT ATC AAG GGC CCG 144 Phe Gin Gin Ala Trp Gin His Gly Met Pro Val Leu He Lys Gly Pro 35 40 45 ACC GGC TGC GGC AAG ACC CGT TTC GTA CAG CAC ATG GCG CAT CGC CTG 192 Thr Gly Cys Gly Lys Thr Arg Phe Val Gin His Met Ala His Arg Leu 50 55 60 AAT CTG CCG CTG TAC ACC GTG GCC TGC CAT GAC GAC CTG TCG GCG GCC 240 Asn Leu Pro Leu Tyr Thr Val Ala Cys His Asp Asp Leu Ser Ala Ala 65 70 75 80 GAC CTG GTC GGC CGA CAC CTG ATC GGC GCA CAG GGC ACC TGG TGC CAG 288 Asp Leu Val Gly Arg His Leu He Gly Ala Gin Gly Thr Trp Trp Gin 85 90 95 GAC GGT CCG CTG ACC CGC GCG GTC CGC GAA GGA GGC ATC TGC TAC CTG 336 Asp Gly Pro Leu Thr Arg Ala Val Arg Glu Gly Gly He Cys Tyr Leu 100 105 110 GAC GAA GTG GTG GAA GCA CGG CAG GAC ACC GCC GTG GTA CTG CAC CCG 384 Asp Glu Val Val Glu Ala Arg Gin Asp Thr Ala Val Val Leu His Pro 115 120 125 CTG GCC GAT GAT CGC CGC GAA CTG TTC ATC GAG CGC ACC GGC GAG GCG 432 Leu Ala Asp Asp Arg Arg Glu Leu Phe He Glu Arg Thr Gly Glu Ala 130 135 140 CTC AAG GCG CCG CCG GGC TTC ATG CTG GTG GTG TCC TAC AAC CCC GGT 480 Leu Lys Ala Pro Pro Gly Phe Met Leu Val Val Ser Tyr Asn Pro Gly 145 150 155 160 TAC CAA AAC CTG CTC AAG GGC ATG AAG CCC AGC ACC CGC CAG CGC TTC 528 Tyr Gin Asn Leu Leu Lys Gly Met Lys Pro Ser Thr Arg Gin Arg Phe 165 170 175 GTG GCG ATG CGC TTC GAC TAT CCG CCG ACC GCC GAG GAA GAG CGC ATC 576 Val Ala Met Arg Phe Asp Tyr Pro Pro Thr Ala Glu Glu Glu Arg He 180 185 190 GTC GCC AAC GAG GCG CAG GTC GAT GCC GCG CTC GCC GCC CAG GTG GTC 624 Val Ala Asn Glu Ala Gin Val Asp Ala Ala Leu Ala Ala Gin Val Val 195 200 205 AAG CTT GGC CAG GCA CTG CGT CGG CTG GAA CAG CAC GAT CTG GAG GAA 672 Lys Leu Gly Gin Ala Leu Arg Arg Leu Glu Gin His Asp Leu Glu Glu 210 215 220 GTC GCC TCG ACC CGC CTG CTG ATC TTC ACC GCA CGC ATG ATC CGC TCC 720 Val Ala Ser Thr Arg Leu Leu He Phe Thr Ala Arg Met He Arg Ser 225 230 235 240 GGC ATG ACG CCG CGG CAG GCC TGC CTG GCC TGC CTC GCC GAA CCG CTG 768 Gly Met Thr Pro Arg Gin Ala Cys Leu Ala Cys Leu Ala Glu Pro Leu 245 250 255 TCG GAT GAT CCG CAG ACC GTT GCC GCG CTG ATG GAT GTG GTC TAT GTC 816 Ser Asp Asp Pro Gin Thr Val Ala Ala Leu Met Asp Val Val Tyr Val 260 265 270 CAC TTC GGC TGA 828 His Phe Gly 275 (2) INFORMATION FOR SEQ ID NO : 12 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 275 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: Val Arg Tyr Leu Pro Val Asn Ala He Glu He Pro Thr Thr Ala Gly 1 5 10 15 Thr Pro Asp Ala Pro Phe Tyr Gin Pro Leu Gly Asn Glu Glu Gin Leu 20 25 30 Phe Gin Gin Ala Trp Gin His Gly Met Pro Val Leu He Lys Gly Pro 35 40 45 Thr Gly Cys Gly Lys Thr Arg Phe Val Gin His Met Ala His Arg Leu 50 55 60 Asn Leu Pro Leu Tyr Thr Val Ala Cys His Asp Asp Leu Ser Ala Ala 65 70 75 80 Asp Leu Val Gly Arg His Leu He Gly Ala Gin Gly Thr Trp Trp Gin 85 90 95 Asp Gly Pro Leu Thr Arg Ala Val Arg Glu Gly Gly He Cys Tyr Leu 100 105 110 Asp Glu Val Val Glu Ala Arg Gin Asp Thr Ala Val Val Leu His Pro 115 120 125 Leu Ala Asp Asp Arg Arg Glu Leu Phe He Glu Arg Thr Gly Glu Ala 130 135 140 Leu Lys Ala Pro Pro Gly Phe Met Leu Val Val Ser Tyr Asn Pro Gly 145 150 155 160 Tyr Gin Asn Leu Leu Lys Gly Met Lys Pro Ser Thr Arg Gin Arg Phe 165 170 175 Val Ala Met Arg Phe Asp Tyr Pro Pro Thr Ala Glu Glu Glu Arg He 180 185 190 Val Ala Asn Glu Ala Gin Val Asp Ala Ala Leu Ala Ala Gin Val Val 195 200 205 Lys Leu Gly Gin Ala Leu Arg Arg Leu Glu Gin His Asp Leu Glu Glu 210 215 220 Val Ala Ser Thr Arg Leu Leu He Phe Thr Ala Arg Met He Arg Ser 225 230 235 240 Gly Met Thr Pro Arg Gin Ala Cys Leu Ala Cys Leu Ala Glu Pro Leu 245 250 255 Ser Asp Asp Pro Gin Thr Val Ala Ala Leu Met Asp Val Val Tyr Val 260 265 270 His Phe Gly 275 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 528 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p9b66) " Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B ) LOCATION : 1 . . 525 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: ATG GAA AGG ATG TCA AAA ATG AAT ATT AAT ACA GCT TAT TTT GCC GGA 48 Met Glu Arg Met Ser Lys Met Asn He Asn Thr Ala Tyr Phe Ala Gly 1 5 10 15 GGT TGC TTT TGG TGT ATG ACG AAA CCA TTT GAC ACC TTT GAC GGC ATA 96 Gly Cys Phe Trp Cys Met Thr Lys Pro Phe Asp Thr Phe Asp Gly He 20 25 30 GAA AAA GTA ACT TCT GGA TAT ATG GGC GGA CAT ATT GAA AAT CCT ACT 144 Glu Lys Val Thr Ser Gly Tyr Met Gly Gly His He Glu Asn Pro Thr 35 40 45 TAC GAA CAA GTA AAA TCA GGT ACG AGT GGT CAT TTA GAA ACT GTT GAA 192 Tyr Glu Gin Val Lys Ser Gly Thr Ser Gly His Leu Glu Thr Val Glu 50 55 60 ATT CAA TAT GAT GTT GCA TTA TTC TCA TAC AAT AAG TTA TTA GAA ATA 240 He Gin Tyr Asp Val Ala Leu Phe Ser Tyr Asn Lys Leu Leu Glu He 65 70 75 80 TTT TTC TCA GTC ATT GAC CCA TTA GAT ACA GGT GGT CAA TAT CAA GAC 288 Phe Phe Ser Val He Asp Pro Leu Asp Thr Gly Gly Gin Tyr Gin Asp 85 90 95 CGT GGT CCT CAA TAT nAA ACA GCT ATT TTC TAC ACT AAT GAT CAT CAA 336 Arg Gly Pro Gin Tyr Xaa Thr Ala He Phe Tyr Thr Asn Asp His Gin 100 105 110 AAA GAA CTC GCT GAG ACT TAT ATC GAG CAG CTT AAA AAT ACG ATT AAT 384 Lys Glu Leu Ala Glu Thr Tyr He Glu Gin Leu Lys Asn Thr He Asn 115 120 125 GCT GAT AAG GCA ATT GCA ACA AAA ATA yTA CCA GCG TCA CAA TTT TAC 432 Ala Asp Lys Ala He Ala Thr Lys He Leu Pro Ala Ser Gin Phe Tyr 130 135 140 AAA GCC GAA GAC TAT CAC CAA GAT TTT TAT AAG AAA AAT CCA GAG CGC 480 Lys Ala Glu Asp Tyr His Gin Asp Phe Tyr Lys Lys Asn Pro Glu Arg 145 150 155 160 TAT GCA GAA GAA CAA AAA ATA CGC CAA GAA TAC AAA AAT AAG CAA 525 Tyr Ala Glu Glu Gin Lys He Arg Gin Glu Tyr Lys Asn Lys Gin 165 170 175 TAA 528 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 175 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: Met Glu Arg Met Ser Lys Met Asn He Asn Thr Ala Tyr Phe Ala Gly 1 5 10 15 Gly Cys Phe Trp Cys Met Thr Lys Pro Phe Asp Thr Phe Asp Gly He 20 25 30 Glu Lys Val Thr Ser Gly Tyr Met Gly Gly His He Glu Asn Pro Thr 35 40 45 Tyr Glu Gin Val Lys Ser Gly Thr Ser Gly His Leu Glu Thr Val Glu 50 55 60 He Gin Tyr Asp Val Ala Leu Phe Ser Tyr Asn Lys Leu Leu Glu He 65 70 75 80 Phe Phe Ser Val He Asp Pro Leu Asp Thr Gly Gly Gin Tyr Gin Asp 85 90 95 Arg Gly Pro Gin Tyr Xaa Thr Ala He Phe Tyr Thr Asn Asp His Gin 100 105 110 Lys Glu Leu Ala Glu Thr Tyr He Glu Gin Leu Lys Asn Thr He Asn 115 120 125 Ala Asp Lys Ala He Ala Thr Lys He Leu Pro Ala Ser Gin Phe Tyr 130 135 140 Lys Ala Glu Asp Tyr His Gin Asp Phe Tyr Lys Lys Asn Pro Glu Arg 145 150 155 160 Tyr Ala Glu Glu Gin Lys He Arg Gin Glu Tyr Lys Asn Lys Gin 165 170 175 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 702 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p7c26)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..699 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: ATG ATT GAG TTA AAA CAT GTG ACT TTT GGT TAT AAT AAA AAG CAG ATG 48 Met He Glu Leu Lys His Val Thr Phe Gly Tyr Asn Lys Lys Gin Met 1 5 10 15 GTG CTA CAA GAT ATC AAT ATT ACT ATA CCT GAT GGA GAA AAT GTT GGT 96 Val Leu Gin Asp He Asn He Thr He Pro Asp Gly Glu Asn Val Gly 20 25 30 ATT TTA GGC GAA AGT GGC TGT GGT AAA AGT ACG CTC GCT TCA TTG GTT 144 He Leu Gly Glu Ser Gly Cys Gly Lys Ser Thr Leu Ala Ser Leu Val 35 40 45 CTT GGC TTG TTT AAA CCT GTT AAA GGA GAG ATT TAC TTA AGT GAC AAT 192 Leu Gly Leu Phe Lys Pro Val Lys Gly Glu He Tyr Leu Ser Asp Asn 50 55 60 GCT GTG TTA CCG ATT TTC CAA CAC CCT TTA ACT AGC TTT AAC CCT GAT 240 Ala Val Leu Pro He Phe Gin His Pro Leu Thr Ser Phe Asn Pro Asp 65 70 75 80 TGG ACG ATT GAG ACC TCA TTA AAA GAA GCG TTA TAT TAT TAC AGA GGT 288 Trp Thr He Glu Thr Ser Leu Lys Glu Ala Leu Tyr Tyr Tyr Arg Gly 85 90 95 CTA ACT GAT AAT ACT GCT CAG GAT CAA TTA TTA TTA CAA CAT TTA TCT 336 Leu Thr Asp Asn Thr Ala Gin Asp Gin Leu Leu Leu Gin His Leu Ser 100 105 110 ACT TTT GAG TTA AAC GCG CAA TTA TTG ACT AAA TTA CCA AGC GAA GTG 384 Thr Phe Glu Leu Asn Ala Gin Leu Leu Thr Lys Leu Pro Ser Glu Val 115 120 125 AGT GGC GGA CAA TTA CAA AGA TTT AAT GTC ATG CGT TCG TTA TTA GCA 432 Ser Gly Gly Gin Leu Gin Arg Phe Asn Val Met Arg Ser Leu Leu Ala 130 135 140 CAG CCT CGC GTT TTA ATA TGT GAT GAG ATA ACT TCA AAT TTA GAT GTT 480 Gin Pro Arg Val Leu He Cys Asp Glu He Thr Ser Asn Leu Asp Val 145 150 155 160 ATA GCT GAA CAA AAT GTA ATC AAT ATA TTA AAA GCG CAA ACG ATT ACG 528 He Ala Glu Gin Asn Val He Asn He Leu Lys Ala Gin Thr He Thr 165 170 175 AAC TTA AAT CAT TTT ATC GTT ATT TCT CAT GAT TTA TCC GTG TTA CAA 576 Asn Leu Asn His Phe He Val He Ser His Asp Leu Ser Val Leu Gin 180 185 190 CGC TTA GTT AAT AGA ATT ATC GTT CTT AAG GAT GGC ATG ATA GTC GAT 624 Arg Leu Val Asn Arg He He Val Leu Lys Asp Gly Met He Val Asp 195 200 205 GAT TTT GCA ATA GAG GAA TTA TTT AAT GTT GAT AGA CAC CCT TAT ACA 672 Asp Phe Ala He Glu Glu Leu Phe Asn Val Asp Arg His Pro Tyr Thr 210 215 220 AAA GAA TTA GTG CAA GCA TTT TCA TAT TAG 702 Lys Glu Leu Val Gin Ala Phe Ser Tyr 225 230 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 233 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: Met He Glu Leu Lys His Val Thr Phe Gly Tyr Asn Lys Lys Gin Met 1 5 10 15 Val Leu Gin Asp He Asn He Thr He Pro Asp Gly Glu Asn Val Gly 20 25 30 He Leu Gly Glu Ser Gly Cys Gly Lys Ser Thr Leu Ala Ser Leu Val 35 40 45 Leu Gly Leu Phe Lys Pro Val Lys Gly Glu He Tyr Leu Ser Asp Asn 50 55 60 Ala Val Leu Pro He Phe Gin His Pro Leu Thr Ser Phe Asn Pro Asp 65 70 75 80 Trp Thr He Glu Thr Ser Leu Lys Glu Ala Leu Tyr Tyr Tyr Arg Gly 85 90 95 Leu Thr Asp Asn Thr Ala Gin Asp Gin Leu Leu Leu Gin His Leu Ser 100 105 110 Thr Phe Glu Leu Asn Ala Gin Leu Leu Thr Lys Leu Pro Ser Glu Val 115 120 125 Ser Gly Gly Gin Leu Gin Arg Phe Asn Val Met Arg Ser Leu Leu Ala 130 135 140 Gin Pro Arg Val Leu He Cys Asp Glu He Thr Ser Asn Leu Asp Val 145 150 155 160 He Ala Glu Gin Asn Val He Asn He Leu Lys Ala Gin Thr He Thr 165 170 175 Asn Leu Asn His Phe He Val He Ser His Asp Leu Ser Val Leu Gin 180 185 190 Arg Leu Val Asn Arg He He Val Leu Lys Asp Gly Met He Val Asp 195 200 205 Asp Phe Ala He Glu Glu Leu Phe Asn Val Asp Arg His Pro Tyr Thr 210 215 220 Lys Glu Leu Val Gin Ala Phe Ser Tyr 225 230 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0cl5)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..774 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: ATG ATG AGT CTC ATT GAT ATA CAA AAT TTA ACA ATA AAG AAT ACT AGT 48 Met Met Ser Leu He Asp He Gin Asn Leu Thr He Lys Asn Thr Ser 1 5 10 15 GAG AAA TCT CTT ATT AAA GGG ATT GAT TTG AAA ATT TTT AGT CAA CAG 96 Glu Lys Ser Leu He Lys Gly He Asp Leu Lys He Phe Ser Gin Gin 20 25 30 ATT AAT GCC TTG ATT GGA GAG AGC GGC GCT GGA AAA AGT TTG ATT GCT 144 He Asn Ala Leu He Gly Glu Ser Gly Ala Gly Lys Ser Leu He Ala 35 40 45 AAA GCT TTA CTT GAA TAT TTA CCA TTT GAT TTA AGC TGC ACG TAT GAT 192 Lys Ala Leu Leu Glu Tyr Leu Pro Phe Asp Leu Ser Cys Thr Tyr Asp 50 55 60 TCG TAC CAA TTT GAT GGG GAA AAT GTT AGT AGA TTG AGT CAA TAT TAT 240 Ser Tyr Gin Phe Asp Gly Glu Asn Val Ser Arg Leu Ser Gin Tyr Tyr 65 70 75 80 GGT CAT ACA ATT GGC TAT ATT TCT CAA AAT TAT GCA GAA AGT TTT AAC 288 Gly His Thr He Gly Tyr He Ser Gin Asn Tyr Ala Glu Ser Phe Asn 85 90 95 GAC CAT ACT AAA TTA GGT AAA CAG TTA ACT GCG ATT TAT CGT AAG CAT 336 Asp His Thr Lys Leu Gly Lys Gin Leu Thr Ala He Tyr Arg Lys His 100 105 110 TAT AAA GGT AGT AAA GAA GAG GCT TTG TCC AAA GTT GAT AAG GCT TTG 384 Tyr Lys Gly Ser Lys Glu Glu Ala Leu Ser Lys Val Asp Lys Ala Leu 115 120 125 TCG TGG GTT AAT TTA CAA AGC AAA GAT ATA TTA AAT AAA TAT AGT TTC 432 Ser Trp Val Asn Leu Gin Ser Lys Asp He Leu Asn Lys Tyr Ser Phe 130 135 140 CAA CTT TCT GGG GGC CAA CTT GAA CGC GTA TAC ATA GCA AGC GTT CTC 480 Gin Leu Ser Gly Gly Gin Leu Glu Arg Val Tyr He Ala Ser Val Leu 145 150 155 160 ATG TTG GAG CCT AAA TTA ATC ATT GCA GAC GAA CCA GTT GCA TCA TTG 528 Met Leu Glu Pro Lys Leu He He Ala Asp Glu Pro Val Ala Ser Leu 165 170 175 GAT GCT TTG AAC GGT AAT CAA GTG ATG GAT TTA TTA CAG CAT ATT GTA 576 Asp Ala Leu Asn Gly Asn Gin Val Met Asp Leu Leu Gin His He Val 180 185 190 TTA GAA CAT GGT CAA ACA TTA TTT ATT ATC ACA CAT AAC TTA AGT CAT 624 Leu Glu His Gly Gin Thr Leu Phe He He Thr His Asn Leu Ser His 195 200 205 GTA TTG AAA TAT TGT CAG TAC ATT TAT GTT TTA AAA GAA GGT CAA ATC 672 Val Leu Lys Tyr Cys Gin Tyr He Tyr Val Leu Lys Glu Gly Gin He 210 215 220 ATT GAA CGA GGT AAT ATT AAT CAT TTC AAG TAT GAG CAT TTG CAT CCG 720 He Glu Arg Gly Asn He Asn His Phe Lys Tyr Glu His Leu His Pro 225 230 235 240 TAT ACT GAA CGT CTA ATT AAA TAT AGA ACA CAA TTA AAG AGG GAT TAC 768 Tyr Thr Glu Arg Leu He Lys Tyr Arg Thr Gin Leu Lys Arg Asp Tyr 245 250 255 TAT GAT TGAGTTAAAA CATGTGACTT TTGGTTATAA TAAAAAGCAG ATGGTGCTAC 824 Tyr Asp AAGATATCAA TATTACTATA CCTGATGGAG AAAATGTTGG TATTTTAGGC GAAAGTGGCT 884 GTGGTAAAAG TACGCTCGCT TCATTGGTTC TTGGCTTGTT TAAACCTGTT AAAGGAGAGA 944 TTTACTTAAG TGACAATGCT GTGTTACCGA TTTTCCAACA CCCTTTAACT AGCTTTAACC 1004 CTGATTGGAC GATTGAGACC TCATTAAAAG AAGCGTTATA TTATTACAGA GGTCTAACTG 1064 ATAATACTGC TCAGGATCAA TTATTATTAC AACATTTATC TACTTTTGAG TTAAACGCGC 1124 AATTATTGAC TAAATTACCA AGCGAAGTGA GTGGCGGACA ATTACAAAGA TTTAATGTCA 1184 TGCGTTCGTT ATTAGCACAG CCTCGCGTTT TAATATGTGA TGAGATAACT TCAAATTTAG 1244 ATGTTATAGC TGAACAAAAT GTAATCAATA TATTAAAAGC GCAAACGATT ACGAACTTAA 1304 ATCATTTTAT CGTTATTTCT CATGATTTAT CCGTGTTACA ACGCTTAGTT AATAGAATTA 1364 TCGTTCTTAA GGATGGCATG ATAGTCGATG ATTTTGCAAT AGAGGAATTA TTTAATGTTG 1424 ATAGACACCC TTATACAAAA GAATTAGTGC AAGCATTTTC ATATTAG 1471 (2) INFORMATION FOR SEQ ID NO 18 (l) SEQUENCE CHARACTERISTICS (A) LENGTH 258 ammo acids (D) TOPOLOGY linear (ii) MOLECULE TYPE protein (xi) SEQUENCE DESCRIPTION SEQ ID NO 18 Met Met Ser Leu He Asp He Gin Asn Leu Thr He Lys Asn Thr Ser 1 5 10 15 Glu Lys Ser Leu He Lys Gly He Asp Leu Lys He Phe Ser Gin Gin 20 25 30 He Asn Ala Leu He Gly Glu Ser Gly Ala Gly Lys Ser Leu He Ala 35 40 45 Lys Ala Leu Leu Glu Tyr Leu Pro Phe Asp Leu Ser Cys Thr Tyr Asp 50 55 60 Ser Tyr Gin Phe Asp Gly Glu Asn Val Ser Arg Leu Ser Gin Tyr Tyr 65 70 75 80 Gly His Thr He Gly Tyr He Ser Gin Asn Tyr Ala Glu Ser Phe Asn 85 90 95 Asp His Thr Lys Leu Gly Lys Gin Leu Thr Ala He Tyr Arg Lys His 100 105 110 Tyr Lys Gly Ser Lys Glu Glu Ala Leu Ser Lys Val Asp Lys Ala Leu 115 120 125 Ser Trp Val Asn Leu Gin Ser Lys Asp He Leu Asn Lys Tyr Ser Phe 130 135 140 Gin Leu Ser Gly Gly Gin Leu Glu Arg Val Tyr He Ala Ser Val Leu 145 150 155 160 Met Leu Glu Pro Lys Leu He He Ala Asp Glu Pro Val Ala Ser Leu 165 170 175 Asp Ala Leu Asn Gly Asn Gin Val Met Asp Leu Leu Gin His He Val 180 185 190 Leu Glu His Gly Gin Thr Leu Phe He He Thr His Asn Leu Ser His 195 200 205 Val Leu Lys Tyr Cys Gin Tyr He Tyr Val Leu Lys Glu Gly Gin He 210 215 220 He Glu Arg Gly Asn He Asn His Phe Lys Tyr Glu His Leu His Pro 225 230 235 240 Tyr Thr Glu Arg Leu He Lys Tyr Arg Thr Gin Leu Lys Arg Asp Tyr 245 250 255 Tyr Asp (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0cl5)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 770..1468 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: ATGATGAGTC TCATTGATAT ACAAAATTTA ACAATAAAGA ATACTAGTGA GAAATCTCTT 60 ATTAAAGGGA TTGATTTGAA AATTTTTAGT CAACAGATTA ATGCCTTGAT TGGAGAGAGC 120 GGCGCTGGAA AAAGTTTGAT TGCTAAAGCT TTACTTGAAT ATTTACCATT TGATTTAAGC 180 TGCACGTATG ATTCGTACCA ATTTGATGGG GAAAATGTTA GTAGATTGAG TCAATATTAT 240 GGTCATACAA TTGGCTATAT TTCTCAAAAT TATGCAGAAA GTTTTAACGA CCATACTAAA 300 TTAGGTAAAC AGTTAACTGC GATTTATCGT AAGCATTATA AAGGTAGTAA AGAAGAGGCT 360 TTGTCCAAAG TTGATAAGGC TTTGTCGTGG GTTAATTTAC AAAGCAAAGA TATATTAAAT 420 AAATATAGTT TCCAACTTTC TGGGGGCCAA CTTGAACGCG TATACATAGC AAGCGTTCTC 480 ATGTTGGAGC CTAAATTAAT CATTGCAGAC GAACCAGTTG CATCATTGGA TGCTTTGAAC 540 GGTAATCAAG TGATGGATTT ATTACAGCAT ATTGTATTAG AACATGGTCA AACATTATTT 600 ATTATCACAC ATAACTTAAG TCATGTATTG AAATATTGTC AGTACATTTA TGTTTTAAAA 660 GAAGGTCAAA TCATTGAACG AGGTAATATT AATCATTTCA AGTATGAGCA TTTGCATCCG 720 TATACTGAAC GTCTAATTAA ATATAGAACA CAATTAAAGA GGGATTACT ATG ATT 775 Met He 1 GAG TTA AAA CAT GTG ACT TTT GGT TAT AAT AAA AAG CAG ATG GTG CTA 823 Glu Leu Lys His Val Thr Phe Gly- Tyr Asn Lys Lys Gin Met Val Leu 5 10 15 CAA GAT ATC AAT ATT ACT ATA CCT GAT GGA GAA AAT GTT GGT ATT TTA 871 Gin Asp He Asn He Thr He Pro Asp Gly Glu Asn Val Gly He Leu 20 25 30 GGC GAA AGT GGC TGT GGT AAA AGT ACG CTC GCT TCA TTG GTT CTT GGC 919 Gly Glu Ser Gly Cys Gly Lys Ser Thr Leu Ala Ser Leu Val Leu Gly 35 40 45 50 TTG TTT AAA CCT GTT AAA GGA GAG ATT TAC TTA AGT GAC AAT GCT GTG 967 Leu Phe Lys Pro Val Lys Gly Glu He Tyr Leu Ser Asp Asn Ala Val 55 60 65 TTA CCG ATT TTC CAA CAC CCT TTA ACT AGC TTT AAC CCT GAT TGG ACG 1015 Leu Pro He Phe Gin His Pro Leu Thr Ser Phe Asn Pro Asp Trp Thr 70 75 80 ATT GAG ACC TCA TTA AAA GAA GCG TTA TAT TAT TAC AGA GGT CTA ACT 1063 He Glu Thr Ser Leu Lys Glu Ala Leu Tyr Tyr Tyr Arg Gly Leu Thr 85 90 95 GAT AAT ACT GCT CAG GAT CAA TTA TTA TTA CAA CAT TTA TCT ACT TTT 1111 Asp Asn Thr Ala Gin Asp Gin Leu Leu Leu Gin His Leu Ser Thr Phe 100 105 110 GAG TTA AAC GCG CAA TTA TTG ACT AAA TTA CCA AGC GAA GTG AGT GGC 1159 Glu Leu Asn Ala Gin Leu Leu Thr Lys Leu Pro Ser Glu Val Ser Gly 115 120 125 130 GGA CAA TTA CAA AGA TTT AAT GTC ATG CGT TCG TTA TTA GCA CAG CCT 1207 Gly Gin Leu Gin Arg Phe Asn Val Met Arg Ser Leu Leu Ala Gin Pro 135 140 145 CGC GTT TTA ATA TGT GAT GAG ATA ACT TCA AAT TTA GAT GTT ATA GCT 1255 Arg Val Leu He Cys Asp Glu He Thr Ser Asn Leu Asp Val He Ala 150 155 160 GAA CAA AAT GTA ATC AAT ATA TTA AAA GCG CAA ACG ATT ACG AAC TTA 1303 Glu Gin Asn Val He Asn He Leu Lys Ala Gin Thr He Thr Asn Leu 165 170 175 AAT CAT TTT ATC GTT ATT TCT CAT GAT TTA TCC GTG TTA CAA CGC TTA 1351 Asn His Phe He Val He Ser His Asp Leu Ser Val Leu Gin Arg Leu 180 185 190 GTT AAT AGA ATT ATC GTT CTT AAG GAT GGC ATG ATA GTC GAT GAT TTT 1399 Val Asn Arg He He Val Leu Lys Asp Gly Met He Val Asp Asp Phe 195 200 205 210 GCA ATA GAG GAA TTA TTT AAT GTT GAT AGA CAC CCT TAT ACA AAA GAA 1447 Ala He Glu Glu Leu Phe Asn Val Asp Arg His Pro Tyr Thr Lys Glu 215 220 225 TTA GTG CAA GCA TTT TCA TAT TAG 1471 Leu Val Gin Ala Phe Ser Tyr 230 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 233 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: Met He Glu Leu Lys His Val Thr Phe Gly Tyr Asn Lys Lys Gin Met 1 5 10 15 Val Leu Gin Asp He Asn He Thr He Pro Asp Gly Glu Asn Val Gly 20 25 30 He Leu Gly Glu Ser Gly Cys Gly Lys Ser Thr Leu Ala Ser Leu Val 35 40 45 Leu Gly Leu Phe Lys Pro Val Lys Gly Glu He Tyr Leu Ser Asp Asn 50 55 60 Ala Val Leu Pro He Phe Gin His Pro Leu Thr Ser Phe Asn Pro Asp 65 70 75 80 Trp Thr He Glu Thr Ser Leu Lys Glu Ala Leu Tyr Tyr Tyr Arg Gly 85 90 95 Leu Thr Asp Asn Thr Ala Gin Asp Gin Leu Leu Leu Gin His Leu Ser 100 105 110 Thr Phe Glu Leu Asn Ala Gin Leu Leu Thr Lys Leu Pro Ser Glu Val 115 120 125 Ser Gly Gly Gin Leu Gin Arg Phe Asn Val Met Arg Ser Leu Leu Ala 130 135 140 Gin Pro Arg Val Leu He Cys Asp Glu He Thr Ser Asn Leu Asp Val 145 150 155 160 He Ala Glu Gin Asn Val He Asn He Leu Lys Ala Gin Thr He Thr 165 170 175 Asn Leu Asn His Phe He Val He Ser His Asp Leu Ser Val Leu Gin 180 185 190 Arg Leu Val Asn Arg He He Val Leu Lys Asp Gly Met He Val Asp 195 200 205 Asp Phe Ala He Glu Glu Leu Phe Asn Val Asp Arg His Pro Tyr Thr 210 215 220 Lys Glu Leu Val Gin Ala Phe Ser Tyr 225 230 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 396 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl3b74)" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: AATCATAAAT TACGAATTAG ATATAACAAA AAAGAGCTTG GGACATTAAG TCCTTAAAGT 60 CTTAGGCAAT GTAAAAAAGC TGATTTCTAT TATTTATTTG ATAGAAATCA GCTTTTTTGA 120 TATGTATTTT ATAATGTACA GCTCGTTGAG CTGCTATTTT CCTTATATTA AGTGCCATTA 180 ATACAAAACC TAGCTCTCGT TTAACTTTAT TTATTCCCGA ACTGACATTC GAGTGAAACC 240 CAAAATAGCC TTCTAATCCA AAAACAGGCT CTACTCAATT TTCCTTTTGA CTAATAGATT 300 TTTTCGTTTC TGGTTCCAAA GCCTTGAGGT TGTAGAATTC TTGAAGACGA AAAGGGCCCC 360 GTGATACGCC CTATTTTTAA AGGTTAATGT TCTGAA 396 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1845 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl4cl5)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..788 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 856..1842 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: GC ATC AAT GAA CAT CAG GAA TTA ACA ACT TTA GGC AGA GGT GGT TCT 47 He Asn Glu His Gin Glu Leu Thr Thr Leu Gly Arg Gly Gly Ser 1 5 10 15 GAT ACG ACC GCT GTG GCA CTT GCT GTT AGT AAT CAA ATA CCT TGT GAA 95 Asp Thr Thr Ala Val Ala Leu Ala Val Ser Asn Gin He Pro Cys Glu 20 25 30 ATT TAT ACC GAC GTT GAT GGT GTG TAT GCC ACT GAC CCA AGA CTT TTA 143 He Tyr Thr Asp Val Asp Gly Val Tyr Ala Thr Asp Pro Arg Leu Leu 35 40 45 CCA AAG GCT AAA CGA CTA GAC ATC GTC TCA TAT GAA GAA ATG ATG GAA 191 Pro Lys Ala Lys Arg Leu Asp He Val Ser Tyr Glu Glu Met Met Glu 50 55 60 ATG AGC GCT TTA GGT GCT GGT GTA CTT GAA ACA AGA AGT GTT GAA TTA 239 Met Ser Ala Leu Gly Ala Gly Val Leu Glu Thr Arg Ser Val Glu Leu 65 70 75 GCT AAA AAC TAT AAT ATC CCT TTA TAT TTA GGA AAA ACT TTA TCG AAC 287 Ala Lys Asn Tyr Asn He Pro Leu Tyr Leu Gly Lys Thr Leu Ser Asn 80 85 90 95 GTG AAA GGA ACA TGG ATT ATG TCA AAT GAA GAA ATA TTA GAG AAA AAA 335 Val Lys Gly Thr Trp He Met Ser Asn Glu Glu He Leu Glu Lys Lys 100 105 110 GCA GTT ACT GGT GTG GCT TTG GAT AAA CAT ATG ATG CAT GTA ACA ATT 383 Ala Val Thr Gly Val Ala Leu Asp Lys His Met Met His Val Thr He 115 120 125 AGT TAT CCC CTA CCT GAC AAT CAG CTA CTT ACC CAA CTA TTT ACG GAA 431 Ser Tyr Pro Leu Pro Asp Asn Gin Leu Leu Thr Gin Leu Phe Thr Glu 130 135 140 CTT GAA GAA GGT GCT GTA AAT GTT GAT ATG ATT TCA CAA ATC GTC AAC 479 Leu Glu Glu Gly Ala Val Asn Val Asp Met He Ser Gin He Val Asn 145 150 155 TTG GAT GGG CTA CAA CTA TCC TTC ACG ATT AAA GAT AGT GAT TTT CAT 527 Leu Asp Gly Leu Gin Leu Ser Phe Thr He Lys Asp Ser Asp Phe His 160 165 170 175 CAA ATT TCT ATG ATT CTT GAA ACA TTA AAG AAT CAA TAT GAA GCA TTA 575 Gin He Ser Met He Leu Glu Thr Leu Lys Asn Gin Tyr Glu Ala Leu 180 185 190 GCT TAT AAA ATC AAT GAG CAT TAT GTC AAA ATT TCA TTA ATT GGC TCA 623 Ala Tyr Lys He Asn Glu His Tyr Val Lys He Ser Leu He Gly Ser 195 200 205 GGC ATG CGT GAT ATG TCA GGT GTG GCA TCA AAA GCA TTT TTG ACA TTA 671 Gly Met Arg Asp Met Ser Gly Val Ala Ser Lys Ala Phe Leu Thr Leu 210 215 220 ATT GAA AAT AAT ATA CCT TTC TAC CAA ACA ACA ACA TCT GAA ATA AGT 719 He Glu Asn Asn He Pro Phe Tyr Gin Thr Thr Thr Ser Glu He Ser 225 230 235 240 ATT TCA TAC GTC ATT GAT GAT TTT AAT GGG CAA CAA GCG GTA GAA AAA 767 He Ser Tyr Val He Asp Asp Phe Asn Gly Gin Gin Ala Val Glu Lys 245 250 255 CTA TAT GAC GCA TTT AAC ATT TAATGGTAAA ATGATTGTTA AAATATTCTA 818 Leu Tyr Asp Ala Phe Asn He 260 AAAATTGGGA AATTATTATA AAATGGAGTG ACAAGTT ATG ACA AAG TTA GCA GTT 873 Met Thr Lys Leu Ala Val 1 5 GTG GGT GCA ACA GGA TTA GTA GGT ACA AAA ATG TTG GAG ACA TTA AAT 921 Val Gly Ala Thr Gly Leu Val Gly Thr Lys Met Leu Glu Thr Leu Asn 10 15 20 CGT AAA AAT ATT CCT TTC GAT GAA TTA GTA TTA TTT TCA TCA GCA CGT 969 Arg Lys Asn He Pro Phe Asp Glu Leu Val Leu Phe Ser Ser Ala Arg 25 30 35 TCT GCA GGG CAA GAA GTT GAA TTT CAA GGA AAA ACA TAT ACA GTT CAA 1017 Ser Ala Gly Gin Glu Val Glu Phe Gin Gly Lys Thr Tyr Thr Val Gin 40 45 50 GAA TTA ACT GAT GCT CGT GCA AGT GAA CAT TTC GAT TAT GTA TTA ATG 1065 Glu Leu Thr Asp Ala Arg Ala Ser Glu His Phe Asp Tyr Val Leu Met 55 60 65 70 AGT GCT GGT GGC GGT ACA AGC GAA CAC TTT GCC CCA CTT TTT GAA AAA 1113 Ser Ala Gly Gly Gly Thr Ser Glu His Phe Ala Pro Leu Phe Glu Lys 75 80 85 GCT GGT GCA ATC GTT ATA GAC AAT TCA AGT CAA TGG CGT ATG GCA GAA 1161 Ala Gly Ala He Val He Asp Asn Ser Ser Gin Trp Arg Met Ala Glu 90 95 100 GAT ATT GAT TTA ATC GTT CCG GAA GTC AAT GAA CCT ACA TTT ACA AGA 1209 Asp He Asp Leu He Val Pro Glu Val Asn Glu Pro Thr Phe Thr Arg 105 110 115 GGT ATC ATT GCC AAT CCA AAC TGC TCT ACG ATT CAA TCT GTT GTA CCT 1257 Gly He He Ala Asn Pro Asn Cys Ser Thr He Gin Ser Val Val Pro 120 125 130 CTA AAA GTA TTG CAA GAT GCT TAT GGT TTA AAA CGA GTG GCA TAT ACA 1305 Leu Lys Val Leu Gin Asp Ala Tyr Gly Leu Lys Arg Val Ala Tyr Thr 135 140 145 150 ACA TAT CAA GCT GTA TCA GGT TCA GGG ATG AAA GGT AAG AAA GAT TTA 1353 Thr Tyr Gin Ala Val Ser Gly Ser Gly Met Lys Gly Lys Lys Asp Leu 155 160 165 GCT GAA GGT GTA AAT GGT AAA GCA CCA GAA GCA TAT CCA CAT CCA ATT 1401 Ala Glu Gly Val Asn Gly Lys Ala Pro Glu Ala Tyr Pro His Pro He 170 175 180 TAT AAT AAT GTG TTA CCG CAT ATT GAT GTG TTT TTA GAA AAC GGA TAT 1449 Tyr Asn Asn Val Leu Pro His He Asp Val Phe Leu Glu Asn Gly Tyr 185 190 195 ACA AAA GAA GAA CAA AAA ATG ATT GAT GAG ACG AGA AAA ATT TTA AAT 1497 Thr Lys Glu Glu Gin Lys Met He Asp Glu Thr Arg Lys He Leu Asn 200 205 210 GCG CCA GAC TTA AAA GTA ACA GCA ACA TGC GCA CGT GTG CCT GTT CAA 1545 Ala Pro Asp Leu Lys Val Thr Ala Thr Cys Ala Arg Val Pro Val Gin 215 220 225 " 230 GAT AGT CAT AGT GTT GAA ATT GAT GTA ACG CTT GAC AAA GAA ACA ACA 1593 Asp Ser His Ser Val Glu He Asp Val Thr Leu Asp Lys Glu Thr Thr 235 240 245 GCA GAA GAT ATT AAA GCG TTA TTT GAT CAA GAT GAC CGC GTT GTT TTA 1641 Ala Glu Asp He Lys Ala Leu Phe Asp Gin Asp Asp Arg Val Val Leu 250 255 260 GTA GAC AAT CCA GAG AAC AAT GAA TAT CCA ATG GCA ATC AAT TCT ACT 1689 Val Asp Asn Pro Glu Asn Asn Glu Tyr Pro Met Ala He Asn Ser Thr 265 270 275 AAT AAA GAT GAA GTG TTT GTT GGC CGT ATA CGT AGA GAT GAT TCA TTA 1737 Asn Lys Asp Glu Val Phe Val Gly Arg He Arg Arg Asp Asp Ser Leu 280 285 290 GAA AAT ACT TTC CAT GTA TGG TGT ACA TCA GAC AAT TTA TTA AAA GGT 1785 Glu Asn Thr Phe His Val Trp Cys Thr Ser Asp Asn Leu Leu Lys Gly 295 300 305 310 GCT GCA TTA AAT GCT GTA CAA GTA TTG GAA CAA GTT ATG CGT TTA AAA 1833 Ala Ala Leu Asn Ala Val Gin Val Leu Glu Gin Val Met Arg Leu Lys 315 320 325 GGA GCG AAT TAA 1845 Gly Ala Asn (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 262 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: He Asn Glu His Gin Glu Leu Thr Thr Leu Gly Arg Gly Gly Ser Asp 1 5 10 15 Thr Thr Ala Val Ala Leu Ala Val Ser Asn Gin He Pro Cys Glu He 20 25 30 Tyr Thr Asp Val Asp Gly Val Tyr Ala Thr Asp Pro Arg Leu Leu Pro 35 40 45 Lys Ala Lys Arg Leu Asp He Val Ser Tyr Glu Glu Met Met Glu Met 50 55 60 Ser Ala Leu Gly Ala Gly Val Leu Glu Thr Arg Ser Val Glu Leu Ala 65 70 75 80 Lys Asn Tyr Asn He Pro Leu Tyr Leu Gly Lys Thr Leu Ser Asn Val 85 90 95 Lys Gly Thr Trp He Met Ser Asn Glu Glu He Leu Glu Lys Lys Ala 100 105 110 Val Thr Gly Val Ala Leu Asp Lys His Met Met His Val Thr He Ser 115 120 125 Tyr Pro Leu Pro Asp Asn Gin Leu Leu Thr Gin Leu Phe Thr Glu Leu 130 135 140 Glu Glu Gly Ala Val Asn Val Asp Met He Ser Gin He Val Asn Leu 145 150 155 160 Asp Gly Leu Gin Leu Ser Phe Thr He Lys Asp Ser Asp Phe His Gin 165 170 175 He Ser Met He Leu Glu Thr Leu Lys Asn Gin Tyr Glu Ala Leu Ala 180 185 190 Tyr Lys He Asn Glu His Tyr Val Lys He Ser Leu He Gly Ser Gly 195 200 205 Met Arg Asp Met Ser Gly Val Ala Ser Lys Ala Phe Leu Thr Leu He 210 215 220 Glu Asn Asn He Pro Phe Tyr Gin Thr Thr Thr Ser Glu He Ser He 225 230 235 240 Ser Tyr Val He Asp Asp Phe Asn Gly Gin Gin Ala Val Glu Lys Leu 245 250 255 Tyr Asp Ala Phe Asn He 260 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 329 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: Met Thr Lys Leu Ala Val Val Gly Ala Thr Gly Leu Val Gly Thr Lys 1 5 10 15 Met Leu Glu Thr Leu Asn Arg Lys Asn He Pro Phe Asp Glu Leu Val 20 25 30 Leu Phe Ser Ser Ala Arg Ser Ala Gly Gin Glu Val Glu Phe Gin Gly 35 40 45 Lys Thr Tyr Thr Val Gin Glu Leu Thr Asp Ala Arg Ala Ser Glu His 50 55 60 Phe Asp Tyr Val Leu Met Ser Ala Gly Gly Gly Thr Ser Glu His Phe 65 70 75 80 Ala Pro Leu Phe Glu Lys Ala Gly Ala He Val He Asp Asn Ser Ser 85 90 95 Gin Trp Arg Met Ala Glu Asp He Asp Leu He Val Pro Glu Val Asn 100 105 110 Glu Pro Thr Phe Thr Arg Gly He He Ala Asn Pro Asn Cys Ser Thr 115 120 125 He Gin Ser Val Val Pro Leu Lys Val Leu Gin Asp Ala Tyr Gly Leu 130 135 140 Lys Arg Val Ala Tyr Thr Thr Tyr Gin Ala Val Ser Gly Ser Gly Met 145 150 155 160 Lys Gly Lys Lys Asp Leu Ala Glu Gly Val Asn Gly Lys Ala Pro Glu 165 170 175 Ala Tyr Pro His Pro He Tyr Asn Asn Val Leu Pro His He Asp Val 180 185 190 Phe Leu Glu Asn Gly Tyr Thr Lys Glu Glu Gin Lys Met He Asp Glu 195 200 205 Thr Arg Lys He Leu Asn Ala Pro Asp Leu Lys Val Thr Ala Thr Cys 210 215 220 Ala Arg Val Pro Val Gin Asp Ser His Ser Val Glu He Asp Val Thr 225 230 235 240 Leu Asp Lys Glu Thr Thr Ala Glu Asp He Lys Ala Leu Phe Asp Gin 245 250 255 Asp Asp Arg Val Val Leu Val Asp Asn Pro Glu Asn Asn Glu Tyr Pro 260 265 270 Met Ala He Asn Ser Thr Asn Lys Asp Glu Val Phe Val Gly Arg He 275 280 285 Arg Arg Asp Asp Ser Leu Glu Asn Thr Phe His Val Trp Cys Thr Ser 290 295 300 Asp Asn Leu Leu Lys Gly Ala Ala Leu Asn Ala Val Gin Val Leu Glu 305 310 315 320 Gin Val Met Arg Leu Lys Gly Ala Asn 325 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 927 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl3b26) " (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..924 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: ATG AAC GAA GCC GAC ATG CTG TTC TCT GTC ACT GTT CCC GGA AGC ACA 48 Met Asn Glu Ala Asp Met Leu Phe Ser Val Thr Val Pro Gly Ser Thr 1 5 10 15 GCT AAC CTA GGC CCC GGC TTT GAT TCA GTC GGA ATG GCG CTC AGC AGA 96 Ala Asn Leu Gly Pro Gly Phe Asp Ser Val Gly Met Ala Leu Ser Arg 20 25 30 TAT TTG AAG CTG ACC GTC TTT GAA AGC GAC AAA TGG TCT TTT GAG GCT 144 Tyr Leu Lys Leu Thr Val Phe Glu Ser Asp Lys Trp Ser Phe Glu Ala 35 40 45 GAA ACA GAA ACA GTC GCC GGA ATT CGC GGT ACA GAT AAC CTG ATC TAC 192 Glu Thr Glu Thr Val Ala Gly He Arg Gly Thr Asp Asn Leu He Tyr 50 55 60 CAA GTG GCT AAA CGG ACC GCA GAT TTG TAC GGA AAA GAA ATG CCT CCT 240 Gin Val Ala Lys Arg Thr Ala Asp Leu Tyr Gly Lys Glu Met Pro Pro 65 70 75 80 GTC CAT GTG AAG GTG TGG AGC GAC ATC CCG CTT GCA CGC GGC CTT GGC 288 Val His Val Lys Val Trp Ser Asp He Pro Leu Ala Arg Gly Leu Gly 85 90 95 AGC AGC GCC GCA GCG ATT GTA GCG GCC ATT GAA CTG GCT GAT GAA TTA 336 Ser Ser Ala Ala Ala He Val Ala Ala He Glu Leu Ala Asp Glu Leu 100 105 110 TGC GGC TTA AAG CTG TCT GAA GCG GAC AAG CTG CAT TTA GCG AGT CTA 384 Cys Gly Leu Lys Leu Ser Glu Ala Asp Lys Leu His Leu Ala Ser Leu 115 120 125 GAA GAA GGA CAC CCG GAC AAT GCT GGC GCT TCT CTC GTC GGC GGA CTT 432 Glu Glu Gly His Pro Asp Asn Ala Gly Ala Ser Leu Val Gly Gly Leu 130 135 140 GTG ATC GGC CTG CAT GAG GAT GAC GAG ACC CAA ATG ATC CGC GTC CCG 480 Val He Gly Leu His Glu Asp Asp Glu Thr Gin Met He Arg Val Pro 145 150 155 160 AAT GCT GAC ATT GAC GTA GTC GTT GTC ATT CCT TTT TAT GAA GTG CTG 528 Asn Ala Asp He Asp Val Val Val Val He Pro Phe Tyr Glu Val Leu 165 170 175 ACA AGA GAC GCG AGA GAC GTG CTT CCG AAG GAG TTT CCA TAT GCC GAT 576 Thr Arg Asp Ala Arg Asp Val Leu Pro Lys Glu Phe Pro Tyr Ala Asp 180 185 190 GCC GTA AAA GCA AGT GCT GTC AGC AAT ATC CTC ATT GCT GCG ATC ATG 624 Ala Val Lys Ala Ser Ala Val Ser Asn He Leu He Ala Ala He Met 195 200 205 TCC AAG GAT TGG CCG CTT GTC GGG AAA ATC ATG AAG AAG GAT ATG TTC 672 Ser Lys Asp Trp Pro Leu Val Gly Lys He Met Lys Lys Asp Met Phe 210 215 220 CAT CAG CCG TAC CGG GCG ATG CTT GTG CCT GAG CTG TCA AAA GTA GAG 720 His Gin Pro Tyr Arg Ala Met Leu Val Pro Glu Leu Ser Lys Val Glu 225 230 235 240 CAC GTC GCC GAG ATG AAG GGC GCA TAT GGA ACG GCT CTC AGC GGA GCA 768 His Val Ala Glu Met Lys Gly Ala Tyr Gly Thr Ala Leu Ser Gly Ala 245 250 255 GGC CCA ACG ATT CTC GTC ATG ACC GAA AAA GGA AAG GGA GAA GAG CTA 816 Gly Pro Thr He Leu Val Met Thr Glu Lys Gly Lys Gly Glu Glu Leu 260 265 270 AAA GAA CAG CTC GCG CTT CAT TTC CCT CAT TGT GAA GTA GAC GCT TTG 864 Lys Glu Gin Leu Ala Leu His Phe Pro His Cys Glu Val Asp Ala Leu 275 280 285 ACC GTT CCG AAA GAG GGA AGT ATA ATA GAG CGA AAT CCT TTA TAT CAA 912 Thr Val Pro Lys Glu Gly Ser He He Glu Arg Asn Pro Leu Tyr Gin 290 295 300 GTA AAA AGT GTA TAG 927 Val Lys Ser Val 305 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 308 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 26: Met Asn Glu Ala Asp Met Leu Phe Ser Val Thr Val Pro Gly Ser Thr 1 5 10 15 Ala Asn Leu Gly Pro Gly Phe Asp Ser Val Gly Met Ala Leu Ser Arg 20 25 30 Tyr Leu Lys Leu Thr Val Phe Glu Ser Asp Lys Trp Ser Phe Glu Ala 35 40 45 Glu Thr Glu Thr Val Ala Gly He Arg Gly Thr Asp Asn Leu He Tyr 50 55 60 Gin Val Ala Lys Arg Thr Ala Asp Leu Tyr Gly Lys Glu Met Pro Pro 65 70 75 80 Val His Val Lys Val Trp Ser Asp He Pro Leu Ala Arg Gly Leu Gly 85 90 95 Ser Ser Ala Ala Ala He Val Ala Ala He Glu Leu Ala Asp Glu Leu 100 105 110 Cys Gly Leu Lys Leu Ser Glu Ala Asp Lys Leu His Leu Ala Ser Leu 115 120 125 Glu Glu Gly His Pro Asp Asn Ala Gly Ala Ser Leu Val Gly Gly Leu 130 135 140 Val He Gly Leu His Glu Asp Asp Glu Thr Gin Met He Arg Val Pro 145 150 155 160 Asn Ala Asp He Asp Val Val Val Val He Pro Phe Tyr Glu Val Leu 165 170 175 Thr Arg Asp Ala Arg Asp Val Leu Pro Lys Glu Phe Pro Tyr Ala Asp 180 185 190 Ala Val Lys Ala Ser Ala Val Ser Asn He Leu He Ala Ala He Met 195 200 205 Ser Lys Asp Trp Pro Leu Val Gly Lys He Met Lys Lys Asp Met Phe 210 215 220 His Gin Pro Tyr Arg Ala Met Leu Val Pro Glu Leu Ser Lys Val Glu 225 230 235 240 His Val Ala Glu Met Lys Gly Ala Tyr Gly Thr Ala Leu Ser Gly Ala 245 250 255 Gly Pro Thr He Leu Val Met Thr Glu Lys Gly Lys Gly Glu Glu Leu 260 265 270 Lys Glu Gin Leu Ala Leu His Phe Pro His Cys Glu Val Asp Ala Leu 275 280 285 Thr Val Pro Lys Glu Gly Ser He He Glu Arg Asn Pro Leu Tyr Gin 290 295 300 Val Lys Ser Val 305 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1320 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p7cl8)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1317 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: TTG TTC TTA CAC GGC ACA AGC AGA CAA AAT CAA CAT GGT CAT TTA GAA 48 Leu Phe Leu His Gly Thr Ser Arg Gin Asn Gin His Gly His Leu Glu 1 5 10 15 ATC GGA GGT GTG GAT GCT CTC TAT TTA GCG GAG AAA TAT GGT ACA CCT 96 He Gly Gly Val Asp Ala Leu Tyr Leu Ala Glu Lys Tyr Gly Thr Pro 20 25 30 CTT TAC GTA TAT GAT GTG GCT TTA ATA CGT GAG CGT GCT AAA AGC TTT 144 Leu Tyr Val Tyr Asp Val Ala Leu He Arg Glu Arg Ala Lys Ser Phe 35 40 45 AAG CAG GCG TTT ATT TCT GCA GGG CTG AAA GCA CAG GTG GCA TAT GCG 192 Lys Gin Ala Phe He Ser Ala Gly Leu Lys Ala Gin Val Ala Tyr Ala 50 55 60 AGC AAA GCA TTC TCA TCA GTC GCA ATG ATT CAG CTC GCT GAG GAA GAG 240 Ser Lys Ala Phe Ser Ser Val Ala Met He Gin Leu Ala Glu Glu Glu 65 70 75 80 GGA CTT TCT TTA GAT GTC GTA TCC GGA GGA GAG CTA TAT ACG GCT GTT 288 Gly Leu Ser Leu Asp Val Val Ser Gly Gly Glu Leu Tyr Thr Ala Val 85 90 95 GCA GCA GGC TTT CCG GCA GAA CGC ATC CAC TTT CAT GGA AAC AAT AAG 336 Ala Ala Gly Phe Pro Ala Glu Arg He His Phe His Gly Asn Asn Lys 100 105 110 AGC AGG GAA GAA CTG CGG ATG GCG CTT GAG CAC CGC ATC GGC TGC ATT 384 Ser Arg Glu Glu Leu Arg Met Ala Leu Glu His Arg He Gly Cys He 115 120 125 GTG GTG GAT AAT TTC TAT GAA ATC GCG CTT CTT GAA GAC CTA TGT AAA 432 Val Val Asp Asn Phe Tyr Glu He Ala Leu Leu Glu Asp Leu Cys Lys 130 135 140 GAA ACG GGT CAC TCC ATC GAT GTT CTT CTT CGG ATC ACG CCC GGA GTA 480 Glu Thr Gly His Ser He Asp Val Leu Leu Arg He Thr Pro Gly Val 145 150 155 160 GAA GCG CAT ACG CAT GAC TAC ATT ACA ACG GGC CAG GAA GAT TCA AAG 528 Glu Ala His Thr His Asp Tyr He Thr Thr Gly Gin Glu Asp Ser Lys 165 170 175 TTT GGT TTC GAT CTT CAT AAC GGA CAA ACT GAA CGG GCC ATT GAA CAA 576 Phe Gly Phe Asp Leu His Asn Gly Gin Thr Glu Arg Ala He Glu Gin 180 185 190 GTA TTA CAA TCG GAA CAC ATT CAG CTG CTG GGT GTC CAT TGC CAT ATC 624 Val Leu Gin Ser Glu His He Gin Leu Leu Gly Val His Cys His He 195 200 205 GGC TCG CAA ATC TTT GAT ACG GCC GGT TTT GTG TTA GCA GCG GAA AAA 672 Gly Ser Gin He Phe Asp Thr Ala Gly Phe Val Leu Ala Ala Glu Lys 210 215 220 ATC TTC AAA AAA CTA GAC GAA TGG AGA GAT TCA TAT TCA TTT GTA TCC 720 He Phe Lys Lys Leu Asp Glu Trp Arg Asp Ser Tyr Ser Phe Val Ser 225 230 235 240 AAG GTG CTG AAT CTT GGA GGA GGT TTC GGC ATT CGT TAT ACG GAA GAT 768 Lys Val Leu Asn Leu Gly Gly Gly Phe Gly He Arg Tyr Thr Glu Asp 245 250 255 GAT GAA CCG CTT CAT GCC ACT GAA TAC GTT GAA AAA ATT ATC GAA GCT 816 Asp Glu Pro Leu His Ala Thr Glu Tyr Val Glu Lys He He Glu Ala 260 265 270 GTG AAA GAA AAT GCT TCC CGT TAC GGT TTT GAC ATT CCG GAA ATT TGG 864 Val Lys Glu Asn Ala Ser Arg Tyr Gly Phe Asp He Pro Glu He Trp 275 280 285 ATC GAA CCG GGC CGT TCT CTC GTG GGA GAC GCA GGC ACA ACT CTT TAT 912 He Glu Pro Gly Arg Ser Leu Val Gly Asp Ala Gly Thr Thr Leu Tyr 290 295 300 ACG GTT GGC TCT CAA AAA GAA GTG CCG GGT GTC CGC CAA TAT GTG GCT 960 Thr Val Gly Ser Gin Lys Glu Val Pro Gly Val Arg Gin Tyr Val Ala 305 310 315 320 GTA GAC GGA GGC ATG AAC GAC AAT ATT CGT CCT GCG CTT TAC CAA GCT 1008 Val Asp Gly Gly Met Asn Asp Asn He Arg Pro Ala Leu Tyr Gin Ala 325 330 335 AAA TAT GAA GCT GCG GCA GCC AAC AGG ATC GGA GAA GCG CAT GAC AAA 1056 Lys Tyr Glu Ala Ala Ala Ala Asn Arg He Gly Glu Ala His Asp Lys 340 345 350 ACG GTA TCA ATT GCC GGA AAG TGC TGT GAA AGC GGA GAT ATG CTG ATT 1104 Thr Val Ser He Ala Gly Lys Cys Cys Glu Ser Gly Asp Met Leu He 355 360 365 TGG GAT ATT GAC CTG CCG GAA GTA AAA GAA GGC GAT CTT CTT GCC GTT 1152 Trp Asp He Asp Leu Pro Glu Val Lys Glu Gly Asp Leu Leu Ala Val 370 375 380 TTT TGT ACA GGC GCT TAT GGA TAC AGC ATG GCC AAC AAT TAT AAC CGT 1200 Phe Cys Thr Gly Ala Tyr Gly Tyr Ser Met Ala Asn Asn Tyr Asn Arg 385 390 395 400 ATT CCG AGA CCC GCC GTT GTA TTT GTC GAA AAC GGT GAG GCT CAT TTA 1248 He Pro Arg Pro Ala Val Val Phe Val Glu Asn Gly Glu Ala His Leu 405 410 415 GTC GTG AAG CGA GAA ACA TAC GAA GAT ATT GTA AAA CTT GAT CTG CCA 1296 Val Val Lys Arg Glu Thr Tyr Glu Asp He Val Lys Leu Asp Leu Pro 420 425 430 TTT AAA ACG GGT GTA AAG CAA TAA 1320 Phe Lys Thr Gly Val Lys Gin 435 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 439 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: Leu Phe Leu His Gly Thr Ser Arg Gin Asn Gin His Gly His Leu Glu 1 5 10 15 He Gly Gly Val Asp Ala Leu Tyr Leu Ala Glu Lys Tyr Gly Thr Pro 20 25 30 Leu Tyr Val Tyr Asp Val Ala Leu He Arg Glu Arg Ala Lys Ser Phe 35 40 45 Lys Gin Ala Phe He Ser Ala Gly Leu Lys Ala Gin Val Ala Tyr Ala 50 55 60 Ser Lys Ala Phe Ser Ser Val Ala Met He Gin Leu Ala Glu Glu Glu 65 70 75 80 Gly Leu Ser Leu Asp Val Val Ser Gly Gly Glu Leu Tyr Thr Ala Val 85 90 95 Ala Ala Gly Phe Pro Ala Glu Arg He His Phe His Gly Asn Asn Lys 100 105 110 Ser Arg Glu Glu Leu Arg Met Ala Leu Glu His Arg He Gly Cys He 115 120 125 Val Val Asp Asn Phe Tyr Glu He Ala Leu Leu Glu Asp Leu Cys Lys 130 135 140 Glu Thr Gly His Ser He Asp Val Leu Leu Arg He Thr Pro Gly Val 145 150 155 160 Glu Ala His Thr His Asp Tyr He Thr Thr Gly Gin Glu Asp Ser Lys 165 170 175 Phe Gly Phe Asp Leu His Asn Gly Gin Thr Glu Arg Ala He Glu Gin 180 185 190 Val Leu Gin Ser Glu His He Gin Leu Leu Gly Val His Cys His He 195 200 205 Gly Ser Gin He Phe Asp Thr Ala Gly Phe Val Leu Ala Ala Glu Lys 210 215 220 He Phe Lys Lys Leu Asp Glu Trp Arg Asp Ser Tyr Ser Phe Val Ser 225 230 235 240 Lys Val Leu Asn Leu Gly Gly Gly Phe Gly He Arg Tyr Thr Glu Asp 245 250 255 Asp Glu Pro Leu His Ala Thr Glu Tyr Val Glu Lys He He Glu Ala 260 265 270 Val Lys Glu Asn Ala Ser Arg Tyr Gly Phe Asp He Pro Glu He Trp 275 280 285 lie Glu Pro Gly Arg Ser Leu Val Gly Asp Ala Gly Thr Thr Leu Tyr 290 295 300 Thr Val Gly Ser Gin Lys Glu Val Pro Gly Val Arg Gin Tyr Val Ala 305 310 315 320 Val Asp Gly Gly Met Asn Asp Asn He Arg Pro Ala Leu Tyr Gin Ala 325 330 335 Lys Tyr Glu Ala Ala Ala Ala Asn Arg He Gly Glu Ala His Asp Lys 340 345 350 Thr Val Ser He Ala Gly Lys Cys Cys Glu Ser Gly Asp Met Leu He 355 360 365 Trp Asp He Asp Leu Pro Glu Val Lys Glu Gly Asp Leu Leu Ala Val 370 375 380 Phe Cys Thr Gly Ala Tyr Gly Tyr Ser Met Ala Asn Asn Tyr Asn Arg 385 390 395 400 He Pro Arg Pro Ala Val Val Phe Val Glu Asn Gly Glu Ala His Leu 405 410 415 Val Val Lys Arg Glu Thr Tyr Glu Asp He Val Lys Leu Asp Leu Pro 420 425 430 Phe Lys Thr Gly Val Lys Gin 435 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2190 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl5c31)" Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..2187 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: ATG TCT AAA TTT ATC GAA CCA AGC GTT GAA GAA ATT AAA CTT GAA AAA 48 Met Ser Lys Phe He Glu Pro Ser Val Glu Glu He Lys Leu Glu Lys 1 5 10 15 GTA TAT CAA GAT ATG GGA TTA AGT GAT CAA GAA TAT GAA AAA GTT TGC 96 Val Tyr Gin Asp Met Gly Leu Ser Asp Gin Glu Tyr Glu Lys Val Cys 20 25 30 GAT ATT TTA GGC AGA CAA CCT AAC TTT ACA GAA ACA GGT ATC TTT TCT 144 Asp He Leu Gly Arg Gin Pro Asn Phe Thr Glu Thr Gly He Phe Ser 35 40 45 GTT ATG TGG AGT GAA CAT TGC TCT TAT AAA CAT TCT AAA CCG TTT TTA 192 Val Met Trp Ser Glu His Cys Ser Tyr Lys His Ser Lys Pro Phe Leu " 50 55 60 AAG CAA TTT CCT ACG TCA GGT GAC CAT GTG CTT ATG GGG CCT GGT GAA 240 Lys Gin Phe Pro Thr Ser Gly Asp His Val Leu Met Gly Pro Gly Glu 65 70 75 80 GGT GCA GGG GTA GTC GAT ATA GGT GAT AAT CAA GCC GTA GTA TTT AAA 288 Gly Ala Gly Val Val Asp He Gly Asp Asn Gin Ala Val Val Phe Lys 85 90 95 GTA GAG TCT CAC AAT CAT CCA TCA GCA ATT GAA CCA TAT CAA GGG GCT 336 Val Glu Ser His Asn His Pro Ser Ala He Glu Pro Tyr Gin Gly Ala 100 105 110 GCT ACA GGC GTT GGT GGA ATC ATT CGT GAC ATT GTC TCT ATT GGG GCT 384 Ala Thr Gly Val Gly Gly He He Arg Asp He Val Ser He Gly Ala 115 120 125 AGA CCT ATT AAT TTG TTA AAC AGT CTT AGA TTT GGA GAA TTA GAT AAT 432 Arg Pro He Asn Leu Leu Asn Ser Leu Arg Phe Gly Glu Leu Asp Asn 130 135 140 AAA CAA AAC CAA AGA TTA CTT AAA GGT GTT GTA AAG GGT ATC GGA GGT 480 Lys Gin Asn Gin Arg Leu Leu Lys Gly Val Val Lys Gly He Gly Gly 145 150 155 160 TAT GGT AAC TGC ATT GGT ATT CCA ACA ACT GCT GGT GAA ATC GAA TTT 528 Tyr Gly Asn Cys He Gly He Pro Thr Thr Ala Gly Glu He Glu Phe 165 170 175 GAT GAA CGT TAT GAT GGC AAT CCA CTT GTT AAT GCA ATG TGT GTT GGT 576 Asp Glu Arg Tyr Asp Gly Asn Pro Leu Val Asn Ala Met Cys Val Gly 180 185 190 GTT ATC AAT CAC GAC ATG ATT CAA AAA GGC ACA GCA AAA GGT GTA GGT 624 Val He Asn His Asp Met He Gin Lys Gly Thr Ala Lys Gly Val Gly 195 200 205 AAT TCG GTC ATT TAT GTT GGT TTG AAA ACT GGT CGA GAT GGT ATT CAT 672 Asn Ser Val He Tyr Val Gly Leu Lys Thr Gly Arg Asp Gly He His 210 215 220 GGT GCT ACT TTT GCA TCT GAA GAA TTG ACG GAA GAA AGC GAA AGT AAA 720 Gly Ala Thr Phe Ala Ser Glu Glu Leu Thr Glu Glu Ser Glu Ser Lys 225 230 235 240 CGA CCT TCT GTA CAA ATC GGT GAT CCA TTT GTA GGT AAA AAA TTA ATG 768 Arg Pro Ser Val Gin He Gly Asp Pro Phe Val Gly Lys Lys Leu Met 245 250 255 GAA GCA ACA CTT GAA GCA ATT ACA TTT GAT GAA TTA GTT GGT ATT CAA 816 Glu Ala Thr Leu Glu Ala He Thr Phe Asp Glu Leu Val Gly He Gin 260 265 270 GAT ATG GGT GCT GCT GGT TTA ACA TCT TCA TCG TCT GAA ATG GCG GCA 864 Asp Met Gly Ala Ala Gly Leu Thr Ser Ser Ser Ser Glu Met Ala Ala 275 280 285 AAA GGT GGT AGT GGG TTA CAT TTG AGA TTA GAA CAA GTG CCA ACA CGT 912 Lys Gly Gly Ser Gly Leu His Leu Arg Leu Glu Gin Val Pro Thr Arg 290 295 300 GAG CCA GGT ATT TCT CCT TAT GAA ATG ATG CTT TCA GAA ACT CAA GAA 960 Glu Pro Gly He Ser Pro Tyr Glu Met Met Leu Ser Glu Thr Gin Glu 305 310 315 320 CGT ATG TTA CTA GTT GTT GAA AAA GGT ACT GAA CAA AAA TTC TTA GAT 1008 Arg Met Leu Leu Val Val Glu Lys Gly Thr Glu Gin Lys Phe Leu Asp 325 330 335 TTA TTT GAT AAG CAC GAA TTG GAT AGT GCT GTT ATA GGT GAA GTT ACA 1056 Leu Phe Asp Lys His Glu Leu Asp Ser Ala Val He Gly Glu Val Thr 340 345 350 GAT ACA AAT CGT TTT GTT TTA ACA TAT GAT GAC GAA GTT TAT GCT GAC 1104 Asp Thr Asn Arg Phe Val Leu Thr Tyr Asp Asp Glu Val Tyr Ala Asp 355 360 365 ATT CCA GTT GAA CCA CTA GCT GAT GAA GCA CCT GTA TAT ATT TTA GAA 1152 He Pro Val Glu Pro Leu Ala Asp Glu Ala Pro Val Tyr He Leu Glu 370 375 380 GGA GAA GAA AAA GAT TAT AAT ACT TCT AAA AAT GAT TAT ACA CAC ATC 1200 Gly Glu Glu Lys Asp Tyr Asn Thr Ser Lys Asn Asp Tyr Thr His He 385 390 395 400 GAT GTT AAA GAT ACT TTC TTT AAA TTA CTT AAG CAT CCG ACT ATA GCA 1248 Asp Val Lys Asp Thr Phe Phe Lys Leu Leu Lys His Pro Thr He Ala 405 410 415 TCT AAA CAC TAT TTA TAT GAT CAA TAC GAC CAA CAA GTT GGT GCC AAT 1296 Ser Lys His Tyr Leu Tyr Asp Gin Tyr Asp Gin Gin Val Gly Ala Asn 420 425 430 ACG ATA ATT AAG CCA GGA CTT CAA GCA TCG GTA GTA CGT GTG GAA GGC 1344 Thr He He Lys Pro Gly Leu Gin Ala Ser Val Val Arg Val Glu Gly 435 440 445 ACA AAT AAG GCA ATT GCT TCA ACA ATT GAT GGT GAA GCG CGT TAT GTA 1392 Thr Asn Lys Ala He Ala Ser Thr He Asp Gly Glu Ala Arg Tyr Val 450 455 460 TAT AAC AAT CCA TAT GAA GGT GGA AAG ATG GTA GTA GCT GAA GCT TAT 1440 Tyr Asn Asn Pro Tyr Glu Gly Gly Lys Met Val Val Ala Glu Ala Tyr 465 470 475 480 CGA AAT TTA ATT GCC GTG GGT GCA ACA CCA TTA GCA ATG ACA GAT TGT 1488 Arg Asn Leu He Ala Val Gly Ala Thr Pro Leu Ala Met Thr Asp Cys 485 490 495 TTA AAT TAT GGT TCT CCT GAA AAG AAA GAA ATC TAT CAA CAG TTG ATA 1536 Leu Asn Tyr Gly Ser Pro Glu Lys Lys Glu He Tyr Gin Gin Leu He 500 505 510 GAT TCA ACG AAA GGT ATG GCA GAA GCA TGC GAC ATT CTT AAG ACA CCA 1584 Asp Ser Thr Lys Gly Met Ala Glu Ala Cys Asp He Leu Lys Thr Pro 515 520 525 GTA GTT TCT GGT AAT GTA TCT TTA TAT AAC GAA ACG AAA GGT ACT TCT 1632 Val Val Ser Gly Asn Val Ser Leu Tyr Asn Glu Thr Lys Gly Thr Ser 530 535 540 ATT TTC CCA ACA CCA GTT GTT GGA ATG GTA GGT TTG ATT GAA AAT GTA 1680 He Phe Pro Thr Pro Val Val Gly Met Val Gly Leu He Glu Asn Val 545 550 555 560 AAT TAT TTA AAT GAT TTT GAA CCT CAA GTT GGA GAT AAA TTA TAT TTA 1728 Asn Tyr Leu Asn Asp Phe Glu Pro Gin Val Gly Asp Lys Leu Tyr Leu 565 570 575 ATC GGT GAT ACT AAG GAC GAC TTT GGT GGT AGT CAA CTT GAA AAG TTA 1776 He Gly Asp Thr Lys Asp Asp Phe Gly Gly Ser Gin Leu Glu Lys Leu 580 585 590 ATT TAT GGC AAA GTT AAT CAT GAA TTT GAG TCA TTA GAT TTG AGT TCA 1824 He Tyr Gly Lys Val Asn His Glu Phe Glu Ser Leu Asp Leu Ser Ser 595 600 605 GAA GTT GAA AAA GGT GAA TCA ATC AAG ACC GCT ATT CGT GAA GGA CTA 1872 Glu Val Glu Lys Gly Glu Ser He Lys Thr Ala He Arg Glu Gly Leu 610 615 620 TTA TCA CAT GTT CAA ACA GTT GGT AAA GGT GGC TTA CTG ATT ACC TTA 1920 Leu Ser His Val Gin Thr Val Gly Lys Gly Gly Leu Leu He Thr Leu 625 630 635 640 GCT AAA CTA AGT GCG CAT TAC GGT TTA GGA TTA AAA TCT TCA ATA GAT 1968 Ala Lys Leu Ser Ala His Tyr Gly Leu Gly Leu Lys Ser Ser He Asp 645 650 655 ATA ACA AAT GCA CAA TTG TTT AGT GAG ACG CAA GGC CGA TAT GTT GTT 2016 He Thr Asn Ala Gin Leu Phe Ser Glu Thr Gin Gly Arg Tyr Val Val 660 665 670 TCT GTT AAA TCA GGT AAA ACT TTA AAT ATT GAT AAT GCA ATA GAA ATT 2064 Ser Val Lys Ser Gly Lys Thr Leu Asn He Asp Asn Ala He Glu He 675 680 685 GGA CTT TTA ACA GAT AGT GAT AAT TyC AAG GTA ACA ACA CCA TAT ACA 2112 Gly Leu Leu Thr Asp Ser Asp Asn Xaa Lys Val Thr Thr Pro Tyr Thr 690 695 700 GAG ATT AGT GAA AAT GTT TCA GAT ATT AAA CAA ATA TGG GAA GGG GCA 2160 Glu He Ser Glu Asn Val Ser Asp He Lys Gin He Trp Glu Gly Ala 705 710 715 720 ATT GCT CAA TGT TTA ACT ACT CAG GAT TAA 2190 He Ala Gin Cys Leu Thr Thr Gin Asp 725 (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 729 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: Met Ser Lys Phe He Glu Pro Ser Val Glu Glu He Lys Leu Glu Lys 1 5 10 15 Val Tyr Gin Asp Met Gly Leu Ser Asp Gin Glu Tyr Glu Lys Val Cys 20 25 30 Asp He Leu Gly Arg Gin Pro Asn Phe Thr Glu Thr Gly He Phe Ser 35 40 45 Val Met Trp Ser Glu His Cys Ser Tyr Lys His Ser Lys Pro Phe Leu 50 55 60 Lys Gin Phe Pro Thr Ser Gly Asp His Val Leu Met Gly Pro Gly Glu 65 70 75 80 Gly Ala Gly Val Val Asp He Gly Asp Asn Gin Ala Val Val Phe Lys 85 90 95 Val Glu Ser His Asn His Pro Ser Ala He Glu Pro Tyr Gin Gly Ala 100 105 110 Ala Thr Gly Val Gly Gly He He Arg Asp He Val Ser He Gly Ala 115 120 125 Arg Pro He Asn Leu Leu Asn Ser Leu Arg Phe Gly Glu Leu Asp Asn 130 135 140 Lys Gin Asn Gin Arg Leu Leu Lys Gly Val Val Lys Gly He Gly Gly 145 150 155 160 Tyr Gly Asn Cys He Gly He Pro Thr Thr Ala Gly Glu He Glu Phe 165 170 175 Asp Glu Arg Tyr Asp Gly Asn Pro Leu Val Asn Ala Met Cys Val Gly 180 185 190 Val He Asn His Asp Met He Gin Lys Gly Thr Ala Lys Gly Val Gly 195 200 205 Asn Ser Val He Tyr Val Gly Leu Lys Thr Gly Arg Asp Gly He His 210 215 220 Gly Ala Thr Phe Ala Ser Glu Glu Leu Thr Glu Glu Ser Glu Ser Lys 225 230 235 240 Arg Pro Ser Val Gin He Gly Asp Pro Phe Val Gly Lys Lys Leu Met 245 250 255 Glu Ala Thr Leu Glu Ala He Thr Phe Asp Glu Leu Val Gly He Gin 260 265 270 Asp Met Gly Ala Ala Gly Leu Thr Ser Ser Ser Ser Glu Met Ala Ala 275 280 285 Lys Gly Gly Ser Gly Leu His Leu Arg Leu Glu Gin Val Pro Thr Arg 290 295 300 Glu Pro Gly He Ser Pro Tyr Glu Met Met Leu Ser Glu Thr Gin Glu 305 310 315 320 Arg Met Leu Leu Val Val Glu Lys Gly Thr Glu Gin Lys Phe Leu Asp 325 330 335 Leu Phe Asp Lys His Glu Leu Asp Ser Ala Val He Gly Glu Val Thr 340 345 350 Asp Thr Asn Arg Phe Val Leu Thr Tyr Asp Asp Glu Val Tyr Ala Asp 355 360 365 He Pro Val Glu Pro Leu Ala Asp Glu Ala Pro Val Tyr He Leu Glu 370 375 380 Gly Glu Glu Lys Asp Tyr Asn Thr Ser Lys Asn Asp Tyr Thr His He 385 390 395 00 Asp Val Lys Asp Thr Phe Phe Lys Leu Leu Lys His Pro Thr He Ala 405 410 415 Ser Lys His Tyr Leu Tyr Asp Gin Tyr Asp Gin Gin Val Gly Ala Asn 420 425 430 Thr He He Lys Pro Gly Leu Gin Ala Ser Val Val Arg Val Glu Gly 435 440 445 Thr Asn Lys Ala He Ala Ser Thr He Asp Gly Glu Ala Arg Tyr Val 450 455 460 Tyr Asn Asn Pro Tyr Glu Gly Gly Lys Met Val Val Ala Glu Ala Tyr 465 470 475 480 Arg Asn Leu He Ala Val Gly Ala Thr Pro Leu Ala Met Thr Asp Cys 485 490 495 Leu Asn Tyr Gly Ser Pro Glu Lys Lys Glu He Tyr Gin Gin Leu He 500 505 510 Asp Ser Thr Lys Gly Met Ala Glu Ala Cys Asp He Leu Lys Thr Pro 515 520 525 Val Val Ser Gly Asn Val Ser Leu Tyr Asn Glu Thr Lys Gly Thr Ser 530 535 540 He Phe Pro Thr Pro Val Val Gly Met Val Gly Leu He Glu Asn Val 545 550 555 560 Asn Tyr Leu Asn Asp Phe Glu Pro Gin Val Gly Asp Lys Leu Tyr Leu 565 570 575 He Gly Asp Thr Lys Asp Asp Phe Gly Gly Ser Gin Leu Glu Lys Leu 580 585 590 He Tyr Gly Lys Val Asn His Glu Phe Glu Ser Leu Asp Leu Ser Ser 595 600 605 Glu Val Glu Lys Gly Glu Ser He Lys Thr Ala He Arg Glu Gly Leu 610 615 620 Leu Ser His Val Gin Thr Val Gly Lys Gly Gly Leu Leu He Thr Leu 625 630 635 640 Ala Lys Leu Ser Ala His Tyr Gly Leu Gly Leu Lys Ser Ser He Asp 645 650 655 He Thr Asn Ala Gin Leu Phe Ser Glu Thr Gin Gly Arg Tyr Val Val 660 665 670 Ser Val Lys Ser Gly Lys Thr Leu Asn He Asp Asn Ala He Glu He 675 680 685 Gly Leu Leu Thr Asp Ser Asp Asn Xaa Lys Val Thr Thr Pro Tyr Thr 690 695 700 Glu He Ser Glu Asn Val Ser Asp He Lys Gin He Trp Glu Gly Ala 705 710 715 720 He Ala Gin Cys Leu Thr Thr Gin Asp 725 (2) INFORMATION FOR SEQ ID NO: 31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 729 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0bl8/p6bl8) " (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..726 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 31: ATG ACT AAA TTA TTT ATA CCT TAT ATT ATG GGC AAT AAA GAT TTG ATT 48 Met Thr Lys Leu Phe He Pro Tyr He Met Gly Asn Lys Asp Leu He 1 5 10 15 GAA AAT GCA ACA TTG TTG AGT GAA AAT GGT GCA GAT ATA ATT GAA ATT 96 Glu Asn Ala Thr Leu Leu Ser Glu Asn Gly Ala Asp He He Glu He 20 25 30 GGA GTA CCT TTC TCT GAT CCG GTT GCT GAT GGT CCA GTT ATC ATG GAA 144 Gly Val Pro Phe Ser Asp Pro Val Ala Asp Gly Pro Val He Met Glu 35 40 45 GCA GGT CAA CAA GCG ATT AAA CAA GGC ATC ACG ATA GAT TAT ATT TTC 192 Ala Gly Gin Gin Ala He Lys Gin Gly He Thr He Asp Tyr He Phe 50 55 60 AAT CAA TTA GAA AAA CAT GGT GAT CAA ATT AAG TGT AAC TAT GTA TTA 240 Asn Gin Leu Glu Lys His Gly Asp Gin He Lys Cys Asn Tyr Val Leu 65 70 75 80 ATG ACG TAT TAT AAT ATT ATT TGT CAT TAT GGA GAA CAA GCG TTT TTT 288 Met Thr Tyr Tyr Asn He He Cys His Tyr Gly Glu Gin Ala Phe Phe 85 90 95 GAA AAA TGT CGA GAT ACT GGT GTC TAC GGC TTA ATT ATT CCT GAT TTA 336 Glu Lys Cys Arg Asp Thr Gly Val Tyr Gly Leu He He Pro Asp Leu 100 105 110 CCA TAT GAA TTA TCG CAG CGT TTA AAA CAA CAA TTT AGT CAC TAT GGC 384 Pro Tyr Glu Leu Ser Gin Arg Leu Lys Gin Gin Phe Ser His Tyr Gly 115 120 125 GTC AAA ATC ATA TCG TTA GTT GCG ATG ACT ACT GAT GAC AAA CGT ATA 432 Val Lys He He Ser Leu Val Ala Met Thr Thr Asp Asp Lys Arg He 130 135 140 AAA GAT ATC GTA TCC CAT GCG GAA GGC TTT ATT TAT ACT GTG ACG ATG 480 Lys Asp He Val Ser His Ala Glu Gly Phe He Tyr Thr Val Thr Met 145 150 155 160 AAT GCG ACA ACA GGG CAA AAC GGT GCG TTT CAT CCA GAA TTA AAA CGA 528 Asn Ala Thr Thr Gly Gin Asn Gly Ala Phe His Pro Glu Leu Lys Arg 165 170 175 AAA ATT GAG TCA ATT AAA GCG ATA GCC AAT GTG CCA GTT GTC GCA GGA 576 Lys He Glu Ser He Lys Ala He Ala Asn Val Pro Val Val Ala Gly 180 185 190 TTT GGT ATA AGA ACA CCA CAA CAT GTT GCA GAT ATA AAA GAG GTT GCA 624 Phe Gly He Arg Thr Pro Gin His Val Ala Asp He Lys Glu Val Ala 195 200 205 GAT GGC ATT GTC ATT GGT AGC GAA ATC GTT AAG CGA TTT AAA TCT AAC 672 Asp Gly He Val He Gly Ser Glu He Val Lys Arg Phe Lys Ser Asn 210 215 220 ACG CGT GAG GAA ATC ATT AAA TAT TTA CAA TCT ATC CAA CAA ACA TTG 720 Thr Arg Glu Glu He He Lys Tyr Leu Gin Ser He Gin Gin Thr Leu 225 230 235 240 AAT AAT TAA 729 Asn Asn (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 242 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32: Met Thr Lys Leu Phe He Pro Tyr He Met Gly Asn Lys Asp Leu He 1 5 10 15 Glu Asn Ala Thr Leu Leu Ser Glu Asn Gly Ala Asp He He Glu He 20 25 30 Gly Val Pro Phe Ser Asp Pro Val Ala Asp Gly Pro Val He Met Glu 35 40 45 Ala Gly Gin Gin Ala He Lys Gin Gly He Thr He Asp Tyr He Phe 50 55 60 Asn Gin Leu Glu Lys His Gly Asp Gin He Lys Cys Asn Tyr Val Leu 65 70 75 80 Met Thr Tyr Tyr Asn He He Cys His Tyr Gly Glu Gin Ala Phe Phe 85 90 95 Glu Lys Cys Arg Asp Thr Gly Val Tyr Gly Leu He He Pro Asp Leu 100 105 110 Pro Tyr Glu Leu Ser Gin Arg Leu Lys Gin Gin Phe Ser His Tyr Gly 115 120 125 Val Lys He He Ser Leu Val Ala Met Thr Thr Asp Asp Lys Arg He 130 135 140 Lys Asp He Val Ser His Ala Glu Gly Phe He Tyr Thr Val Thr Met 145 150 155 160 Asn Ala Thr Thr Gly Gin Asn Gly Ala Phe His Pro Glu Leu Lys Arg 165 170 175 Lys He Glu Ser He Lys Ala He Ala Asn Val Pro Val Val Ala Gly 180 185 190 Phe Gly He Arg Thr Pro Gin His Val Ala Asp He Lys Glu Val Ala 195 200 205 Asp Gly He Val He Gly Ser Glu He Val Lys Arg Phe Lys Ser Asn 210 215 220 Thr Arg Glu Glu He He Lys Tyr Leu Gin Ser He Gin Gin Thr Leu 225 230 235 240 Asn Asn (2) INFORMATION FOR SEQ ID NO: 33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1215 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b66)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1212 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33: ATG AAT AAA CAA ATA CAA ACA GAA GCA GAT GAA TTA GGT TTC TTT GGT 48 Met Asn Lys Gin He Gin Thr Glu Ala Asp Glu Leu Gly Phe Phe Gly 1 5 10 15 GAA TAT GGA GGG CAA TAT GTT CCA GAA ACA TTA ATG CCA GCA ATT ATT 96 Glu Tyr Gly Gly Gin Tyr Val Pro Glu Thr Leu Met Pro Ala He He 20 25 30 GAG TTG AAA AAA GCT TAT AAA GAG GCA AAA GCA GAC CCA GAG TTT CAA 144 Glu Leu Lys Lys Ala Tyr Lys Glu Ala Lys Ala Asp Pro Glu Phe Gin 35 40 45 AGA GAA CTG GAA TAC TAT TTA TCA GAG TAT GTA GGA CGC GCG ACA CCA 192 Arg Glu Leu Glu Tyr Tyr Leu Ser Glu Tyr Val Gly Arg Ala Thr Pro 50 55 60 CTT ACA TAT GCT GCA TCA TAT ACT GAA AGC CTA GGT GGC GCT AAA ATA 240 Leu Thr Tyr Ala Ala Ser Tyr Thr Glu Ser Leu Gly Gly Ala Lys He 65 70 75 80 TAT TTG AAA CGA GAG GAT CTA AAT CAT ACA GGC GCC CAT AAA ATT AAT 288 Tyr Leu Lys Arg Glu Asp Leu Asn His Thr Gly Ala His Lys He Asn 85 90 95 AAT GCG TTA GGT CAA GCG TTG CTT GCT AAA AGA ATG GGC AAG AAG AAG 336 Asn Ala Leu Gly Gin Ala Leu Leu Ala Lys Arg Met Gly Lys Lys Lys 100 105 110 CTT GTT GCT GAA ACT GGT GCG GGT CAA CAT GGT GTA GCT AGT GCT ACG 384 Leu Val Ala Glu Thr Gly Ala Gly Gin His Gly Val Ala Ser Ala Thr 115 120 125 GTT GCT GCA TTA TTT GAT ATG GAA CTT GTT GTC TTT ATG GGA AGT GAA 432 Val Ala Ala Leu Phe Asp Met Glu Leu Val Val Phe Met Gly Ser Glu 130 135 140 GAT ATT AAA AGA CAA CAA CTT AAT GTA TTT AGA ATG GAA TTA CTT GGT 480 Asp He Lys Arg Gin Gin Leu Asn Val Phe Arg Met Glu Leu Leu Gly 145 150 155 160 GCA AAG GTT GTG GCA GTT GAA GAT GGT CAA GGG ACT TTA TCG GAT GCA 528 Ala Lys Val Val Ala Val Glu Asp Gly Gin Gly Thr Leu Ser Asp Ala 165 170 175 GTT AAT AAA GCA TTG CAA TAT TGG GTA AGT CAT GTA GAT GAT ACA CAT 576 Val Asn Lys Ala Leu Gin Tyr Trp Val Ser His Val Asp Asp Thr His 180 185 190 TAT TTA TTA GGT TCT GCA TTA GGT CCA GAC CCG TTC CCA ACG ATT GTT 624 Tyr Leu Leu Gly Ser Ala Leu Gly Pro Asp Pro Phe Pro Thr He Val 195 200 205 AGA GAT TTT CAG AGT GTG ATT GGT AAA GAA ATA AAA TCA CAG ATA TTG 672 Arg Asp Phe Gin Ser Val He Gly Lys Glu He Lys Ser Gin He Leu 210 215 220 AAG AAA GAA GGT CGA CTT CCG GAT GCA ATT GTA GCA TGT ATC GGT GGT 720 Lys Lys Glu Gly Arg Leu Pro Asp Ala He Val Ala Cys He Gly Gly 225 230 235 240 GGC TCA AAT GCA ATC GGT ACA TTT TAT CCA TTT ATT AAA GAT GAT GTT 768 Gly Ser Asn Ala He Gly Thr Phe Tyr Pro Phe He Lys Asp Asp Val 245 250 255 GCA TTA TAC GGT GTT GAA GCC GCA GGT CAA GGC GAT GAT ACT GAT AAA 816 Ala Leu Tyr Gly Val Glu Ala Ala Gly Gin Gly Asp Asp Thr Asp Lys 260 265 270 CAT GCA CTT GCA ATT GGC AAA GGA TCA CCT GGC GTA TTA CAT GGT ACT 864 His Ala Leu Ala He Gly Lys Gly Ser Pro Gly Val Leu His Gly Thr 275 280 285 AAA ATG TAT TTA ATT CAA GAT GAA GAT GGG CAA GTG CAA CTA GCA CAT 912 Lys Met Tyr Leu He Gin Asp Glu Asp Gly Gin Val Gin Leu Ala His 290 295 300 TCT ATT TCA GCA GGA CTT GAT TAT CCT GGT ATT GGA CCA GAA CAT TCT 960 Ser He Ser Ala Gly Leu Asp Tyr Pro Gly He Gly Pro Glu His Ser 305 310 315 320 TAT TAC CAC GAC ATT GGT AGA GTA ACT TTT GAA AAT GCT AGT GAT ACA 1008 Tyr Tyr His Asp He Gly Arg Val Thr Phe Glu Asn Ala Ser Asp Thr 325 330 335 CAA GCA ATG AAT GCT TTA ATC AAC TTT ACA AAA CAT GAA GGT ATT ATA 1056 Gin Ala Met Asn Ala Leu He Asn Phe Thr Lys His Glu Gly He He 340 345 350 CCT GCA ATT GAA AGT GCA CAT GCA CTG AGT TAT GTT GAA AGA CTA GCG 1104 Pro Ala He Glu Ser Ala His Ala Leu Ser Tyr Val Glu Arg Leu Ala 355 360 365 CCT ACG ATG TCG AAA GAA GAT ATT ATT GTA GTA ACT ATT TCT GGA CGT 1152 Pro Thr Met Ser Lys Glu Asp He He Val Val Thr He Ser Gly Arg 370 375 380 GGC GAT AAA GAT ATG GAA ACA ATT AGA CAA TAT ATG GTA GAG CGA GGT 1200 Gly Asp Lys Asp Met Glu Thr He Arg Gin Tyr Met Val Glu Arg Gly 385 390 395 400 CTT GCA AAT GAC TAA 1215 Leu Ala Asn Asp (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 404 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34: Met Asn Lys Gin He Gin Thr Glu Ala Asp Glu Leu Gly Phe Phe Gly 1 5 10 15 Glu Tyr Gly Gly Gin Tyr Val Pro Glu Thr Leu Met Pro Ala He He 20 25 30 Glu Leu Lys Lys Ala Tyr Lys Glu Ala Lys Ala Asp Pro Glu Phe Gin 35 40 45 Arg Glu Leu Glu Tyr Tyr Leu Ser Glu Tyr Val Gly Arg Ala Thr Pro 50 55 60 Leu Thr Tyr Ala Ala Ser Tyr Thr Glu Ser Leu Gly Gly Ala Lys He 65 70 75 80 Tyr Leu Lys Arg Glu Asp Leu Asn His Thr Gly Ala His Lys He Asn 85 90 95 Asn Ala Leu Gly Gin Ala Leu Leu Ala Lys Arg Met Gly Lys Lys Lys 100 105 110 Leu Val Ala Glu Thr Gly Ala Gly Gin His Gly Val Ala Ser Ala Thr 115 120 125 Val Ala Ala Leu Phe Asp Met Glu Leu Val Val Phe Met Gly Ser Glu 130 135 140 Asp He Lys Arg Gin Gin Leu Asn Val Phe Arg Met Glu Leu Leu Gly 145 150 155 160 Ala Lys Val Val Ala Val Glu Asp Gly Gin Gly Thr Leu Ser Asp Ala 165 170 175 Val Asn Lys Ala Leu Gin Tyr Trp Val Ser His Val Asp Asp Thr His 180 185 190 Tyr Leu Leu Gly Ser Ala Leu Gly Pro Asp Pro Phe Pro Thr He Val 195 200 205 Arg Asp Phe Gin Ser Val He Gly Lys Glu He Lys Ser Gin He Leu 210 215 220 Lys Lys Glu Gly Arg Leu Pro Asp Ala He Val Ala Cys He Gly Gly 225 230 235 240 Gly Ser Asn Ala He Gly Thr Phe Tyr Pro Phe He Lys Asp Asp Val 245 250 255 Ala Leu Tyr Gly Val Glu Ala Ala Gly Gin Gly Asp Asp Thr Asp Lys 260 265 270 His Ala Leu Ala He Gly Lys Gly Ser Pro Gly Val Leu His Gly Thr 275 280 285 Lys Met Tyr Leu He Gin Asp Glu Asp Gly Gin Val Gin Leu Ala His 290 295 300 Ser He Ser Ala Gly Leu Asp Tyr Pro Gly He Gly Pro Glu His Ser 305 310 315 320 Tyr Tyr His Asp He Gly Arg Val Thr Phe Glu Asn Ala Ser Asp Thr 325 330 335 Gin Ala Met Asn Ala Leu He Asn Phe Thr Lys His Glu Gly He He 340 345 350 Pro Ala He Glu Ser Ala His Ala Leu Ser Tyr Val Glu Arg Leu Ala 355 360 365 Pro Thr Met Ser Lys Glu Asp He He Val Val Thr He Ser Gly Arg 370 375 380 Gly Asp Lys Asp Met Glu Thr He Arg Gin Tyr Met Val Glu Arg Gly 385 390 395 400 Leu Ala Asn Asp (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1008 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0c34)" Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1005 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: ATG AAA ACC ATG ACA TTA CTA ACA AGA ATA AAA ACT GAA ACT ATA TTA 48 Met Lys Thr Met Thr Leu Leu Thr Arg He Lys Thr Glu Thr He Leu 1 5 10 15 CTT GAA AGC GAC ATT AAA GAG CTA ATC GAT ATA CTT ATT TCT CCT AGT 96 Leu Glu Ser Asp He Lys Glu Leu He Asp He Leu He Ser Pro Ser 20 25 30 ATT GGA ACT GAT ATT AAA TAT GAA TTA CTT AGT TCC TAT TCG GAG CGA 144 He Gly Thr Asp He Lys Tyr Glu Leu Leu Ser Ser Tyr Ser Glu Arg 35 40 45 GAA ATC CAA CAA CAA GAA TTA ACA TAT ATT GTA CGT AGC TTA ATT AAT 192 Glu He Gin Gin Gin Glu Leu Thr Tyr He Val Arg Ser Leu He Asn 50 55 60 ACA ATG TAT CCA CAT CAA CCA TGT TAT GAA GGG GCT ATG TGT GTG TGC 240 Thr Met Tyr Pro His Gin Pro Cys Tyr Glu Gly Ala Met Cys Val Cys 65 70 75 80 GGC ACA GGT GGT GAC AAG TCA AAT AGT TTC AAC ATT TCA ACG ACT GTT 288 Gly Thr Gly Gly Asp Lys Ser Asn Ser Phe Asn He Ser Thr Thr Val 85 90 95 GCT TTT GTT GTA GCA AGT GCT GGC GTA AAA GTT ATA AAA CAT GGT AAT 336 Ala Phe Val Val Ala Ser Ala Gly Val Lys Val He Lys His Gly Asn 100 105 110 AAA AGT ATT ACC TCA AAT TCA GGT AGT ACG GAT TTG TTA AAT CAA ATG 384 Lys Ser He Thr Ser Asn Ser Gly Ser Thr Asp Leu Leu Asn Gin Met 115 120 125 AAC ATA CAA ACA ACA ACT GTT GAT GAT ACA CCT AAC CAA TTA AAT GAn 432 Asn He Gin Thr Thr Thr Val Asp Asp Thr Pro Asn Gin Leu Asn Xaa 130 135 140 AAA GAC CTT GTA TTC ATT GGT GCA ACT GAA TCA TAT CCA ATC ATG AAG 480 Lys Asp Leu Val Phe He Gly Ala Thr Glu Ser Tyr Pro He Met Lys 145 150 155 160 TAT ATG CAA CCA GTT AGA AAA ATG ATT GGA AAG CCT ACA ATA TTA AAC 528 Tyr Met Gin Pro Val Arg Lys Met He Gly Lys Pro Thr He Leu Asn 165 170 175 CTT GTG GGT CCA TTA ATT AAT CCA TAT CAC TTA ACG TAT CAA ATG GTA 576 Leu Val Gly Pro Leu He Asn Pro Tyr His Leu Thr Tyr Gin Met Val 180 185 190 GGC GTC TTT GAT CCT ACA AAG TTA AAG TTA GTT GCT AAA ACG ATT AAA 624 Gly Val Phe Asp Pro Thr Lys Leu Lys Leu Val Ala Lys Thr He Lys 195 200 205 GAT TTA GGT AGA AAA CGT GCA ATC GTT TTA CAT GGT GCA AAT GGT ATG 672 Asp Leu Gly Arg Lys Arg Ala He Val Leu His Gly Ala Asn Gly Met 210 215 220 GAT GAA GCA ACA CTA TCT GGT GAT AAT TTG ATA TAT GAA TTG ACT GAA 720 Asp Glu Ala Thr Leu Ser Gly Asp Asn Leu He Tyr Glu Leu Thr Glu 225 230 235 240 GAT GGA GAA ATC AAA AAT TAC ACA TTA AAT GCG ACT GAT TAT GGT TTG 768 Asp Gly Glu He Lys Asn Tyr Thr Leu Asn Ala Thr Asp Tyr Gly Leu 245 250 255 AAA CAT GCG CCG AAT AGT GAT TTT AAA GGC GGT TCA CCT GAA GAA AAT 816 Lys His Ala Pro Asn Ser Asp Phe Lys Gly Gly Ser Pro Glu Glu Asn 260 265 270 TTA GCA ATC TCC CTT AAT ATC TTG AAT GGT AAA GAT CAG TCA rGT CGA 864 Leu Ala He Ser Leu Asn He Leu Asn Gly Lys Asp Gin Ser Xaa Arg 275 280 285 CGT GAT GTT GTC TTA CTA AAT GCG GGT TTA AGC CTT TAT GTT GCA GAG 912 Arg Asp Val Val Leu Leu Asn Ala Gly Leu Ser Leu Tyr Val Ala Glu 290 295 300 AAA rTG GAT ACC ATC GCA GAA GGC ATA GAA CTT GCA ACT ACA TTG ATT 960 Lys Xaa Asp Thr He Ala Glu Gly He Glu Leu Ala Thr Thr Leu He 305 310 315 320 GAT AAT GGT GAA GCA TTG GAA AAA TAC CAT CAA ATG AGA GGT GAA 1005 Asp Asn Gly Glu Ala Leu Glu Lys Tyr His Gin Met Arg Gly Glu 325 330 335 TAA 1008 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 335 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: Met Lys Thr Met Thr Leu Leu Thr Arg He Lys Thr Glu Thr He Leu 1 5 10 15 Leu Glu Ser Asp He Lys Glu Leu He Asp He Leu He Ser Pro Ser 20 25 30 He Gly Thr Asp He Lys Tyr Glu Leu Leu Ser Ser Tyr Ser Glu Arg 35 40 45 Glu He Gin Gin Gin Glu Leu Thr Tyr He Val Arg Ser Leu He Asn 50 55 60 Thr Met Tyr Pro His Gin Pro Cys Tyr Glu Gly Ala Met Cys Val Cys 65 70 75 80 Gly Thr Gly Gly Asp Lys Ser Asn Ser Phe Asn He Ser Thr Thr Val 85 90 95 Ala Phe Val Val Ala Ser Ala Gly Val Lys Val He Lys His Gly Asn 100 105 110 Lys Ser He Thr Ser Asn Ser Gly Ser Thr Asp Leu Leu Asn Gin Met 115 120 125 Asn He Gin Thr Thr Thr Val Asp Asp Thr Pro Asn Gin Leu Asn Xaa 130 135 140 Lys Asp Leu Val Phe He Gly Ala Thr Glu Ser Tyr Pro He Met Lys 145 150 155 160 Tyr Met Gin Pro Val Arg Lys Met He Gly Lys Pro Thr He Leu Asn 165 170 175 Leu Val Gly Pro Leu He Asn Pro Tyr His Leu Thr Tyr Gin Met Val 180 185 190 Gly Val Phe Asp Pro Thr Lys Leu Lys Leu Val Ala Lys Thr He Lys 195 200 205 Asp Leu Gly Arg Lys Arg Ala He Val Leu His Gly Ala Asn Gly Met 210 215 220 Asp Glu Ala Thr Leu Ser Gly Asp Asn Leu He Tyr Glu Leu Thr Glu 225 230 235 240 Asp Gly Glu He Lys Asn Tyr Thr Leu Asn Ala Thr Asp Tyr Gly Leu 245 250 255 Lys His Ala Pro Asn Ser Asp Phe Lys Gly Gly Ser Pro Glu Glu Asn 260 265 270 Leu Ala He Ser Leu Asn He Leu Asn Gly Lys Asp Gin Ser Xaa Arg 275 280 285 Arg Asp Val Val Leu Leu Asn Ala Gly Leu Ser Leu Tyr Val Ala Glu 290 295 300 Lys Xaa Asp Thr He Ala Glu Gly He Glu Leu Ala Thr Thr Leu He 305 310 315 320 Asp Asn Gly Glu Ala Leu Glu Lys Tyr His Gin Met Arg Gly Glu 325 330 335 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1254 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p4c27)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1251 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: ATG GCG GAA ATT AAG GTA CCT GAA TTA GCA GAA TCA ATC TCA GAA GGA 48 Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 ' 5 10 15 ACA ATA GCC CAA TGG TTA AAG CAG CCT GGT GAC TAT GTA GAA CAG GGT 96 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 GAA TAT CTG CTT GAA CTA GAA ACG GAT AAA GTG AAT GTT GAA TTG ACA 144 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35 40 45 GCA GAA GAA TCG GGT GTA CTT CAA GAG GTA TTG AAA GAT TCG GGT GAT 192 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 ACC GTC CAG GTC GGA GAA ATT ATC GGT ACG ATT TCA GAA GGC GCG GGT 240 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 65 70 75 80 GAA AGT TCT GCC CCT GCT CCT ACA GAG AAA ACA GAA AGC AAG GAA AGC 288 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 GTA AAA GAA GAG AAA CAG GCT GAA CCA GCT GCA CAA GAG GTG AGC GAG 336 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 GAA GCA CAA TCT GAA GCA AAA TCA AGA ACG ATC GCT TCT CCG TCG GCC 384 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 CGT AAG CTT GCG AGA GAA AAA GGA ATT GAC CTG TCT CAA GTT CCA ACT 432 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 GGA GAT CCG CTT GGA AGA GTG CGC AAG CAG GAT GTC GAA GCG TAC GAA 480 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 AAA CCG GCA TCA AAA CCG GCT CCT CAG CAA AAG CAG CAG CCT CAG GCT 528 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 CAA AAA GCA CAG CAA AGC TTT GAC AAA CCT GTT GAA GTG CAA AAA ATG 576 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 TCA CGC CGC AGA CAA ACG ATT GCA AAA CGC CTT GTA GAG GTA CAG CAA 624 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 ACA TCA GCG ATG CTG ACT ACA TTT AAT GAA GTG GAC ATG ACG GCT GTC 672 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 ATG AAT CTC AGA AAA CGC CGC AAA GAT CAA TTT TTT GAG CAA AAT GAA 720 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 GTG AAG CTC GGC TTT ATG TCT TTC TTC ACG AAA GCG GTC GTG GCT GCA 768 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 TTG AAA AAA TAT CCG CTG TTG AAT GCA GAA ATT CAA GGC GAT GAG TTG 816 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 ATC GTT AAA AAA TTC TAC GAT ATC GGA ATC GCT GTT GCT GCT GTA GAA 864 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 GGT CTT GTC GTT CCG GTT GTA CGG GAT GCG GAT CGC CTG ACA TTT GCA 912 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 GGA ATC GAA AAA GAG ATC GGC GAG CTT GCG AAA AAA GCA AGA AAC AAT 960 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 AAA TTA ACC CTT AGC GAG CTT GAG GGA GGC TCC TTC ACG ATT ACA AAC 1008 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 GGA GGG ACT TTC GGT TCA TTG ATG TCA ACT CCA ATT TTA AAC AGC CCG 1056 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 CAA GTC GGT ATA CTG GGC ATG CAT AAG ATT CAG CTG CGC CCT GTA GCC 1104 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 ATT GAT GAA GAG CGT TTC GAA AAC CGT CCG ATG ATG TAT ATC GCT TTA 1152 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 TCT TAT GAT CAC CGA ATT GTA GAC GGT AAA GAA GCG GTT GGT TTC CTC 1200 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 GTG ACA ATC AAA AAT TTA CTG GAA GAT CCT GAA CAG CTT TTA TTA GAA 1248 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 GGA TAA 1254 Gly (2) INFORMATION FOR SEQ ID NO: 38- (l) SEQUENCE CHARACTERISTICS. (A) LENGTH 417 ammo acids (D) TOPOLOGY linear (ii) MOLECULE TYPE protein (xi) SEQUENCE DESCRIPTION SEQ ID NO: 38 Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 5 10 15 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35 40 45 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 65 70 75 80 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 Gly (2) INFORMATION FOR SEQ ID NO: 39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1254 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p4c52)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1251 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: ATG GCG GAA ATT AAG GTA CCT GAA TTA GCA GAA TCA ATC TCA GAA GGA 48 Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 5 10 15 ACA ATA GCC CAA TGG TTA AAG CAG CCT GGT GAC TAT GTA GAA CAG GGT 96 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 GAA TAT CTG CTT GAA CTA GAA ACG GAT AAA GTG AAT GTT GAA TTG ACA 144 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35 40 45 GCA GAA GAA TCG GGT GTA CTT CAA GAG GTA TTG AAA GAT TCG GGT GAT 192 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 ACC GTC CAG GTC GGA GAA ATT ATC GGT ACG ATT TCA GAA GGC GCG GGT 240 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 65 70 75 80 GAA AGT TCT GCC CCT GCT CCT ACA GAG AAA ACA GAA AGC AAG GAA AGC 288 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 GTA AAA GAA GAG AAA CAG GCT GAA CCA GCT GCA CAA GAG GTG AGC GAG 336 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 GAA GCA CAA TCT GAA GCA AAA TCA AGA ACG ATC GCT TCT CCG TCG GCC 384 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 CGT AAG CTT GCG AGA GAA AAA GGA ATT GAC CTG TCT CAA GTT CCA ACT 432 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 GGA GAT CCG CTT GGA AGA GTG CGC AAG CAG GAT GTC GAA GCG TAC GAA 480 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 AAA CCG GCA TCA AAA CCG GCT CCT CAG CAA AAG CAG CAG CCT CAG GCT 528 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 CAA AAA GCA CAG CAA AGC TTT GAC AAA CCT GTT GAA GTG CAA AAA ATG 576 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 TCA CGC CGC AGA CAA ACG ATT GCA AAA CGC CTT GTA GAG GTA CAG CAA 624 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 ACA TCA GCG ATG CTG ACT ACA TTT AAT GAA GTG GAC ATG ACG GCT GTC 672 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 ATG AAT CTC AGA AAA CGC CGC AAA GAT CAA TTT TTT GAG CAA AAT GAA 720 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 GTG AAG CTC GGC TTT ATG TCT TTC TTC ACG AAA GCG GTC GTG GCT GCA 768 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 TTG AAA AAA TAT CCG CTG TTG AAT GCA GAA ATT CAA GGC GAT GAG TTG 816 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 ATC GTT AAA AAA TTC TAC GAT ATC GGA ATC GCT GTT GCT GCT GTA GAA 864 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 GGT CTT GTC GTT CCG GTT GTA CGG GAT GCG GAT CGC CTG ACA TTT GCA 912 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 GGA ATC GAA AAA GAG ATC GGC GAG CTT GCG AAA AAA GCA AGA AAC AAT 960 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 AAA TTA ACC CTT AGC GAG CTT GAG GGA GGC TCC TTC ACG ATT ACA AAC 1008 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 GGA GGG ACT TTC GGT TCA TTG ATG TCA ACT CCA ATT TTA AAC AGC CCG 1056 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 CAA GTC GGT ATA CTG GGC ATG CAT AAG ATT CAG CTG CGC CCT GTA GCC 1104 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 ATT GAT GAA GAG CGT TTC GAA AAC CGT CCG ATG ATG TAT ATC GCT TTA 1152 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 TCT TAT GAT CAC CGA ATT GTA GAC GGT AAA GAA GCG GTT GGT TTC CTC 1200 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 GTG ACA ATC AAA AAT TTA CTG GAA GAT CCT GAA CAG CTT TTA TTA GAA 1248 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 GGA TAA 1254 Gly (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 417 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 40: Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 5 10 15 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35- 40 45 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 6-5 70 75 80 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 Gly (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1254 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b2)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1251 (xi) SEQUENCE DESCRIPTION: SEQ ID NO -.41: ATG GCG GAA ATT AAG GTA CCT GAA TTA GCA GAA TCA ATC TCA GAA GGA 48 Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 5 10 15 ACA ATA GCC CAA TGG TTA AAG CAG CCT GGT GAC TAT GTA GAA CAG GGT 96 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 GAA TAT CTG CTT GAA CTA GAA ACG GAT AAA GTG AAT GTT GAA TTG ACA 144 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35 40 45 GCA GAA GAA TCG GGT GTA CTT CAA GAG GTA TTG AAA GAT TCG GGT GAT 192 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 ACC GTC CAG GTC GGA GAA ATT ATC GGT ACG ATT TCA GAA GGC GCG GGT 240 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 65 70 75 80 GAA AGT TCT GCC CCT GCT CCT ACA GAG AAA ACA GAA AGC AAG GAA AGC 288 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 GTA AAA GAA GAG AAA CAG GCT GAA CCA GCT GCA CAA GAG GTG AGC GAG 336 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 GAA GCA CAA TCT GAA GCA AAA TCA AGA ACG ATC GCT TCT CCG TCG GCC 384 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 CGT AAG CTT GCG AGA GAA AAA GGA ATT GAC CTG TCT CAA GTT CCA ACT 432 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 GGA GAT CCG CTT GGA AGA GTG CGC AAG CAG GAT GTC GAA GCG TAC GAA 480 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 AAA CCG GCA TCA AAA CCG GCT CCT CAG CAA AAG CAG CAG CCT CAG GCT 528 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 CAA AAA GCA CAG CAA AGC TTT GAC AAA CCT GTT GAA GTG CAA AAA ATG 576 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 TCA CGC CGC AGA CAA ACG ATT GCA AAA CGC CTT GTA GAG GTA CAG CAA 624 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 ACA TCA GCG ATG CTG ACT ACA TTT AAT GAA GTG GAC ATG ACG GCT GTC 672 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 ATG AAT CTC AGA AAA CGC CGC AAA GAT CAA TTT TTT GAG CAA AAT GAA 720 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 GTG AAG CTC GGC TTT ATG TCT TTC TTC ACG AAA GCG GTC GTG GCT GCA 768 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 TTG AAA AAA TAT CCG CTG TTG AAT GCA GAA ATT CAA GGC GAT GAG TTG 816 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 ATC GTT AAA AAA TTC TAC GAT ATC GGA ATC GCT GTT GCT GCT GTA GAA 864 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 GGT CTT GTC GTT CCG GTT GTA CGG GAT GCG GAT CGC CTG ACA TTT GCA 912 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 GGA ATC GAA AAA GAG ATC GGC GAG CTT GCG AAA AAA GCA AGA AAC AAT 960 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 AAA TTA ACC CTT AGC GAG CTT GAG GGA GGC TCC TTC ACG ATT ACA AAC 1008 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 GGA GGG ACT TTC GGT TCA TTG ATG TCA ACT CCA ATT TTA AAC AGC CCG 1056 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 CAA GTC GGT ATA CTG GGC ATG CAT AAG ATT CAG CTG CGC CCT GTA GCC 1104 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 ATT GAT GAA GAG CGT TTC GAA AAC CGT CCG ATG ATG TAT ATC GCT TTA 1152 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 TCT TAT GAT CAC CGA ATT GTA GAC GGT AAA GAA GCG GTT GGT TTC CTC 1200 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 GTG ACA ATC AAA AAT TTA CTG GAA GAT CCT GAA CAG CTT TTA TTA GAA 1248 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 GGA TAA 1254 Gly (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 417 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42: Met Ala Glu He Lys Val Pro Glu Leu Ala Glu Ser He Ser Glu Gly 1 5 10 15 Thr He Ala Gin Trp Leu Lys Gin Pro Gly Asp Tyr Val Glu Gin Gly 20 25 30 Glu Tyr Leu Leu Glu Leu Glu Thr Asp Lys Val Asn Val Glu Leu Thr 35 40 45 Ala Glu Glu Ser Gly Val Leu Gin Glu Val Leu Lys Asp Ser Gly Asp 50 55 60 Thr Val Gin Val Gly Glu He He Gly Thr He Ser Glu Gly Ala Gly 65 70 75 80 Glu Ser Ser Ala Pro Ala Pro Thr Glu Lys Thr Glu Ser Lys Glu Ser 85 90 95 Val Lys Glu Glu Lys Gin Ala Glu Pro Ala Ala Gin Glu Val Ser Glu 100 105 110 Glu Ala Gin Ser Glu Ala Lys Ser Arg Thr He Ala Ser Pro Ser Ala 115 120 125 Arg Lys Leu Ala Arg Glu Lys Gly He Asp Leu Ser Gin Val Pro Thr 130 135 140 Gly Asp Pro Leu Gly Arg Val Arg Lys Gin Asp Val Glu Ala Tyr Glu 145 150 155 160 Lys Pro Ala Ser Lys Pro Ala Pro Gin Gin Lys Gin Gin Pro Gin Ala 165 170 175 Gin Lys Ala Gin Gin Ser Phe Asp Lys Pro Val Glu Val Gin Lys Met 180 185 190 Ser Arg Arg Arg Gin Thr He Ala Lys Arg Leu Val Glu Val Gin Gin 195 200 205 Thr Ser Ala Met Leu Thr Thr Phe Asn Glu Val Asp Met Thr Ala Val 210 215 220 Met Asn Leu Arg Lys Arg Arg Lys Asp Gin Phe Phe Glu Gin Asn Glu 225 230 235 240 Val Lys Leu Gly Phe Met Ser Phe Phe Thr Lys Ala Val Val Ala Ala 245 250 255 Leu Lys Lys Tyr Pro Leu Leu Asn Ala Glu He Gin Gly Asp Glu Leu 260 265 270 He Val Lys Lys Phe Tyr Asp He Gly He Ala Val Ala Ala Val Glu 275 280 285 Gly Leu Val Val Pro Val Val Arg Asp Ala Asp Arg Leu Thr Phe Ala 290 295 300 Gly He Glu Lys Glu He Gly Glu Leu Ala Lys Lys Ala Arg Asn Asn 305 310 315 320 Lys Leu Thr Leu Ser Glu Leu Glu Gly Gly Ser Phe Thr He Thr Asn 325 330 335 Gly Gly Thr Phe Gly Ser Leu Met Ser Thr Pro He Leu Asn Ser Pro 340 345 350 Gin Val Gly He Leu Gly Met His Lys He Gin Leu Arg Pro Val Ala 355 360 365 He Asp Glu Glu Arg Phe Glu Asn Arg Pro Met Met Tyr He Ala Leu 370 375 380 Ser Tyr Asp His Arg He Val Asp Gly Lys Glu Ala Val Gly Phe Leu 385 390 395 400 Val Thr He Lys Asn Leu Leu Glu Asp Pro Glu Gin Leu Leu Leu Glu 405 410 415 Gly (2) INFORMATION FOR SEQ ID NO: 43: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 524 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0c20)" (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43: TTTCGAAGAT CGGCTCTTAC AATATTGACG GTAAAGAACA GTTGGATTCT TAAAAACAAT 60 TAAAGAATTA ATTGAAAACC CAAAGACTTA TTATAGAATC TTAATCCACA ACACAAAATA 120 GTTTACTATT CCTAAAAGCG GGATTAAATC AATAACAAAC AGCATAAGAT TATTTCCTAG 180 TCGAAATATC TTACTGCTGT ACTTTATTTT TATAATGATC TTTAATGTGG GTTTAATTTT 240 GACTACTTAA AAATATATCA TTTCTATTGA AATAGACTCA CAATACAAAT ATAGTAGAAT 300 GCGTGTTTCA ATATGCTAAT GAATGCATTT TAGATATAAC AAACGAGAAA TATATGAATT 360 CTATAAGCGC CTTTAGTTAA TTTAAATCTC TGAACATGAT GTAATTCGCT TTATGGACAC 420 CACATTATAT GTTTTCATGT CCTACAACAC AACACATATT CAATTGTATA TACAGATATT 480 CTTAATGACA CACTCATAGC CCCATAACAA TATATGTTAC CTAT 524 (2) INFORMATION FOR SEQ ID NO: 44: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2799 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl2c32)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..2796 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 44: ATG ACT AAC GAA AGA AAA GAA GTT TCA GAG GCT CCT GTA AAC TTC GGT 48 Met Thr Asn Glu Arg Lys Glu Val Ser Glu Ala Pro Val Asn Phe Gly 1 5 10 15 GCG AAT TTA GGT CTA ATG TTA GAT CTA TAT GAT GAC TTT TTA CAA GAT 96 Ala Asn Leu Gly Leu Met Leu Asp Leu Tyr Asp Asp Phe Leu Gin Asp 20 25 30 CCA TCA TCT GTA CCA GAA GAT TTA CAA GTC TTA TTC AGC ACA ATT AAG 144 Pro Ser Ser Val Pro Glu Asp Leu Gin Val Leu Phe Ser Thr He Lys 35 40 45 AAT GAT GAC TCA ATT GTA CCA GCT TTA AAA AGT ACA AGT AGT CAA AAT 192 Asn Asp Asp Ser He Val Pro Ala Leu Lys Ser Thr Ser Ser Gin Asn 50 55 60 AGC GAC GGC ACA ATT AAG CGT GTC ATG CGT TTA ATT GAT AAT ATT CGC 240 Ser Asp Gly Thr He Lys Arg Val Met Arg Leu He Asp Asn He Arg 65 70 75 80 CAA TAC GGG CAT CTT AAA GCC GAT ATT TAT CCT GTA AAT CCT CCA AAA 288 Gin Tyr Gly His Leu Lys Ala Asp He Tyr Pro Val Asn Pro Pro Lys 85 90 95 AGG AAA CAT GTA CCT AAA TTA GAG ATT GAA GAC TTT GAT TTA GAT CAA 336 Arg Lys His Val Pro Lys Leu Glu He Glu Asp Phe Asp Leu Asp Gin 100 105 110 CAG ACT TTG GAA GGT ATA TCA GCA GGA ATT GTT TCA GAT CAC TTT GCC 384 Gin Thr Leu Glu Gly He Ser Ala Gly He Val Ser Asp His Phe Ala 115 120 125 GAC ATT TAT GAT AAT GCT TAT GAA GCA ATT TTA AGA ATG GAA AAA CGT 432 Asp He Tyr Asp Asn Ala Tyr Glu Ala He Leu Arg Met Glu Lys Arg 130 135 140 TAC AAA GGA CCA ATT GCA TTT GAG TAT ACA CAT ATT AAT AAC AAT ACC 480 Tyr Lys Gly Pro He Ala Phe Glu Tyr Thr His He Asn Asn Asn Thr 145 150 155 160 GAA CGT GGT TGG TTA AAA AGA AGA ATT GAA ACG CCA TAT AAA GTA ACG 528 Glu Arg Gly Trp Leu Lys Arg Arg He Glu Thr Pro Tyr Lys Val Thr 165 170 175 TTA AAT AAT AAC GAA AAA AGG GCA CTA TTC AAA CAA TTA GCG TAT GTT 576 Leu Asn Asn Asn Glu Lys Arg Ala Leu Phe Lys Gin Leu Ala Tyr Val 180 185 190 GAA GGG TTT GAA AAA TAT CTT CAT AAA AAC TTC GTT GGT GCA AAG CGT 624 Glu Gly Phe Glu Lys Tyr Leu His Lys Asn Phe Val Gly Ala Lys Arg 195 200 205 TTT TCA ATT GAA GGG GTA GAC GCA CTT GTA CCG ATG TTA CAA CGT ACT 672 Phe Ser He Glu Gly Val Asp Ala Leu Val Pro Met Leu Gin Arg Thr 210 215 220 ATT ACG ATT GCT GCG AAA GAA GGT ATT AAA AAT ATA CAA ATA GGC ATG 720 He Thr He Ala Ala Lys Glu Gly He Lys Asn He Gin He Gly Met 225 230 235 240 GCT CAC CGT GGA CGT TTA AAC GTT TTA ACG CAT GTC TTA GAA AAA CCG 768 Ala His Arg Gly Arg Leu Asn Val Leu Thr His Val Leu Glu Lys Pro 245 250 255 TAC GAA ATG ATG ATT TCA GAA TTT ATG CAT ACA GAT CCA ATG AAA TTC 816 Tyr Glu Met Met He Ser Glu Phe Met His Thr Asp Pro Met Lys Phe 260 265 270 TTA CCT GAA GAT GGT AGC TTG CAG TTA ACT GCT GGA TGG ACT GGT GAT 864 Leu Pro Glu Asp Gly Ser Leu Gin Leu Thr Ala Gly Trp Thr Gly Asp 275 280 285 GTG AAA TAT CAC CTT GGT GGC ATT AAA ACT ACT GAT TCA TAC GGT ACA 912 Val Lys Tyr His Leu Gly Gly He Lys Thr Thr Asp Ser Tyr Gly Thr 290 295 300 ATG CAG CGT ATT GCA CTG GCT AAC AAT CCA AGT CAC TTG GAA ATT GTT 960 Met Gin Arg He Ala Leu Ala Asn Asn Pro Ser His Leu Glu He Val 305 310 315 320 GCA CCT GTT GTT GAG GGG CGT ACG AGA GCA GCA CAA GAT GAT ACA CAA 1008 Ala Pro Val Val Glu Gly Arg Thr Arg Ala Ala Gin Asp Asp Thr Gin 325 330 335 CGA GCT GGG GCT CCG ACG ACT GAT CAT CAT AAA GCA ATG CCA ATT ATT 1056 Arg Ala Gly Ala Pro Thr Thr Asp His His Lys Ala Met Pro He He 340 345 350 ATA CAT GGC GAT GCT GCT TAT CCT GGT CAA GGA ATT AAC TTC GAA ACA 1104 He His Gly Asp Ala Ala Tyr Pro Gly Gin Gly He Asn Phe Glu Thr 355 360 365 ATG AAC TTA GGA AAC TTG AAA GGC TAT TCT ACG GGT GGT TCA TTG CAT 1152 Met Asn Leu Gly Asn Leu Lys Gly Tyr Ser Thr Gly Gly Ser Leu His 370 375 380 ATT ATT ACT AAC AAT AGA ATT GGA TTT ACT ACA GAA CCA ATT GAT GCA 1200 He He Thr Asn Asn Arg He Gly Phe Thr Thr Glu Pro He Asp Ala 385 390 395 400 CGT TCA ACA ACT TAT TCT ACA GAT GTG GCC AAA GGT TAT GAT GTG CCA 1248 Arg Ser Thr Thr Tyr Ser Thr Asp Val Ala Lys Gly Tyr Asp Val Pro 405 410 415 ATA TTC CAT GTC AAT GCA GAT GAC GTT GAA GCT ACT ATT GAA GCA ATT 1296 He Phe His Val Asn Ala Asp Asp Val Glu Ala Thr He Glu Ala He 420 425 430 GAT ATT GCA ATG GAA TTT AGA AAA GAG TTT CAT AAA GAC GTC GTT ATT 1344 Asp He Ala Met Glu Phe Arg Lys Glu Phe His Lys Asp Val Val He 435 440 445 GAT TTA GTA GGT TAT CGT CGT TTC GGA CAT AAC GAA ATG GAT GAA CCA 1392 Asp Leu Val Gly Tyr Arg Arg Phe Gly His Asn Glu Met Asp Glu Pro 450 455 460 TCA ATT ACT AAT CCA GTT CCT TAT CAG AAT ATT CGC AAA CAT GAC TCT 1440 Ser He Thr Asn Pro Val Pro Tyr Gin Asn He Arg Lys His Asp Ser 465 470 475 480 GTT GAA TAT GTG TTT GGT AAA AAG CTT GTT AAT GAA GGT GTC ATT TCA 1488 Val Glu Tyr Val Phe Gly Lys Lys Leu Val Asn Glu Gly Val He Ser 485 490 495 GAA GAT GAA ATG CAT TCA TTT ATA GAA CAA GTC CAA AAG GAA CTA AGA 1536 Glu Asp Glu Met His Ser Phe He Glu Gin Val Gin Lys Glu Leu Arg 500 505 510 CAA GCT CAT GAT AAA ATT AAT AAA GCT GAT AAA ATG GAT AAT CCA GAT 1584 Gin Ala His Asp Lys He Asn Lys Ala Asp Lys Met Asp Asn Pro Asp 515 520 525 ATG GAA AAG CCT GCA GAT CTT GCA TTA CCG TTA CAA GCA GAC GAA CAA 1632 Met Glu Lys Pro Ala Asp Leu Ala Leu Pro Leu Gin Ala Asp Glu Gin 530 535 540 TCA TTT ACT TTT GAT CAC TTG AAA GAA ATA AAT GAT GCA TTG TTA ACA 1680 Ser Phe Thr Phe Asp His Leu Lys Glu He Asn Asp Ala Leu Leu Thr 545 550 555 560 TAT CCG GAT GGC TTT AAC ATT TTG AAA AAG TTA AAC AAA GTT CTT GAG 1728 Tyr Pro Asp Gly Phe Asn He Leu Lys Lys Leu Asn Lys Val Leu Glu 565 570 575 AAG CGT CAT GAG CCG TTT AAT AAA GAA GAT GGT TTA GTT GAT TGG GCA 1776 Lys Arg His Glu Pro Phe Asn Lys Glu Asp Gly Leu Val Asp Trp Ala 580 585 590 CAA GCA GAA CAA CTT GCA TTT GCG ACA ATT TTA CAA GAT GGT ACA CCG 1824 Gin Ala Glu Gin Leu Ala Phe Ala Thr He Leu Gin Asp Gly Thr Pro 595 600 605 ATT CGC TTA ACT GGT CAA GAT AGT GAA CGT GGT ACA TTC AGT CAT AGG 1872 He Arg Leu Thr Gly Gin Asp Ser Glu Arg Gly Thr Phe Ser His Arg 610 615 620 CAT GCC GTG TTA CAT GAT GAG CAA ACA GGT GAA ACA TAT ACA CCT TTA 1920 His Ala Val Leu His Asp Glu Gin Thr Gly Glu Thr Tyr Thr Pro Leu 625 630 635 640 CAT CAT GTT CCT GAT CAA AAA GCG ACA TTT GAT ATA CAC AAT TCT CCG 1968 His His Val Pro Asp Gin Lys Ala Thr Phe Asp He His Asn Ser Pro 645 650 655 CTT TCA GAA GCA GCA GTA GTT GGT TTT GAA TAC GGC TAT AAT GTG GAA 2016 Leu Ser Glu Ala Ala Val Val Gly Phe Glu Tyr Gly Tyr Asn Val Glu 660 665 670 AAC AAA AAA AGC TTC AAT ATT TGG GAA GCA CAA TAT GGT GAT TTT GCA 2064 Asn Lys Lys Ser Phe Asn He Trp Glu Ala Gin Tyr Gly Asp Phe Ala 675 680 685 AAT ATG TCA CAA ATG ATT TTT GAC AAC TTC TTA TTC AGT TCT CGC TCA 2112 Asn Met Ser Gin Met He Phe Asp Asn Phe Leu Phe Ser Ser Arg Ser 690 695 700 AAA TGG GGA GAA CGT TCA GGA TTA ACA TTA TTC TTA CCT CAT GCA TAT 2160 Lys Trp Gly Glu Arg Ser Gly Leu Thr Leu Phe Leu Pro His Ala Tyr 705 710 715 720 GAG GGT CAA GGG CCT GAA CAT TCA TCA GCA AGA TTA GAG CGA TTT TTA 2208 Glu Gly Gin Gly Pro Glu His Ser Ser Ala Arg Leu Glu Arg Phe Leu 725 730 735 CAA TTA GCT GCT GAA AAT AAT TGC ACA GTT GTC AAC TTA TCT AGT TCA 2256 Gin Leu Ala Ala Glu Asn Asn Cys Thr Val Val Asn Leu Ser Ser Ser 740 745 750 AGT AAT TAT TTC CAC TTA TTG CGT GCA CAA GCG GCT AGT TTA GAT TCT 2304 Ser Asn Tyr Phe His Leu Leu Arg Ala Gin Ala Ala Ser Leu Asp Ser 755 760 765 GAA CAA ATG CGA CCA TTG GTT GTT ATG TCA CCA AAA AGC TTA CTG AGA 2352 Glu Gin Met Arg Pro Leu Val Val Met Ser Pro Lys Ser Leu Leu Arg 770 775 780 AAT AAA ACA GTT GCA AAA CCA ATT GAT GAA TTT ACT TCT GGT GGA TTT 2400 Asn Lys Thr Val Ala Lys Pro He Asp Glu Phe Thr Ser Gly Gly Phe 785 790 795 800 GAG CCA ATT TTG ACA GAA TCA TAT CAA GCG GAT AAG GTT ACA AAA GTT 2448 Glu Pro He Leu Thr Glu Ser Tyr Gin Ala Asp Lys Val Thr Lys Val 805 810 815 ATT TTG GCA ACT GGT AAA ATG TTC ATT GAT TTA AAA GAA GCA TTA GCT 2496 He Leu Ala Thr Gly Lys Met Phe He Asp Leu Lys Glu Ala Leu Ala 820 825 830 AAA AAT CCA GAC GAA TCA GTA TTA CTC GTT GCG ATT GAA AGA TTG TAT 2544 Lys Asn Pro Asp Glu Ser Val Leu Leu Val Ala He Glu Arg Leu Tyr 835 840 845 CCA TTC CCA GAG GAA GAG ATT GAA GCA TTA CTA GCA CAA TTG CCA AAC 2592 Pro Phe Pro Glu Glu Glu He Glu Ala Leu Leu Ala Gin Leu Pro Asn 850 855 860 CTT GAA GAA GTG TCA TGG GTA CAA GAA GAA CCT AAA AAT CAA GGT GCA 2640 Leu Glu Glu Val Ser Trp Val Gin Glu Glu Pro Lys Asn Gin Gly Ala 865 870 875 880 TGG TTA TAT GTC TAT CCA TAT GTT AAA GTG CTA GTT GCA GAT AAA TAT 2688 Trp Leu Tyr Val Tyr Pro Tyr Val Lys Val Leu Val Ala Asp Lys Tyr 885 890 895 GAT TTA AGT TAT CAT GGC AGA ATT CAA AGG GCT GCT CCA GCT GAA GGC 2736 Asp Leu Ser Tyr His Gly Arg He Gin Arg Ala Ala Pro Ala Glu Gly 900 905 910 GAT GGA GAA ATT CAT AAA CTT GTT CAA AAT AAA ATT ATA GAA AAT GCA 2784 Asp Gly Glu He His Lys Leu Val Gin Asn Lys He He Glu Asn Ala 915 920 925 TTA AAA AAT AAC TAG 2799 Leu Lys Asn Asn 930 (2) INFORMATION FOR SEQ ID NO: 45 (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 932 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: Met Thr Asn Glu Arg Lys Glu Val Ser Glu Ala Pro Val Asn Phe Gly 1 5 10 15 Ala Asn Leu Gly Leu Met Leu Asp Leu Tyr Asp Asp Phe Leu Gin Asp 20 25 30 Pro Ser Ser Val Pro Glu Asp Leu Gin Val Leu Phe Ser Thr He Lys 35 40 45 Asn Asp Asp Ser He Val Pro Ala Leu Lys Ser Thr Ser Ser Gin Asn 50 55 60 Ser Asp Gly Thr He Lys Arg Val Met Arg Leu He Asp Asn He Arg 65 70 75 80 Gin Tyr Gly His Leu Lys Ala Asp He Tyr Pro Val Asn Pro Pro Lys 85 90 95 Arg Lys His Val Pro Lys Leu Glu He Glu Asp Phe Asp Leu Asp Gin 100 105 110 Gin Thr Leu Glu Gly He Ser Ala Gly He Val Ser Asp His Phe Ala 115 120 125 Asp He Tyr Asp Asn Ala Tyr Glu Ala He Leu Arg Met Glu Lys Arg 130 135 140 Tyr Lys Gly Pro He Ala Phe Glu Tyr Thr His He Asn Asn Asn Thr 145 150 155 160 Glu Arg Gly Trp Leu Lys Arg Arg He Glu Thr Pro Tyr Lys Val Thr 165 170 175 Leu Asn Asn Asn Glu Lys Arg Ala Leu Phe Lys Gin Leu Ala Tyr Val 180 185 190 Glu Gly Phe Glu Lys Tyr Leu His Lys Asn Phe Val Gly Ala Lys Arg 195 200 205 Phe Ser He Glu Gly Val Asp Ala Leu Val Pro Met Leu Gin Arg Thr 210 215 220 He Thr He Ala Ala Lys Glu Gly He Lys Asn He Gin He Gly Met 225 230 235 240 Ala His Arg Gly Arg Leu Asn Val Leu Thr His Val Leu Glu Lys Pro 245 250 255 Tyr Glu Met Met He Ser Glu Phe Met His Thr Asp Pro Met Lys Phe 260 265 270 Leu Pro Glu Asp Gly Ser Leu Gin Leu Thr Ala Gly Trp Thr Gly Asp 275 280 285 Val Lys Tyr His Leu Gly Gly He Lys Thr Thr Asp Ser Tyr Gly Thr 290 295 300 Met Gin Arg He Ala Leu Ala Asn Asn Pro Ser His Leu Glu He Val 305 310 315 320 Ala- Pro Val Val Glu Gly Arg Thr Arg Ala Ala Gin Asp Asp Thr Gin 325 330 335 Arg Ala Gly Ala Pro Thr Thr Asp His His Lys Ala Met Pro He He 340 345 350 He His Gly Asp Ala Ala Tyr Pro Gly Gin Gly He Asn Phe Glu Thr 355 360 365 Met Asn Leu Gly Asn Leu Lys Gly Tyr Ser Thr Gly Gly Ser Leu His 370 375 380 He He Thr Asn Asn Arg He Gly Phe Thr Thr Glu Pro He Asp Ala 385 390 395 400 Arg Ser Thr Thr Tyr Ser Thr Asp Val Ala Lys Gly Tyr Asp Val Pro 405 410 415 He Phe His Val Asn Ala Asp Asp Val Glu Ala Thr He Glu Ala He 420 425 430 Asp He Ala Met Glu Phe Arg Lys Glu Phe His Lys Asp Val Val He 435 440 445 Asp Leu Val Gly Tyr Arg Arg Phe Gly His Asn Glu Met Asp Glu Pro 450 455 460 Ser He Thr Asn Pro Val Pro Tyr Gin Asn He Arg Lys His Asp Ser 465 470 475 480 Val Glu Tyr Val Phe Gly Lys Lys Leu Val Asn Glu Gly Val He Ser 485 490 495 Glu Asp Glu Met His Ser Phe He Glu Gin Val Gin Lys Glu Leu Arg 500 505 510 Gin Ala His Asp Lys He Asn Lys Ala Asp Lys Met Asp Asn Pro Asp 515 520 525 Met Glu Lys Pro Ala Asp Leu Ala Leu Pro Leu Gin Ala Asp Glu Gin 530 535 540 Ser Phe Thr Phe Asp His Leu Lys Glu He Asn Asp Ala Leu Leu Thr 545 550 555 560 Tyr Pro Asp Gly Phe Asn He Leu Lys Lys Leu Asn Lys Val Leu Glu 565 570 575 Lys Arg His Glu Pro Phe Asn Lys Glu Asp Gly Leu Val Asp Trp Ala 580 585 590 Gin Ala Glu Gin Leu Ala Phe Ala Thr He Leu Gin Asp Gly Thr Pro 595 600 605 He Arg Leu Thr Gly Gin Asp Ser Glu Arg Gly Thr Phe Ser His Arg 610 615 620 His Ala Val Leu His Asp Glu Gin Thr Gly Glu Thr Tyr Thr Pro Leu 625 630 635 640 His His Val Pro Asp Gin Lys Ala Thr Phe Asp He His Asn Ser Pro 645 650 655 Leu Ser Glu Ala Ala Val Val Gly Phe Glu Tyr Gly Tyr Asn Val Glu 660 665 670 Asn Lys Lys Ser Phe Asn He Trp Glu Ala Gin Tyr Gly Asp Phe Ala 675 680 685 Asn Met Ser Gin Met He Phe Asp Asn Phe Leu Phe Ser Ser Arg Ser 690 695 700 Lys Trp Gly Glu Arg Ser Gly Leu Thr Leu Phe Leu Pro His Ala Tyr 705 710 715 720 Glu Gly Gin Gly Pro Glu His Ser Ser Ala Arg Leu Glu Arg Phe Leu 725 730 735 Gin Leu Ala Ala Glu Asn Asn Cys Thr Val Val Asn Leu Ser Ser Ser 740 745 750 Ser Asn Tyr Phe His Leu Leu Arg Ala Gin Ala Ala Ser Leu Asp Ser 755 760 765 Glu Gin Met Arg Pro Leu Val Val Met Ser Pro Lys Ser Leu Leu Arg 770 775 780 Asn Lys Thr Val Ala Lys Pro He Asp Glu Phe Thr Ser Gly Gly Phe 785 790 795 800 Glu Pro He Leu Thr Glu Ser Tyr Gin Ala Asp Lys Val Thr Lys Val 805 810 815 He Leu Ala Thr Gly Lys Met Phe He Asp Leu Lys Glu Ala Leu Ala 820 825 830 Lys Asn Pro Asp Glu Ser Val Leu Leu Val Ala He Glu Arg Leu Tyr 835 840 845 Pro Phe Pro Glu Glu Glu He Glu Ala Leu Leu Ala Gin Leu Pro Asn 850 855 860 Leu Glu Glu Val Ser Trp Val Gin Glu Glu Pro Lys Asn Gin Gly Ala 865 870 875 880 Trp Leu Tyr Val Tyr Pro Tyr Val Lys Val Leu Val Ala Asp Lys Tyr 885 890 895 Asp Leu Ser Tyr His Gly Arg He Gin Arg Ala Ala Pro Ala Glu Gly 900 905 910 Asp Gly Glu He His Lys Leu Val Gin Asn Lys He He Glu Asn Ala 915 920 925 Leu Lys Asn Asn 930 (2) INFORMATION FOR SEQ ID NO: 46: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2574 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b30)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..2571 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 46: ATG CGT CTG GAT CGT CTT ACT AAT AAA TTC CAG CTT GCT CTT GCC GAT 48 Met Arg Leu Asp Arg Leu Thr Asn Lys Phe Gin Leu Ala Leu Ala Asp 1 5 10 15 GCC CAA TCA CTT GCA CTC GGG CAC GAC AAC CAA TTT ATC GAA CCA CTT 96 Ala Gin Ser Leu Ala Leu Gly His Asp Asn Gin Phe He Glu Pro Leu 20 25 30 CAT TTA ATG AGC GCC CTG CTG AAT CAG GAA GGG GGT TCG GTT AGT CCT 144 His Leu Met Ser Ala Leu Leu Asn Gin Glu Gly Gly Ser Val Ser Pro 35 40 45 TTA TTA ACA TCC GCT GGC ATA AAT GCT GGC CAG TTG CGC ACA GAT ATC 192 Leu Leu Thr Ser Ala Gly He Asn Ala Gly Gin Leu Arg Thr Asp He 50 55 60 AAT CAG GCA TTA AAT CGT TTA CCG CAG GTT GAA GGT ACT GGT GGT GAT 240 Asn Gin Ala Leu Asn Arg Leu Pro Gin Val Glu Gly Thr Gly Gly Asp 65 70 75 80 GTC CAG CCA TCA CAG GAT CTG GTG CGC GTT CTT AAT CTT TGC GAC AAC 288 Val Gin Pro Ser Gin Asp Leu Val Arg Val Leu Asn Leu Cys Asp Asn 85 90 95 GTG GCG CAA AAA CGT GGT GAT AAC TTT ATC TCG TCA GAA CTG TTC GTT 336 Val Ala Gin Lys Arg Gly Asp Asn Phe He Ser Ser Glu Leu Phe Val 100 105 110 CTG GCG GCA CTT GAG TCT CGC GGC ACC GTG GCC GAC ATC CTG AAA GCA 384 Leu Ala Ala Leu Glu Ser Arg Gly Thr Val Ala Asp He Leu Lys Ala 115 120 125 GCA GGG GCG ACC ACC GCC AAC ATT ACT CAA GCG ATT GAA CAA ATG CGT 432 Ala Gly Ala Thr Thr Ala Asn He Thr Gin Ala He Glu Gin Met Arg 130 135 140 GGA GGT GAA AGC GTG AAC GAT CAA GGT GCT GAA GAC CAA CGT CAG GCT 480 Gly Gly Glu Ser Val Asn Asp Gin Gly Ala Glu Asp Gin Arg Gin Ala 145 150 155 160 TTG AAA AAA TAT ACC ATC GAC CTT ACC GAA CGA GCC GAA CAG GGC AAA 528 Leu Lys Lys Tyr Thr He Asp Leu Thr Glu Arg Ala Glu Gin Gly Lys 165 170 175 CTC GAT CCG GTG ATT GGT CGT GAT GAA GAA ATT CGC CGT ACC ATT CAG 576 Leu Asp Pro Val He Gly Arg Asp Glu Glu He Arg Arg Thr He Gin 180 185 190 GTG CTG CAA CGT CGT ACT AAA AAT AAC CCG GTA CTG ATT GGT GAA CCC 624 Val Leu Gin Arg Arg Thr Lys Asn Asn Pro Val Leu He Gly Glu Pro 195 200 205 GGC GTC GGT AAA ACT GCC ATC GTT GAA GGT CTG GCG CAG CGT ATT ATC 672 Gly Val Gly Lys Thr Ala He Val Glu Gly Leu Ala Gin Arg He He 210 215 220 AAC GGC GAA GTG CCG GAA GGG TTG AAA GGC CGC CGG GTA CTG GCG CTG 720 Asn Gly Glu Val Pro Glu Gly Leu Lys Gly Arg Arg Val Leu Ala Leu 225 230 235 240 GAT ATG GGC GCG CTG GTG GCT GGG GCG AAA TAT CGC GGT GAG TTT GAA 768 Asp Met Gly Ala Leu Val Ala Gly Ala Lys Tyr Arg Gly Glu Phe Glu 245 250 255 GAA CGT TTA AAA GGC GTG CTT AAC GAT CTT GCC AAA CAG GAA GGC AAC 816 Glu Arg Leu Lys Gly Val Leu Asn Asp Leu Ala Lys Gin Glu Gly Asn 260 265 270 GTC ATC CTA TTT ATC GAC GAA TTA CAT ACC ATG GTC GGC GCG GGT AAA 864 Val He Leu Phe He Asp Glu Leu His Thr Met Val Gly Ala Gly Lys 275 280 285 GCC GAT GGC GCA ATG GAC GCC GGA AAC ATG CTG AAA CCG GCG CTG GCG 912 Ala Asp Gly Ala Met Asp Ala Gly Asn Met Leu Lys Pro Ala Leu Ala 290 295 300 CGT GGT GAA TTG CAC TGC GTA GGT GCC ACG ACG CTT GAC GAA TAT CGC 960 Arg Gly Glu Leu His Cys Val Gly Ala Thr Thr Leu Asp Glu Tyr Arg 305 310 315 320 CAG TAC ATT GAA AAA GAT GCT GCG CTG GAA CGT CGT TTC CAG AAA GTG 1008 Gin Tyr He Glu Lys Asp Ala Ala Leu Glu Arg Arg Phe Gin Lys Val 325 330 335 TTT GTT GCC GAG CCT TCT GTT GAA GAT ACC ATT GCG ATT CTG CGT GGC 1056 Phe Val Ala Glu Pro Ser Val Glu Asp Thr He Ala He Leu Arg Gly 340 345 350 CTG AAA GAA CGT TAC GAA TTG CAC CAC CAT GTG CAA ATT ACT GAC CCG 1104 Leu Lys Glu Arg Tyr Glu Leu His His His Val Gin He Thr Asp Pro 355 360 365 GCA ATT GTT GCA GCG GCG ACG TTG TCT CAT CGC TAC ATT GCT GAC CGT 1152 Ala He Val Ala Ala Ala Thr Leu Ser His Arg Tyr He Ala Asp Arg 370 375 380 CAG CTG CCG GAT AAA GCC ATC GAC CTG ATC GAT GAA GCA GCA TCC AGC 1200 Gin Leu Pro Asp Lys Ala He Asp Leu He Asp Glu Ala Ala Ser Ser 385 390 395 400 ATT CGT ATG CAG ATT GAC TCA AAA CCA GAA GAA CTC GAC CGA CTC GAT 1248 He Arg Met Gin He Asp Ser Lys Pro Glu Glu Leu Asp Arg Leu Asp 405 410 415 CGT CGT ATC ATC CAG CTC AAA CTG GAA CAA CAG GCG TTA ATG AAA GAG 1296 Arg Arg He He Gin Leu Lys Leu Glu Gin Gin Ala Leu Met Lys Glu 420 425 430 TCT GAT GAA GCC AGT AAA AAA CGT CTG GAT ATG CTC AAC GAA GAA CTG 1344 Ser Asp Glu Ala Ser Lys Lys Arg Leu Asp Met Leu Asn Glu Glu Leu 435 440 445 AGC GAC AAA GAA CGT CAG TAC TCC GAG TTA GAA GAA GAG TGG AAA GCA 1392 Ser Asp Lys Glu Arg Gin Tyr Ser Glu Leu Glu Glu Glu Trp Lys Ala 450 455 460 GAG AAG GCA TCG CTT TCT GGT ACG CAG ACC ATT AAA GCG GAA CTG GAA 1440 Glu Lys Ala Ser Leu Ser Gly Thr Gin Thr He Lys Ala Glu Leu Glu 465 470 475 480 CAG GCG AAA ATC GCT ATT GAA CAG GCT CGC CGT GTG GGG GAC CTG GCG 1488 Gin Ala Lys He Ala He Glu Gin Ala Arg Arg Val Gly Asp Leu Ala 485 490 495 CGG ATG TCT GAA CTG CAA TAC GGC AAA ATC CCG GAA CTG GAA AAG CAA 1536 Arg Met Ser Glu Leu Gin Tyr Gly Lys He Pro Glu Leu Glu Lys Gin 500 505 510 CTG GAA GCC GCA ACG CAG CTC GAA GGC AAA ACT ATG CGT CTG TTG CGT 1584 Leu Glu Ala Ala Thr Gin Leu Glu Gly Lys Thr Met Arg Leu Leu Arg 515 520 525 AAT AAA GTG ACC GAC GCC GAA ATT GCT GAA GTG CTG GCG CGT TGG ACG 1632 Asn Lys Val Thr Asp Ala Glu He Ala Glu Val Leu Ala Arg Trp Thr 530 535 540 GGG ATT CCG GTT TCT CGC ATG ATG GAA AGC GAG CGC GAA AAA CTG CTG 1680 Gly He Pro Val Ser Arg Met Met Glu Ser Glu Arg Glu Lys Leu Leu 545 550 555 560 CGT ATG GAG CAA GAA CTG CAC CAT CGC GTA ATT GGT CAG AAC GAA GCG 1728 Arg Met Glu Gin Glu Leu His His Arg Val He Gly Gin Asn Glu Ala 565 570 575 GTT GAT GCG GTA TCT AAC GCT ATT CGT CGT AGC CGT GCG GGG CTG GCG 1776 Val Asp Ala Val Ser Asn Ala He Arg Arg Ser Arg Ala Gly Leu Ala 580 585 590 GAT CCA AAT CGC CCG ATT GGT TCA TTC CTG TTC CTC GGC CCA ACT GGT 1824 Asp Pro Asn Arg Pro He Gly Ser Phe Leu Phe Leu Gly Pro Thr Gly 595 600 605 GTG GGG AAA ACA GAG CTT TGT AAG GCG CTG GCG AAC TTT ATG TTT GAT 1872 Val Gly Lys Thr Glu Leu Cys Lys Ala Leu Ala Asn Phe Met Phe Asp 610 615 620 AGC GAC GAG GCG ATG GTC CGT ATC GAT ATG TCC GAG TTT ATG GAG AAA 1920 Ser Asp Glu Ala Met Val Arg He Asp Met Ser Glu Phe Met Glu Lys 625 630 635 640 CAC TCG GTG TCT CGT TTG GTT GGT GCG CCT CCG GGA TAT GTC GGT TAT 1968 His Ser Val Ser Arg Leu Val Gly Ala Pro Pro Gly Tyr Val Gly Tyr 645 650 655 GAA GAA GGT GGC TAC CTG ACC GAA GCG GTG CGT CGT CGT CCG TAT TCC 2016 Glu Glu Gly Gly Tyr Leu Thr Glu Ala Val Arg Arg Arg Pro Tyr Ser 660 665 670 GTC ATC CTG CTG GAT GAA GTG GAA AAA GCG CAT CCG GAT GTC TTC AAC 2064 Val He Leu Leu Asp Glu Val Glu Lys Ala His Pro Asp Val Phe Asn 675 680 685 ATT CTG TTG CAG GTA CTG GAT GAT GGG CGT CTG ACT GAC GGG CAA GGG 2112 He Leu Leu Gin Val Leu Asp Asp Gly Arg Leu Thr Asp Gly Gin Gly 690 695 700 AGA ACG GTC GAC TTC CGT AAT ACG GTC GTC ATT ATG ACC TCT AAC CTC 2160 Arg Thr Val Asp Phe Arg Asn Thr Val Val He Met Thr Ser Asn Leu 705 710 715 720 GGT TCC GAT CTG ATT CAG GAA CGC TTC GGT GAA CTG GAT TAT GCG CAC 2208 Gly Ser Asp Leu He Gin Glu Arg Phe Gly Glu Leu Asp Tyr Ala His 725 730 735 ATG AAA GAG CTG GTG CTC GGT GTG GTA AGC CAT AAC TTC CGT CCG GAA 2256 Met Lys Glu Leu Val Leu Gly Val Val Ser His Asn Phe Arg Pro Glu 740 745 750 TTC ATT AAC CGT ATC GAT GAA GTG GTG GTC TTC CAT CCG CTG GGT GAA 2304 Phe He Asn Arg He Asp Glu Val Val Val Phe His Pro Leu Gly Glu 755 760 765 CAG CAC ATT GCC TCG ATT GCG CAG ATT CAG TTG AAA CGT CTG TAC AAA 2352 Gin His He Ala Ser He Ala Gin He Gin Leu Lys Arg Leu Tyr Lys 770 775 780 CGT CTG GAA GAA CGT GGT TAT GAA ATC CAC ATT TCT GAC GAG GCG CTG 2400 Arg Leu Glu Glu Arg Gly Tyr Glu He His He Ser Asp Glu Ala Leu 785 790 795 800 AAA CTG CTG AGC GAG AAC GGT TAC GAT CCG GTC TAT GGT GCA CGT CCT 2448 Lys Leu Leu Ser Glu Asn Gly Tyr Asp Pro Val Tyr Gly Ala Arg Pro 805 810 815 CTG AAA CGT GCA ATT CAG CAG CAG ATC GAA AAC CCG CTG GCA CAG CAA 2496 Leu Lys Arg Ala He Gin Gin Gin He Glu Asn Pro Leu Ala Gin Gin 820 825 830 ATA CTG TCT GGT GAA TTG GTT CCG GGT AAA GTG ATT CGC CTG GAA GTT 2544 He Leu Ser Gly Glu Leu Val Pro Gly Lys Val He Arg Leu Glu Val 835 840 845 AAT GAA GAC CGG ATT GTC GCC GTC CAG TAA 2574 Asn Glu Asp Arg He Val Ala Val Gin 850 855 (2) INFORMATION FOR SEQ ID NO: 47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 857 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: Met Arg Leu Asp Arg Leu Thr Asn Lys Phe Gin Leu Ala Leu Ala Asp 1 5 10 15 Ala Gin Ser Leu Ala Leu Gly His Asp Asn Gin Phe He Glu Pro Leu 20 25 30 His Leu Met Ser Ala Leu Leu Asn Gin Glu Gly Gly Ser Val Ser Pro 35 40 45 Leu Leu Thr Ser Ala Gly He Asn Ala Gly Gin Leu Arg Thr Asp He 50 55 60 Asn Gin Ala Leu Asn Arg Leu Pro Gin Val Glu Gly Thr Gly Gly Asp 65 70 75 80 Val Gin Pro Ser Gin Asp Leu Val Arg Val Leu Asn Leu Cys Asp Asn 85 90 95 Val Ala Gin Lys Arg Gly Asp Asn Phe He Ser Ser Glu Leu Phe Val 100 105 110 Leu Ala Ala Leu Glu Ser Arg Gly Thr Val Ala Asp He Leu Lys Ala 115 120 125 Ala- Gly Ala Thr Thr Ala Asn He Thr Gin Ala He Glu Gin Met Arg 130 135 140 Gly Gly Glu Ser Val Asn Asp Gin Gly Ala Glu Asp Gin Arg Gin Ala 145 150 155 160 Leu Lys Lys Tyr Thr He Asp Leu Thr Glu Arg Ala Glu Gin Gly Lys 165 170 175 Leu Asp Pro Val He Gly Arg Asp Glu Glu He Arg Arg Thr He Gin 180 185 190 Val Leu Gin Arg Arg Thr Lys Asn Asn Pro Val Leu He Gly Glu Pro 195 200 205 Gly Val Gly Lys Thr Ala He Val Glu Gly Leu Ala Gin Arg He He 210 215 220 Asn Gly Glu Val Pro Glu Gly Leu Lys Gly Arg Arg Val Leu Ala Leu 225 230 235 240 Asp Met Gly Ala Leu Val Ala Gly Ala Lys Tyr Arg Gly Glu Phe Glu 245 250 255 Glu Arg Leu Lys Gly Val Leu Asn Asp Leu Ala Lys Gin Glu Gly Asn 260 265 270 Val He Leu Phe He Asp Glu Leu His Thr Met Val Gly Ala Gly Lys 275 280 285 Ala Asp Gly Ala Met Asp Ala Gly Asn Met Leu Lys Pro Ala Leu Ala 290 295 300 Arg Gly Glu Leu His Cys Val Gly Ala Thr Thr Leu Asp Glu Tyr Arg 305 310 315 320 Gin Tyr He Glu Lys Asp Ala Ala Leu Glu Arg Arg Phe Gin Lys Val 325 330 335 Phe Val Ala Glu Pro Ser Val Glu Asp Thr He Ala He Leu Arg Gly 340 345 350 Leu Lys Glu Arg Tyr Glu Leu His His His Val Gin He Thr Asp Pro 355 360 365 Ala He Val Ala Ala Ala Thr Leu Ser His Arg Tyr He Ala Asp Arg 370 375 380 Gin Leu Pro Asp Lys Ala He Asp Leu He Asp Glu Ala Ala Ser Ser 385 390 395 400 He Arg Met Gin He Asp Ser Lys Pro Glu Glu Leu Asp Arg Leu Asp 405 410 415 Arg Arg He He Gin Leu Lys Leu Glu Gin Gin Ala Leu Met Lys Glu 420 425 430 Ser Asp Glu Ala Ser Lys Lys Arg Leu Asp Met Leu Asn Glu Glu Leu 435 440 445 Ser Asp Lys Glu Arg Gin Tyr Ser Glu Leu Glu Glu Glu Trp Lys Ala 450 455 460 Glu Lys Ala Ser Leu Ser Gly Thr Gin Thr He Lys Ala Glu Leu Glu 465 470 475 480 Gin Ala Lys He Ala He Glu Gin Ala Arg Arg Val Gly Asp Leu Ala 485 490 495 Arg Met Ser Glu Leu Gin Tyr Gly Lys He Pro Glu Leu Glu Lys Gin 500 505 510 Leu Glu Ala Ala Thr Gin Leu Glu Gly Lys Thr Met Arg Leu Leu Arg 515 520 525 Asn Lys Val Thr Asp Ala Glu He Ala Glu Val Leu Ala Arg Trp Thr 530 535 540 Gly He Pro Val Ser Arg Met Met Glu Ser Glu Arg Glu Lys Leu Leu 545 550 555 560 Arg Met Glu Gin Glu Leu His His Arg Val He Gly Gin Asn Glu Ala 565 570 575 Val Asp Ala Val Ser Asn Ala He Arg Arg Ser Arg Ala Gly Leu Ala 580 585 590 Asp Pro Asn Arg Pro He Gly Ser Phe Leu Phe Leu Gly Pro Thr Gly 595 600 605 Val Gly Lys Thr Glu Leu Cys Lys Ala Leu Ala Asn Phe Met Phe Asp 610 615 620 Ser Asp Glu Ala Met Val Arg He Asp Met Ser Glu Phe Met Glu Lys 625 630 635 640 His Ser Val Ser Arg Leu Val Gly Ala Pro Pro Gly Tyr Val Gly Tyr 645 650 655 Glu Glu Gly Gly Tyr Leu Thr Glu Ala Val Arg Arg Arg Pro Tyr Ser 660 665 670 Val He Leu Leu Asp Glu Val Glu Lys Ala His Pro Asp Val Phe Asn 675 680 685 He Leu Leu Gin Val Leu Asp Asp Gly Arg Leu Thr Asp Gly Gin Gly 690 695 700 Arg Thr Val Asp Phe Arg Asn Thr Val Val He Met Thr Ser Asn Leu 705 710 715 720 Gly Ser Asp Leu He Gin Glu Arg Phe Gly Glu Leu Asp Tyr Ala His 725 730 735 Met Lys Glu Leu Val Leu Gly Val Val Ser His Asn Phe Arg Pro Glu 740 745 750 Phe He Asn Arg He Asp Glu Val Val Val Phe His Pro Leu Gly Glu 755 760 765 Gin His He Ala Ser He Ala Gin He Gin Leu Lys Arg Leu Tyr Lys 770 775 780 Arg Leu Glu Glu Arg Gly Tyr Glu He His He Ser Asp Glu Ala Leu 785 790 795 800 Lys Leu Leu Ser Glu Asn Gly Tyr Asp Pro Val Tyr Gly Ala Arg Pro 805 810 815 Leu Lys Arg Ala He Gin Gin Gin He Glu Asn Pro Leu Ala Gin Gin 820 825 830 He Leu Ser Gly Glu Leu Val Pro Gly Lys Val He Arg Leu Glu Val 835 840 845 Asn Glu Asp Arg He Val Ala Val Gin 850 855 (2) INFORMATION FOR SEQ ID NO: 48: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1239 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl3c3)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1236 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 48: ATG ATG AAA GAA AAA GTG ATT TTT CTC GTT GAC ATG CAA TCG TTT TAT 48 Met Met Lys Glu Lys Val He Phe Leu Val Asp Met Gin Ser Phe Tyr 1 5 10 15 GCA TCT GTA GAG AAA GCG GAA AAT CCA CAT TTG AAA AAT AGG CCC GTC 96 Ala Ser Val Glu Lys Ala Glu Asn Pro His Leu Lys Asn Arg Pro Val 20 25 30 ATT GTT TCG GGT GAC CCT GAA AAA AGG GGC GGA GTC GTA TTG GCT GCC 144 He Val Ser Gly Asp Pro Glu Lys Arg Gly Gly Val Val Leu Ala Ala 35 40 45 TGC CCG CTG GCG AAA CAA AAG GGT GTG GTG AAT GCT TCA CGG CTG TGG 192 Cys Pro Leu Ala Lys Gin Lys Gly Val Val Asn Ala Ser Arg Leu Trp 50 55 60 GAG GCG CAG GAA AAG TGT CCT GAG GCT GTT GTG CTC CGG CCG CGT ATG 240 Glu Ala Gin Glu Lys Cys Pro Glu Ala Val Val Leu Arg Pro Arg Met 65 70 75 80 CAG CGG TAT ATT GAT GTA TCA CTG CAA ATT ACG GCC ATT CTC GAG GAG 288 Gin Arg Tyr He Asp Val Ser Leu Gin He Thr Ala He Leu Glu Glu 85 90 95 TAT ACA GAC CTT GTG GAG CCG TAT TCC ATC GAT GAA CAG TTC ATG GAC 336 Tyr Thr Asp Leu Val Glu Pro Tyr Ser He Asp Glu Gin Phe Met Asp 100 105 110 ATT ACA GGC AGC CAG AAG CTG TTT GGG ACG CCG ATG GAG ATC GCG AAA 384 He Thr Gly Ser Gin Lys Leu Phe Gly Thr Pro Met Glu He Ala Lys 115 120 125 AGC ATT CAG GGC AGA ATC ATG CGG GAG ATC GGC GTT TAT GCA CGG GTC 432 Ser He Gin Gly Arg He Met Arg Glu He Gly Val Tyr Ala Arg Val 130 135 140 GGA ATC GGC CCT AAC AAA GCG CTG GCC AAA ATT GCG TGT GAC AAT TTT 480 Gly He Gly Pro Asn Lys Ala Leu Ala Lys He Ala Cys Asp Asn Phe 145 150 155 160 GCC AAA AAG AAT AAG AAC GGT ATT TTT ACC TTA ACG AAA GAA AAT ATG 528 Ala Lys Lys Asn Lys Asn Gly He Phe Thr Leu Thr Lys Glu Asn Met 165 170 175 AAA ACC GAA ATG TGG CCG CTC CCG GTG GGC AGC ATG TTT GGC GTC GGG 576 Lys Thr Glu Met Trp Pro Leu Pro Val Gly Ser Met Phe Gly Val Gly 180 185 190 AGC CGC ATG AAG CAT CAT TTA AAT CGA ATG GGC ATC AGC ACG ATC GGC 624 Ser Arg Met Lys His His Leu Asn Arg Met Gly He Ser Thr He Gly 195 200 205 GGG CTC GCG GCT TTT CCG CTC GAT CTT TTA AAA AAG AAA TGG GGC ATT 672 Gly Leu Ala Ala Phe Pro Leu Asp Leu Leu Lys Lys Lys Trp Gly He 210 215 220 AAC GGC CAC GTG CTG TGG ATG ACG GCA AAC GGA ATC GAC TAT TCC CCT 720 Asn Gly His Val Leu Trp Met Thr Ala Asn Gly He Asp Tyr Ser Pro 225 230 235 240 GTG TCA ACT TCG TCT CTG GAC GGG CAA AAG GCG ATA GGT CAT GGA ATG 768 Val Ser Thr Ser Ser Leu Asp Gly Gin Lys Ala He Gly His Gly Met 245 250 255 ACT CTC CCG AGA GAC TAC GAA CAC TTT GAC AAA GAA ATC AAG GTC GTA 816 Thr Leu Pro Arg Asp Tyr Glu His Phe Asp Lys Glu He Lys Val Val 260 265 270 TTG CTT GAG CTG AGT GAA GAG GTG TGC AGG CGA AGC CGA AAC GCC GGG 864 Leu Leu Glu Leu Ser Glu Glu Val Cys Arg Arg Ser Arg Asn Ala Gly 275 280 285 GTC ATG GGG CAG ACA GTG TCA GTG AGC TGC CGG GGT GCT GAT TTT GAT 912 Val Met Gly Gin Thr Val Ser Val Ser Cys Arg Gly Ala Asp Phe Asp 290 295 300 TGG CCG ACG GGC TTC AAC CGG CAA GTG AAG CTG GCA GAG CCG ACT AAT 960 Trp Pro Thr Gly Phe Asn Arg Gin Val Lys Leu Ala Glu Pro Thr Asn 305 310 315 320 TCT ACG CAG GAT GTA TAT GAG GCT GTA CGA CGG CTG TTT CTT ACA TTT 1008 Ser Thr Gin Asp Val Tyr Glu Ala Val Arg Arg Leu Phe Leu Thr Phe 325 330 335 TGG GAC GGG AAA CCC GTC CGC CGC CTC GGT GTC AAT CTG TCT CAG CTC 1056 Trp Asp Gly Lys Pro Val Arg Arg Leu Gly Val Asn Leu Ser Gin Leu 340 345 350 TCA TCT GAT GAC ATA TGG CAG CTC AAT TTA TTT CAG GAT TAT GCA AAG 1104 Ser Ser Asp Asp He Trp Gin Leu Asn Leu Phe Gin Asp Tyr Ala Lys 355 360 365 AAA ATG AGC CTA GGC TAT GTG ATG GAT GGC ATT AAA AAT CGA TTC GGC 1152 Lys Met Ser Leu Gly Tyr Val Met Asp Gly He Lys Asn Arg Phe Gly 370 375 380 GAT ACA GCA ATC ATC AGG GCG GCG TCA CTG ACA GCG GCA GGC CAG GCA 1200 Asp Thr Ala He He Arg Ala Ala Ser Leu Thr Ala Ala Gly Gin Ala 385 390 395 400 TTT GAA CGT GCG GCT AAA ATA GGG GGG CAT TAT AAA TGA 1239 Phe Glu Arg Ala Ala Lys He Gly Gly His Tyr Lys 405 410 (2) INFORMATION FOR SEQ ID NO: 49: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 412 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 49: Met Met Lys Glu Lys Val He Phe Leu Val Asp Met Gin Ser Phe Tyr 1 5 10 15 Ala Ser Val Glu Lys Ala Glu Asn Pro His Leu Lys Asn Arg Pro Val 20 25 30 He Val Ser Gly Asp Pro Glu Lys Arg Gly Gly Val Val Leu Ala Ala 35 40 45 Cys Pro Leu Ala Lys Gin Lys Gly Val Val Asn Ala Ser Arg Leu Trp 50 55 60 Glu Ala Gin Glu Lys Cys Pro Glu Ala Val Val Leu Arg Pro Arg Met 65 70 75 80 Gin Arg Tyr He Asp Val Ser Leu Gin He Thr Ala He Leu Glu Glu 85 90 95 Tyr Thr Asp Leu Val Glu Pro Tyr Ser He Asp Glu Gin Phe Met Asp 100 105 110 He Thr Gly Ser Gin Lys Leu Phe Gly Thr Pro Met Glu He Ala Lys 115 120 125 Ser He Gin Gly Arg He Met Arg Glu He Gly Val Tyr Ala Arg Val 130 135 140 Gly He Gly Pro Asn Lys Ala Leu Ala Lys He Ala Cys Asp Asn Phe 145 150 155 160 Ala Lys Lys Asn Lys Asn Gly He Phe Thr Leu Thr Lys Glu Asn Met 165 170 175 Lys Thr Glu Met Trp Pro Leu Pro Val Gly Ser Met Phe Gly Val Gly 180 185 190 Ser Arg Met Lys His His Leu Asn Arg Met Gly He Ser Thr He Gly 195 200 205 Gly Leu Ala Ala Phe Pro Leu Asp Leu Leu Lys Lys Lys Trp Gly He 210 215 220 Asn Gly His Val Leu Trp Met Thr Ala Asn Gly He Asp Tyr Ser Pro 225 230 235 240 Val Ser Thr Ser Ser Leu Asp Gly Gin Lys Ala He Gly His Gly Met 245 250 255 Thr Leu Pro Arg Asp Tyr Glu His Phe Asp Lys Glu He Lys Val Val 260 265 270 Leu Leu Glu Leu Ser Glu Glu Val Cys Arg Arg Ser Arg Asn Ala Gly 275 280 285 Val Met Gly Gin Thr Val Ser Val Ser Cys Arg Gly Ala Asp Phe Asp 290 295 300 Trp Pro Thr Gly Phe Asn Arg Gin Val Lys Leu Ala Glu Pro Thr Asn 305 310 315 320 Ser Thr Gin Asp Val Tyr Glu Ala Val Arg Arg Leu Phe Leu Thr Phe 325 330 335 Trp Asp Gly Lys Pro Val Arg Arg Leu Gly Val Asn Leu Ser Gin Leu 340 345 350 Ser Ser Asp Asp He Trp Gin Leu Asn Leu Phe Gin Asp Tyr Ala Lys 355 360 365 Lys Met Ser Leu Gly Tyr Val Met Asp Gly He Lys Asn Arg Phe Gly 370 375 380 Asp Thr Ala He He Arg Ala Ala Ser Leu Thr Ala Ala Gly Gin Ala 385 390 395 400 Phe Glu Arg Ala Ala Lys He Gly Gly His Tyr Lys 405 410 (2) INFORMATION FOR SEQ ID NO: 50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1452 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p4b3)" Unknown = Xaa Unknown for codon no. 296 = TAA (stop codon) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1449 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50: ATG AGT AAA ATT ATT GGA TCA GAC AGA GTC AAA AGA GGT ATG GCT GAA 48 Met Ser Lys He He Gly Ser Asp Arg Val Lys Arg Gly Met Ala Glu 1 5 10 15 ATG CAA AAA GGC GGC GTT ATT ATG GAT GTC GTT AAT GCT GAG CAA GCA 96 Met Gin Lys Gly Gly Val He Met Asp Val Val Asn Ala Glu Gin Ala 20 25 30 AGA ATT GCA GAA GAA GCT GGC GCG GTA GCA GTT ATG GCA TTA GAA CGA 144 Arg He Ala Glu Glu Ala Gly Ala Val Ala Val Met Ala Leu Glu Arg 35 40 45 GTA CCT TCT GAT ATT AGA GCT GCT GGT GGT GTT GCA CGT ATG GCA AAC 192 Val Pro Ser Asp He Arg Ala Ala Gly Gly Val Ala Arg Met Ala Asn 50 55 60 CCT AAA ATT GTA GAA GAA GTA ATG AAT GCT GTT TCT ATT CCA GTC ATG 240 Pro Lys He Val Glu Glu Val Met Asn Ala Val Ser He Pro Val Met 65. 70 75 80 GCT AAA GCA CGT ATT GGT CAT ATC ACT GAA GCA AGA GTA TTA GAG GCG 288 Ala Lys Ala Arg He Gly His He Thr Glu Ala Arg Val Leu Glu Ala 85 90 95 ATG GGT GTT GAC TAT ATT GAT GAA TCA GAA GTG TTA ACA CCA GCA GAT 336 Met Gly Val Asp Tyr He Asp Glu Ser Glu Val Leu Thr Pro Ala Asp 100 105 110 GAG GAA TAT CAC TTA AGA AAA GAT CAA TTT ACA GTA CCA TTT GTA TGT 384 Glu Glu Tyr His Leu Arg Lys Asp Gin Phe Thr Val Pro Phe Val Cys 115 120 125 GGA TGT CGT AAT TTA GGT GAA GmT GCG CGT AGA ATT GGT GAA GGT GCT 432 Gly Cys Arg Asn Leu Gly Glu Xaa Ala Arg Arg He Gly Glu Gly Ala 130 135 140 GCT ATG TTA CGT ACT AAA GGT GAA CCA GGT ACA GGT AAT ATT GTT GAA 480 Ala Met Leu Arg Thr Lys Gly Glu Pro Gly Thr Gly Asn He Val Glu 145 150 155 160 GCT GTA AGA CAT ATG AGA CAA GTT AAT TCA GAA GTT AGT CGA TTG ACT 528 Ala Val Arg His Met Arg Gin Val Asn Ser Glu Val Ser Arg Leu Thr 165 170 175 GTA ATG AAT GAT GAT GAG ATT ATG ACT TTT GCG AAA GAT ATC GGT GCG 576 Val Met Asn Asp Asp Glu He Met Thr Phe Ala Lys Asp He Gly Ala 180 185 190 CCT TAT GAA ATT TTA AAA CAA ATT AAA GAC AAT GGT CGT TTA CCG GTA 624 Pro Tyr Glu He Leu Lys Gin He Lys Asp Asn Gly Arg Leu Pro Val 195 200 205 GTT AAC TTT GCA GCT GGT GGC GTT GCG ACT CCT CAA GAT GCT GCT TTA 672 Val Asn Phe Ala Ala Gly Gly Val Ala Thr Pro Gin Asp Ala Ala Leu 210 215 220 ATG ATG GAA TTA GGT GCT GAC GGT GTA TTC GTT GGA TCA GGT ATT TTT 720 Met Met Glu Leu Gly Ala Asp Gly Val Phe Val Gly Ser Gly He Phe 225 230 235 240 AAA TCA GAA GAT CCA GAA AAA TTT GCT AAA GCA ATT GTT CAA GCA ACA 768 Lys Ser Glu Asp Pro Glu Lys Phe Ala Lys Ala He Val Gin Ala Thr 245 250 255 ACA CAT TAC CAA GAC TAT GAA CTA ATT GGA AGA TTA GCA AGT GAA CTT 816 Thr His Tyr Gin Asp Tyr Glu Leu He Gly Arg Leu Ala Ser Glu Leu 260 265 270 GGC ACT GCT ATG AAA GGT TTA GAT ATC AAT CAA TTA TCA TTA GAA GAA 864 Gly Thr Ala Met Lys Gly Leu Asp He Asn Gin Leu Ser Leu Glu Glu 275 280 285 CGT ATG CAA GAG CGT GGT TGG TAA GAT ATG AAA ATA GGT GTA TTA GCA 912 Arg Met Gin Glu Arg Gly Trp Xaa Asp Met Lys He Gly Val Leu Ala 290 295 300 TTA CAA GGT GCA GTA CGT GAA CAT ATT AGA CAT ATT GAA TTA AGT GGT 960 Leu Gin Gly Ala Val Arg Glu His He Arg His He Glu Leu Ser Gly 305 310 315 320 CAT GAA GGT ATT GCA GTT AAA AAA GTT GAA CAA TTA GAA GAA ATC GAG 1008 His Glu Gly He Ala Val Lys Lys Val Glu Gin Leu Glu Glu He Glu 325 330 335 GGC TTA ATA TTA CCT GGT GGC GAG TCT ACA ACG TTA CGT CGA TTA ATG 1056 Gly Leu He Leu Pro Gly Gly Glu Ser Thr Thr Leu Arg Arg Leu Met 340 345 350 AAT TTA TAT GGA TTT AAA GAG GCT TTA CAA AAT TCA ACT TTA CCT ATG 1104 Asn Leu Tyr Gly Phe Lys Glu Ala Leu Gin Asn Ser Thr Leu Pro Met 355 360 365 TTT GGT ACA TGC GCA GGA TTA ATA GTT CTA GCG CAA GAT ATA GTT GGT 1152 Phe Gly Thr Cys Ala Gly Leu He Val Leu Ala Gin Asp He Val Gly 370 375 380 GAA GAA GGA TAC CTT AAC AAG TTG AAT ATT ACT GTA CAA CGA AAC TCA 1200 Glu Glu Gly Tyr Leu Asn Lys Leu Asn He Thr Val Gin Arg Asn Ser 385 390 395 400 TTC GGT AGA CAA GTT GAC AGC TTT GAA ACA GAA TTA GAT ATT AAA GGT 1248 Phe Gly Arg Gin Val Asp Ser Phe Glu Thr Glu Leu Asp He Lys Gly 405 410 415 ATC GCT ACA GAT ATT GAA GGT GTC TTT ATA AGA GCC CCA CAT ATT GAA 1296 He Ala Thr Asp He Glu Gly Val Phe He Arg Ala Pro His He Glu 420 425 430 AAA GTA GGT CAA GGC GTA GAT ATC CTA TGT AAG GTT AAT GAG AAA ATT 1344 Lys Val Gly Gin Gly Val Asp He Leu Cys Lys Val Asn Glu Lys He 435 440 445 GTA GCT GTT CAG CAA GGT AAA TAT TTA GGC GTA TCA TTC CAT CCT GAA 1392 Val Ala Val Gin Gin Gly Lys Tyr Leu Gly Val Ser Phe His Pro Glu 450 455 460 TTA ACA GAT GAC TAT AGA GTA ACT GAT TAC TTT ATT AAT CAT ATT GTA 1440 Leu Thr Asp Asp Tyr Arg Val Thr Asp Tyr Phe He Asn His He Val 465 470 475 480 AAA AAA GCA TAG 1452 Lys Lys Ala (2) INFORMATION FOR SEQ ID NO: 51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 483 ammo acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: Met Ser Lys He He Gly Ser Asp Arg Val Lys Arg Gly Met Ala Glu 1 5 10 15 Met Gin Lys Gly Gly Val He Met Asp Val Val Asn Ala Glu Gin Ala 20 25 30 Arg He Ala Glu Glu Ala Gly Ala Val Ala Val Met Ala Leu Glu Arg 35 40 45 Val Pro Ser Asp He Arg Ala Ala Gly Gly Val Ala Arg Met Ala Asn 50 55 60 Pro Lys He Val Glu Glu Val Met Asn Ala Val Ser He Pro Val Met 65 70 75 80 Ala Lys Ala Arg He Gly His He Thr Glu Ala Arg Val Leu Glu Ala 85 90 95 Met Gly Val Asp Tyr He Asp Glu Ser Glu Val Leu Thr Pro Ala Asp 100 105 110 Glu Glu Tyr His Leu Arg Lys Asp Gin Phe Thr Val Pro Phe Val Cys 115 120 125 Gly Cys Arg Asn Leu Gly Glu Xaa Ala Arg Arg He Gly Glu Gly Ala 130 135 140 Ala Met Leu Arg Thr Lys Gly Glu Pro Gly Thr Gly Asn He Val Glu 145 150 155 160 Ala Val Arg His Met Arg Gin Val Asn Ser Glu Val Ser Arg Leu Thr 165 170 175 Val Met Asn Asp Asp Glu He Met Thr Phe Ala Lys Asp He Gly Ala 180 185 190 Pro Tyr Glu He Leu Lys Gin He Lys Asp Asn Gly Arg Leu Pro Val 195 200 205 Val Asn Phe Ala Ala Gly Gly Val Ala Thr Pro Gin Asp Ala Ala Leu 210 215 220 Met Met Glu Leu Gly Ala Asp Gly Val Phe Val Gly Ser Gly He Phe 225 230 235 240 Lys Ser Glu Asp Pro Glu Lys Phe Ala Lys Ala He Val Gin Ala Thr 245 250 255 Thr His Tyr Gin Asp Tyr Glu Leu He Gly Arg Leu Ala Ser Glu Leu 260 265 270 Gly Thr Ala Met Lys Gly Leu Asp He Asn Gin Leu Ser Leu Glu Glu 275 280 285 Arg Met Gin Glu Arg Gly Trp Xaa Asp Met Lys He Gly Val Leu Ala 290 295 300 Leu Gin Gly Ala Val Arg Glu His He Arg His He Glu Leu Ser Gly 305 310 315 320 His Glu Gly He Ala Val Lys Lys Val Glu Gin Leu Glu Glu He Glu 325 330 335 Gly Leu He Leu Pro Gly Gly Glu Ser Thr Thr Leu Arg Arg Leu Met 340 345 350 Asn Leu Tyr Gly Phe Lys Glu Ala Leu Gin Asn Ser Thr Leu Pro Met 355 360 365 Phe Gly Thr Cys Ala Gly Leu He Val Leu Ala Gin Asp He Val Gly 370 375 380 Glu Glu Gly Tyr Leu Asn Lys Leu Asn He Thr Val Gin Arg Asn Ser 385 390 395 400 Phe Gly Arg Gin Val Asp Ser Phe Glu Thr Glu Leu Asp He Lys Gly 405 410 415 He Ala Thr Asp He Glu Gly Val Phe He Arg Ala Pro His He Glu 420 425 430 Lys Val Gly Gin Gly Val Asp He Leu Cys Lys Val Asn Glu Lys He 435 440 445 Val Ala Val Gin Gin Gly Lys Tyr Leu Gly Val Ser Phe His Pro Glu 450 455 460 Leu Thr Asp Asp Tyr Arg Val Thr Asp Tyr Phe He Asn His He Val 465 470 475 480 Lys Lys Ala (2) INFORMATION FOR SEQ ID NO: 52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 977 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p4c63)" Unknown = Xaa Unknown for codon no. 318 = TAG (stop codon) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..975 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: AAC AAA GCC TTC CAA TTA TCT GCG TCG GTA GAA CAA GTA TTA GCA ACT 48 Asn Lys Ala Phe Gin Leu Ser Ala Ser Val Glu Gin Val Leu Ala Thr 1 5 10 15 TTA TCA CCT ACG CTA AAC AGT CCT TAC GAT TTA TAC GGC ACG ACA AAA 96 Leu Ser Pro Thr Leu Asn Ser Pro Tyr Asp Leu Tyr Gly Thr Thr Lys 20 25 30 ATG CTA GAT ATT ACA TTC GAT TCA TTT GAA CAT GAT GGT ACA ACG TAC 144 Met Leu Asp He Thr Phe Asp Ser Phe Glu His Asp Gly Thr Thr Tyr 35 40 45 CCT GTC GAC TAT GCT ACG TTT GAA AAT GAT TAT GAA GAT AAT AAA GAT 192 Pro Val Asp Tyr Ala Thr Phe Glu Asn Asp Tyr Glu Asp Asn Lys Asp 50 55 60 CCT GAG TTT AGA CGT AAA AGT TTC AAA TCG TTT AGC GAT GGG ATT CGA 240 Pro Glu Phe Arg Arg Lys Ser Phe Lys Ser Phe Ser Asp Gly He Arg 65 70 75 80 AAA TAT CAG CAT ACT ACC GCG GCT ACA TAT AAT ATG CAA GTA CAA CAA 288 Lys Tyr Gin His Thr Thr Ala Ala Thr Tyr Asn Met Gin Val Gin Gin 85 90 95 GAA AAA ATT GAA GCT GAT TTA CGT GGA TTT GAA TCA GTC ATC GAT TAT 336 Glu Lys He Glu Ala Asp Leu Arg Gly Phe Glu Ser Val He Asp Tyr 100 105 110 TTA. TTA CAT AGT CAA GAA GTA ACG CGT GAT ATG TTT GAC CGT CAA ATC 384 Leu Leu His Ser Gin Glu Val Thr Arg Asp Met Phe Asp Arg Gin He 115 120 125 GAT ATG ATT ATG CGT GAC TTG GCA CCA GTT ATG CAG AAA TAT GCT AAA 432 Asp Met He Met Arg Asp Leu Ala Pro Val Met Gin Lys Tyr Ala Lys 130 135 140 CTT TTA CAA CGT ATT CAC GGA TTA GAT AAC ATG CGT TTT GAA GAC TTG 480 Leu Leu Gin Arg He His Gly Leu Asp Asn Met Arg Phe Glu Asp Leu 145 150 155 160 AAG ATT TCT GTA GAC CCT GAT TAT GAA CCA GAG ATT TCA ATT GAA GAC 528 Lys He Ser Val Asp Pro Asp Tyr Glu Pro Glu He Ser He Glu Asp 165 170 175 TCA AAA AAT TAT ATT TTC GGT GCG TTA AGT GTT TTA GGT GAT GAC TAT 576 Ser Lys Asn Tyr He Phe Gly Ala Leu Ser Val Leu Gly Asp Asp Tyr 180 185 190 ACA AAC ATG TTA CGT GAA GCA TAC GAT CAG CGA TGG ATT GAT TTT GCA 624 Thr Asn Met Leu Arg Glu Ala Tyr Asp Gin Arg Trp He Asp Phe Ala 195 200 205 CAA AAT AAA GGT AAA GAT ACA GGC GCA TTT TGT GCA AGT CCA TAC TTT 672 Gin Asn Lys Gly Lys Asp Thr Gly Ala Phe Cys Ala Ser Pro Tyr Phe 210 215 220 ACA CAT TCA TAT GTG TTT ATT TCT TGG ACT GGT AAA ATG GCT GAA GCA 720 Thr His Ser Tyr Val Phe He Ser Trp Thr Gly Lys Met Ala Glu Ala 225 230 235 240 TTT GTC TTA GCA CAT GAA TTA GGT CAT GCA GGT CAT TTT ACA TTA GCT 768 Phe Val Leu Ala His Glu Leu Gly His Ala Gly His Phe Thr Leu Ala 245 250 255 CAA AAA CAT CAA CCA TAT CTT GAA TCA GAA GCA TCA ATG TAC TTT GTT 816 Gin Lys His Gin Pro Tyr Leu Glu Ser Glu Ala Ser Met Tyr Phe Val 260 265 270 GAA GCC CCT TCT ACA ATG AAT GAA ATG TTG ATG GCC AAT TAT TTA TTT 864 Glu Ala Pro Ser Thr Met Asn Glu Met Leu Met Ala Asn Tyr Leu Phe 275 280 285 AAC ACA AGT GAT AAT CCA AGA TTT AAG CGT TGG GTT ATT GGC TCA ATT 912 Asn Thr Ser Asp Asn Pro Arg Phe Lys Arg Trp Val He Gly Ser He 290 295 300 TTA TCT AGA ACA TAT TAT CAT AAT ATG GTA CCC mTT TAT TAG AAG CnG 960 Leu Ser Arg Thr Tyr Tyr His Asn Met Val Pro Xaa Tyr Xaa Lys Xaa 305 310 315 320 CTT ATC CAC GGG GAG TG 977 Leu He His Gly Glu 325 (2) INFORMATION FOR SEQ ID NO:53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 325 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:53: Asn Lys Ala Phe Gin Leu Ser Ala Ser Val Glu Gin Val Leu Ala Thr 1 5 10 15 Leu Ser Pro Thr Leu Asn Ser Pro Tyr Asp Leu Tyr Gly Thr Thr Lys 20 25 30 Met Leu Asp He Thr Phe Asp Ser Phe Glu His Asp Gly Thr Thr Tyr 35 40 45 Pro Val Asp Tyr Ala Thr Phe Glu Asn Asp Tyr Glu Asp Asn Lys Asp 50 55 60 Pro Glu Phe Arg Arg Lys Ser Phe Lys Ser Phe Ser Asp Gly He Arg 65 70 75 80 Lys Tyr Gin His Thr Thr Ala Ala Thr Tyr Asn Met Gin Val Gin Gin 85 90 95 Glu Lys He Glu Ala Asp Leu Arg Gly Phe Glu Ser Val He Asp Tyr 100 105 110 Leu Leu His Ser Gin Glu Val Thr Arg Asp Met Phe Asp Arg Gin He 115 120 125 Asp Met He Met Arg Asp Leu Ala Pro Val Met Gin Lys Tyr Ala Lys 130 135 140 Leu Leu Gin Arg He His Gly Leu Asp Asn Met Arg Phe Glu Asp Leu 145 150 155 160 Lys He Ser Val Asp Pro Asp Tyr Glu Pro Glu He Ser He Glu Asp 165 170 175 Ser Lys Asn Tyr He Phe Gly Ala Leu Ser Val Leu Gly Asp Asp Tyr 180 185 190 Thr Asn Met Leu Arg Glu Ala Tyr Asp Gin Arg Trp He Asp Phe Ala 195 200 205 Gin Asn Lys Gly Lys Asp Thr Gly Ala Phe Cys Ala Ser Pro Tyr Phe 210 215 220 Thr His Ser Tyr Val Phe He Ser Trp Thr Gly Lys Met Ala Glu Ala 225 230 235 240 Phe Val Leu Ala His Glu Leu Gly His Ala Gly His Phe Thr Leu Ala 245 250 255 Gin Lys His Gin Pro Tyr Leu Glu Ser Glu Ala Ser Met Tyr Phe Val 260 265 270 Glu Ala Pro Ser Thr Met Asn Glu Met Leu Met Ala Asn Tyr Leu Phe 275 280 285 Asn Thr Ser Asp Asn Pro Arg Phe Lys Arg Trp Val He Gly Ser He 290 295 300 Leu Ser Arg Thr Tyr Tyr His Asn Met Val Pro Xaa Tyr Xaa Lys Xaa 305 310 315 320 Leu He His Gly Glu 325 (2) INFORMATION FOR SEQ ID NO: 54: (l) SEQUENCE CHARACTERISTICS. (A) LENGTH: 471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p5c3)" Unknown = Xaa Unknown for codon no. 110 = TAA (stop codon) Unknown for codon no. 113 = TAA (stop codon) (ix) FEATURE: (A) NAME/KEY. CDS (B) LOCATION- 1..465 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 54: ATG TAT CAA CTA CAA TTT ATA AAT TTA GTT TAC GAC ACA ACC AAA CTC 48 Met Tyr Gin Leu Gin Phe He Asn Leu Val Tyr Asp Thr Thr Lys Leu 1 5 10 15 ACA CAT CTA GAA CAA ACC AAT ATC AAT TTA TTC ATT GGT AAT TGG AGT 96 Thr His Leu Glu Gin Thr Asn He Asn Leu Phe He Gly Asn Trp Ser 20 25 30 AAT CAT CAA TTA CAA AAA TCA ATT TGT ATA CGT CAT GGC GAT GAT ACA 144 Asn His Gin Leu Gin Lys Ser He Cys He Arg His Gly Asp Asp Thr 35 40 45 AGT CAC AAT CAA TAT CAT ATT CTT TTT ATA GAT ACG GCA CAT CAA CGC 192 Ser His Asn Gin Tyr His He Leu Phe He Asp Thr Ala His Gin Arg 50 55 60 ATT AAA TTT TCA TCT ATT GAT AAT GAA GAA ATC ATT TAT ATT CTT GAT 240 He Lys Phe Ser Ser He Asp Asn Glu Glu He He Tyr He Leu Asp 65 70 75 80 TAT GAT GAT ACA CAG CAT ATC CTC ATG CAA ACG TCA TCC AAA CAA GGT 288 Tyr Asp Asp Thr Gin His He Leu Met Gin Thr Ser Ser Lys Gin Gly 85 90 95 ATT GGC ACT TCG CGA CCA ATC GTT TAT GAG CGC TTA GTA TAA CTA ATT 336 He Gly Thr Ser Arg Pro He Val Tyr Glu Arg Leu Val Xaa Leu He 100 105 110 TAA ATG ATT TCA CTT CAT AAA GCG GGT TGG CGA GAA TTC AAT TTC TCA 384 Xaa Met He Ser Leu His Lys Ala Gly Trp Arg Glu Phe Asn Phe Ser 115 120 125 CCA GCT CGT TTT TTC ATT GTA ATA ATA ATC TTT AAC ATT TAT TCT TTC 432 Pro Ala Arg Phe Phe He Val He He He Phe Asn He Tyr Ser Phe 130 135 140 TCT ATT AAT TTT TCT CAA ACT ATC TTA TCT TTA TGATAA 471 Ser He Asn Phe Ser Gin Thr He Leu Ser Leu 145 150 155 (2) INFORMATION FOR SEQ ID NO: 55: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 155 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 55: Met Tyr Gin Leu Gin Phe He Asn Leu Val Tyr Asp Thr Thr Lys Leu 1 5 10 15 Thr His Leu Glu Gin Thr Asn He Asn Leu Phe He Gly Asn Trp Ser 20 25 30 Asn His Gin Leu Gin Lys Ser He Cys He Arg His Gly Asp Asp Thr 35 40 45 Ser His Asn Gin Tyr His He Leu Phe He Asp Thr Ala His Gin Arg 50 55 60 He Lys Phe Ser Ser He Asp Asn Glu Glu He He Tyr He Leu Asp 65 70 75 80 Tyr Asp Asp Thr Gin His He Leu Met Gin Thr Ser Ser Lys Gin Gly 85 90 95 He Gly Thr Ser Arg Pro He Val Tyr Glu Arg Leu Val Xaa Leu He 100 105 110 Xaa Met He Ser Leu His Lys Ala Gly Trp Arg Glu Phe Asn Phe Ser 115 120 125 Pro Ala Arg Phe Phe He Val He He He Phe Asn He Tyr Ser Phe 130 135 140 Ser He Asn Phe Ser Gin Thr He Leu Ser Leu 145 150 155 (2) INFORMATION FOR SEQ ID NO: 56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 588 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p8d26)" Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 14..343 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 56: ATTTNTAGAA TAA TAT TTC CAT ATT GGA AAA AGG GAA GAA TTC GTT ATG 49 Tyr Phe His He Gly Lys Arg Glu Glu Phe Val Met 1 5 10 AAA AGC TAT AAG TGT AAA GGT TCA TTC TTA ATA GAT AGT ATG GCT GGA 97 Lys. Ser Tyr Lys Cys Lys Gly Ser Phe Leu He Asp Ser Met Ala Gly 15 20 25 TTT TTG CTA ATT GGA TTG ATN ACA TTA CTA TTG ATA CCA ATG ATG AAT 145 Phe Leu Leu He Gly Leu Xaa Thr Leu Leu Leu He Pro Met Met Asn 30 35 40 CAA ATG CAA GCG AGT ATA AAC CAT AAA CTA CAA ACA ATT GAT GCT TCT 193 Gin Met Gin Ala Ser He Asn His Lys Leu Gin Thr He Asp Ala Ser 45 50 55 60 AAA GTA ATT TTG ACG ACT GTA TCT AAA ATT AAT AAA GAA GAA CTT AAG 241 Lys Val He Leu Thr Thr Val Ser Lys He Asn Lys Glu Glu Leu Lys 65 70 75 AAG GGG GTA ACT ATA GGG AAG TAT GAT ATT AAG CAA AGT GAC CAA CAA 289 Lys Gly Val Thr He Gly Lys Tyr Asp He Lys Gin Ser Asp Gin Gin 80 85 90 ATT TGT GCT ATT TCA ANA AAT ACC ANT TCT TAT CAA AAG ACA TGT ATA 337 He Cys Ala He Ser Xaa Asn Thr Xaa Ser Tyr Gin Lys Thr Cys He 95 100 105 CAG TAT AAATGTCAAA GCTTTTTCGC TCATTGAAAT GTTAGTAGCG ATGATGGTTA 393 Gin Tyr 110 TAAGTATAAC TTTACTAATT GTTCCAGACT TAATTAGACT TAGTAAAACT TTTCTAATTG 453 AAAGTAGGGA TTTAACAACT GTAGATTTCG AATTTTTCTC AAGAGATATT CTAGATGATT 513 TTAAAGGAGT AGATAGAAAC GATATTGAAA TTAGGCAACA CCGTATCATT GTACATAAAG 573 GTGAATAAAA ATGGC 588 (2) INFORMATION FOR SEQ ID NO: 57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 110 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 57: Tyr Phe His He Gly Lys Arg Glu Glu Phe Val Met Lys Ser Tyr Lys 1 5 10 15 Cys Lys Gly Ser Phe Leu He Asp Ser Met Ala Gly Phe Leu Leu He 20 25 30 Gly Leu Xaa Thr Leu Leu Leu He Pro Met Met Asn Gin Met Gin Ala 35 40 45 Ser He Asn His Lys Leu Gin Thr He Asp Ala Ser Lys Val He Leu 50 55 60 Thr Thr Val Ser Lys He Asn Lys Glu Glu Leu Lys Lys Gly Val Thr 88S 0 06 S8 08 d_ιχ sAq BBX BBX Aχo sAq STH IBΛ 3X1 3TI B^V STR uχo B-x ail Z.8S OOX VW WX NND XDD VW XVO VXD XXV DXV XOO OVO WO DDV XXV SL O S9 09 TO sχi dsv usv B^V dsv T B Λ Aχo sAq aqd dsv dsv naq aχι dsv B^V εt-S WD XXV XVO OW VOV XVO VXD VOD VW XXX XVO XVO VXD XXV XVO VOV SS OS S ;ras 3qd 3^ nχo aqd dsv XBA ^qx ^qx naq dsv B^V ^as nχo aχi naq Ϋ6 VOX OXX XXX WD OXX XVD VXD XOV VOV VXX XVO DDV XOV WD XXV VXD ofr sε oε aqd Jqx sAq xss naq B;tv aχi naq dsv o d XB 3X1 nsq naq ;tqχ aχι 9frfr XXX XDV VW XOV XXD VOV XXV VXX DVO VOD XXO XXV VXD VXX XOV VXV ass 311 XB 33W 33W BXV X A naq 33W nχo aχi nsq xa aqd BXV sAq 86 ε XOV VXV XXO DXV OXV DOO VXD VXX DXV WD XXV OXD OOX XXX XDD VW 01 S I XBA usv 3X1 3Ξ -*Aχ XBA STH Bα sAq aχι nsq OS DXD XW VXV XOV OVX VXD XVO VOV VW DXV XXO XXWODV XWWWDXX 00 ε XVXOOXDXXX VWOWOOVO XDVWODWX XVXVDXVXDV VODDVXVXOV VXODDDOWD Oϊ-ε WXXDWDW OVWXWXXV VWXOXVXOX DVODVOXXXX WXDVWXOX XDOXVOXXW 08 X DVWOVXOW VXVDOVWXV XOVDOOWOO XVWOXWDX oxwoovxv oxxvxovxxv Oεi OWXVDXXVD OXXWXODXX XXXVDDXDDO XVXDVXVOVX WXXOXXVOX XDDVWXDXD 09 WXVXOOVW VDXVXXOOXX WOWDDOW vwooxxvxv ooxxxvxwx WOVXVXXXV =8S : ON αi Oas :NθiXdiHθsaα aoNanOas (τ χ ) Z.8S""8iε ^NOIXVDOT (H) : aπnxvaa (x ) (uopoo dons) VVX = 88 " ou uopoo xoj uwoiqun BX = UMOUi{Un ,. (9εP8d) (oτuiouaB) VNα.. = =>sap/ :NOIXdIHOSaσ (V) pτoB oτaχonu x^mo :aλx ainoaiow ( TT ) αεauτx :AD010dOX (σ) aχ6uτs : ssaNαaONVHXS (O) pτoB oτaχonu :adΛX (a) SJtτBd assq 88S : HXDN3T (V) :soixsiHaxDaHo aDNanoas (T) =8S : ON σi Oas πoa NoixvwπoaNi (ε) oττ soτ ooτ Ax uχo aχi sAo x sAq uχo -iAχ as BBX tqχ usv BBX as S6 06 S8 s τi BXV sAo aχι uχo uχo dsv -*3S uχo sAq sχι dsv J:Aχ sAq Aχo aχi 08 L 0 S9 -L£l- PL6lQ/S6QD/±Dd £Ltl Q /66 OΛV (2) INFORMATION FOR SEQ ID NO: 59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 90 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 59: Leu He Lys Arg His Val Tyr Ser He Asn Val Lys Ala Phe Ser Leu 1 5 10 15 He Glu Met Leu Val Ala Met Met Val He Ser He Thr Leu Leu He 20 25 30 Val Pro Asp Leu He Arg Leu Ser Lys Thr Phe Leu He Glu Ser Arg 35 40 45 Asp Leu Thr Thr Val Asp Phe Glu Phe Phe Ser Arg Asp He Leu Asp 50 55 60 Asp Phe Lys Gly Val Asp Arg Asn Asp He Glu He Arg Gin His Arg 65 70 75 80 He He Val His Lys Gly Xaa Xaa Lys Trp 85 90 (2) INFORMATION FOR SEQ ID NO: 60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1338 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (p9b65)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1335 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: ATG ATC CGG CTT GTG ACG ATG GGG AAA AGT TCT GAG GCC GGG GTG TCT 48 Met He Arg Leu Val Thr Met Gly Lys Ser Ser Glu Ala Gly Val Ser 1 5 10 15 TCT TTC CAG GCG TTG ACG ATG TCG TTG TCC GGC CGC ATC GGC GTC GGG 96 Ser Phe Gin Ala Leu Thr Met Ser Leu Ser Gly Arg He Gly Val Gly 20 25 30 AAC GTG GCC GGG ACG GCG ACG GGG ATT GCG TAC GGG GGG CCG GGC GCG 144 Asn Val Ala Gly Thr Ala Thr Gly He Ala Tyr Gly Gly Pro Gly Ala 35 40 45 GTC TTT TGG ATG TGG GTG ATC ACC TTT ATC GGA GCG GCG ACC GCG TAT 192 Val Phe Trp Met Trp Val He Thr Phe He Gly Ala Ala Thr Ala Tyr 50 55 60 GTC GAG TCG ACG TGG CGC AAA TTT ATA AAG AGG AAC AAG ACG GAC AAT 240 sεε oεε sεε usv -iqx nχo XV aχi -i χ xAx :tΛχ BXV X X αaw X ' ^ xm, 3tf BXV aqd 8001 OW DDV DVD DOD XXV XVX OVX XVX DOD OVX OXV DOV DDV XXX ODD OXX oεε sτε oxε soε aqd 3Hd naq BXV 3"[I B χv aχi sqd XV XSS Aχo sqd Aχo o ; t sqd naq 096 OXX OXX DXO XOO OXV DOO XXV XXX DOO DOX DOO OXX VOD ODD OXX OXD xqx dsv XBA X sAq εi6 DOV OVO OXD DOO DOD DVD OOV XVX ODD VOD ODD DOO WD OXD ODD VW ssε osε sz.ε naq STR nχo IBA aχi xqx nχo Aχo xqx sAq nχo usv ail TBA usv λ∑ ϊ-98 OXX XVO OVO DXO XXV DDV DVD VDO DOV VW WD XW OXV OXD XW OVX uχo Aχo XBA naq aqd 918 WO XDD V DXO OXX OXX ssε osε s^ε XBA dsv naq ;ιAχ aχι xas aqd BXV uχo XBA nsq Aχo uχo sAq BXV oαa 89Δ OXD OVO OXX XVX OXV OOX XXX VDO DVD DXO XXO ODD DVD DW DDO ODD oϊ>ε sεε oεε sεε STR 3S XBA nχo BXV XV BXV B V ojd STR XV Aχo qx Aχo uχo Aχo oε. MD OOX OXD WD DOD DDO DOD VOD ODD D^D ODD ODD DOV DOO WO DDO oεε sτε oτε BXV nχo usv X xAx naq Aχo B-^V sAq XBA Aχo dxx }3W XBA XV X3S εt.9 DOD WD XW DOO XVX XXO ODD ODD VW DXO ODD DOX OXV OXD DOD DOX soε ooε sετ Aχo naq aχι Aχo Aχo aqd XBA uχo dsv BXV Aχo aqd BXV -ias sAq aqd fr£9 XDD XXO XXV ODD ODD XXX DXO WO XVO XOO DOD XXX ODD DDV WV OXX 061 S8I 081 3χi naq Aχo aqd T . BΛ dsv ox TBA sAq nχo aχi usv XV XV 3X1 aχi 9LS XXV OXX XDD XXX DXO XVD DOD DXO VW WD XXV XW ODD ODD XXV XXV SLZ 0ΔI S9I BXV 3TI BXV X A sqd naq Ax Aχo X A BX 33W sqd d XBA X A aχi 8SS ODD XXV DOO OXD OXX OXX XVX ODD XXO VOO DXV XXX DOO OXD OXD XXV 09i ssτ osτ s^τ nχo XV xqx sAq BXV sχi Bxv sAq XBA Aχo Aχo aqd aχi xqx aqd Aχo 08Ϊ- WO ODD DOV VW DOO DXV ODD OW OXD VOD ODD XXX XXV OOV XXX ODD o i sετ oετ naq X A X aχi TBA 3^d 3X1 Aχo xqx IBA naq sAq oxa aχι Aχo aqd εεϊ- XXO XXD ODD XXV DXO OXX XXV VOD DOV DXO OXX VW DOD XXV ODD XXX sετ oετ sττ XV usv 3S aqd X3S dsv BXV aχi X3S usv BXV uχo ail Aχo o 33W ϊ-βε DOD XW DOX XXX DDV DVD ODD XXV DOX OW VDO WD XXV VDO ODD DXV oττ soτ ooτ naq XBA BXV 3W XSS nsq sχι aχι V XV B V XSS SAO BJΓV naq Aχo 9εε 0X0 DXO ODD OXV DOX OXD XXV OXV DOO DOD DDO XOV XDX ODD OXX XOO S6 06 S8 usv Aχo X naq BX sAq sAq naq xqx j-as 5x\} Bxv T A BXV XBA xqx 88ε XW VOD XDD OXX ODD DW VW OXX VOV XOX XDO ODD DXO ODD OXD OOV 08 SL O L S9 usv dsv xqx sAq usv Bxv sAq aχι aqd sAq BJI dxx xqx ss nχo XBA -6ει- PL6lO/S6tLD/LDd C H0/66 OM CTC GCC TAT TTG GTG CGC AGT GAA AAG AGG GGA ACG GCC TTC TTT GCC 1056 Leu Ala Tyr Leu Val Arg Ser Glu Lys Arg Gly Thr Ala Phe Phe Ala 340 345 350 TTG -AAG CTC GTC TTT TTG GCG GCC ACG TTC TAT GGA ACG GTC AAA ACG 1104 Leu Lys Leu Val Phe Leu Ala Ala Thr Phe Tyr Gly Thr Val Lys Thr 355 360 365 GCG ACG ACG GCG TGG GCG ATG GGC GAC ATC GGG CTT GGC ATC ATG GTG 1152 Ala Thr Thr Ala Trp Ala Met Gly Asp He Gly Leu Gly He Met Val 370 375 380 TGG CTC AAC TTG ATT GCG ATC TTG TTG TTG TTT AAA CCG GCC TAT ATG 1200 Trp Leu Asn Leu He Ala He Leu Leu Leu Phe Lys Pro Ala Tyr Met 385 390 395 400 GCC TTG AAA GAT TAT GAA GAA CAG CTG AAG CAA GCG AAA GAT CCG GAG 1248 Ala Leu Lys Asp Tyr Glu Glu Gin Leu Lys Gin Gly Lys Asp Pro Glu 405 410 415 TTC AAC GCG TCG AAA TAC GGA ATC AAG AAC GCG AAA TTC TGG GAA AAT 1296 Phe Asn Ala Ser Lys Tyr Gly He Lys Asn Ala Lys Phe Trp Glu Asn 420 425 430 GGA TAT AAG AGA TGG GAA GAA AAG AAA GGG AAG GCA TTG TAA 1338 Gly Tyr Lys Arg Trp Glu Glu Lys Lys Gly Lys Ala Leu 435 440 445 (2) INFORMATION FOR SEQ ID NO: 61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 445 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 61: Met He Arg Leu Val Thr Met Gly Lys Ser Ser Glu Ala Gly Val Ser 1 5 10 15 Ser Phe Gin Ala Leu Thr Met Ser Leu Ser Gly Arg He Gly Val Gly 20 25 30 Asn Val Ala Gly Thr Ala Thr Gly He Ala Tyr Gly Gly Pro Gly Ala 35 40 45 Val Phe Trp Met Trp Val He Thr Phe He Gly Ala Ala Thr Ala Tyr 50 55 60 Val Glu Ser Thr Trp Arg Lys Phe He Lys Arg Asn Lys Thr Asp Asn 65 70 75 80 Thr Val Ala Val Arg Arg Ser Thr Leu Lys Lys Ala Leu Ala Gly Asn 85 90 95 Gly Leu Arg Cys Ser Arg Ala Ala He He Leu Ser Met Ala Val Leu 100 105 110 Met Pro Gly He Gin Ala Asn Ser He Ala Asp Ser Phe Ser Asn Ala 115 120 125 Phe Gly He Pro Lys Leu Val Thr Gly He Phe Val He Ala Val Leu 130 135 140 Gly Phe Thr He Phe Gly Gly Val Lys Arg He Ala Lys Thr Ala Glu 145 150 155 160 He Val Val Pro Phe Met Ala Val Gly Tyr Leu Phe Val Ala He Ala 165 170 175 He He Ala Ala Asn He Glu Lys Val Pro Asp Val Phe Gly Leu He 180 185 190 Phe Lys Ser Ala Phe Gly Ala Asp Gin Val Phe Gly Gly He Leu Gly 195 200 205 Ser Ala Val Met Trp Gly Val Lys Arg Gly Leu Tyr Ala Asn Glu Ala 210 215 220 Gly Gin Gly Thr Gly Ala His Pro Ala Ala Ala Ala Glu Val Ser His 225 230 235 240 Pro Ala Lys Gin Gly Leu Val Gin Ala Phe Ser He Tyr Leu Asp Val 245 250 255 Phe Leu Val Val Thr Ala Thr Ala Leu Met He Leu Phe Thr Gly Gin 260 265 270 Tyr Asn Val He Asn Glu Lys Thr Gly Glu Thr He Val Glu His Leu 275 280 285 Lys Gly Val Glu Pro Gly Ala Gly Tyr Thr Gin Ala Ala Val Asp Thr 290 295 300 Leu Phe Pro Gly Phe Gly Ser Ala Phe He Ala He Ala Leu Phe Phe 305 310 315 320 Phe Ala Phe Thr Thr Met Tyr Ala Tyr Tyr Tyr He Ala Glu Thr Asn 325 330 335 Leu Ala Tyr Leu Val Arg Ser Glu Lys Arg Gly Thr Ala Phe Phe Ala 340 345 350 Leu Lys Leu Val Phe Leu Ala Ala Thr Phe Tyr Gly Thr Val Lys Thr 355 360 365 Ala Thr Thr Ala Trp Ala Met Gly Asp He Gly Leu Gly He Met Val 370 375 380 Trp Leu Asn Leu He Ala He Leu Leu Leu Phe Lys Pro Ala Tyr Met 385 390 395 400 Ala Leu Lys Asp Tyr Glu Glu Gin Leu Lys Gin Gly Lys Asp Pro Glu 405 410 415 Phe Asn Ala Ser Lys Tyr Gly He Lys Asn Ala Lys Phe Trp Glu Asn 420 425 430 Gly Tyr Lys Arg Trp Glu Glu Lys Lys Gly Lys Ala Leu 435 440 445 (2) INFORMATION FOR SEQ ID NO: 62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 296 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear . (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b32)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..294 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: ATG CAA ATA GAA CTT ACT GAT GCA GCA GTA ACT TGG TTT AAA AAT GAA 48 Met Gin He Glu Leu Thr Asp Ala Ala Val Thr Trp Phe Lys Asn Glu 1 5 10 15 CTT GAG TTG CCT GAA AAT AAT AAA GTG CTC GTG TTT TTT GTA AGA TAT 96 Leu Glu Leu Pro Glu Asn Asn Lys Val Leu Val Phe Phe Val Arg Tyr 20 25 30 GGT GGC GAA TTC CAA CTC AAG CAA GGA TTT AGT CCT GCT TTT ACA GTT 144 Gly Gly Glu Phe Gin Leu Lys Gin Gly Phe Ser Pro Ala Phe Thr Val 35 40 45 GAA CCA AAG GAA GAT GTT GAT ATT GGC TAT GAA CAA CAA TAT GAC GAT 192 Glu Pro Lys Glu Asp Val Asp He Gly Tyr Glu Gin Gin Tyr Asp Asp 50 55 60 TTA AAT GTT GTC GTA GCG GAA AAA GAT TTG TGG TAC TTT GAA GAT GAC 240 Leu Asn Val Val Val Ala Glu Lys Asp Leu Trp Tyr Phe Glu Asp Asp 65 70 75 80 CAC ATT ATT GTA AAT GTA GTT GTC ACG AAG ATG AAT TTC TTA TTC CAC 288 His He He Val Asn Val Val Val Thr Lys Met Asn Phe Leu Phe His 85 90 95 CAA ATA AC 296 Gin He (2) INFORMATION FOR SEQ ID NO: 63: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 98 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:63: Met Gin He Glu Leu Thr Asp Ala Ala Val Thr Trp Phe Lys Asn Glu 1 5 10 15 Leu Glu Leu Pro Glu Asn Asn Lys Val Leu Val Phe Phe Val Arg Tyr 20 25 30 Gly Gly Glu Phe Gin Leu Lys Gin Gly Phe Ser Pro Ala Phe Thr Val 35 40 45 Glu Pro Lys Glu Asp Val Asp He Gly Tyr Glu Gin Gin Tyr Asp Asp 50 55 60 Leu Asn Val Val Val Ala Glu Lys Asp Leu Trp Tyr Phe Glu Asp Asp 65 70 75 80 His He He Val Asn Val Val Val Thr Lys Met Asn Phe Leu Phe His 85 90 95 Gin He (2) INFORMATION FOR SEQ ID NO: 64: ( i ) SEQUENCE ■ CHARACTERISTICS : (A) LENGTH: 433 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b85)" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: GNAACACTNC TNTTTCATTT GTGAATAATT TCACAATTAT TTTATCCTTT GGTTATGAAT 60 ATGTAAATAC CATTAATTAA TTATTCATAT TTTATCTATA ATTTGTTAAT AAATATTTAA 120 TATATTATNN TTATNCTTAA ATATTANGNG CAATTATACC ACTATATTTA TTTCTTATAC 180 TCCATTTGAT TTATAGTTGT ATTAATACAT TGACTCAAAA ACTAATTAAT CAAATATGTT 240 TTTTAGATTN ATAAAGTTGT AACTGTACTA TTTNGTAGTG TANGGTAATT TATTNGGATG 300 AAATATAATT CNNNNTACTC TATNGATTAA TCAAATATGT ATCTATCAAA ATTCGGCTTA 360 TTTATNCACT CTGACATATC CANATACGCA AAAAGACTAT NNCTACCTTG TATCGANAGA 420 AATAGTCTTT TTA 433 (2) INFORMATION FOR SEQ ID NO: 65: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 208 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0b89) " Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..207 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: TAC TAT AAA AGC ACC CAC TCA GTC ACT AGT TTG GGC AGT TAT TGT ATG 48 Tyr Tyr Lys Ser Thr His Ser Val Thr Ser Leu Gly Ser Tyr Cys Met 1 5 10 15 CCT ATT GAA CTC AAT GCG TAT ATT ACA ATA CCT TTT TCG CAT ATT CAT 96 Pro. He Glu Leu Asn Ala Tyr He Thr He Pro Phe Ser His He His 20 25 30 ATA AGA TCT TTG CAT TCN TTA AGC TTA AAT TTT CTA TTC TTC NTT CTC 144 He Arg Ser Leu His Ser Leu Ser Leu Asn Phe Leu Phe Phe Xaa Leu 35 40 45 TAC GGC GGC ATA GCA TTA ATA TTA CCG GAA CTA ATC CCA GTA NCN GTA 192 Tyr Gly Gly He Ala Leu He Leu Pro Glu Leu He Pro Val Xaa Val 50 55 60 TTA ATT GGA TAC CCG G 208 Leu He Gly Tyr Pro 65 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 69 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: Tyr Tyr Lys Ser Thr His Ser Val Thr Ser Leu Gly Ser Tyr Cys Met 1 5 10 15 Pro He Glu Leu Asn Ala Tyr He Thr He Pro Phe Ser His He His 20 25 30 He Arg Ser Leu His Ser Leu Ser Leu Asn Phe Leu Phe Phe Xaa Leu 35 40 45 Tyr Gly Gly He Ala Leu He Leu Pro Glu Leu He Pro Val Xaa Val 50 55 60 Leu He Gly Tyr Pro 65 (2) INFORMATION FOR SEQ ID NO:67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1041 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0c30) " Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1038 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 67: AGA AGT CAA ATC ATT ANT GGC GTC NTA TCG AGT ATA CTA TTA ACT TCA 48 Arg Ser Gin He He Xaa Gly Val Xaa Ser Ser He Leu Leu Thr Ser 1 5 10 15 ACT ATT TTA GCA ATT GCA TAT ATT TTA ATG TGG TTT AAC GGC CAT ATG 96 Thr He Leu Ala He Ala Tyr He Leu Met Trp Phe Asn Gly His Met 20 25 30 ACA CTA ACT TTG ACC TTA ACG ACA ATA ATT ACA AGC TGT TTA ACC TTA 144 Thr Leu Thr Leu Thr Leu Thr Thr He He Thr Ser Cys Leu Thr Leu 35 40 45 TTA ATA TGT AGT ATT TTT ATT AAT CCA CTT ATA CAA AAA ATT AAG CAG 192 Leu He Cys Ser He Phe He Asn Pro Leu He Gin Lys He Lys Gin 50 55 60 TTT AAT ATA AAA ACT AAG CAA TTT GCT AAC GGA AAT TAC GCA AGC AAT 240 Phe Asn He Lys Thr Lys Gin Phe Ala Asn Gly Asn Tyr Ala Ser Asn 65 70 75 80 GAT AAA ACG TTT AAT TCA CCA AAA GAA ATT TAT GAA TTA AAT CAA TCT 288 Asp Lys Thr Phe Asn Ser Pro Lys Glu He Tyr Glu Leu Asn Gin Ser 85 90 95 TTT AAT AAA ATG GCT TCT GAA ATT ACG CAA CAA ATG AAT CAA ATT AAA 336 Phe Asn Lys Met Ala Ser Glu He Thr Gin Gin Met Asn Gin He Lys 100 105 110 TCC GAA CAA CAA GAA AAA ACA GAA CTG ATT CAA AAC TTA GCC CAT GAT 384 Ser Glu Gin Gin Glu Lys Thr Glu Leu He Gin Asn Leu Ala His Asp 115 120 125 TTA AAA ACA CCT TTA GCA AGC ATT ATT TCA TAT TCT GAA GGA CTA CGT 432 Leu Lys Thr Pro Leu Ala Ser He He Ser Tyr Ser Glu Gly Leu Arg 130 135 140 GAT GGT ATA ATC ACT AAG GAT CAT GAG ATT AAA GAG TCA TAC GAC ATA 480 Asp Gly He He Thr Lys Asp His Glu He Lys Glu Ser Tyr Asp He 145 150 155 160 TTA ATT AAA CAA GCA AAC AGA TTA TCA ACA TTA TTT GAT GAT ATG ACT 528 Leu He Lys Gin Ala Asn Arg Leu Ser Thr Leu Phe Asp Asp Met Thr 165 170 175 CAT ATT ATC ACT TTA AAT ACA GGT AAA ACA TAT CCC CCA GAA TTA ATA 576 His He He Thr Leu Asn Thr Gly Lys Thr Tyr Pro Pro Glu Leu He 180 185 190 CAA CTA GAC CAA TTA CTT GTA TCA ATA TTG CAA CCA TAT GAG CAA CGT 624 Gin Leu Asp Gin Leu Leu Val Ser He Leu Gin Pro Tyr Glu Gin Arg 195 200 205 ATC AAA CAT GAA AAC CGC ACA TTA GAA GTG AAT TTC TGT AAC GAA ATT 672 He Lys His Glu Asn Arg Thr Leu Glu Val Asn Phe Cys Asn Glu He 210 215 220 GAT GCA TTT TAT CAA TAT CGA ACG CCA CTT GAG CGT ATT TTA ACA AAC 720 Asp Ala Phe Tyr Gin Tyr Arg Thr Pro Leu Glu Arg He Leu Thr Asn 225 230 235 240 TTA CTT GAT AAT GCG CTA AAA TTT TCA AAT GTT GGT AGT CGC ATT GAT 768 Leu Leu Asp Asn Ala Leu Lys Phe Ser Asn Val Gly Ser Arg He Asp 245 250 255 ATT AAT ATT AGT GAA AAC GAA GAT CAA GAT ACT ATC GAC ATT GCT ATT 816 He Asn He Ser Glu Asn Glu Asp Gin Asp Thr He Asp He Ala He 260 265 270 AGC GAT GAA GGT ATT GGC ATT ATA CCA GAA CTA CAA GAA CGT ATA TTC 864 Ser Asp Glu Gly He Gly He He Pro Glu Leu Gin Glu Arg He Phe 275 280 285 GAA CGT ACA TTC AGA GTA GAA AAC TCT CGT AAT ACA AAA ACG GGT GGT 912 Glu Arg Thr Phe Arg Val Glu Asn Ser Arg Asn Thr Lys Thr Gly Gly 290 295 300 TCT GGA TTA GGC TTA TAT ATA GCT AAT GAA CTC GCG CAA CAA AAT AAC 960 Ser Gly Leu Gly Leu Tyr He Ala Asn Glu Leu Ala Gin Gin Asn Asn 305 310 315 320 GCA AAA ATC AGT GTA AGC AGT GAT ATA GAT GTA GGA ACT ACG ATG ACT 1008 Ala Lys He Ser Val Ser Ser Asp He Asp Val Gly Thr Thr Met Thr 325 330 335 GTA ACA TTA CAC AAA TTA GAC ATT ACG TCA TAA 1041 Val Thr Leu His Lys Leu Asp He Thr Ser 340 345 (2) INFORMATION FOR SEQ ID NO: 68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 346 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:68: Arg Ser Gin He He Xaa Gly Val Xaa Ser Ser He Leu Leu Thr Ser 1 5 10 15 Thr He Leu Ala He Ala Tyr He Leu Met Trp Phe Asn Gly His Met 20 25 30 Thr Leu Thr Leu Thr Leu Thr Thr He He Thr Ser Cys Leu Thr Leu 35 40 45 Leu He Cys Ser He Phe He Asn Pro Leu He Gin Lys He Lys Gin 50 55 60 Phe Asn He Lys Thr Lys Gin Phe Ala Asn Gly Asn Tyr Ala Ser Asn 65 70 75 80 Asp Lys Thr Phe Asn Ser Pro Lys Glu He Tyr Glu Leu Asn Gin Ser 85 90 95 Phe Asn Lys Met Ala Ser Glu He Thr Gin Gin Met Asn Gin He Lys 100 105 110 Ser Glu Gin Gin Glu Lys Thr Glu Leu He Gin Asn Leu Ala His Asp 115 120 125 Leu Lys Thr Pro Leu Ala Ser He He Ser Tyr Ser Glu Gly Leu Arg 130 135 140 Asp Gly He He Thr Lys Asp His Glu He Lys Glu Ser Tyr Asp He 145 150 155 160 Leu He Lys Gin Ala Asn Arg Leu Ser Thr Leu Phe Asp Asp Met Thr 165 170 175 His He He Thr Leu Asn Thr Gly Lys Thr Tyr Pro Pro Glu Leu He 180 185 190 Gin Leu Asp Gin Leu Leu Val Ser He Leu Gin Pro Tyr Glu Gin Arg 195 200 205 He Lys His Glu Asn Arg Thr Leu Glu Val Asn Phe Cys Asn Glu He 210 215 220 Asp Ala Phe Tyr Gin Tyr Arg Thr Pro Leu Glu Arg He Leu Thr Asn 225 230 235 240 Leu Leu Asp Asn Ala Leu Lys Phe Ser Asn Val Gly Ser Arg He Asp 245 250 255 He Asn He Ser Glu Asn Glu Asp Gin Asp Thr He Asp He Ala He 260 265 270 Ser Asp Glu Gly He Gly He He Pro Glu Leu Gin Glu Arg He Phe 275 280 285 Glu Arg Thr Phe Arg Val Glu Asn Ser Arg Asn Thr Lys Thr Gly Gly 290 295 300 Ser Gly Leu Gly Leu Tyr He Ala Asn Glu Leu Ala Gin Gin Asn Asn 305 310 315 320 Ala Lys He Ser Val Ser Ser Asp He Asp Val Gly Thr Thr Met Thr 325 330 335 Val Thr Leu His Lys Leu Asp He Thr Ser 340 345 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 392 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0c52) " Unknown = Xaa Unknown for codon no. 125 = TGA (stop codon) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..390 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: GTG AAC TAT GAA TAT TTC GAA TAT TCG GTT AAT TTA GGT GGT ACC ACG 48 Val Asn Tyr Glu Tyr Phe Glu Tyr Ser Val Asn Leu Gly Gly Thr Thr 1 5 10 15 yGT CAC GTC CTT TAT ATT GAT AAG GAT GCT GGC GCT TTT TTG AAA GGA 96 Xaa His Val Leu Tyr He Asp Lys Asp Ala Gly Ala Phe Leu Lys Gly 20 25 30 GCG TAT AGA ATG GAT ATA TTT TAT AAA AAA ATA AAA GCA AAT GTA ACG 144 Ala Tyr Arg Met Asp He Phe Tyr Lys Lys He Lys Ala Asn Val Thr 35 40 45 CCC GAA GTT TTA GCA CAA CTT CAT TCC AAG AAG ATC ATT TTG GAA AGT 192 Pro Glu Val Leu Ala Gin Leu His Ser Lys Lys He He Leu Glu Ser 50 55 60 ACA AAT CAA CAA CAA ACT AAA GGT CGC TAT TCA GTT GTT ATT TTT GAT 240 Thr Asn Gin Gin Gin Thr Lys Gly Arg Tyr Ser Val Val He Phe Asp 65 70 75 80 ATT TAT GGC ACT TTA ACT TTA GAT AAT GAT GTA TTA TCA GTA AGT ACT 288 He Tyr Gly Thr Leu Thr Leu Asp Asn Asp Val Leu Ser Val Ser Thr 85 90 95 TTA AAA GAA TCG TAT CAA ATC ACT GAA AGA CCG TAC CAT TAT TTA ACG 336 Leu Lys Glu Ser Tyr Gin He Thr Glu Arg Pro Tyr His Tyr Leu Thr 100 105 110 ACT AAn ATA AAT GAA GAC TAC CAT AAT ATT CCA AGA TGA GGC AAC TTA 384 Thr Xaa He Asn Glu Asp Tyr His Asn He Pro Arg Xaa Gly Asn Leu 115 120 125 AGT CAT TA 392 Ser His 130 (2) INFORMATION FOR SEQ ID NO: 70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 130 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 70: Val Asn Tyr Glu Tyr Phe Glu Tyr Ser Val Asn Leu Gly Gly Thr Thr 1 5 10 15 Xaa His Val Leu Tyr He Asp Lys Asp Ala Gly Ala Phe Leu Lys Gly 20 25 30 Ala Tyr Arg Met Asp He Phe Tyr Lys Lys He Lys Ala Asn Val Thr 35 40 45 Pro Glu Val Leu Ala Gin Leu His Ser Lys Lys He He Leu Glu Ser 50 55 60 Thr Asn Gin Gin Gin Thr Lys Gly Arg Tyr Ser Val Val He Phe Asp 65 70 75 80 He Tyr Gly Thr Leu Thr Leu Asp Asn Asp Val Leu Ser Val Ser Thr 85 90 95 Leu Lys Glu Ser Tyr Gin He Thr Glu Arg Pro Tyr His Tyr Leu Thr 100 105 110 Thr Xaa He Asn Glu Asp Tyr His Asn He Pro Arg Xaa Gly Asn Leu 115 120 125 Ser His 130 (2) INFORMATION FOR SEQ ID NO: 71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1071 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl0d9) " (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1068 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 71: ATG AAA ATG AGA ACA ATT GCT AAA ACC AGT TTA GCA CTA GGG CTT TTA 48 Met Lys Met Arg Thr He Ala Lys Thr Ser Leu Ala Leu Gly Leu Leu 1 5 10 15 ACA ACA GGC GCA ATT ACA GTA ACG ACG CAA TCG GTC AAA GCA GAA AAA 96 Thr Thr Gly Ala He Thr Val Thr Thr Gin Ser Val Lys Ala Glu Lys 20 25 30 ATA CAA TCA ACT AAA GTT GAC AAA GTA CCA ACG CTT AAA GCA GAG CGA 144 He Gin Ser Thr Lys Val Asp Lys Val Pro Thr Leu Lys Ala Glu Arg 35 40 45 TTA GCA ATG ATA AAC ATA ACA GCA GGT GCA AAT TCA GCG ACA ACA CAA 192 Leu Ala Met He Asn He Thr Ala Gly Ala Asn Ser Ala Thr Thr Gin 50 55 60 GCA GCT AAC ACA AGA CAA GAA CGC ACG CCT AAA CTC GAA AAG GCA CCA 240 Ala Ala Asn Thr Arg Gin Glu Arg Thr Pro Lys Leu Glu Lys Ala Pro 65 70 75 80 AAT ACT AAT GAG GAA AAA ACC TCA GCT TCC AAA ATA GAA AAA ATA TCA 288 Asn Thr Asn Glu Glu Lys Thr Ser Ala Ser Lys He Glu Lys He Ser 85 90 95 CAA CCT AAA CAA GAA GAG CAG AAA ACG CTT AAT ATA TCA GCA ACG CCA 336 Gin Pro Lys Gin Glu Glu Gin Lys Thr Leu Asn He Ser Ala Thr Pro 100 105 110 GCG CCT AAA CAA GAA CAA TCA CAA ACG ACA ACC GAA TCC ACA ACG CCG 384 Ala Pro Lys Gin Glu Gin Ser Gin Thr Thr Thr Glu Ser Thr Thr Pro 115 120 125 AAA ACT AAA GTG ACA ACA CCT CCA TCA ACA AAC ACG CCA CAA CCA ATG 432 Lys Thr Lys Val Thr Thr Pro Pro Ser Thr Asn Thr Pro Gin Pro Met 130 135 140 CAA TCT ACT AAA TCA GAC ACA CCA CAA TCT CCA ACC ATA AAA CAA GCA 480 Gin Ser Thr Lys Ser Asp Thr Pro Gin Ser Pro Thr He Lys Gin Ala 145 150 155 160 CAA ACA GAT ATG ACT CCT AAA TAT GAA GAT TTA AGA GCG TAT TAT ACA 528 Gln Thr Asp Met Thr Pro Lys Tyr Glu Asp Leu Arg Ala Tyr Tyr Thr 165 170 175 AAA CCG AGT TTT GAA TTT GAA AAG CAG TTT GGA TTT ATG CTC AAA CCA 576 Lys Pro Ser Phe Glu Phe Glu Lys Gin Phe Gly Phe Met Leu Lys Pro 180 185 190 TGG ACG ACG GTT AGG TTT ATG AAT GTT ATT CCA AAT AGG TTC ATC TAT 624 Trp Thr Thr Val Arg Phe Met Asn Val He Pro Asn Arg Phe He Tyr 195 200 205 AAA ATA GCT TTA GTT GGA AAA GAT GAG AAA AAA TAT AAA GAT GGA CCT 672 Lys He Ala Leu Val Gly Lys Asp Glu Lys Lys Tyr Lys Asp Gly Pro 210 215 220 TAC GAT AAT ATC GAT GTA TTT ATC GTT TTA GAA GAC AAT AAA TAT CAA 720 Tyr Asp Asn He Asp Val Phe He Val Leu Glu Asp Asn Lys Tyr Gin 225 230 235 240 TTG AAA AAA TAT TCT GTC GGT GGC ATC ACG AAG ACT AAT AGT AAA AAA 768 Leu Lys Lys Tyr Ser Val Gly Gly He Thr Lys Thr Asn Ser Lys Lys 245 250 255 GTT AAT CAC AAA GTA GAA TTA AGC ATT ACT AAA AAA GAT AAT CAA GGT 816 Val Asn His Lys Val Glu Leu Ser He Thr Lys Lys Asp Asn Gin Gly 260 265 270 ATG ATT TCA CGC GAT GTT TCA GAA TAC ATG ATT ACT AAG GAA GAG ATT 864 Met He Ser Arg Asp Val Ser Glu Tyr Met He Thr Lys Glu Glu He 275 280 285 TCC TTG AAA GAG CTT GAT TTT AAA TTG AGA AAA CAA CTT ATT GAA AAA 912 Ser Leu Lys Glu Leu Asp Phe Lys Leu Arg Lys Gin Leu He Glu Lys 290 295 300 CAT AAT CTT TAC GGT AAC ATG GGT TCA GGA ACA ATC GTT ATT AAA ATG 960 His Asn Leu Tyr Gly Asn Met Gly Ser Gly Thr He Val He Lys Met 305 310 315 320 AAA AAC GGT GGG AAA TAT ACG TTT GAA TTA CAC AAA AAA CTG CAA GAG 1008 Lys Asn Gly Gly Lys Tyr Thr Phe Glu Leu His Lys Lys Leu Gin Glu 325 330 335 CAT CGT ATG GCA GAC GTC ATA GAT GGC ACT AAT ATT GAT AAC ATT GAA 1056 His Arg Met Ala Asp Val He Asp Gly Thr Asn He Asp Asn He Glu 340 345 350 GTG AAT ATA AAA TAA 1071 Val Asn He Lys 355 (2) INFORMATION FOR SEQ ID NO: 72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 356 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:72: Met Lys Met Arg Thr He Ala Lys Thr Ser Leu Ala Leu Gly Leu Leu 1 5 10 15 Thr Thr Gly Ala He Thr Val Thr Thr Gin Ser Val Lys Ala Glu Lys 20 25 30 He Gin Ser Thr Lys Val Asp Lys Val Pro Thr Leu Lys Ala Glu Arg 35 40 45 Leu Ala Met He Asn He Thr Ala Gly Ala Asn Ser Ala Thr Thr Gin 50 55 60 Ala Ala Asn Thr Arg Gin Glu Arg Thr Pro Lys Leu Glu Lys Ala Pro 65 70 75 80 Asn Thr Asn Glu Glu Lys Thr Ser Ala Ser Lys He Glu Lys He Ser 85 90 95 Gin Pro Lys Gin Glu Glu Gin Lys Thr Leu Asn He Ser Ala Thr Pro 100 105 110 Ala Pro Lys Gin Glu Gin Ser Gin Thr Thr Thr Glu Ser Thr Thr Pro 115 120 125 Lys Thr Lys Val Thr Thr Pro Pro Ser Thr Asn Thr Pro Gin Pro Met 130 135 140 Gin Ser Thr Lys Ser Asp Thr Pro Gin Ser Pro Thr He Lys Gin Ala 145 150 155 160 Gin Thr Asp Met Thr Pro Lys Tyr Glu Asp Leu Arg Ala Tyr Tyr Thr 165 170 175 Lys Pro Ser Phe Glu Phe Glu Lys Gin Phe Gly Phe Met Leu Lys Pro 180 185 190 Trp Thr Thr Val Arg Phe Met Asn Val He Pro Asn Arg Phe He Tyr 195 200 205 Lys He Ala Leu Val Gly Lys Asp Glu Lys Lys Tyr Lys Asp Gly Pro 210 215 220 Tyr Asp Asn He Asp Val Phe He Val Leu Glu Asp Asn Lys Tyr Gin 225 230 235 240 Leu Lys Lys Tyr Ser Val Gly Gly He Thr Lys Thr Asn Ser Lys Lys 245 250 255 Val Asn His Lys Val Glu Leu Ser He Thr Lys Lys Asp Asn Gin Gly 260 265 270 Met He Ser Arg Asp Val Ser Glu Tyr Met He Thr Lys Glu Glu He 275 280 285 Ser Leu Lys Glu Leu Asp Phe Lys Leu Arg Lys Gin Leu He Glu Lys 290 295 300 His Asn Leu Tyr Gly Asn Met Gly Ser Gly Thr He Val He Lys Met 305 310 315 320 Lys Asn Gly Gly Lys Tyr Thr Phe Glu Leu His Lys Lys Leu Gin Glu 325 330 335 His Arg Met Ala Asp Val He Asp Gly Thr Asn He Asp Asn He Glu 340 345 350 Val Asn He Lys 355 (2) INFORMATION FOR SEQ ID NO:73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1590 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pllcl2)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1587 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 73: AGA GCA AAC CCT AGA AAA GGA GGT GTT TGT GTG AAT TTA TTA AGC CTC 48 Arg Ala Asn Pro Arg Lys Gly Gly Val Cys Val Asn Leu Leu Ser Leu 1 5 10 15 CTA CTC ATT TTG CTG GGG ATC ATT CTA GGA GTT GTT GGA GGG TAT GTT 96 Leu Leu He Leu Leu Gly He He Leu Gly Val Val Gly Gly Tyr Val 20 25 30 GTT GCC CGA AAT TTG TTG CTT CAA AAG CAA TCA CAA GCT AGA CAA ACT 144 Val Ala Arg Asn Leu Leu Leu Gin Lys Gin Ser Gin Ala Arg Gin Thr 35 40 45 GCC GAA GAT ATT GTA AAT CAA GCA CAT AAA GAA GCT GAC AAT ATC AAA 192 Ala Glu Asp He Val Asn Gin Ala His Lys Glu Ala Asp Asn He Lys 50 55 60 AAA GAG AAA TTA CTT GAG GCA AAA GAA GAA AAC CAA ATC CTA AGA GAA 240 Lys Glu Lys Leu Leu Glu Ala Lys Glu Glu Asn Gin He Leu Arg Glu 65 70 75 80 CAA ACT GAA GCA GAA CTA CGA GAA AGA CGT AGC GAA CTT CAA AGA CAA 288 Gin Thr Glu Ala Glu Leu Arg Glu Arg Arg Ser Glu Leu Gin Arg Gin 85 90 95 GAA ACC CGA CTT CTT CAA AAA GAA GAA AAC TTA GAG CGC AAA TCT GAT 336 Glu Thr Arg Leu Leu Gin Lys Glu Glu Asn Leu Glu Arg Lys Ser Asp 100 105 110 CTA TTA GAT AAA AAA GAT GAG ATT TTA GAG CAA AAA GAA TCA AAA ATT 384 Leu Leu Asp Lys Lys Asp Glu He Leu Glu Gin Lys Glu Ser Lys He 115 120 125 GAA GAA AAA CAA CAA CAA GTA GAT GCA AAA GAG AGT AGT GTT CAA ACG 432 Glu Glu Lys Gin Gin Gin Val Asp Ala Lys Glu Ser Ser Val Gin Thr 130 135 140 TTA ATA ATG AAG CAT GAA CAA GAA TTA GAA CGC ATC TCC GGT CTC ACT 480 Leu He Met Lys His Glu Gin Glu Leu Glu Arg He Ser Gly Leu Thr 145 150 155 160 CAA GAA GAA GCT ATT AAT GAG CAA CTT CAA AGA GTA GAG GAA GAA CTG 528 Gln Glu Glu Ala He Asn Glu Gin Leu Gin Arg Val Glu Glu Glu Leu 165 170 175 TCA CAA GAT ATT GCA GTA CTT GTT AAA GAA AAA GAA AAA GAA GCT AAA 576 Ser Gin Asp He Ala Val Leu Val Lys Glu Lys Glu Lys Glu Ala Lys 180 185 190 GAA AAA GTT GAT AAA ACA GCA AAA GAA TTA TTA GCT ACA GCA GTA CAA 624 Glu Lys Val Asp Lys Thr Ala Lys Glu Leu Leu Ala Thr Ala Val Gin 195 200 205 AGA TTA GCA GCA GAT CAC ACA AGT GAA TCA ACG GTA TCA GTA GTT AAC 672 Arg Leu Ala Ala Asp His Thr Ser Glu Ser Thr Val Ser Val Val Asn 210 215 220 TTA CCT AAT GAT GAG ATG AAA GGT CGA ATC ATT GGA CGA GAA GGA CGA 720 Leu Pro Asn Asp Glu Met Lys Gly Arg He He Gly Arg Glu Gly Arg 225 230 235 240 AAC ATC CGC ACA CTT GAA ACT TTA ACT GGC ATT GAT TTA ATT ATT GAT 768 Asn He Arg Thr Leu Glu Thr Leu Thr Gly He Asp Leu He He Asp 245 250 255 GAC ACA CCA GAA GCG GTT ATA TTA TCT GGT TTT GAT CCA ATA AGA AGA 816 Asp Thr Pro Glu Ala Val He Leu Ser Gly Phe Asp Pro He Arg Arg 260 265 270 GAA ATT GCT AGA ACA GCA CTT GTT AAC TTA GTA TCT GAT GGA CGT ATT 864 Glu He Ala Arg Thr Ala Leu Val Asn Leu Val Ser Asp Gly Arg He 275 280 285 CAT CCA GGT AGA ATT GAA GAT ATG GTC GAA AAA GCT AGA AAA GAA GTA 912 His Pro Gly Arg He Glu Asp Met Val Glu Lys Ala Arg Lys Glu Val 290 295 300 GAC GAT ATT ATT AGA GAA GCA GGT GAA CAA GCT ACA TTT GAA GTG AAC 960 Asp Asp He He Arg Glu Ala Gly Glu Gin Ala Thr Phe Glu Val Asn 305 310 315 320 GCA CAT AAT ATG CAT CCT GAC TTA GTA AAA ATT GTA GGG CGT TTA AAC 1008 Ala His Asn Met His Pro Asp Leu Val Lys He Val Gly Arg Leu Asn 325 330 335 TAT CGT ACG AGT TAC GGT CAA AAT GTA CTT AAA CAT TCA ATT GAA GTT 1056 Tyr Arg Thr Ser Tyr Gly Gin Asn Val Leu Lys His Ser He Glu Val 340 345 350 GCG CAT CTT GCT AGT ATG TTA GCT GCT GAG CTA GGC GAA GAT GAG ACA 1104 Ala His Leu Ala Ser Met Leu Ala Ala Glu Leu Gly Glu Asp Glu Thr 355 360 365 TTA GCG AAA CGA GCT GGA CTT TTA CAT GAT GTT GGT AAA GCA ATT GAT 1152 Leu Ala Lys Arg Ala Gly Leu Leu His Asp Val Gly Lys Ala He Asp 370 375 380 CAT GAA GTA GAA GGT AGT CAT GTT GAA ATC GGT GTA GAA TTA GCG AAA 1200 His Glu Val Glu Gly Ser His Val Glu He Gly Val Glu Leu Ala Lys 385 390 395 400 AAA TAT GGT GAA AAT GAA ACA GTT ATT AAT GCA ATC CAT TCT CAT CAT 1248 Lys Tyr Gly Glu Asn Glu Thr Val He Asn Ala He His Ser His His 405 410 415 GGT GAT GTT GAA CCT ACA TCT ATT ATA TCT ATC CTT GTT GCT GCT GCA 1296 Gly Asp Val Glu Pro Thr Ser He He Ser He Leu Val Ala Ala Ala 420 425 430 GAT GCA TTG TCT GCG GCT CGT CCA GGT GCA AGA AAA GAA ACA TTA GAG 1344 Asp Ala Leu Ser Ala Ala Arg Pro Gly Ala Arg Lys Glu Thr Leu Glu 435 440 445 AAT TAT ATT CGT CGA TTA GAA CGT TTA GAA ACG TTA TCA GAA AGT TAT 1392 Asn Tyr He Arg Arg Leu Glu Arg Leu Glu Thr Leu Ser Glu Ser Tyr 450 455 460 GAT GGT GTA GAA AAA GCA TTT GCG ATT CAG GCA GGT AGA GAA ATC CGA 1440 Asp Gly Val Glu Lys Ala Phe Ala He Gin Ala Gly Arg Glu He Arg 465 470 475 480 GTG ATT GTA TCT CCT GAA GAA ATT GAT GAT TTA AAA TCT TAT CGA TTG 1488 Val He Val Ser Pro Glu Glu He Asp Asp Leu Lys Ser Tyr Arg Leu 485 490 495 GCT AGA GAT ATT AAA AAT CAG ATT GAA GAT GAA TTA CAA TAT CCT GGT 1536 Ala Arg Asp He Lys Asn Gin He Glu Asp Glu Leu Gin Tyr Pro Gly 500 505 510 CAT ATC AAG GTG ACA GTT GTT CGA GAG ACT AGA GCA GTA GAA TAT GCG 1584 His He Lys Val Thr Val Val Arg Glu Thr Arg Ala Val Glu Tyr Ala 515 520 525 AAA TAA 1590 Lys (2) INFORMATION FOR SEQ ID NO: 74: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 529 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: Arg Ala Asn Pro Arg Lys Gly Gly Val Cys Val Asn Leu Leu Ser Leu 1 5 10 15 Leu Leu He Leu Leu Gly He He Leu Gly Val Val Gly Gly Tyr Val 20 25 30 Val Ala Arg Asn Leu Leu Leu Gin Lys Gin Ser Gin Ala Arg Gin Thr 35 40 45 Ala Glu Asp He Val Asn Gin Ala His Lys Glu Ala Asp Asn He Lys 50 55 60 Lys Glu Lys Leu Leu Glu Ala Lys Glu Glu Asn Gin He Leu Arg Glu 65 70 75 80 Gin Thr Glu Ala Glu Leu Arg Glu Arg Arg Ser Glu Leu Gin Arg Gin 85 90 95 Glu Thr Arg Leu Leu Gin Lys Glu Glu Asn Leu Glu Arg Lys Ser Asp 100 105 110 Leu Leu Asp Lys Lys Asp Glu He Leu Glu Gin Lys Glu Ser Lys He 115 120 125 Glu Glu Lys Gin Gin Gin Val Asp Ala Lys Glu Ser Ser Val Gin Thr 130 135 140 Leu He Met Lys His Glu Gin Glu Leu Glu Arg He Ser Gly Leu Thr 145 150 155 160 Gin Glu Glu Ala He Asn Glu Gin Leu Gin Arg Val Glu Glu Glu Leu 165 170 175 Ser Gin Asp He Ala Val Leu Val Lys Glu Lys Glu Lys Glu Ala Lys 180 185 190 Glu Lys Val Asp Lys Thr Ala Lys Glu Leu Leu Ala Thr Ala Val Gin 195 200 205 Arg Leu Ala Ala Asp His Thr Ser Glu Ser Thr Val Ser Val Val Asn 210 215 220 Leu Pro Asn Asp Glu Met Lys Gly Arg He He Gly Arg Glu Gly Arg 225 230 235 240 Asn He Arg Thr Leu Glu Thr Leu Thr Gly He Asp Leu He He Asp 245 250 255 Asp Thr Pro Glu Ala Val He Leu Ser Gly Phe Asp Pro He Arg Arg 260 265 270 Glu He Ala Arg Thr Ala Leu Val Asn Leu Val Ser Asp Gly Arg He 275 280 285 His Pro Gly Arg He Glu Asp Met Val Glu Lys Ala Arg Lys Glu Val 290 295 300 Asp Asp He He Arg Glu Ala Gly Glu Gin Ala Thr Phe Glu Val Asn 305 310 315 320 Ala His Asn Met His Pro Asp Leu Val Lys He Val Gly Arg Leu Asn 325 330 335 Tyr Arg Thr Ser Tyr Gly Gin Asn Val Leu Lys His Ser He Glu Val 340 345 350 Ala His Leu Ala Ser Met Leu Ala Ala Glu Leu Gly Glu Asp Glu Thr 355 360 365 Leu Ala Lys Arg Ala Gly Leu Leu His Asp Val Gly Lys Ala He Asp 370 375 380 His Glu Val Glu Gly Ser His Val Glu He Gly Val Glu Leu Ala Lys 385 390 395 400 Lys Tyr Gly Glu Asn Glu Thr Val He Asn Ala He His Ser His His 405 410 415 Gly Asp Val Glu Pro Thr Ser He He Ser He Leu Val Ala Ala Ala 420 425 430 Asp Ala Leu Ser Ala Ala Arg Pro Gly Ala Arg Lys Glu Thr Leu Glu 435 440 445 Asn Tyr He Arg Arg Leu Glu Arg Leu Glu Thr Leu Ser Glu Ser Tyr 450 455 460 Asp Gly Val Glu Lys Ala Phe Ala He Gin Ala Gly Arg Glu He Arg 465 470 475 480 Val He Val Ser Pro Glu Glu He Asp Asp Leu Lys Ser Tyr Arg Leu 485 490 495 Ala Arg Asp He Lys Asn Gin He Glu Asp Glu Leu Gin Tyr Pro Gly 500 505 510 His He Lys Val Thr Val Val Arg Glu Thr Arg Ala Val Glu Tyr Ala 515 520 525 Lys (2) INFORMATION FOR SEQ ID NO: 75: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 799 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pllc66) " Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..384 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:75: TCA TGG TAT TAT ATT GTT TGG AGT GAT TTG ATG AGA TTT GTC TTT GAT 48 Ser Trp Tyr Tyr He Val Trp Ser Asp Leu Met Arg Phe Val Phe Asp 1 5 10 15 ATT GAT GGT ACG CTT TGT TTT GAC GGC CGA TTA ATT GAC CAG ACT ATT 96 He Asp Gly Thr Leu Cys Phe Asp Gly Arg Leu He Asp Gin Thr He 20 25 30 ATT GAT ACA TTG TTA CAA TTA CAA CAT GAT GGT CAT GAA CTT ATA TTT 144 He Asp Thr Leu Leu Gin Leu Gin His Asp Gly His Glu Leu He Phe 35 40 45 GCA TCA GCA CGT CCG ATT CGT GAT TTG TTG CCA GTT TTA CCA TCA GTA 192 Ala Ser Ala Arg Pro He Arg Asp Leu Leu Pro Val Leu Pro Ser Val 50 55 60 TTT CAT CAG CAC ACA TTA ATT GGC GCA AAT GGT GCT ATG ATT TCA CAG 240 Phe His Gin His Thr Leu He Gly Ala Asn Gly Ala Met He Ser Gin 65 70 75 80 CAA TCA AAG ATT TCT GTT ATC AAA CCA ATT CAT ACT GAT ACA TAT CAT 288 Gin Ser Lys He Ser Val He Lys Pro He His Thr Asp Thr Tyr His 85 90 95 CAT ATC TTC AAA ATA ATT CAA AAG TAT GAG TTA GAT TAT ATT ATT GAT 336 His He Phe Lys He He Gin Lys Tyr Glu Leu Asp Tyr He He Asp 100 105 110 GAT GAT TGG AAT TAT GCT GCA CAA CTT GAC GCT GnA GAA CGC GAT TTT 384 Asp Asp Trp Asn Tyr Ala Ala Gin Leu Asp Ala Xaa Glu Arg Asp Phe 115 120 125 TGAGCGTTTA GATCCACATA AGCTGGCCAG TTGTATTGAT GTTGCAAATA TCGACACGCC 444 AATCAAGAkT ATTTTATTAA ATATAGACCC GGCACAAATT ACAACTATAT TAGACGAGCT 504 AGATAAATAC CATCAAGAAT TGGAAATGAT TCACCATTCA AATGAGTATA ACATTGATAT 564 AACAGCGCAA AATATTAACA AATATACTGC ATTACAATAT ATATTTGATG CAGATGTTAA 624 ATATATAGCA TTTGGTAATG ACCACAATGA TATTGTCATG TTACAACATG CTAGTAGTGG 684 CTATATTATA GGACCATCAG AAGCATACAC ACACGCAATA TTGAAACTTG ATAAAATCAA 744 ACACATCAAT AATAATGCAC AAGCTATTTG CAAAGTCTTA AAATCATATA AATAA 799 (2) INFORMATION FOR SEQ ID NO: 76: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 128 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: Ser Trp Tyr Tyr He Val Trp Ser Asp Leu Met Arg Phe Val Phe Asp 1 5 10 15 He Asp Gly Thr Leu Cys Phe Asp Gly Arg Leu He Asp Gin Thr He 20 25 30 He Asp Thr Leu Leu Gin Leu Gin His Asp Gly His Glu Leu He Phe 35 40 45 Ala Ser Ala Arg Pro He Arg Asp Leu Leu Pro Val Leu Pro Ser Val 50 55 60 Phe His Gin His Thr Leu He Gly Ala Asn Gly Ala Met He Ser Gin 65 70 75 80 Gin Ser Lys He Ser Val He Lys Pro He His Thr Asp Thr Tyr His 85 90 95 His He Phe Lys He He Gin Lys Tyr Glu Leu Asp Tyr He He Asp 100 105 110 Asp Asp Trp Asn Tyr Ala Ala Gin Leu Asp Ala Xaa Glu Arg Asp Phe 115 120 125 (2) INFORMATION FOR SEQ ID NO: 77: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 799 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pllc66)" Unknown = Xaa ( ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 335..796 . (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 77: TCATGGTATT ATATTGTTTG GAGTGATTTG ATGAGATTTG TCTTTGATAT TGATGGTACG 60 CTTTGTTTTG ACGGCCGATT AATTGACCAG ACTATTATTG ATACATTGTT ACAATTACAA 120 CATGATGGTC ATGAACTTAT ATTTGCATCA GCACGTCCGA TTCGTGATTT GTTGCCAGTT 180 TTACCATCAG TATTTCATCA GCACACATTA ATTGGCGCAA ATGGTGCTAT GATTTCACAG 240 CAATCAAAGA TTTCTGTTAT CAAACCAATT CATACTGATA CATATCATCA TATCTTCAAA 300 ATAATTCAAA AGTATGAGTT AGATTATATT ATTG ATG ATG ATT GGA ATT ATG 352 Met Met He Gly He Met 1 5 CTG CAC AAC TTG ACG CTG nAG AAC GCG ATT TTT GAG CGT TTA GAT CCA 400 Leu His Asn Leu Thr Leu Xaa Asn Ala He Phe Glu Arg Leu Asp Pro 10 15 20 CAT AAG CTG GCC AGT TGT ATT GAT GTT GCA AAT ATC GAC ACG CCA ATC 448 His Lys Leu Ala Ser Cys He Asp Val Ala Asn He Asp Thr Pro He 25 30 35 AAG AkT ATT TTA TTA AAT ATA GAC CCG GCA CAA ATT ACA ACT ATA TTA 496 Lys Xaa He Leu Leu Asn He Asp Pro Ala Gin He Thr Thr He Leu 40 45 50 GAC GAG CTA GAT AAA TAC CAT CAA GAA TTG GAA ATG ATT CAC CAT TCA 544 Asp Glu Leu Asp Lys Tyr His Gin Glu Leu Glu Met He His His Ser 55 60 65 70 AAT GAG TAT AAC ATT GAT ATA ACA GCG CAA AAT ATT AAC AAA TAT ACT 592 Asn Glu Tyr Asn He Asp He Thr Ala Gin Asn He Asn Lys Tyr Thr 75 80 85 GCA TTA CAA TAT ATA TTT GAT GCA GAT GTT AAA TAT ATA GCA TTT GGT 640 Ala Leu Gin Tyr He Phe Asp Ala Asp Val Lys Tyr He Ala Phe Gly 90 95 100 AAT GAC CAC AAT GAT ATT GTC ATG TTA CAA CAT GCT AGT AGT GGC TAT 688 Asn Asp His Asn Asp He Val Met Leu Gin His Ala Ser Ser Gly Tyr 105 110 115 ATT ATA GGA CCA TCA GAA GCA TAC ACA CAC GCA ATA TTG AAA CTT GAT 736 He He Gly Pro Ser Glu Ala Tyr Thr His Ala He Leu Lys Leu Asp 120 125 130 AAA ATC AAA CAC ATC AAT AAT AAT GCA CAA GCT ATT TGC AAA GTC TTA 784 Lys He Lys His He Asn Asn Asn Ala Gin Ala He Cys Lys Val Leu 135 140 145 150 AAA TCA TAT AAA TAA 799 Lys Ser Tyr Lys (2) INFORMATION FOR SEQ ID NO: 78: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 154 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 78: Met Met He Gly He Met Leu His Asn Leu Thr Leu Xaa Asn Ala He 1 5 10 15 Phe Glu Arg Leu Asp Pro His Lys Leu Ala Ser Cys He Asp Val Ala 20 25 30 Asn He Asp Thr Pro He Lys Xaa He Leu Leu Asn He Asp Pro Ala 35 40 45 Gin He Thr Thr He Leu Asp Glu Leu Asp Lys Tyr His Gin Glu Leu 50 55 60 Glu Met He His His Ser Asn Glu Tyr Asn He Asp He Thr Ala Gin 65 70 75 80 Asn He Asn Lys Tyr Thr Ala Leu Gin Tyr He Phe Asp Ala Asp Val 85 90 95 Lys Tyr He Ala Phe Gly Asn Asp His Asn Asp He Val Met Leu Gin 100 105 110 His Ala Ser Ser Gly Tyr He He Gly Pro Ser Glu Ala Tyr Thr His 115 120 125 Ala He Leu Lys Leu Asp Lys He Lys His He Asn Asn Asn Ala Gin 130 135 140 Ala He Cys Lys Val Leu Lys Ser Tyr Lys 145 150 (2) INFORMATION FOR SEQ ID NO: 79: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1236 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) p5c34" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1233 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 79: AGC TCT ACG TTC AAC ATT TTT CCA TTG GGG ATT CCA TGC TTG GGC TGT 48 Ser Ser Thr Phe Asn He Phe Pro Leu Gly He Pro Cys Leu Gly Cys 1 5 10 15 TTA TGG TGT TGT TGC GTT ACG TTG GCA TAT TCG CAA TTC CGT AAA GGT 96 Leu Trp Cys Cys Cys Val Thr Leu Ala Tyr Ser Gin Phe Arg Lys Gly 20 25 30 GAA CCA GGT TTA TTA TCT AGA ACT TTA CGT CCT CTT TTA GGT GAT AAA 144 Glu Pro Gly Leu Leu Ser Arg Thr Leu Arg Pro Leu Leu Gly Asp Lys 35 40 45 GTA GAA GGT CCT ATT GGG ATT TTT ATT GAC GTT TTA TCT GTA TTT GCG 192 Val Glu Gly Pro He Gly He Phe He Asp Val Leu Ser Val Phe Ala 50 55 60 ACA ATC GTT GGG GTA GCC GTT TCG TTA GGT ATG GGT GCT CTA CAA ATT 240 Thr He Val Gly Val Ala Val Ser Leu Gly Met Gly Ala Leu Gin He 65 70 75 80 AAT GGT GGT TTA CAT TAC TTG TTC AAT GTT CCA AAC AAT ACG TTT GTA 288 Asn Gly Gly Leu His Tyr Leu Phe Asn Val Pro Asn Asn Thr Phe Val 85 90 95 CAA GCG ATT ATC ATC ATT GTT GTT ACT ATC TTA TTT ATA GCA AGT GCA 336 Gin Ala He He He He Val Val Thr He Leu Phe He Ala Ser Ala 100 105 110 TGG TCT GGA TTA AGT AAA GGT ATT CAA TAC TTA AGT AAC TTG AAC ATT 384 Trp Ser Gly Leu Ser Lys Gly He Gin Tyr Leu Ser Asn Leu Asn He 115 120 125 GGT TTA GGT ACT ATT TTA ATG GTA GCT GCT TTA ATT GTT GGA CCA ACT 432 Gly Leu Gly Thr He Leu Met Val Ala Ala Leu He Val Gly Pro Thr 130 135 140 GTT CTT ATT TTA AAT ATG TTA ACT AGC TCT ACG GGT AGT TTA CTA AAC 480 Val Leu He Leu Asn Met Leu Thr Ser Ser Thr Gly Ser Leu Leu Asn 145 150 155 160 ACA TTC TTG TTT AAT AGT TTT GAT ACA GCA GCT TTA AAT CCT CAA AAA 528 Thr Phe Leu Phe Asn Ser Phe Asp Thr Ala Ala Leu Asn Pro Gin Lys 165 170 175 CGT GAA TGG ATG TCT TCA TGG ACA CTT TAT TAC TGG GGT TGG TGG TTA 576 Arg Glu Trp Met Ser Ser Trp Thr Leu Tyr Tyr Trp Gly Trp Trp Leu 180 185 190 AGT TGG AGT CCA TTC GTT GGA GTG TTT ATT GCA CGA GTT TCA AAA GGA 624 Ser Trp Ser Pro Phe Val Gly Val Phe He Ala Arg Val Ser Lys Gly 195 200 205 CGT TCA ATT AGA GAG TTC ATT TCT GGT GTC TTG CTA GTT CCA GCA ATT 672 Arg Ser He Arg Glu Phe He Ser Gly Val Leu Leu Val Pro Ala He 210 215 220 GTT AGT TTT GTT TGG TTT AGT GTC TTT GGT GTA TTA GGC ATC GAG ACA 720 Val Ser Phe Val Trp Phe Ser Val Phe Gly Val Leu Gly He Glu Thr 225 230 235 240 GGT AAG AAA CAC AAA GAA ATT TTT GAT ATG ACT CCT GAA ACA CAG CTA 768 Gly Lys Lys His Lys Glu He Phe Asp Met Thr Pro Glu Thr Gin Leu 245 250 255 TTT GGA GTG TTT AAT CAT GTG CCA TTT GGC ATT GTT TTA TCG TTG ATT 816 Phe Gly Val Phe Asn His Val Pro Phe Gly He Val Leu Ser Leu He 260 265 270 GCA TTA TTA TTA ATT GCA TCA TTC TTT ATT ACA TCT GCT GAC TCA GCA 864 Ala Leu Leu Leu He Ala Ser Phe Phe He Thr Ser Ala Asp Ser Ala 275 280 285 ACA TTT GTA TTA GGA ATG CAA ACA ACA TTT GGT TCA TTA AAT CCA TCT 912 Thr Phe Val Leu Gly Met Gin Thr Thr Phe Gly Ser Leu Asn Pro Ser 290 295 300 AGT ATG GTA AAA GTT GTT TGG GGA ATT TCA CAG GCC TTA ATA GCA TTT 960 Ser Met Val Lys Val Val Trp Gly He Ser Gin Ala Leu He Ala Phe 305 310 315 320 GTA CTT TTA TTA GCT GGT GGC GGT AAC GGC GCT GAA GCT TTA AAT GCG 1008 Val Leu Leu Leu Ala Gly Gly Gly Asn Gly Ala Glu Ala Leu Asn Ala 325 330 335 ATT CAA AGT GCT GCA ATT ATA AGT GCA TTC CCA TTC TCC TTT GTC GTC 1056 He Gin Ser Ala Ala He He Ser Ala Phe Pro Phe Ser Phe Val Val 340 345 350 ATA CTC ATG ATG GTA AGT TTC TAC AAG GAT GCG AAC CAG GAA CGT AAA 1104 He Leu Met Met Val Ser Phe Tyr Lys Asp Ala Asn Gin Glu Arg Lys 355 360 365 TTC CTA GGT TTA ACA TTG ACT CCG AAT AAA CAT CGC TTA CAA GAA TAT 1152 Phe Leu Gly Leu Thr Leu Thr Pro Asn Lys His Arg Leu Gin Glu Tyr 370 375 380 ATC AAG AGT CAA CAA GAA GAT TAT GAA TCT GAC ATT CTT GAA AAG CGT 1200 He Lys Ser Gin Gin Glu Asp Tyr Glu Ser Asp He Leu Glu Lys Arg 385 390 395 400 CAG TCA CGT AGA AAT ATA GAG AAA AAA GAT AAC TAA 1236 Gin Ser Arg Arg Asn He Glu Lys Lys Asp Asn 405 410 (2) INFORMATION FOR SEQ ID NO: 80: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 411 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 80: Ser Ser Thr Phe Asn He Phe Pro Leu Gly He Pro Cys Leu Gly Cys 1 5 10 15 Leu Trp Cys Cys Cys Val Thr Leu Ala Tyr Ser Gin Phe Arg Lys Gly 20 25 30 Glu Pro Gly Leu Leu Ser Arg Thr Leu Arg Pro Leu Leu Gly Asp Lys 35 40 45 Val Glu Gly Pro He Gly He Phe He Asp Val Leu Ser Val Phe Ala 50 55 60 Thr He Val Gly Val Ala Val Ser Leu Gly Met Gly Ala Leu Gin He 65 70 75 80 Asn Gly Gly Leu His Tyr Leu Phe Asn Val Pro Asn Asn Thr Phe Val 85 90 95 Gin Ala He He He He Val Val Thr He Leu Phe He Ala Ser Ala 100 105 110 Trp Ser Gly Leu Ser Lys Gly He Gin Tyr Leu Ser Asn Leu Asn He 115 120 125 Gly Leu Gly Thr He Leu Met Val Ala Ala Leu He Val Gly Pro Thr 130 135 140 Val Leu He Leu Asn Met Leu Thr Ser Ser Thr Gly Ser Leu Leu Asn 145 150 155 160 Thr Phe Leu Phe Asn Ser Phe Asp Thr Ala Ala Leu Asn Pro Gin Lys 165 170 175 Arg Glu Trp Met Ser Ser Trp Thr Leu Tyr Tyr Trp Gly Trp Trp Leu 180 185 190 Ser Trp Ser Pro Phe Val Gly Val Phe He Ala Arg Val Ser Lys Gly 195 200 205 Arg Ser He Arg Glu Phe He Ser Gly Val Leu Leu Val Pro Ala He 210 215 220 Val Ser Phe Val Trp Phe Ser Val Phe Gly Val Leu Gly He Glu Thr 225 230 235 240 Gly Lys Lys His Lys Glu He Phe Asp Met Thr Pro Glu Thr Gin Leu 245 250 255 Phe Gly Val Phe Asn His Val Pro Phe Gly He Val Leu Ser Leu He 260 265 270 Ala Leu Leu Leu He Ala Ser Phe Phe He Thr Ser Ala Asp Ser Ala 275 280 285 Thr Phe Val Leu Gly Met Gin Thr Thr Phe Gly Ser Leu Asn Pro Ser 290 295 300 Ser Met Val Lys Val Val Trp Gly He Ser Gin Ala Leu He Ala Phe 305 310 315 320 Val Leu Leu Leu Ala Gly Gly Gly Asn Gly Ala Glu Ala Leu Asn Ala 325 330 335 He Gin Ser Ala Ala He He Ser Ala Phe Pro Phe Ser Phe Val Val 340 345 350 He Leu Met Met Val Ser Phe Tyr Lys Asp Ala Asn Gin Glu Arg Lys 355 360 365 Phe Leu Gly Leu Thr Leu Thr Pro Asn Lys His Arg Leu Gin Glu Tyr 370 375 380 He Lys Ser Gin Gin Glu Asp Tyr Glu Ser Asp He Leu Glu Lys Arg 385 390 395 400 Gin Ser Arg Arg Asn He Glu Lys Lys Asp Asn 405 410 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 477 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (plOclθ)" Unknown = N (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: ATTATAGAGT TTTTCCGCTG TTTCTAAAGT TAAATTATTC ACTTTTCTTT TCCCGCTTCT 60 TAATTCACTT ATACCACCAT AAGAAACATC AGTGTCTTGA TTAATTCTAT AATTAGATAT 120 TGATYTATCA TTTAGTARTT TTTCTATTGT ATTATNAATT TCTTTAARCT GGTTCWTAAT 180 TTTNGTCNAA ATGAAAGAAT AATTTATTTT NTCTCTANGT TATATTAATC AATNAANTAA 240 TATTANAGTT GCAANTTAAG NATAGAGAGT TNATTTTTTT CCTTTANATT CCTCCTTGGT 300 CNCTNAANAT TANCCANCCT NCCCCTTATT TTTAAATTTG GTGGGTNNAA AGGGGTTNTT 360 CTNGGCCCCN TTTTTNCCCT NTTTTTTTTN ANAAAGNANC CGNAATTCTG GATCCTAACT 420 TTTANTNTTN NCTTGGGAAC TCTAATTCAA GGGNCCTCNG CTCGNCNAGC NCTAATT 477 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1212 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl2c3)" Unknown = Xaa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1209 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: GAA AGA AAG CGT TTT CAC ATA ACA AAG GGG GAG TTT CAA ATG AAA GTC 48 Glu Arg Lys Arg Phe His He Thr Lys Gly Glu Phe Gin Met Lys Val 1 5 10 15 GAA GTT TAT AAA GGA GCG CAA GGT AAA CAT AAC CTT AAA GAT TAT GAA 96 Glu Val Tyr Lys Gly Ala Gin Gly Lys His Asn Leu Lys Asp Tyr Glu 20 25 30 GAA ACA TAT AAT ACT TTT GAT TGG AAA GAC GTA GAA CAA GCA TTT TCT 144 Glu Thr Tyr Asn Thr Phe Asp Trp Lys Asp Val Glu Gin Ala Phe Ser 35 40 45 TGG AGT GAA ACT GGA AAA ATG AAC ATG GCA TAT GAA TGC ATA GAT CGC 192 Trp Ser Glu Thr Gly Lys Met Asn Met Ala Tyr Glu Cys He Asp Arg 50 55 60 CAT GTA GAT CAA GGA TTA GGG GAT AAA ATA GCG TTA AAT TAC AAA GAT 240 His Val Asp Gin Gly Leu Gly Asp Lys He Ala Leu Asn Tyr Lys Asp 65 70 75 80 GAG CAC AGA AAA GAA TCG TAT ACT TAT AAA GAT ATG CAA CGG TTA TCT 288 Glu His Arg Lys Glu Ser Tyr Thr Tyr Lys Asp Met Gin Arg Leu Ser 85 90 95 AAT AAA GCA GCG AAT GTT TTG TCT GAA CAT GCA GAA GTT GAC AAA GGT 336 Asn Lys Ala Ala Asn Val Leu Ser Glu His Ala Glu Val Asp Lys Gly 100 105 110 GAC AGA GTA TTT ATA TTT ATG TCG CGT ACA CCT GAA CTA TAT TTT GCG 384 Asp Arg Val Phe He Phe Met Ser Arg Thr Pro Glu Leu Tyr Phe Ala 115 120 125 TTG TTA GGT GTT TTA AAA ATT GGT GCA ATT GTT GGG CCG TTA TTT GAA 432 Leu Leu Gly Val Leu Lys He Gly Ala He Val Gly Pro Leu Phe Glu 130 135 140 GCA TTT ATG GAA AAG GCA GTT GCG GAT AGA TTA GAG AAC AGT GAA GCT 480 Ala Phe Met Glu Lys Ala Val Ala Asp Arg Leu Glu Asn Ser Glu Ala 145 150 155 160 AAA GTG TTA ATT ACT AAT AAG GCA TTG TTA CCT CGA GTA CCT GTA GAT 528 Lys Val Leu He Thr Asn Lys Ala Leu Leu Pro Arg Val Pro Val Asp 165 170 175 AAA TTA CCA AAC TTG AAA AAA ATT GTT GTC GTA GAT GAG GAT GTA GAA 576 Lys Leu Pro Asn Leu Lys Lys He Val Val Val Asp Glu Asp Val Glu 180 185 190 GAC AAT TAC ATA GAC TTC ATT AGT TTG ATG GAA ACT GCT AGC GAT GAA 624 Asp Asn Tyr He Asp Phe He Ser Leu Met Glu Thr Ala Ser Asp Glu 195 200 205 TTT GAC ATT GAA TGG TTA AAG TCG GAT GAT GGT TTG ATT TTA CAT TAT 672 Phe Asp He Glu Trp Leu Lys Ser Asp Asp Gly Leu He Leu His Tyr 210 215 220 ACA TCA GGT TCT ACT GGG CAA CCT AAA GGT GTA TTG CAT GTT CAA CAA 720 Thr Ser Gly Ser Thr Gly Gin Pro Lys Gly Val Leu His Val Gin Gin 225 230 235 240 GCA ATG TTA GTG CAC TAT ATT TCT GGr AAA TAT GTA TTA GAT TTA CAA 768 Ala Met Leu Val His Tyr He Ser Gly Lys Tyr Val Leu Asp Leu Gin 245 250 255 GAA GAT GAT GTT TAT TGG TGT ACA GCA GAT CCA GGT TGG GTT ACA GGA 816 Glu Asp Asp Val Tyr Trp Cys Thr Ala Asp Pro Gly Trp Val Thr Gly 260 265 270 ACA TCT TAT GGT ATT TTT GCA CCA TGG TTA AAT GGC GCT ACA AAT TGT 864 Thr Ser Tyr Gly He Phe Ala Pro Trp Leu Asn Gly Ala Thr Asn Cys 275 280 285 ATA GCT GGT GGT CGC TTT TCG CCA GAA CAG TGG TAT AGT ATG ATT GAA 912 He Ala Gly Gly Arg Phe Ser Pro Glu Gin Trp Tyr Ser Met He Glu 290 295 300 GAT TTT AAA GTG ACG ATT TGG TAT ACG GCA CCA ACA GCT TTA AGA ATG 960 Asp Phe Lys Val Thr He Trp Tyr Thr Ala Pro Thr Ala Leu Arg Met 305 310 315 320 TTA ATG AGT GCT GGT GAC GAT ATT GTT GAG AAA TAT GAC TTG TCA TCG 1008 Leu Met Ser Ala Gly Asp Asp He Val Glu Lys Tyr Asp Leu Ser Ser 325 330 335 TTA CGT TCG ATT CTA TCA GTA GGT GAG CCT TTA AAT CCT GAA GTT ATA 1056 Leu Arg Ser He Leu Ser Val Gly Glu Pro Leu Asn Pro Glu Val He 340 345 350 AAA TGG GCG AAA AAA GTA TAC GGT TTA ACG GTG TTA GAT ACT TGG TGG 1104 Lys Trp Ala Lys Lys Val Tyr Gly Leu Thr Val Leu Asp Thr Trp Trp 355 360 365 ATG ACA GAA ACA GGT GGA CAT ATG ATT GTT AAC TAT CCA ACG ATG GAC 1152 Met Thr Glu Thr Gly Gly His Met He Val Asn Tyr Pro Thr Met Asp 370 375 380 GTn CAA GCT TGG CTC mAT GGG CAA ACC ATT ACC TGG TAT TCA AGC TGC 1200 Val Gin Ala Trp Leu Xaa Gly Gin Thr He Thr Trp Tyr Ser Ser Cys 385 390 395 400 AAT TAT CGA TGA 1212 Asn Tyr Arg (2) INFORMATION FOR SEQ ID NO: 83: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 403 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: Glu Arg Lys Arg Phe His He Thr Lys Gly Glu Phe Gin Met Lys Val 1 5 10 15 Glu Val Tyr Lys Gly Ala Gin Gly Lys His Asn Leu Lys Asp Tyr Glu 20 25 30 Glu Thr Tyr Asn Thr Phe Asp Trp Lys Asp Val Glu Gin Ala Phe Ser 35 40 45 Trp Ser Glu Thr Gly Lys Met Asn Met Ala Tyr Glu Cys He Asp Arg 50 55 60 His Val Asp Gin Gly Leu Gly Asp Lys He Ala Leu Asn Tyr Lys Asp 65 70 75 80 Glu His Arg Lys Glu Ser Tyr Thr Tyr Lys Asp Met Gin Arg Leu Ser 85 90 95 Asn Lys Ala Ala Asn Val Leu Ser Glu His Ala Glu Val Asp Lys Gly 100 105 110 Asp Arg Val Phe He Phe Met Ser Arg Thr Pro Glu Leu Tyr Phe Ala 115 120 125 Leu Leu Gly Val Leu Lys He Gly Ala He Val Gly Pro Leu Phe Glu 130 135 140 Ala Phe Met Glu Lys Ala Val Ala Asp Arg Leu Glu Asn Ser Glu Ala 145 150 155 160 Lys Val Leu He Thr Asn Lys Ala Leu Leu Pro Arg Val Pro Val Asp 165 170 175 Lys Leu Pro Asn Leu Lys Lys He Val Val Val Asp Glu Asp Val Glu 180 185 190 Asp Asn Tyr He Asp Phe He Ser Leu Met Glu Thr Ala Ser Asp Glu 195 200 205 Phe Asp He Glu Trp Leu Lys Ser Asp Asp Gly Leu He Leu His Tyr 210 215 220 Thr Ser Gly Ser Thr Gly Gin Pro Lys Gly Val Leu His Val Gin Gin 225 230 235 240 Ala Met Leu Val His Tyr He Ser Gly Lys Tyr Val Leu Asp Leu Gin 245 250 255 Glu Asp Asp Val Tyr Trp Cys Thr Ala Asp Pro Gly Trp Val Thr Gly 260 265 270 Thr Ser Tyr Gly He Phe Ala Pro Trp Leu Asn Gly Ala Thr Asn Cys 275 280 285 He Ala Gly Gly Arg Phe Ser Pro Glu Gin Trp Tyr Ser Met He Glu 290 295 300 Asp Phe Lys Val Thr He Trp Tyr Thr Ala Pro Thr Ala Leu Arg Met 305 310 315 320 Leu Met Ser Ala Gly Asp Asp He Val Glu Lys Tyr Asp Leu Ser Ser 325 330 335 Leu Arg Ser He Leu Ser Val Gly Glu Pro Leu Asn Pro Glu Val He 340 345 350 Lys Trp Ala Lys Lys Val Tyr Gly Leu Thr Val Leu Asp Thr Trp Trp 355 360 365 Met Thr Glu Thr Gly Gly His Met He Val Asn Tyr Pro Thr Met Asp 370 375 380 Val Gin Ala Trp Leu Xaa Gly Gin Thr He Thr Trp Tyr Ser Ser Cys 385 390 395 400 Asn Tyr Arg (2) INFORMATION FOR SEQ ID NO: 84: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3147 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl4b25)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..3144 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 84: ATG AAA ATT CTC AGC CTG CGC CTG AAA AAC CTG AAC TCA TTA AAA GGC 48 Met Lys He Leu Ser Leu Arg Leu Lys Asn Leu Asn Ser Leu Lys Gly 1 5 10 15 GAA TGG AAG ATT GAT TTC ACC CGC GAG CCG TTC GCC AGC AAC GGG CTG 96 Glu Trp Lys He Asp Phe Thr Arg Glu Pro Phe Ala Ser Asn Gly Leu 20 25 30 TTT GCT ATT ACC GGC CCA ACA GGT GCG GGG AAA ACC ACC CTG CTG GAC 144 Phe Ala He Thr Gly Pro Thr Gly Ala Gly Lys Thr Thr Leu Leu Asp 35 40 45 GCC ATT TGT CTG GCG CTG TAT CAC GAA ACT CCG CGT CTC TCT AAC GTT 192 Ala He Cys Leu Ala Leu Tyr His Glu Thr Pro Arg Leu Ser Asn Val 50 55 60 TCA CAA TCG CAA AAT GAT CTC ATG ACC CGC GAT ACC GCC GAA TGT CTG 240 Ser Gin Ser Gin Asn Asp Leu Met Thr Arg Asp Thr Ala Glu Cys Leu 65 70 75 80 GCG GAG GTG GAG TTT GAA GTG AAA GGT GAA GCG TAC CGT GCA TTC TGG 288 Ala Glu Val Glu Phe Glu Val Lys Gly Glu Ala Tyr Arg Ala Phe Trp 85 90 95 AGC CAG AAT CGG GCG CGT AAC CAA CCC GAC GGT AAT TTG CAG GTG CCA 336 Ser Gin Asn Arg Ala Arg Asn Gin Pro Asp Gly Asn Leu Gin Val Pro 100 105 110 CGC GTA GAG CTG GCG CGC TGC GCC GAC GGC AAA ATT CTC GCC GAC AAA 384 Arg Val Glu Leu Ala Arg Cys Ala Asp Gly Lys He Leu Ala Asp Lys 115 120 125 GTG AAA GAT AAG CTG GAA CTG ACA GCG ACG TTA ACC GGG CTG GAT TAC 432 Val Lys Asp Lys Leu Glu Leu Thr Ala Thr Leu Thr Gly Leu Asp Tyr 130 135 140 GGG CGC TTC ACC CGT TCG ATG CTG CTT TCG CAG GGG CAA TTT GCT GCC 480 Gly Arg Phe Thr Arg Ser Met Leu Leu Ser Gin Gly Gin Phe Ala Ala 145 150 155 160 TTC CTG AAT GCC AAA CCC AAA GAA CGC GCG GAA TTG CTC GAG GAG TTA 528 Phe Leu Asn Ala Lys Pro Lys Glu Arg Ala Glu Leu Leu Glu Glu Leu 165 170 175 ACC GGC ACT GAA ATC TAC GGG CAA ATC TCG GCG ATG GTT TTT GAG CAG 576 Thr Gly Thr Glu He Tyr Gly Gin He Ser Ala Met Val Phe Glu Gin 180 185 190 CAC AAA TCG GCC CGC ACA GAG CTG GAG AAG CTG CAA GCG CAG GCC AGC 624 His Lys Ser Ala Arg Thr Glu Leu Glu Lys Leu Gin Ala Gin Ala Ser 195 200 205 GGC GTC ACG TTG CTC ACG CCG GAA CAA GTG CAA TCG CTG ACA GCG AGT 672 Gly Val Thr Leu Leu Thr Pro Glu Gin Val Gin Ser Leu Thr Ala Ser 210 215 220 TTG CAG GTA CTT ACT GAC GAA GAA AAA CAG TTA ATT ACC GCG CAG CAG 720 Leu Gin Val Leu Thr Asp Glu Glu Lys Gin Leu He Thr Ala Gin Gin 225 230 235 240 CAA GAA CAA CAA TCG CTA AAC TGG TTA ACG CGT CAG GAC GAA TTG CAG 768 Gin Glu Gin Gin Ser Leu Asn Trp Leu Thr Arg Gin Asp Glu Leu Gin 245 250 255 CAA GAA GCC AGC CGC CGT CAG CAG GCC TTG CAA CAG GCG TTA GCC GAA 816 Gin Glu Ala Ser Arg Arg Gin Gin Ala Leu Gin Gin Ala Leu Ala Glu 260 265 270 GAA GAA AAA GCG CAA CCT CAA CTG GCG GCG CTT AGT CTG GCA CAA CCG 864 Glu Glu Lys Ala Gin Pro Gin Leu Ala Ala Leu Ser Leu Ala Gin Pro 275 280 285 GCA CGA AAT CTT CGT CCA CAC TGG GAA CGC ATC GCA GAA CAC AGC GCG 912 Ala Arg Asn Leu Arg Pro His Trp Glu Arg He Ala Glu His Ser Ala 290 295 300 GCG CTG GCG CAT ATT CGC CAG CAG ATT GAA GAA GTA AAT ACT CGC TTA 960 Ala Leu Ala His He Arg Gin Gin He Glu Glu Val Asn Thr Arg Leu 305 310 315 320 CAG AGC ACA ATG GCG CTT CGC GCG AGC ATT CGC CAC CAC GCG GCG AAG 1008 Gin Ser Thr Met Ala Leu Arg Ala Ser He Arg His His Ala Ala Lys 325 330 335 CAG TCA GCA GAA TTA CAG CAG CAG CAA CAA AGC CTG AAT ACC TGG TTA 1056 Gin Ser Ala Glu Leu Gin Gin Gin Gin Gin Ser Leu Asn Thr Trp Leu 340 345 350 CAG GAA CAC GAC CGC TTC CGT CAG TGG AAC AAC GAA CCG GCG GGT TGG 1104 Gin Glu His Asp Arg Phe Arg Gin Trp Asn Asn Glu Pro Ala Gly Trp 355 360 365 CGT GCG CAG TTC TCC CAA CAA ACC AGC GAT CGC GAG CAT CTG CGG CAA 1152 Arg Ala Gin Phe Ser Gin Gin Thr Ser Asp Arg Glu His Leu Arg Gin 370 375 380 TGG CAG CAA CAG TTA ACC CAT GCT GAG CAA AAA CTT AAT GCG CTT GCG 1200 Trp Gin Gin Gin Leu Thr His Ala Glu Gin Lys Leu Asn Ala Leu Ala 385 390 395 400 GCG ATC ACG TTG ACG TTA ACC GCC GAT GAA GTT GCT ACC GCC CTG GCG 1248 Ala He Thr Leu Thr Leu Thr Ala Asp Glu Val Ala Thr Ala Leu Ala 405 410 415 CAA CAT GCT GAG CAA CGC CCA CTG CGT CAG CAC CTG GTC GCG CTG CAT 1296 Gin His Ala Glu Gin Arg Pro Leu Arg Gin His Leu Val Ala Leu His 420 425 430 GGA CAG ATT GTT CCC CAA CAA AAA CGT CTG GCG CAG TTA CAG GTC GCT 1344 Gly Gin He Val Pro Gin Gin Lys Arg Leu Ala Gin Leu Gin Val Ala 435 440 445 ATC CAG AAT GTC ACG CAA GAA CAG ACG CAA CGT AAC GCC GCA CTT AAC 1392 He Gin Asn Val Thr Gin Glu Gin Thr Gin Arg Asn Ala Ala Leu Asn 450 455 460 GAA ATG CGC CAG CGT TAT AAA GAA AAG ACG CAG CAA CTT GCC GAT GTG 1440 Glu Met Arg Gin Arg Tyr Lys Glu Lys Thr Gin Gin Leu Ala Asp Val 465 470 475 480 AAA ACC ATT TGC GAG CAG GAA GCG CGC ATC AAA ACG CTG GAA GCT CAA 1488 Lys Thr He Cys Glu Gin Glu Ala Arg He Lys Thr Leu Glu Ala Gin 485 490 495 CGT GCA CAG TTA CAG GCG GGT CAG CCT TGC CCA CTT TGT GGT TCC ACC 1536 Arg Ala Gin Leu Gin Ala Gly Gin Pro Cys Pro Leu Cys Gly Ser Thr 500 505 510 AGC CAC CCG GCG GTC GAG GCG TAT CAG GCG CTG GAG CCT GGC GTT AAT 1584 Ser His Pro Ala Val Glu Ala Tyr Gin Ala Leu Glu Pro Gly Val Asn 515 520 525 CAG TCT CGA TTA CTG GCG CTG GAA AAC GAA GTT AAA AAG CTC GGT GAA 1632 Gin Ser Arg Leu Leu Ala Leu Glu Asn Glu Val Lys Lys Leu Gly Glu 530 535 540 GAA GGT GCG ACG CTA CGT GGG CAA CTG GAC GCC ATA ACA AAG CAG CTT 1680 Glu Gly Ala Thr Leu Arg Gly Gin Leu Asp Ala He Thr Lys Gin Leu 545 550 555 560 CAG CGT GAT GAA AAC GAA GCG CAA AGC CTC CGA CAA GAT GAG CAA GCA 1728 Gin Arg Asp Glu Asn Glu Ala Gin Ser Leu Arg Gin Asp Glu Gin Ala 565 570 575 CTT ACT CAA CAA TGG CAA GCC GTC ACG GCC AGC CTC AAT ATC ACC TTG 1776 Leu Thr Gin Gin Trp Gin Ala Val Thr Ala Ser Leu Asn He Thr Leu 580 585 590 CAG CCA CTG GAC GAT ATT CAA CCG TGG CTG GAT GCA CAA GAT GAG CAC 1824 Gin Pro Leu Asp Asp He Gin Pro Trp Leu Asp Ala Gin Asp Glu His 595 600 605 GAA CGC CAG CTG CGG TTA CTC AGC CAA CGG CAT GAA TTA CAA GGG CAG 1872 Glu Arg Gin Leu Arg Leu Leu Ser Gin Arg His Glu Leu Gin Gly Gin 610 615 620 ATT GCC GCG CAT AAT CAG CAA ATT ATC CAG TAT CAA CAG CAA ATT GAA 1920 He Ala Ala His Asn Gin Gin He He Gin Tyr Gin Gin Gin He Glu 625 630 635 640 CAA CGC CAG CAA CTA CTT TTA ACG ACA TTG ACG GGT TAT GCA CTG ACA 1968 Gin Arg Gin Gin Leu Leu Leu Thr Thr Leu Thr Gly Tyr Ala Leu Thr 645 650 655 TTG CCA CAG GAA GAT GAA GAA GAG AGC TGG TTG GCG ACA CGT CAG CAA 2016 Leu Pro Gin Glu Asp Glu Glu Glu Ser Trp Leu Ala Thr Arg Gin Gin 660 665 670 GAA GCG CAG AGC TGG CAG CAA CGC CAG AAC GAA TTA ACC GCG CTG CAA 2064 Glu Ala Gin Ser Trp Gin Gin Arg Gin Asn Glu Leu Thr Ala Leu Gin 675 680 685 AAC CGT ATT CAG CAG CTG ACG CCG ATT CTG GAA ACG TTG CCG CAA AGT 2112 Asn Arg He Gin Gin Leu Thr Pro He Leu Glu Thr Leu Pro Gin Ser 690 695 700 GAT GAA CTC CCG CAC TGC GAA GAA ACT GTG GTA TTG GAA AAC TGG CGG 2160 Asp Glu Leu Pro His Cys Glu Glu Thr Val Val Leu Glu Asn Trp Arg 705 710 715 720 CAG GTA CAT GAA CAA TGT CTC GCA TTA CAC AGC CAG CAG CAG ACG TTA 2208 Gin Val His Glu Gin Cys Leu Ala Leu His Ser Gin Gin Gin Thr Leu 725 730 735 CAG CAA CAG GAT GTT CTG GCG GCG CAA AGT CTG CAA AAA GCC CAG GCG 2256 Gin Gin Gin Asp Val Leu Ala Ala Gin Ser Leu Gin Lys Ala Gin Ala 740 745 750 CAG TTT GAC ACC GCG CTA CAG GCC AGC GTC TTT GAC GAT CAG CAG GCG 2304 Gin Phe Asp Thr Ala Leu Gin Ala Ser Val Phe Asp Asp Gin Gin Ala 755 760 765 TTC CTT GCG GCG CTA ATG GAT GAA CAA ACA CTA ACG CAG CTG GAA CAG 2352 Phe Leu Ala Ala Leu Met Asp Glu Gin Thr Leu Thr Gin Leu Glu Gin 770 775 780 CTC AAG CAG AAT CTG GAA AAC CAG CGC CGT CAG GCG CAA ACT CTG GTC 2400 Leu Lys Gin Asn Leu Glu Asn Gin Arg Arg Gin Ala Gin Thr Leu Val 785 790 795 800 ACT CAG ACA GCA GAA ACG CTG GCA CAG CAT CAA CAA CAC CGA CCT GAC 2448 Thr Gin Thr Ala Glu Thr Leu Ala Gin His Gin Gin His Arg Pro Asp 805 810 815 GAC GGG TTG GCT CTC ACT GTG ACG GTG GAG CAG ATT CAG CAA GAG TTA 2496 Asp Gly Leu Ala Leu Thr Val Thr Val Glu Gin He Gin Gin Glu Leu 820 825 830 GCG CAA ACT CAC CAA AAG TTG CGT GAA AAC ACC ACG AGT CAA GGC GAG 2544 Ala Gin Thr His Gin Lys Leu Arg Glu Asn Thr Thr Ser Gin Gly Glu 835 840 845 ATT CGC CAG CAG CTG AAG CAG GAT GCA GAT AAC CGT CAG CAA CAA CAA 2592 He Arg Gin Gin Leu Lys Gin Asp Ala Asp Asn Arg Gin Gin Gin Gin 850 855 860 ACC TTA ATG CAG CAA ATT GCT CAA ATG ACG CAG CAG GTT GAG GAC TGG 2640 Thr Leu Met Gin Gin He Ala Gin Met Thr Gin Gin Val Glu Asp Trp 865 870 875 880 GGA TAT CTG AAT TCG CTA ATA GGT TCC AAA GAG GGC GAT AAA TTC CGC 2688 Gly Tyr Leu Asn Ser Leu He Gly Ser Lys Glu Gly Asp Lys Phe Arg 885 890 895 AAG TTT GCC CAG GGG CTG ACG CTG GAT AAT TTA GTC CAT CTC GCT AAT 2736 Lys Phe Ala Gin Gly Leu Thr Leu Asp Asn Leu Val His Leu Ala Asn 900 905 910 CAG CAA CTT ACC CGG CTG CAC GGG CGC TAT CTG TTA CAG CGC AAA GCC 2784 Gin Gin Leu Thr Arg Leu His Gly Arg Tyr Leu Leu Gin Arg Lys Ala 915 920 925 AGC GAG GCG CTG GAA GTC GAG GTT GTT GAT ACC TGG CAG GCA GAT GCG 2832 Ser Glu Ala Leu Glu Val Glu Val Val Asp Thr Trp Gin Ala Asp Ala 930 935 940 GTA CGC GAT ACC CGT ACC CTT TCC GGC GGC GAA AGT TTC CTC GTT AGT 2880 Val Arg Asp Thr Arg Thr Leu Ser Gly Gly Glu Ser Phe Leu Val Ser 945 950 955 960 CTG GCG CTG GCG CTG GCG CTT TCG GAT CTG GTC AGC CAT AAA ACA CGT 2928 Leu Ala Leu Ala Leu Ala Leu Ser Asp Leu Val Ser His Lys Thr Arg 965 970 975 ATT GAC TCG CTG TTC CTT GAT GAA GGT TTT GGC ACG CTG GAT AGC GAA 2976 He Asp Ser Leu Phe Leu Asp Glu Gly Phe Gly Thr Leu Asp Ser Glu 980 985 990 ACG CTG GAT ACC GCC CTT GAT GCG CTG GAT GCC CTG AAC GCC AGT GGC 3024 Thr Leu Asp Thr Ala Leu Asp Ala Leu Asp Ala Leu Asn Ala Ser Gly 995 1000 1005 AAA ACC ATC GGT GTG ATT AGC CAC GTA GAA GCG ATG AAA GAG CGT ATT 3072 Lys Thr He Gly Val He Ser His Val Glu Ala Met Lys Glu Arg He 1010 1015 1020 CCG GTG CAG ATC AAA GTG AAA AAG ATC AAC GGC CTG GGC TAC AGC AAA 3120 Pro Val Gin He Lys Val Lys Lys He Asn Gly Leu Gly Tyr Ser Lys 1025 1030 1035 1040 CTG GAA AGT ACG TTT GCA GTG AAA TAA 3147 Leu Glu Ser Thr Phe Ala Val Lys 1045 (2) INFORMATION FOR SEQ ID NO: 85: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1048 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 85: Met Lys He Leu Ser Leu Arg Leu Lys Asn Leu Asn Ser Leu Lys Gly 1 5 10 15 Glu Trp Lys He Asp Phe Thr Arg Glu Pro Phe Ala Ser Asn Gly Leu 20 25 30 Phe Ala He Thr Gly Pro Thr Gly Ala Gly Lys Thr Thr Leu Leu Asp 35 40 45 Ala He Cys Leu Ala Leu Tyr His Glu Thr Pro Arg Leu Ser Asn Val 50 55 60 Ser Gin Ser Gin Asn Asp Leu Met Thr Arg Asp Thr Ala Glu Cys Leu 65 70 75 80 Ala Glu Val Glu Phe Glu Val Lys Gly Glu Ala Tyr Arg Ala Phe Trp 85 90 95 Ser Gin Asn Arg Ala Arg Asn Gin Pro Asp Gly Asn Leu Gin Val Pro 100 105 110 Arg Val Glu Leu Ala Arg Cys Ala Asp Gly Lys He Leu Ala Asp Lys 115 120 125 Val Lys Asp Lys Leu Glu Leu Thr Ala Thr Leu Thr Gly Leu Asp Tyr 130 135 140 Gly Arg Phe Thr Arg Ser Met Leu Leu Ser Gin Gly Gin Phe Ala Ala 145 150 155 160 Phe Leu Asn Ala Lys Pro Lys Glu Arg Ala Glu Leu Leu Glu Glu Leu 165 170 175 Thr Gly Thr Glu He Tyr Gly Gin He Ser Ala Met Val Phe Glu Gin 180 185 190 His Lys Ser Ala Arg Thr Glu Leu Glu Lys Leu Gin Ala Gin Ala Ser 195 200 205 Gly Val Thr Leu Leu Thr Pro Glu Gin Val Gin Ser Leu Thr Ala Ser 210 215 220 Leu Gin Val Leu Thr Asp Glu Glu Lys Gin Leu He Thr Ala Gin Gin 225 230 235 240 Gin Glu Gin Gin Ser Leu Asn Trp Leu Thr Arg Gin Asp Glu Leu Gin 245 250 255 Gin Glu Ala Ser Arg Arg Gin Gin Ala Leu Gin Gin Ala Leu Ala Glu 260 265 270 Glu Glu Lys Ala Gin Pro Gin Leu Ala Ala Leu Ser Leu Ala Gin Pro 275 280 285 Ala Arg Asn Leu Arg Pro His Trp Glu Arg He Ala Glu His Ser Ala 290 295 300 Ala Leu Ala His He Arg Gin Gin He Glu Glu Val Asn Thr Arg Leu 305 310 315 320 Gin Ser Thr Met Ala Leu Arg Ala Ser He Arg His His Ala Ala Lys 325 330 335 Gin Ser Ala Glu Leu Gin Gin Gin Gin Gin Ser Leu Asn Thr Trp Leu 340 345 350 Gin Glu His Asp Arg Phe Arg Gin Trp Asn Asn Glu Pro Ala Gly Trp 355 360 365 Arg Ala Gin Phe Ser Gin Gin Thr Ser Asp Arg Glu His Leu Arg Gin 370 375 380 Trp Gin Gin Gin Leu Thr His Ala Glu Gin Lys Leu Asn Ala Leu Ala 385 390 395 400 Ala He Thr Leu Thr Leu Thr Ala Asp Glu Val Ala Thr Ala Leu Ala 405 410 415 Gin His Ala Glu Gin Arg Pro Leu Arg Gin His Leu Val Ala Leu His 420 425 430 Gly Gin He Val Pro Gin Gin Lys Arg Leu Ala Gin Leu Gin Val Ala 435 440 445 He Gin Asn Val Thr Gin Glu Gin Thr Gin Arg Asn Ala Ala Leu Asn 450 455 460 Glu Met Arg Gin Arg Tyr Lys Glu Lys Thr Gin Gin Leu Ala Asp Val 465 470 475 480 Lys Thr He Cys Glu Gin Glu Ala Arg He Lys Thr Leu Glu Ala Gin 485 490 495 Arg Ala Gin Leu Gin Ala Gly Gin Pro Cys Pro Leu Cys Gly Ser Thr 500 505 510 Ser His Pro Ala Val Glu Ala Tyr Gin Ala Leu Glu Pro Gly Val Asn 515 520 525 Gin Ser Arg Leu Leu Ala Leu Glu Asn Glu Val Lys Lys Leu Gly Glu 530 535 540 Glu Gly Ala Thr Leu Arg Gly Gin Leu Asp Ala He Thr Lys Gin Leu 545 550 555 560 Gin Arg Asp Glu Asn Glu Ala Gin Ser Leu Arg Gin Asp Glu Gin Ala 565 570 575 Leu Thr Gin Gin Trp Gin Ala Val Thr Ala Ser Leu Asn He Thr Leu 580 585 590 Gin Pro Leu Asp Asp He Gin Pro Trp Leu Asp Ala Gin Asp Glu His 595 600 605 Glu Arg Gin Leu Arg Leu Leu Ser Gin Arg His Glu Leu Gin Gly Gin 610 615 620 Ile Ala Ala His Asn Gin Gin He He Gin Tyr Gin Gin Gin He Glu 625 630 635 640 Gin Arg Gin Gin Leu Leu Leu Thr Thr Leu Thr Gly Tyr Ala Leu Thr 645 650 655 Leu Pro Gin Glu Asp Glu Glu Glu Ser Trp Leu Ala Thr Arg Gin Gin 660 665 670 Glu Ala Gin Ser Trp Gin Gin Arg Gin Asn Glu Leu Thr Ala Leu Gin 675 680 685 Asn Arg He Gin Gin Leu Thr Pro He Leu Glu Thr Leu Pro Gin Ser 690 695 700 Asp Glu Leu Pro His Cys Glu Glu Thr Val Val Leu Glu Asn Trp Arg 705 710 715 720 Gin Val His Glu Gin Cys Leu Ala Leu His Ser Gin Gin Gin Thr Leu 725 730 735 Gin Gin Gin Asp Val Leu Ala Ala Gin Ser Leu Gin Lys Ala Gin Ala 740 745 750 Gin Phe Asp Thr Ala Leu Gin Ala Ser Val Phe Asp Asp Gin Gin Ala 755 760 765 Phe Leu Ala Ala Leu Met Asp Glu Gin Thr Leu Thr Gin Leu Glu Gin 770 775 780 Leu Lys Gin Asn Leu Glu Asn Gin Arg Arg Gin Ala Gin Thr Leu Val 785 790 795 800 Thr Gin Thr Ala Glu Thr Leu Ala Gin His Gin Gin His Arg Pro Asp 805 810 815 Asp Gly Leu Ala Leu Thr Val Thr Val Glu Gin He Gin Gin Glu Leu 820 825 830 Ala Gin Thr His Gin Lys Leu Arg Glu Asn Thr Thr Ser Gin Gly Glu 835 840 845 He Arg Gin Gin Leu Lys Gin Asp Ala Asp Asn Arg Gin Gin Gin Gin 850 855 860 Thr Leu Met Gin Gin He Ala Gin Met Thr Gin Gin Val Glu Asp Trp 865 870 875 880 Gly Tyr Leu Asn Ser Leu He Gly Ser Lys Glu Gly Asp Lys Phe Arg 885 890 895 Lys Phe Ala Gin Gly Leu Thr Leu Asp Asn Leu Val His Leu Ala Asn 900 905 910 Gin Gin Leu Thr Arg Leu His Gly Arg Tyr Leu Leu Gin Arg Lys Ala 915 920 925 Ser Glu Ala Leu Glu Val Glu Val Val Asp Thr Trp Gin Ala Asp Ala 930 935 940 Val Arg Asp Thr Arg Thr Leu Ser Gly Gly Glu Ser Phe Leu Val Ser 945 950 955 960 Leu Ala Leu Ala Leu Ala Leu Ser Asp Leu Val Ser His Lys Thr Arg 965 970 975 Ile Asp Ser Leu Phe Leu Asp Glu Gly Phe Gly Thr Leu Asp Ser Glu 980 985 990 Thr Leu Asp Thr Ala Leu Asp Ala Leu Asp Ala Leu Asn Ala Ser Gly 995 1000 1005 Lys Thr He Gly Val He Ser His Val Glu Ala Met Lys Glu Arg He 1010 1015 1020 Pro Val Gin He Lys Val Lys Lys He Asn Gly Leu Gly Tyr Ser Lys 1025 1030 1035 1040 Leu Glu Ser Thr Phe Ala Val Lys 1045 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1239 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl4b74)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1236 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: ATG ATG AAA GAA AAA GTG ATT TTT CTC GTT GAC ATG CAA TCG TTT TAT 48 Met Met Lys Glu Lys Val He Phe Leu Val Asp Met Gin Ser Phe Tyr 1 5 10 15 GCA TCT GTA GAG AAA GCG GAA AAT CCA CAT TTG AAA AAT AGG CCC GTC 96 Ala Ser Val Glu Lys Ala Glu Asn Pro His Leu Lys Asn Arg Pro Val 20 25 30 ATT GTT TCG GGT GAC CCT GAA AAA AGG GGC GGA GTC GTA TTG GCT GCC 144 He Val Ser Gly Asp Pro Glu Lys Arg Gly Gly Val Val Leu Ala Ala 35 40 45 TGC CCG CTG GCG AAA CAA AAG GGT GTG GTG AAT GCT TCA CGG CTG TGG 192 Cys Pro Leu Ala Lys Gin Lys Gly Val Val Asn Ala Ser Arg Leu Trp 50 55 60 GAG GCG CAG GAA AAG TGT CCT GAG GCT GTT GTG CTC CGG CCG CGT ATG 240 Glu Ala Gin Glu Lys Cys Pro Glu Ala Val Val Leu Arg Pro Arg Met 65 70 75 80 CAG CGG TAT ATT GAT GTA TCA CTG CAA ATT ACG GCC ATT CTC GAG GAG 288 Gin Arg Tyr He Asp Val Ser Leu Gin He Thr Ala He Leu Glu Glu 85 90 95 TAT ACA GAC CTT GTG GAG CCG TAT TCC ATC GAT GAA CAG TTC ATG GAC 336 Tyr Thr Asp Leu Val Glu Pro Tyr Ser He Asp Glu Gin Phe Met Asp 100 105 110 ATT ACA GGC AGC CAG AAG CTG TTT GGG ACG CCG ATG GAG ATC GCG AAA 384 He Thr Gly Ser Gin Lys Leu Phe Gly Thr Pro Met Glu He Ala Lys 115 120 125 AGC ATT CAG GGC AGA ATC ATG CGG GAG ATC GGC GTT TAT GCA CGG GTC 432 Ser He Gin Gly Arg He Met Arg Glu He Gly Val Tyr Ala Arg Val 130 135 140 GGA ATC GGC CCT AAC AAA GCG CTG GCC AAA ATT GCG TGT GAC AAT TTT 480 Gly He Gly Pro Asn Lys Ala Leu Ala Lys He Ala Cys Asp Asn Phe 145 150 155 160 GCC AAA AAG AAT AAG AAC GGT ATT TTT ACC TTA ACG AAA GAA AAT ATG 528 Ala Lys Lys Asn Lys Asn Gly He Phe Thr Leu Thr Lys Glu Asn Met 165 170 175 AAA ACC GAA ATG TGG CCG CTC CCG GTG GGC AGC ATG TTT GGC GTC GGG 576 Lys Thr Glu Met Trp Pro Leu Pro Val Gly Ser Met Phe Gly Val Gly 180 185 190 AGC CGC ATG AAG CAT CAT TTA AAT CGA ATG GGC ATC AGC ACG ATC GGC 624 Ser Arg Met Lys His His Leu Asn Arg Met Gly He Ser Thr He Gly 195 200 205 GGG CTC GCG GCT TTT CCG CTC GAT CTT TTA AAA AAG AAA TGG GGC ATT 672 Gly Leu Ala Ala Phe Pro Leu Asp Leu Leu Lys Lys Lys Trp Gly He 210 215 220 AAC GGC CAC GTG CTG TGG ATG ACG GCA AAC GGA ATC GAC TAT TCC CCT 720 Asn Gly His Val Leu Trp Met Thr Ala Asn Gly He Asp Tyr Ser Pro 225 230 235 240 GTG TCA ACT TCG TCT CTG GAC GGG CAA AAG GCG ATA GGT CAT GGA ATG 768 Val Ser Thr Ser Ser Leu Asp Gly Gin Lys Ala He Gly His Gly Met 245 250 255 ACT CTC CCG AGA GAC TAC GAA CAC TTT GAC AAA GAA ATC AAG GTC GTA 816 Thr Leu Pro Arg Asp Tyr Glu His Phe Asp Lys Glu He Lys Val Val 260 265 270 TTG CTT GAG CTG AGT GAA GAG GTG TGC AGG CGA AGC CGA AAC GCC GGG 864 Leu Leu Glu Leu Ser Glu Glu Val Cys Arg Arg Ser Arg Asn Ala Gly 275 280 285 GTC ATG GGG CAG ACA GTG TCA GTG AGC TGC CGG GGT GCT GAT TTT GAT 912 Val Met Gly Gin Thr Val Ser Val Ser Cys Arg Gly Ala Asp Phe Asp 290 295 300 TGG CCG ACG GGC TTC AAC CGG CAA GTG AAG CTG GCA GAG CCG ACT AAT 960 Trp Pro Thr Gly Phe Asn Arg Gin Val Lys Leu Ala Glu Pro Thr Asn 305 310 315 320 TCT ACG CAG GAT GTA TAT GAG GCT GTA CGA CGG CTG TTT CTT ACA TTT 1008 Ser Thr Gin Asp Val Tyr Glu Ala Val Arg Arg Leu Phe Leu Thr Phe 325 330 335 TGG GAC GGG AAA CCC GTC CGC CGC CTC GGT GTC AAT CTG TCT CAG CTC 1056 Trp Asp Gly Lys Pro Val Arg Arg Leu Gly Val Asn Leu Ser Gin Leu 340 345 350 TCA TCT GAT GAC ATA TGG CAG CTC AAT TTA TTT CAG GAT TAT GCA AAG 1104 Ser Ser Asp Asp He Trp Gin Leu Asn Leu Phe Gin Asp Tyr Ala Lys 355 360 365 AAA ATG AGC CTA GGC TAT GTG ATG GAT GGC ATT AAA AAT CGA TTC GGC 1152 Lys Met Ser Leu Gly Tyr Val Met Asp Gly He Lys Asn Arg Phe Gly 370 375 380 GAT ACA GCA ATC ATC AGG GCG GCG TCA CTG ACA GCG GCA GGC CAG GCA 1200 Asp Thr Ala He He Arg Ala Ala Ser Leu Thr Ala Ala Gly Gin Ala 385 390 395 400 TTT GAA CGT GCG GCT AAA ATA GGG GGG CAT TAT AAA TGA 1239 Phe Glu Arg Ala Ala Lys He Gly Gly His Tyr Lys 405 410 (2) INFORMATION FOR SEQ ID NO: 87: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 412 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:87: Met Met Lys Glu Lys Val He Phe Leu Val Asp Met Gin Ser Phe Tyr 1 5 10 15 Ala Ser Val Glu Lys Ala Glu Asn Pro His Leu Lys Asn Arg Pro Val 20 25 30 He Val Ser Gly Asp Pro Glu Lys Arg Gly Gly Val Val Leu Ala Ala 35 40 45 Cys Pro Leu Ala Lys Gin Lys Gly Val Val Asn Ala Ser Arg Leu Trp 50 55 60 Glu Ala Gin Glu Lys Cys Pro Glu Ala Val Val Leu Arg Pro Arg Met 65 70 75 80 Gin Arg Tyr He Asp Val Ser Leu Gin He Thr Ala He Leu Glu Glu 85 90 95 Tyr Thr Asp Leu Val Glu Pro Tyr Ser He Asp Glu Gin Phe Met Asp 100 105 110 He Thr Gly Ser Gin Lys Leu Phe Gly Thr Pro Met Glu He Ala Lys 115 120 125 Ser He Gin Gly Arg He Met Arg Glu He Gly Val Tyr Ala Arg Val 130 135 140 Gly He Gly Pro Asn Lys Ala Leu Ala Lys He Ala Cys Asp Asn Phe 145 150 155 160 Ala Lys Lys Asn Lys Asn Gly He Phe Thr Leu Thr Lys Glu Asn Met 165 170 175 Lys Thr Glu Met Trp Pro Leu Pro Val Gly Ser Met Phe Gly Val Gly 180 185 190 Ser Arg Met Lys His His Leu Asn Arg Met Gly He Ser Thr He Gly 195 200 205 Gly Leu Ala Ala Phe Pro Leu Asp Leu Leu Lys Lys Lys Trp Gly He 210 215 220 Asn Gly His Val Leu Trp Met Thr Ala Asn Gly He Asp Tyr Ser Pro 225 230 235 240 Val Ser Thr Ser Ser Leu Asp Gly Gin Lys Ala He Gly His Gly Met 245 250 255 Th Leu Pro Arg Asp Tyr Glu His Phe Asp Lys Glu He Lys Val Val 260 265 270 Leu Leu Glu Leu Ser Glu Glu Val Cys Arg Arg Ser Arg Asn Ala Gly 275 280 285 Val Met Gly Gin Thr Val Ser Val Ser Cys Arg Gly Ala Asp Phe Asp 290 295 300 Trp Pro Thr Gly Phe Asn Arg Gin Val Lys Leu Ala Glu Pro Thr Asn 305 310 315 320 Ser Thr Gin Asp Val Tyr Glu Ala Val Arg Arg Leu Phe Leu Thr Phe 325 330 335 Trp Asp Gly Lys Pro Val Arg Arg Leu Gly Val Asn Leu Ser Gin Leu 340 345 350 Ser Ser Asp Asp He Trp Gin Leu Asn Leu Phe Gin Asp Tyr Ala Lys 355 360 365 Lys Met Ser Leu Gly Tyr Val Met Asp Gly He Lys Asn Arg Phe Gly 370 375 380 Asp Thr Ala He He Arg Ala Ala Ser Leu Thr Ala Ala Gly Gin Ala 385 390 395 400 Phe Glu Arg Ala Ala Lys He Gly Gly His Tyr Lys 405 410 INFORMATION FOR SEQ ID NO: 88: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 441 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl4cl3)" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: TAAGGGGACT TATATAACTG TATGTTTGTG TAGTGTTTAT GTCAGTAAGC TAAATTTACA 60 TTCATGTTAT GTYTCATTAA ACCAATTACT CACGTTTTGG TGCATATTAA ATCTTTTATA 120 TCGATCATAC ATCTATCATC ATTTTTATTT CTAAAATACA AACTGAATAC TTTGCTAGAA 180 TTTGTTACAG CAATCATTGC TCATGCATTT TATAAATTAC AATTAGACAA ATATGACATT 240 TGATATCACA CACTTCAAAC ACACACATAT ATAATCAGAC ATAAATTGTT ATGCTAAGGG 300 TTTATTCACC AAAAATATAA TACATATGGG CTTGTTTTGA GTCCATATTG AATGAATTAA 360 AAAGTATACT CCACTCAATC ATTTACAAAT AGGTGGTGCC ACTCCNAATT TATTTTATGG 4 20 CCAACCCCAA ATATGAGAAC A 441 (2) INFORMATION FOR SEQ ID NO: 89: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 909 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl5b9) " (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..906 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 89: ATG AAC CAA AAA GGC AGA GGG CTT GAG ATC CTC ATC AAT GAA AAA CAG 48 Met Asn Gin Lys Gly Arg Gly Leu Glu He Leu He Asn Glu Lys Gin 1 5 10 15 GAC GGC CAA TGG CTG TTT TCC GTA CTC AAA ACA GCG CTC AAA GCT TCT 96 Asp Gly Gin Trp Leu Phe Ser Val Leu Lys Thr Ala Leu Lys Ala Ser 20 25 30 AAA CCA GTG ATA CAA GAC TGG ATG TCC CAT CAA CAG ATA AAG GTC AAT 144 Lys Pro Val He Gin Asp Trp Met Ser His Gin Gin He Lys Val Asn 35 40 45 CAC GAA TCC GTC TTA AAC AAT ATG ATT GTA AAA AAG GGA GAC CGC GTG 192 His Glu Ser Val Leu Asn Asn Met He Val Lys Lys Gly Asp Arg Val 50 55 60 TTC ATT GAT CTT CAG GAA AGT GAA GCA TCT TCG GTC ATT CCG GAG TAT 240 Phe He Asp Leu Gin Glu Ser Glu Ala Ser Ser Val He Pro Glu Tyr 65 70 75 80 GGC GAG CTT GAT ATT TTA TTT GAG GAC AAT CAT ATG CTC ATC ATC AAT 288 Gly Glu Leu Asp He Leu Phe Glu Asp Asn His Met Leu He He Asn 85 90 95 AAA CCC GCT GGC ATC GCG ACG CAT CCG AAT GAG GAT GGG CAA ACC GGC 336 Lys Pro Ala Gly He Ala Thr His Pro Asn Glu Asp Gly Gin Thr Gly 100 105 110 ACA CTG GCT AAT TTG ATC GCG TAT CAT TAT CAG ATA AAT GGC GAA ACA 384 Thr Leu Ala Asn Leu He Ala Tyr His Tyr Gin He Asn Gly Glu Thr 115 120 125 TGT AAG GTG CGC CAC GTC CAT CGT CTT GAT CAG GAT ACA TCT GGC GCT 432 Cys Lys Val Arg His Val His Arg Leu Asp Gin Asp Thr Ser Gly Ala 130 135 140 ATC GTT TTT GCC AAG CAT CGT TTG GCA CAC GCC ATC TTA GAC CAG CAG 480 He Val Phe Ala Lys His Arg Leu Ala His Ala He Leu Asp Gin Gin 145 150 155 160 TTA GAG AAA AAG ACG CTG AAG CGT ACG TAT ACC GCT ATC GCT GAA GGT 528 Leu Glu Lys Lys Thr Leu Lys Arg Thr Tyr Thr Ala He Ala Glu Gly 165 170 175 AAG CTA CGG ACG AAA AAA GGG ACA ATT AAT CCA CCG ATC GGC AGA GAC 576 Lys Leu Arg Thr Lys Lys Gly Thr He Asn Pro Pro He Gly Arg Asp 180 185 190 CGC TCA CAC CCG ACA AGA CGC CGG GTT TCA CCA GGC GGG CAA ACA GCC 624 Arg Ser His Pro Thr Arg Arg Arg Val Ser Pro Gly Gly Gin Thr Ala 195 200 205 GTC ACT CAT TTC AAG GTA ATG GCC AGC AAT GCG AAA GAA CGG CTG TCG 672 Val Thr His Phe Lys Val Met Ala Ser Asn Ala Lys Glu Arg Leu Ser 210 215 220 CTC GTT GAA TTA GAG CTG GAA ACA GGC AGA ACA CAC CAA ATC CGT GTT 720 Leu Val Glu Leu Glu Leu Glu Thr Gly Arg Thr His Gin He Arg Val 225 230 235 240 CAT CTG GCG AGC CTC GGC CAT CCG TTG ACA GGA GAC TCG CTT TAC GGA 768 His Leu Ala Ser Leu Gly His Pro Leu Thr Gly Asp Ser Leu Tyr Gly 245 250 255 GGC GGG AGC AAG CTG CTA AAC AGG CAG GCA CTG CAC GCC AAT AAA GTA 816 Gly Gly Ser Lys Leu Leu Asn Arg Gin Ala Leu His Ala Asn Lys Val 260 265 270 CAA GCG GTT CAC CCG ATA ACA GAC GAG CTC ATA GTT GCT GAA GCC CCT 864 Gin Ala Val His Pro He Thr Asp Glu Leu He Val Ala Glu Ala Pro 275 280 285 TTC CCT GCT GAT ATG AAA AAC CTT TGC CGC ACA TAT TTT TCA 906 Phe Pro Ala Asp Met Lys Asn Leu Cys Arg Thr Tyr Phe Ser 290 295 300 TGA 909 (2) INFORMATION FOR SEQ ID NO: 90: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 302 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 90: Met Asn Gin Lys Gly Arg Gly Leu Glu He Leu He Asn Glu Lys Gin 1 5 10 15 Asp Gly Gin Trp Leu Phe Ser Val Leu Lys Thr Ala Leu Lys Ala Ser 20 25 30 Lys Pro Val He Gin Asp Trp Met Ser His Gin Gin He Lys Val Asn 35 40 45 His Glu Ser Val Leu Asn Asn Met He Val Lys Lys Gly Asp Arg Val 50 55 60 Phe He Asp Leu Gin Glu Ser Glu Ala Ser Ser Val He Pro Glu Tyr 65 70 75 80 Gly Glu Leu Asp He Leu Phe Glu Asp Asn His Met Leu He He Asn 85 90 95 Lys Pro Ala Gly He Ala Thr His Pro Asn Glu Asp Gly Gin Thr Gly 100 105 110 Thr Leu Ala Asn Leu He Ala Tyr His Tyr Gin He Asn Gly Glu Thr 115 120 125 Cys Lys Val Arg His Val His Arg Leu Asp Gin Asp Thr Ser Gly Ala 130 135 140 He Val Phe Ala Lys His Arg Leu Ala His Ala He Leu Asp Gin Gin 145 150 155 160 Leu Glu Lys Lys Thr Leu Lys Arg Thr Tyr Thr Ala He Ala Glu Gly 165 170 175 Lys Leu Arg Thr Lys Lys Gly Thr He Asn Pro Pro He Gly Arg Asp 180 185 190 Arg Ser His Pro Thr Arg Arg Arg Val Ser Pro Gly Gly Gin Thr Ala 195 200 205 Val Thr His Phe Lys Val Met Ala Ser Asn Ala Lys Glu Arg Leu Ser 210 215 220 Leu Val Glu Leu Glu Leu Glu Thr Gly Arg Thr His Gin He Arg Val 225 230 235 240 His Leu Ala Ser Leu Gly His Pro Leu Thr Gly Asp Ser Leu Tyr Gly 245 250 255 Gly Gly Ser Lys Leu Leu Asn Arg Gin Ala Leu His Ala Asn Lys Val 260 265 270 Gin Ala Val His Pro He Thr Asp Glu Leu He Val Ala Glu Ala Pro 275 280 285 Phe Pro Ala Asp Met Lys Asn Leu Cys Arg Thr Tyr Phe Ser 290 295 300 (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl5b32)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..468 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: ATG GAT GAG TTG CAG CAG GTC TCC GAT GGC TGG CTT GCG CAC CAC AAT 48 Met Asp Glu Leu Gin Gin Val Ser Asp Gly Trp Leu Ala His His Asn 1 5 10 15 ACG CGG GAA AAG CGC TTC TCG CTT GGC GCT TTC GAA CCG GAC TAT ATT 96 Thr Arg Glu Lys Arg Phe Ser Leu Gly Ala Phe Glu Pro Asp Tyr He 20 25 30 CTG TCG CAA CCC GTC GCC GTG CTG CGC AAG GAT GGA AAA ATC ACC GCC 144 Leu Ser Gin Pro Val Ala Val Leu Arg Lys Asp Gly Lys He Thr Ala 35 40 45 TTC GCC AAT CTG ATG GTG ACG GAG ACG AAA AAG GAA GCC ACC ATC GAC 192 Phe Ala Asn Leu Met Val Thr Glu Thr Lys Lys Glu Ala Thr He Asp 50 55 60 CTC ATG CGC TTT TCG GCG GAT GCG CGC GCG GCT CGA TGG ATT TCC TCT 240 Leu Met Arg Phe Ser Ala Asp Ala Arg Ala Ala Arg Trp He Ser Ser 65 70 75 80 TCG TCA GCA TCA TGC AGC ATC TGC GCG AGG CGG GAT ATG AAA GCT TCA 288 Ser Ser Ala Ser Cys Ser He Cys Ala Arg Arg Asp Met Lys Ala Ser 85 90 95 ATC TCG GCA TGG CGC CCA TGT CCG GCA TGT CGA AGC GCG ATG CCG CGC 336 He Ser Ala Trp Arg Pro Cys Pro Ala Cys Arg Ser Ala Met Pro Arg 100 105 110 CGG TCT GGG ACC GTA TCG GCA GCA CGC TGT TCG AGC ACG GCG AAC GTT 384 Arg Ser Gly Thr Val Ser Ala Ala Arg Cys Ser Ser Thr Ala Asn Val 115 120 125 TCT ACA ACT TCA AGG GAC TTC GCG CCT TCA AGG CAA AGT TCC ACC CGA 432 Ser Thr Thr Ser Arg Asp Phe Ala Pro Ser Arg Gin Ser Ser Thr Arg 130 135 140 AAT GGG AAC CCC GTT ACC TTG CTG TGC AGA ACG GCG TGA 471 Asn Gly Asn Pro Val Thr Leu Leu Cys Arg Thr Ala 145 150 155 (2) INFORMATION FOR SEQ ID NO : 92 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 156 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: Met Asp Glu Leu Gin Gin Val Ser Asp Gly Trp Leu Ala His His Asn 1 5 10 15 Thr Arg Glu Lys Arg Phe Ser Leu Gly Ala Phe Glu Pro Asp Tyr He 20 25 30 Leu Ser Gin Pro Val Ala Val Leu Arg Lys Asp Gly Lys He Thr Ala 35 40 45 Phe Ala Asn Leu Met Val Thr Glu Thr Lys Lys Glu Ala Thr He Asp 50 55 60 Leu Met Arg Phe Ser Ala Asp Ala Arg Ala Ala Arg Trp He Ser Ser 65 70 75 80 Ser Ser Ala Ser Cys Ser He Cys Ala Arg Arg Asp Met Lys Ala Ser 85 90 95 He Ser Ala Trp Arg Pro Cys Pro Ala Cys Arg Ser Ala Met Pro Arg 100 105 110 Arg Ser Gly Thr Val Ser Ala Ala Arg Cys Ser Ser Thr Ala Asn Val 115 120 125 Ser Thr Thr Ser Arg Asp Phe Ala Pro Ser Arg Gin Ser Ser Thr Arg 130 135 140 Asn Gly Asn Pro Val Thr Leu Leu Cys Arg Thr Ala 145 150 155 (2) INFORMATION FOR SEQ ID NO: 93: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 192 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "DNA (genomic) (pl5c4)" (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..189 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:93: ATG CCT ATT GCC CAG ATC CAC ATC CTT GAA GGC CGC AGC GAC GAG CAG 48 Met Pro He Ala Gin He His He Leu Glu Gly Arg Ser Asp Glu Gin 1 5 10 15 AAG GAA ACC CTG ATT CGG GAA GTC AGT GAG GCC ATC TCG CGC TCC CTG 96 Lys Glu Thr Leu He Arg Glu Val Ser Glu Ala He Ser Arg Ser Leu 20 25 30 GAT GCG CCG CTG ACC AGC GTG CGA GTG ATT ATC ACG GAG ATG GCC AAG 144 Asp Ala Pro Leu Thr Ser Val Arg Val He He Thr Glu Met Ala Lys 35 40 45 GGC CAC TTC GGC ATC GGC GGC GAA CTG GCC AGC AAG GTC AGA CGC 189 Gly His Phe Gly He Gly Gly Glu Leu Ala Ser Lys Val Arg Arg 50 55 60 TGA 192 (2) INFORMATION FOR SEQ ID NO : 94 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 94: Met Pro He Ala Gin He His He Leu Glu Gly Arg Ser Asp Glu Gin 1 5 10 15 Lys Glu Thr Leu He Arg Glu Val Ser Glu Ala He Ser Arg Ser Leu 20 25 30 Asp Ala Pro Leu Thr Ser Val Arg Val He He Thr Glu Met Ala Lys 35 40 45 Gly His Phe Gly He Gly Gly Glu Leu Ala Ser Lys Val Arg Arg 50 55 60 (2) INFORMATION FOR SEQ ID NO : 95 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: GGAGCTCACT AGTCGGAGGC ATCAGTGACC 30 (2) INFORMATION FOR SEQ ID NO: 96: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: GGGATCCCAT GAGAATTCTT GAAGACG 27 (2) INFORMATION FOR SEQ ID NO : 97 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 89 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "oligonucleotide" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: CTAGGTACCT ACAACCTCAA GCTTNKNKNK NKNKNKNKNK NKNKNKNKNK NKNKNKNKNK 60 NKNKAAGCTT GGTTAGAATG GGTACCATG 89 (2) INFORMATION FOR SEQ ID NO: 98: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 98: CTAGAATTCT ACAACCTCAA GCTT 24 (2) INFORMATION FOR SEQ ID NO: 99: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: AAGCTTGGTT AGAATGGAAT TCATG 25 (2) INFORMATION FOR SEQ ID NO: 100: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 100: GAATTCCATT CTAAC 15 (2) INFORMATION FOR SEQ ID NO: 101: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: ATTCCATTCT AACCAAGC (2) INFORMATION FOR SEQ ID NO: 102: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO.102 TGAACTGCCA CTGTAGAGAG A 21 (2) INFORMATION FOR SEQ ID NO: 103: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 40 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear In) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103 GGCCATCGAT AATGAAATTA ATTAACGAGA GACAAATAGG 40 (2) INFORMATION FOR SEQ ID NO: 104: (l) SEQUENCE CHARACTERISTICS- (A) LENGTH: 55 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xι) SEQUENCE DESCRIPTION: SEQ ID NO: 104 GGCCGGATCC CTAGTGATGG TGATGGTGAT GAAAAATTCT GTCTTTAACT TTTTT 55 (2) INFORMATION FOR SEQ ID NO: 105: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: Single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 105- GGCCGGTACC AAATTAATTA ACGAGAGACA AATAGG 36 (2) INFORMATION FOR SEQ ID NO : 106- (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 55 base pairs (B) TYPE, nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY, linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO.106 GGCCGGATCC CTAGTGATGG TGATGGTGAT GAAAAATTCT GTCTTTAACT TTTTT 55 (2) INFORMATION FOR SEQ ID NO: 107: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 33 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 107 TGGAGATCTA AGCTTTGCAT AACTTTCTCG TCC 33 (2) INFORMATION FOR SEQ ID NO: 108: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE- nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc - "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 108: TCCTGGCGAT TCTGAGAC 18 (2) INFORMATION FOR SEQ ID NO: 109: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 109: TGGGGATCCG AT AGTGTGA CTGGTAG 27 (2) INFORMATION FOR SEQ ID NO:110: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 110: TGGAAGCTTA CATTACTTCA AATAAATTA 29 (2) INFORMATION FOR SEQ ID NO: 111: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 31 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xι) SEQUENCE DESCRIPTION: SEQ ID NO: 111: TGGGGATCCT GCATATCAAA ATGTTTATGG C 31 (2) INFORMATION FOR SEQ ID NO: 112: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 112: TGGAAGCTTA CACATATGCC AATCTCAC 28 (2) INFORMATION FOR SEQ ID NO: 113: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO.113. GTTGGATCCG CTGTTGTTAC TTTGATGC 28 (2) INFORMATION FOR SEQ ID NO: 114: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 114: TGGAAGCTTA CATTACTTCA AATAAATTA 29 12 ) INFORMATTON FOR SEQ ID NO: 115: (ι) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 115: GTTGGATCCG CTGTTGTTAC TTTGATGC 28 (2) INFORMATION FOR SEQ ID NO: 116: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 116: TGGAAGCTTA CACATATGCC AATCTCAC 28 (2) INFORMATION FOR SEQ ID NO: 117: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 117: ATTTGATATG TCTCAACTGC 20 (2) INFORMATION FOR SEQ ID NO: 118: (ι) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 118: GCTCTAATTT TTAAGTGAGG 20 (2) INFORMATION FOR SEQ ID NO: 119: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 119: TATCTGGTGG CGTAACACCT G 21 (2) INFORMATION FOR SEQ ID NO: 120: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer' (xi) SEQUENCE DESCRIPTION: SEQ ID NO.120: GATGAAGCCG TTACGTTGTT C 21 (2) INFORMATION FOR SEQ ID NO: 121: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic ac-d (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 121: GCCATAAGGA TGTGAATGTA TG 22 (2) INFORMATION FOR SEQ ID NO: 122: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 122: GCATTTGCTA GTTATCTTG 19 (2) INFORMATION FOR SEQ ID NO: 123: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 123. AGATCTATCA AGGATGTGAT GGTT 24 (2) INFORMATION FOR SEQ ID NO: 124: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "primer" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 124: GTCATTATAC GATTTAGTAC AATC 2Δ (2) INFORMATION FOR SEQ ID NO : 125: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 124 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 125: Met Lys Asp Glu Gin Leu Tyr Tyr Phe Glu Lys Ser Pro Val Phe Lys 1 5 10 15 Ala Met Met His Phe Ser Leu Pro Met Met He Gly Thr Leu Leu Ser 20 25 30 Val He Tyr Gly He Leu Asn Tyr He Phe He Gly Phe Ser Glu Glu 35 40 45 Ser His Met He Ser Ala He Ser Leu Thr Leu Pro Val Phe Ala He 50 55 60 Leu Met Gly Leu Gly Asn Leu Phe Gly Val Gly Ala Gly Thr Tyr He 65 70 75 80 Ser Arg Leu Leu Gly Ala Lys Asp Tyr Ser Lys Ser Lys Phe Val Ser 85 90 95 Ser Phe Ser He Tyr Gly Gly He Ala Leu Gly Leu He Val He Leu 100 105 110 Val Thr Leu Pro Phe Ser Asp Gin Ser Gin Gin Phe 115 120 (2) INFORMATION FOR SEQ ID NO : 126: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1500 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI -SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 126: GTGTGACTGG TAGAAATCAG TCACTTTGTC TTTAATATTA TAGTTAGATA TCTAATTGTT 60 AGTAAGCTAA TTATTGGAAA AGACAAGGAG TATTGAACAA TGAAAGACGA ACAATTATAT 120 TATTTTGAGA AATCGCCAGT ATTTAAAGCG ATGATGCATT TCTCATTGCC AATGATGATA 180 GGGACTTTAT TAAGCGTTAT TTATGGCATA TTAAATATTT ACTTTATAGG ATTTTTAGAA 240 GATAGCCACA TGATTTCTGC TATCTCTCTA ACACTGCCAG TATTTGCTAT CTTAATGGGG 300 TTAGGTAATT TATTTGGCGT TGGTGCAGGA ACTTATATTT CACGTTTATT AGGTGCGAAA 360 GACTATAGTA AGAGTAAATT TGTAAGTAGT TTCTCTATTT ATGGTGGTAT TGCACTAGGA 420 CTTATCGTGA TTTTAGTTAC TTTACCATTC AGTGATCAAA TCGCAGCAAT TTTAGGGGCG 480 AGAGGTGAAA CGTTAGCTTT AACAAGTAAT TATTTGAAAG TAATGTTTTT AAGTGCACCT 540 TTTGTAATTT TGTTCTTCAT ATTAGAACAA TTTGCACGTG CAATTGGGGC ACCAATGGTT 600 TCTATGATTG GTATGTTAGC TAGTGTAGGC TTAAATATTA TTTTAGATCC AATTTTAATT 660 TTTGGTTTTG ATTTAAACGT TGTTGGTGCA GCTTTGGGTA CTGCAATCAG TAATGTTGCT 720 GCTGCTCTGT TCTTTATCAT TTATTTTATG AAAAATAGTG ACGTTGTGTC AGTTAATATT 780 AAACTTGCGA AACCTAATAA AGAAATGCTT TCTGAAATCT TTAAAATCGG TATTCCTGCA 840 TTTTTAATGA GTATCTTAAT GGGATTCACA GGATTAGTTT TAAATTTATT TTTAGCACAT 900 TATGGAAACT TCGCGATTGC AAGTTATGGT ATCTCATTTA GACTTGTGCA ATTTCCAGAA 960 CTTATTATCA TGGGATTATG TGAAGGTGTT GTACCACTAA TTGCATATAA CTTTATGGCA 1020 AATAAAGGCC GTATGAAAGA CGTTATCAAA GCAGTTATCA TGTCTATCGG CGTTATCTTT 1080 GTTGTATGTA TGAGTGCTGT ATTTACAATT GGACATCATA TGGTCGGACT ATTTACTACT 1140 GATCAAGCCA TTGTTGAGAT GGCGACATTT ATTTTGAAAG TAACAATGGC ATCATTATTA 1200 TTAAATGGTA TAGGTTTCTT GTTTACTGGT ATGCTTCAAG CGACTGGGCA AGGTCGTGGT 1260 GCTACAATTA TGGCCATTTT ACAAGGTGCA ATTATCATTC CAGTATTATT TATTATGAAT 1320 GCTTTGTTTG GACTAACAGG TGTCATTTGG TCATTATTAA TTGCTGAGTC ACTTTGTGCT 1380 TTAGCAGCAA TGTTAATCGT CTATTTATTA CGTGATCGTT TGACAGTTGA TACATCTGAA 1440 TTAATAGAAG GTTAAATATT TCGTCCACTT CTGGCTGAGT ATATTTCGGT CGGAAGTGTA 1500 (2) INFORMATION FOR SEQ ID NO: 127: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 451 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI -SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 127: Met Lys Asp Glu Gin Leu Tyr Tyr Phe Glu Lys Ser Pro Val Phe Lys 1 5 10 15 Ala Met Met His Phe Ser Leu Pro Met Met He Gly Thr Leu Leu Ser 20 25 30 Val He Tyr Gly He Leu Asn He Tyr Phe He Gly Phe Leu Glu Asp 35 40 45 Ser His Met He Ser Ala He Ser Leu Thr Leu Pro Val Phe Ala He 50 55 60 Leu Met Gly Leu Gly Asn Leu Phe Gly Val Gly Ala Gly Thr Tyr He 65 70 75 80 Ser Arg Leu Leu Gly Ala Lys Asp Tyr Ser Lys Ser Lys Phe Val Ser 85 90 95 Ser Phe Ser He Tyr Gly Gly He Ala Leu Gly Leu He Val He Leu 100 105 110 Val Thr Leu Pro Phe Ser Asp Gin He Ala Ala He Leu Gly Ala Arg 115 120 125 Gly Glu Thr Leu Ala Leu Thr Ser Asn Tyr Leu Lys Val Met Phe Leu 130 135 140 Ser Ala Pro Phe Val He Leu Phe Phe He Leu Glu Gin Phe Ala Arg 145 150 155 160 Ala He Gly Ala Pro Met Val Ser Met He Gly Met Leu Ala Ser Val 165 170 175 Gly Leu Asn He He Leu Asp Pro He Leu He Phe Gly Phe Asp Leu 180 185 190 Asn Val Val Gly Ala Ala Leu Gly Thr Ala He Ser Asn Val Ala Ala 195 200 205 Ala Leu Phe Phe He He Tyr Phe Met Lys Asn Ser Asp Val Val Ser 210 215 220 Val Asn He Lys Leu Ala Lys Pro Asn Lys Glu Met Leu Ser Glu He 225 230 235 240 Phe Lys He Gly He Pro Ala Phe Leu Met Ser He Leu Met Gly Phe 245 250 255 Thr Gly Leu Val Leu Asn Leu Phe Leu Ala His Tyr Gly Asn Phe Ala 260 265 270 He Ala Ser Tyr Gly He Ser Phe Arg Leu Val Gin Phe Pro Glu Leu 275 280 285 He He Met Gly Leu Cys Glu Gly Val Val Pro Leu He Ala Tyr Asn 290 295 300 Phe Met Ala Asn Lys Gly Arg Met Lys Asp Val He Lys Ala Val He 305 310 315 320 Met Ser He Gly Val He Phe Val Val Cys Met Ser Ala Val Phe Thr 325 330 335 He Gly His His Met Val Gly Leu Phe Thr Thr Asp Gin Ala He Val 340 345 350 Glu Met Ala Thr Phe He Leu Lys Val Thr Met Ala Ser Leu Leu Leu 355 360 365 Asn Gly He Gly Phe Leu Phe Thr Gly Met Leu Gin Ala Thr Gly Gin 370 375 380 Gly Arg Gly Ala Thr He Met Ala He Leu Gin Gly Ala He He He 385 390 395 400 Pro Val Leu Phe He Met Asn Ala Leu Phe Gly Leu Thr Gly Val He 405 410 415 Trp Ser Leu Leu He Ala Glu Ser Leu Cys Ala Leu Ala Ala Met Leu 420 425 430 He Val Tyr Leu Leu Arg Asp Arg Leu Thr Val Asp Thr Ser Glu Leu 435 440 445 He Glu Gly 450

Claims: WHAT IS CLAIMED IS: 1. A method of identifying an anti-bacterial agent comprising the steps of assaying potential agents for the ability to interfere with expression of virulence gene products represented by the DNA sequences set forth in any one of SEQ ID NOS: 1 through 94, and identifying an agent that interferes with expression of said virulence gene products. 2. A method of identifying an anti-bacterial agent comprising the steps of assaying potential agents for the ability to interfere with the function of a bacterial protein encoded in whole or in part by a DNA sequence set forth in any one of SEQ ID NOS: 1 through 94 or the complementary strand thereof, and identifying an agent that interferes with the function of said bacterial protein. 3. The method of claim 2 wherein the protein is involved in cell surface metabolism and is encoded by the DNA sequence of any one of SEQ ID NOS: 1, 6, 60 and 65 (corresponding to signature tag identification numbers P2C73, P11C29, P13C83, P9B65 and P10B89). 4. The method of claim 2 wherein the protein is an enzyme involved in a cellular biosynthetic pathway and is encoded by the DNA sequence of any one of SEQ ID NOS: 4, 11 , 13, 22, 25, 27, 29, 31 , 33, 35 and 82 (corresponding to signature tag identification numbers P9B74, P5C4, P9B66, P14C15, P13B26, P7C18, P15C31, P10B18, P6B18, P10B66, P10C34 and P12C3). 5. The method of claim 2 wherein the protein is a component of the TCA cycle and is encoded by the DNA sequence of any one of SEQ ID NOS: 37, 39, 41, 43 and 44 (corresponding to signature tag identification numbers P4C27, P4C52, P10B2, P10C20 and P12C32). 6. The method of claim 2 wherein the protein is an oligopeptide transport proteins and is encoded by the DNA sequence of any one of SEQ ID NOS: 15, 17, 19, 54, 75, 77 and 79 (corresponding to signature tag identification numbers P7C26, P10C15, P5C3, P11C66 and P5C34). 7. The method of claim 2 wherein the protein is involved in cellular regulatory and repair processes and is encoded by the DNA sequence of any one of SEQ ID NOS: 8, 21, 46 and 84 (corresponding to signature tag identification numbers P4C15, P6C63, P13B74, P13C72, P10B30 and P14B25). 8. The method of any one of claims 1 through 7 wherein the assay used is an enzyme assay. 9. The method of any one of claims 1 through 7 wherein the assay used is a binding assay. 10. The method of any one of claims 1 through 7 wherein the assay used is a two-hybrid screening assay. 11. The method of any one of claims 1 through 7 wherein the assay is being used to screen for a ligand by binding to target protein. 12. The method of any one of claims 1 through 7 wherein the assay used is an affinity ultrafiltration assay. 13. A Staphylococcus aureus organism containing a functional mutation in a gene represented by any one of SEQ ID NOS: 1 through 94, said functional mutation resulting in a reduction in virulence of the organism. 14. A vaccine composition comprising the S. aureus organism of claim 13.

Inventors: HOLDEN DAVID WILLIAM, HOLDEN, DAVID, WILLIAM
Applicants: HOLDEN DAVID WILLIAM, IMP COLLEGE INNOVATIONS LTD, HOLDEN, DAVID, WILLIAM, IMPERIAL COLLEGE INNOVATIONS LIMITED
Application year: 1998
Main classification: C07K14
IPC codes: A61K39, A61P31, C07K14, C12N1, C12N15, C12Q1, C12R1, G01N33, G01N37